[
  {
    "ApplicationNo": 71,
    "EUNumber": "EU/1/95/001",
    "EUNoShort": 1,
    "BrandName": "GONAL-f",
    "MAH": "Merck Europe B.V.",
    "ActiveSubstance": "Follitropin alfa",
    "DecisionDate": "10/20/1995",
    "DecisionYear": "1995",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 107,
    "ClockStopElapsed": 30,
    "TotalTimeElapsed": 137
  },
  {
    "ApplicationNo": 73,
    "EUNumber": "EU/1/95/002",
    "EUNoShort": 2,
    "BrandName": "Taxotere",
    "MAH": "Sanofi Mature IP",
    "ActiveSubstance": "Docetaxel",
    "DecisionDate": "11/27/1995",
    "DecisionYear": "1995",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 100,
    "ClockStopElapsed": 93,
    "TotalTimeElapsed": 193
  },
  {
    "ApplicationNo": 81,
    "EUNumber": "EU/1/95/003",
    "EUNoShort": 3,
    "BrandName": "Betaferon",
    "MAH": "Bayer AG",
    "ActiveSubstance": "Interferon beta-1b",
    "DecisionDate": "11/30/1995",
    "DecisionYear": "1995",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 138,
    "ClockStopElapsed": 55,
    "TotalTimeElapsed": 193
  },
  {
    "ApplicationNo": 91,
    "EUNumber": "EU/1/96/004",
    "EUNoShort": 4,
    "BrandName": "Fareston",
    "MAH": "Orion Corporation",
    "ActiveSubstance": "Toremifene",
    "DecisionDate": "02/14/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L02",
    "ATCCodeL1": "L",
    "ATCNameL2": "Endocrine therapy",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 240,
    "ClockStopElapsed": 50,
    "TotalTimeElapsed": 290
  },
  {
    "ApplicationNo": 82,
    "EUNumber": "EU/1/96/005",
    "EUNoShort": 5,
    "BrandName": "CellCept",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "Mycophenolate mofetil",
    "DecisionDate": "02/14/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 243,
    "ClockStopElapsed": 47,
    "TotalTimeElapsed": 290
  },
  {
    "ApplicationNo": 74,
    "EUNumber": "EU/1/96/006",
    "EUNoShort": 6,
    "BrandName": "NovoSeven",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "Eptacog alfa (activated)",
    "DecisionDate": "02/23/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 80,
    "TotalTimeElapsed": 290
  },
  {
    "ApplicationNo": 88,
    "EUNumber": "EU/1/96/007",
    "EUNoShort": 7,
    "BrandName": "Humalog",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "Insulin lispro",
    "DecisionDate": "04/30/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 245,
    "ClockStopElapsed": 81,
    "TotalTimeElapsed": 326
  },
  {
    "ApplicationNo": 86,
    "EUNumber": "EU/1/96/008",
    "EUNoShort": 8,
    "BrandName": "Puregon",
    "MAH": "N.V. Organon",
    "ActiveSubstance": "follitropin beta",
    "DecisionDate": "05/03/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 151,
    "TotalTimeElapsed": 354
  },
  {
    "ApplicationNo": 110,
    "EUNumber": "EU/1/96/009",
    "EUNoShort": 9,
    "BrandName": "Zerit",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "Stavudine",
    "DecisionDate": "05/08/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Luxembourg",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 150
  },
  {
    "ApplicationNo": 109,
    "EUNumber": "EU/1/96/010",
    "EUNoShort": 10,
    "BrandName": "Rilutek",
    "MAH": "Sanofi Mature IP",
    "ActiveSubstance": "Riluzole",
    "DecisionDate": "06/10/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 161,
    "ClockStopElapsed": 41,
    "TotalTimeElapsed": 202
  },
  {
    "ApplicationNo": 89,
    "EUNumber": "EU/1/96/011",
    "EUNoShort": 11,
    "BrandName": "Caelyx pegylated liposomal",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "Doxorubicin hydrochloride",
    "DecisionDate": "06/21/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 4.8a(3)",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 222,
    "ClockStopElapsed": 150,
    "TotalTimeElapsed": 372
  },
  {
    "ApplicationNo": 101,
    "EUNumber": "EU/1/96/012",
    "EUNoShort": 12,
    "BrandName": "Bondronat",
    "MAH": "Atnahs Pharma Netherlands B.V.",
    "ActiveSubstance": "Ibandronic acid",
    "DecisionDate": "06/25/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 52,
    "TotalTimeElapsed": 255
  },
  {
    "ApplicationNo": 103,
    "EUNumber": "EU/1/96/013",
    "EUNoShort": 13,
    "BrandName": "Destara",
    "MAH": "Roche Registration Limited",
    "ActiveSubstance": "Ibandronic acid",
    "DecisionDate": "06/25/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 52,
    "TotalTimeElapsed": 255
  },
  {
    "ApplicationNo": 93,
    "EUNumber": "EU/1/96/014",
    "EUNoShort": 14,
    "BrandName": "Tritanrix HepB",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "DTPW-Hepatitis B",
    "DecisionDate": "07/19/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 240,
    "TotalTimeElapsed": 420
  },
  {
    "ApplicationNo": 107,
    "EUNumber": "EU/1/96/015",
    "EUNoShort": 15,
    "BrandName": "Epivir",
    "MAH": "ViiV Healthcare B.V.",
    "ActiveSubstance": "Lamivudine",
    "DecisionDate": "08/08/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 105,
    "TotalTimeElapsed": 255
  },
  {
    "ApplicationNo": 127,
    "EUNumber": "EU/1/96/016",
    "EUNoShort": 16,
    "BrandName": "Norvir",
    "MAH": "AbbVie Deutschland GmbH & Co. KG",
    "ActiveSubstance": "Ritonavir",
    "DecisionDate": "08/26/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Luxembourg",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 69,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 69
  },
  {
    "ApplicationNo": 106,
    "EUNumber": "EU/1/96/017",
    "EUNoShort": 17,
    "BrandName": "Ecokinase",
    "MAH": "Galenus Mannheim GmbH",
    "ActiveSubstance": "Reteplase",
    "DecisionDate": "08/29/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "Germany",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 83,
    "TotalTimeElapsed": 287
  },
  {
    "ApplicationNo": 105,
    "EUNumber": "EU/1/96/018",
    "EUNoShort": 18,
    "BrandName": "Rapilysin",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "Reteplase",
    "DecisionDate": "08/29/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "Germany",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 83,
    "TotalTimeElapsed": 287
  },
  {
    "ApplicationNo": 68,
    "EUNumber": "EU/1/96/019",
    "EUNoShort": 19,
    "BrandName": "Tecnemab-K-1",
    "MAH": "Sorin Radiofarmaci S.r.l.",
    "ActiveSubstance": "Anti-melanoma Mab fragments",
    "DecisionDate": "09/05/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "unknown",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 187,
    "ClockStopElapsed": 320,
    "TotalTimeElapsed": 507
  },
  {
    "ApplicationNo": 112,
    "EUNumber": "EU/1/96/020",
    "EUNoShort": 20,
    "BrandName": "Twinrix Adult",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Hepatitis A and hepatitis B vaccine",
    "DecisionDate": "09/20/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 197,
    "ClockStopElapsed": 83,
    "TotalTimeElapsed": 280
  },
  {
    "ApplicationNo": 115,
    "EUNumber": "EU/1/96/022",
    "EUNoShort": 22,
    "BrandName": "Zyprexa",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "Olanzapine",
    "DecisionDate": "09/27/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "Finland",
    "CoRapporteur": "France",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 198,
    "ClockStopElapsed": 56,
    "TotalTimeElapsed": 254
  },
  {
    "ApplicationNo": 41,
    "EUNumber": "EU/1/96/023",
    "EUNoShort": 23,
    "BrandName": "CEA-Scan",
    "MAH": "Immunomedics GmbH",
    "ActiveSubstance": "Arcitumomab",
    "DecisionDate": "10/04/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "unknown",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 110,
    "ClockStopElapsed": 386,
    "TotalTimeElapsed": 496
  },
  {
    "ApplicationNo": 65,
    "EUNumber": "EU/1/96/025",
    "EUNoShort": 25,
    "BrandName": "Indimacis 125",
    "MAH": "CIS bio international",
    "ActiveSubstance": "Igovomab",
    "DecisionDate": "10/04/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "unknown",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 154,
    "ClockStopElapsed": 363,
    "TotalTimeElapsed": 517
  },
  {
    "ApplicationNo": 128,
    "EUNumber": "EU/1/96/024",
    "EUNoShort": 24,
    "BrandName": "Crixivan",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "Indinavir",
    "DecisionDate": "10/04/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 85,
    "ClockStopElapsed": 12,
    "TotalTimeElapsed": 97
  },
  {
    "ApplicationNo": 113,
    "EUNumber": "EU/1/96/026",
    "EUNoShort": 26,
    "BrandName": "Invirase",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "Saquinavir",
    "DecisionDate": "10/04/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "Austria",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 80,
    "TotalTimeElapsed": 260
  },
  {
    "ApplicationNo": 114,
    "EUNumber": "EU/1/96/021",
    "EUNoShort": 21,
    "BrandName": "Olansek",
    "MAH": "Eli Lilly UK Ltd",
    "ActiveSubstance": "Olanzapine",
    "DecisionDate": "10/07/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "Finland",
    "CoRapporteur": "France",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 198,
    "ClockStopElapsed": 56,
    "TotalTimeElapsed": 254
  },
  {
    "ApplicationNo": 123,
    "EUNumber": "EU/1/96/027",
    "EUNoShort": 27,
    "BrandName": "Hycamtin",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Topotecan hydrochloride",
    "DecisionDate": "11/12/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 154,
    "ClockStopElapsed": 28,
    "TotalTimeElapsed": 182
  },
  {
    "ApplicationNo": 124,
    "EUNumber": "EU/1/96/028",
    "EUNoShort": 28,
    "BrandName": "Evotopin",
    "MAH": "SmithKline Beecham plc",
    "ActiveSubstance": "Topotecan hydrochloride",
    "DecisionDate": "12/09/1996",
    "DecisionYear": "1996",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 154,
    "ClockStopElapsed": 28,
    "TotalTimeElapsed": 182
  },
  {
    "ApplicationNo": 129,
    "EUNumber": "EU/1/97/029",
    "EUNoShort": 29,
    "BrandName": "Twinrix Paediatric",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Hepatitis A and Hepatitis B vaccine",
    "DecisionDate": "02/10/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 132,
    "ClockStopElapsed": 35,
    "TotalTimeElapsed": 167
  },
  {
    "ApplicationNo": 111,
    "EUNumber": "EU/1/97/032",
    "EUNoShort": 32,
    "BrandName": "LeukoScan",
    "MAH": "Immunomedics GmbH",
    "ActiveSubstance": "Sulesomab",
    "DecisionDate": "02/14/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 183,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 201,
    "EUNumber": "EU/1/97/030",
    "EUNoShort": 30,
    "BrandName": "Insuman",
    "MAH": "Sanofi-Aventis Deutschland GmbH",
    "ActiveSubstance": "human insulin",
    "DecisionDate": "02/21/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 158,
    "ClockStopElapsed": 182,
    "TotalTimeElapsed": 340
  },
  {
    "ApplicationNo": 122,
    "EUNumber": "EU/1/97/035",
    "EUNoShort": 35,
    "BrandName": "Refludan",
    "MAH": "Celgene Europe Limited",
    "ActiveSubstance": "Lepirudin",
    "DecisionDate": "03/13/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 112,
    "TotalTimeElapsed": 312
  },
  {
    "ApplicationNo": 102,
    "EUNumber": "EU/1/97/033",
    "EUNoShort": 33,
    "BrandName": "Avonex",
    "MAH": "Biogen Netherlands B.V.",
    "ActiveSubstance": "Interferon Beta - 1a",
    "DecisionDate": "03/13/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Spain",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 216,
    "ClockStopElapsed": 307,
    "TotalTimeElapsed": 523
  },
  {
    "ApplicationNo": 120,
    "EUNumber": "EU/1/97/034",
    "EUNoShort": 34,
    "BrandName": "Vitrasert implant",
    "MAH": "Dr Gerhard Mann Chem.-pharm. Fabrik GmbH",
    "ActiveSubstance": "ganciclovir",
    "DecisionDate": "03/18/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 183,
    "ClockStopElapsed": 119,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 121,
    "EUNumber": "EU/1/97/037",
    "EUNoShort": 37,
    "BrandName": "Vistide",
    "MAH": "Gilead Sciences International Limited",
    "ActiveSubstance": "Cidofovir",
    "DecisionDate": "04/23/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Portugal",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 112,
    "TotalTimeElapsed": 321
  },
  {
    "ApplicationNo": 143,
    "EUNumber": "EU/1/97/038",
    "EUNoShort": 38,
    "BrandName": "Liprolog",
    "MAH": "Eli Lilly UK Ltd",
    "ActiveSubstance": "Insulin lispro",
    "DecisionDate": "05/07/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 48,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 48
  },
  {
    "ApplicationNo": 137,
    "EUNumber": "EU/1/97/040",
    "EUNoShort": 40,
    "BrandName": "Teslascan",
    "MAH": "GE Healthcare AS",
    "ActiveSubstance": "Mangafodipir",
    "DecisionDate": "05/22/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "V08",
    "ATCCodeL1": "V",
    "ATCNameL2": "Contrast media",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 171,
    "ClockStopElapsed": 27,
    "TotalTimeElapsed": 198
  },
  {
    "ApplicationNo": 138,
    "EUNumber": "EU/1/97/036",
    "EUNoShort": 36,
    "BrandName": "Humalog-Humaject",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "Insulin lispro",
    "DecisionDate": "06/16/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 0,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 0
  },
  {
    "ApplicationNo": 153,
    "EUNumber": "EU/1/97/042",
    "EUNoShort": 42,
    "BrandName": "Humalog-Pen",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "Insulin lispro",
    "DecisionDate": "06/16/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 0,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 0
  },
  {
    "ApplicationNo": 125,
    "EUNumber": "EU/1/97/039",
    "EUNoShort": 39,
    "BrandName": "Cystagon",
    "MAH": "Recordati Rare Diseases",
    "ActiveSubstance": "Mercaptamine bitartrate",
    "DecisionDate": "06/23/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Spain",
    "CoRapporteur": "France",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 176,
    "ClockStopElapsed": 181,
    "TotalTimeElapsed": 357
  },
  {
    "ApplicationNo": 77,
    "EUNumber": "EU/1/97/041",
    "EUNoShort": 41,
    "BrandName": "Orlaam",
    "MAH": "Sipaco Internacional Lda",
    "ActiveSubstance": "Levacetylmethadol",
    "DecisionDate": "07/01/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Belgium",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 487,
    "TotalTimeElapsed": 688
  },
  {
    "ApplicationNo": 104,
    "EUNumber": "EU/1/97/043",
    "EUNoShort": 43,
    "BrandName": "Revasc",
    "MAH": "Canyon Pharmaceuticals Ltd",
    "ActiveSubstance": "Desirudin",
    "DecisionDate": "07/09/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Ireland",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 181,
    "ClockStopElapsed": 398,
    "TotalTimeElapsed": 579
  },
  {
    "ApplicationNo": 116,
    "EUNumber": "EU/1/97/031",
    "EUNoShort": 31,
    "BrandName": "NeoRecormon",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "Epoetin beta",
    "DecisionDate": "07/16/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Germany",
    "CoRapporteur": "France",
    "ATCCodeL2": "B03",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antianemic preparations",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 140,
    "TotalTimeElapsed": 349
  },
  {
    "ApplicationNo": 126,
    "EUNumber": "EU/1/97/048",
    "EUNoShort": 48,
    "BrandName": "Infanrix HepB",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Diphteria, tetanus, acellular pertussis and hepatitis B",
    "DecisionDate": "07/30/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 199,
    "ClockStopElapsed": 217,
    "TotalTimeElapsed": 416
  },
  {
    "ApplicationNo": 140,
    "EUNumber": "EU/1/97/045",
    "EUNoShort": 45,
    "BrandName": "Helicobacter Test INFAI",
    "MAH": "INFAI GmbH",
    "ActiveSubstance": "¬π¬≥C - urea",
    "DecisionDate": "08/14/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Austria",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "V04",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 162,
    "ClockStopElapsed": 28,
    "TotalTimeElapsed": 190
  },
  {
    "ApplicationNo": 132,
    "EUNumber": "EU/1/97/044",
    "EUNoShort": 44,
    "BrandName": "Tasmar",
    "MAH": "Meda AB",
    "ActiveSubstance": "Tolcapone",
    "DecisionDate": "08/27/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 170,
    "ClockStopElapsed": 90,
    "TotalTimeElapsed": 260
  },
  {
    "ApplicationNo": 141,
    "EUNumber": "EU/1/97/046",
    "EUNoShort": 46,
    "BrandName": "Aprovel",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "Irbesartan",
    "DecisionDate": "08/27/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Spain",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 163,
    "ClockStopElapsed": 27,
    "TotalTimeElapsed": 190
  },
  {
    "ApplicationNo": 142,
    "EUNumber": "EU/1/97/049",
    "EUNoShort": 49,
    "BrandName": "Karvea",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "Irbesartan",
    "DecisionDate": "08/27/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Spain",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 163,
    "ClockStopElapsed": 27,
    "TotalTimeElapsed": 190
  },
  {
    "ApplicationNo": 139,
    "EUNumber": "EU/1/97/047",
    "EUNoShort": 47,
    "BrandName": "BeneFIX",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "Nonacog alfa",
    "DecisionDate": "08/27/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Germany",
    "CoRapporteur": "France",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 162,
    "ClockStopElapsed": 55,
    "TotalTimeElapsed": 217
  },
  {
    "ApplicationNo": 133,
    "EUNumber": "EU/1/97/050",
    "EUNoShort": 50,
    "BrandName": "Sifrol",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "pramipexole",
    "DecisionDate": "10/14/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 349
  },
  {
    "ApplicationNo": 135,
    "EUNumber": "EU/1/97/052",
    "EUNoShort": 52,
    "BrandName": "Daquiran",
    "MAH": "Dr Karl Thomae GmbH",
    "ActiveSubstance": "pramipexole",
    "DecisionDate": "10/27/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 349
  },
  {
    "ApplicationNo": 157,
    "EUNumber": "EU/1/97/053",
    "EUNoShort": 53,
    "BrandName": "Cerezyme",
    "MAH": "Genzyme Europe B.V.",
    "ActiveSubstance": "imiglucerase",
    "DecisionDate": "11/17/1997",
    "DecisionYear": "1997",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 175,
    "ClockStopElapsed": 30,
    "TotalTimeElapsed": 205
  },
  {
    "ApplicationNo": 164,
    "EUNumber": "EU/1/97/054",
    "EUNoShort": 54,
    "BrandName": "Viracept",
    "MAH": "Roche Registration Limited",
    "ActiveSubstance": "Nelfinavir",
    "DecisionDate": "01/22/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 214
  },
  {
    "ApplicationNo": 156,
    "EUNumber": "EU/1/97/056",
    "EUNoShort": 56,
    "BrandName": "Primavax",
    "MAH": "Aventis Pasteur MSD",
    "ActiveSubstance": "diphteria, tetanus and hepatitis B (recombinant) vaccine, adsorbed",
    "DecisionDate": "02/05/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Italy",
    "CoRapporteur": "France",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 68,
    "TotalTimeElapsed": 269
  },
  {
    "ApplicationNo": 150,
    "EUNumber": "EU/1/97/057",
    "EUNoShort": 57,
    "BrandName": "Quadramet",
    "MAH": "CIS bio international",
    "ActiveSubstance": "Samarium [153 Sm] lexidronam pentasodium",
    "DecisionDate": "02/05/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "V10",
    "ATCCodeL1": "V",
    "ATCNameL2": "Therapeutic radiopharmaceuticals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 198,
    "ClockStopElapsed": 95,
    "TotalTimeElapsed": 293
  },
  {
    "ApplicationNo": 183,
    "EUNumber": "EU/1/97/055",
    "EUNoShort": 55,
    "BrandName": "Viramune",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "nevirapine",
    "DecisionDate": "02/05/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 125,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 125
  },
  {
    "ApplicationNo": 134,
    "EUNumber": "EU/1/97/051",
    "EUNoShort": 51,
    "BrandName": "Mirapexin",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "pramipexole",
    "DecisionDate": "02/23/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 349
  },
  {
    "ApplicationNo": 190,
    "EUNumber": "EU/1/98/058",
    "EUNoShort": 58,
    "BrandName": "Combivir",
    "MAH": "ViiV Healthcare BV",
    "ActiveSubstance": "lamivudine / zidovudine",
    "DecisionDate": "03/18/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 119,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 119
  },
  {
    "ApplicationNo": 136,
    "EUNumber": "EU/1/98/063",
    "EUNoShort": 63,
    "BrandName": "Rebif",
    "MAH": "Merck Europe B.V.",
    "ActiveSubstance": "Interferon beta-1a",
    "DecisionDate": "05/04/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Greece",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 181,
    "ClockStopElapsed": 285,
    "TotalTimeElapsed": 466
  },
  {
    "ApplicationNo": 151,
    "EUNumber": "EU/1/98/064",
    "EUNoShort": 64,
    "BrandName": "Pylobactell",
    "MAH": "Torbet Laboratories Ireland Limited",
    "ActiveSubstance": "¬π¬≥C-urea",
    "DecisionDate": "05/07/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "V04",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 163,
    "ClockStopElapsed": 158,
    "TotalTimeElapsed": 321
  },
  {
    "ApplicationNo": 169,
    "EUNumber": "EU/1/98/066",
    "EUNoShort": 66,
    "BrandName": "Exelon",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Rivastigmine",
    "DecisionDate": "05/12/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 186,
    "ClockStopElapsed": 97,
    "TotalTimeElapsed": 283
  },
  {
    "ApplicationNo": 166,
    "EUNumber": "EU/1/98/065",
    "EUNoShort": 65,
    "BrandName": "Optison",
    "MAH": "GE Healthcare AS",
    "ActiveSubstance": "Perflutren",
    "DecisionDate": "05/18/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "V08",
    "ATCCodeL1": "V",
    "ATCNameL2": "Contrast media",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 192,
    "ClockStopElapsed": 122,
    "TotalTimeElapsed": 314
  },
  {
    "ApplicationNo": 165,
    "EUNumber": "EU/1/98/067",
    "EUNoShort": 67,
    "BrandName": "Mabthera",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "Rituximab",
    "DecisionDate": "06/02/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 179,
    "ClockStopElapsed": 132,
    "TotalTimeElapsed": 311
  },
  {
    "ApplicationNo": 182,
    "EUNumber": "EU/1/98/068",
    "EUNoShort": 68,
    "BrandName": "Pylori-Chek",
    "MAH": "Alimentarics B.V.",
    "ActiveSubstance": "¬π¬≥C-urea",
    "DecisionDate": "06/15/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "V04",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 194,
    "ClockStopElapsed": 56,
    "TotalTimeElapsed": 250
  },
  {
    "ApplicationNo": 160,
    "EUNumber": "EU/1/98/059",
    "EUNoShort": 59,
    "BrandName": "Trovan",
    "MAH": "Pfizer Limited",
    "ActiveSubstance": "trovafloxacin",
    "DecisionDate": "07/03/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "France",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 242
  },
  {
    "ApplicationNo": 161,
    "EUNumber": "EU/1/98/060",
    "EUNoShort": 60,
    "BrandName": "Trovan IV",
    "MAH": "Pfizer Limited",
    "ActiveSubstance": "alatrofloxacin",
    "DecisionDate": "07/03/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "France",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 242
  },
  {
    "ApplicationNo": 159,
    "EUNumber": "EU/1/98/062",
    "EUNoShort": 62,
    "BrandName": "Turvel IV",
    "MAH": "Roerig Farmaceutici Italiana S.p.A.",
    "ActiveSubstance": "alatrofloxacin",
    "DecisionDate": "07/03/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "France",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 242
  },
  {
    "ApplicationNo": 158,
    "EUNumber": "EU/1/98/061",
    "EUNoShort": 61,
    "BrandName": "Turvel",
    "MAH": "Roerig Farmaceutici Italiana S.p.A.",
    "ActiveSubstance": "trovafloxacin",
    "DecisionDate": "07/08/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "France",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 242
  },
  {
    "ApplicationNo": 174,
    "EUNumber": "EU/1/98/069",
    "EUNoShort": 69,
    "BrandName": "Plavix",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "07/15/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 112,
    "TotalTimeElapsed": 312
  },
  {
    "ApplicationNo": 175,
    "EUNumber": "EU/1/98/070",
    "EUNoShort": 70,
    "BrandName": "Iscover",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "07/15/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 112,
    "TotalTimeElapsed": 312
  },
  {
    "ApplicationNo": 149,
    "EUNumber": "EU/1/98/072",
    "EUNoShort": 72,
    "BrandName": "EchoGen",
    "MAH": "Sonus Pharmaceuticals Ltd",
    "ActiveSubstance": "Dodecafluoropentane",
    "DecisionDate": "07/17/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "V08",
    "ATCCodeL1": "V",
    "ATCNameL2": "Contrast media",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 176,
    "ClockStopElapsed": 270,
    "TotalTimeElapsed": 446
  },
  {
    "ApplicationNo": 154,
    "EUNumber": "EU/1/98/071",
    "EUNoShort": 71,
    "BrandName": "Xenical",
    "MAH": "CHEPLAPHARM Arzneimittel GmbH",
    "ActiveSubstance": "Orlistat",
    "DecisionDate": "07/29/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "Greece",
    "ATCCodeL2": "A08",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antiobesity preparations, excluding diet products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 183,
    "ClockStopElapsed": 255,
    "TotalTimeElapsed": 438
  },
  {
    "ApplicationNo": 184,
    "EUNumber": "EU/1/98/073",
    "EUNoShort": 73,
    "BrandName": "Evista",
    "MAH": "SUBSTIPHARM",
    "ActiveSubstance": "Raloxifene hydrochloride",
    "DecisionDate": "08/05/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Finland",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 188,
    "ClockStopElapsed": 84,
    "TotalTimeElapsed": 272
  },
  {
    "ApplicationNo": 185,
    "EUNumber": "EU/1/98/074",
    "EUNoShort": 74,
    "BrandName": "Optruma",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "Raloxifene hydrochloride",
    "DecisionDate": "08/05/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Finland",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 188,
    "ClockStopElapsed": 84,
    "TotalTimeElapsed": 272
  },
  {
    "ApplicationNo": 187,
    "EUNumber": "EU/1/98/076",
    "EUNoShort": 76,
    "BrandName": "NovoNorm",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "Repaglinide",
    "DecisionDate": "08/17/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Luxembourg",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 199,
    "ClockStopElapsed": 97,
    "TotalTimeElapsed": 296
  },
  {
    "ApplicationNo": 178,
    "EUNumber": "EU/1/98/075",
    "EUNoShort": 75,
    "BrandName": "Fortovase",
    "MAH": "Roche Registration Limited",
    "ActiveSubstance": "Saquinavir",
    "DecisionDate": "08/20/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Austria",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 97,
    "TotalTimeElapsed": 306
  },
  {
    "ApplicationNo": 202,
    "EUNumber": "EU/1/98/077",
    "EUNoShort": 77,
    "BrandName": "Viagra",
    "MAH": "Upjohn EESV",
    "ActiveSubstance": "sildenafil",
    "DecisionDate": "09/14/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 188,
    "ClockStopElapsed": 28,
    "TotalTimeElapsed": 216
  },
  {
    "ApplicationNo": 204,
    "EUNumber": "EU/1/98/078",
    "EUNoShort": 78,
    "BrandName": "Patrex",
    "MAH": "Pfizer Limited",
    "ActiveSubstance": "sildenafil",
    "DecisionDate": "09/15/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 188,
    "ClockStopElapsed": 28,
    "TotalTimeElapsed": 216
  },
  {
    "ApplicationNo": 170,
    "EUNumber": "EU/1/98/082",
    "EUNoShort": 82,
    "BrandName": "Comtess",
    "MAH": "Orion Corporation",
    "ActiveSubstance": "entacapone",
    "DecisionDate": "09/16/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Finland",
    "CoRapporteur": "Luxembourg",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 214,
    "ClockStopElapsed": 188,
    "TotalTimeElapsed": 402
  },
  {
    "ApplicationNo": 180,
    "EUNumber": "EU/1/98/079",
    "EUNoShort": 79,
    "BrandName": "Zartra",
    "MAH": "Laboratoires 3M Sant√©",
    "ActiveSubstance": "Imiquimod",
    "DecisionDate": "09/18/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "D06",
    "ATCCodeL1": "D",
    "ATCNameL2": "Antibiotics and chemotherapeutics for dermatological use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 132,
    "TotalTimeElapsed": 341
  },
  {
    "ApplicationNo": 179,
    "EUNumber": "EU/1/98/080",
    "EUNoShort": 80,
    "BrandName": "Aldara",
    "MAH": "Meda AB",
    "ActiveSubstance": "Imiquimod",
    "DecisionDate": "09/18/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "D06",
    "ATCCodeL1": "D",
    "ATCNameL2": "Antibiotics and chemotherapeutics for dermatological use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 132,
    "TotalTimeElapsed": 341
  },
  {
    "ApplicationNo": 171,
    "EUNumber": "EU/1/98/081",
    "EUNoShort": 81,
    "BrandName": "Comtan",
    "MAH": "Orion Corporation",
    "ActiveSubstance": "entacapone",
    "DecisionDate": "09/22/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Finland",
    "CoRapporteur": "Luxembourg",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 214,
    "ClockStopElapsed": 188,
    "TotalTimeElapsed": 402
  },
  {
    "ApplicationNo": 145,
    "EUNumber": "EU/1/98/083",
    "EUNoShort": 83,
    "BrandName": "HumaSPECT",
    "MAH": "KS Biomedix Llmited",
    "ActiveSubstance": "votumumab",
    "DecisionDate": "09/25/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 145,
    "ClockStopElapsed": 407,
    "TotalTimeElapsed": 552
  },
  {
    "ApplicationNo": 207,
    "EUNumber": "EU/1/98/084",
    "EUNoShort": 84,
    "BrandName": "Simulect",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "basiliximab",
    "DecisionDate": "10/09/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Germany",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 153,
    "ClockStopElapsed": 91,
    "TotalTimeElapsed": 244
  },
  {
    "ApplicationNo": 222,
    "EUNumber": "EU/1/98/086",
    "EUNoShort": 86,
    "BrandName": "CoAprovel",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "Irbesartan / hydrochlorothiazide",
    "DecisionDate": "10/15/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Spain",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 153,
    "ClockStopElapsed": 63,
    "TotalTimeElapsed": 216
  },
  {
    "ApplicationNo": 221,
    "EUNumber": "EU/1/98/085",
    "EUNoShort": 85,
    "BrandName": "Karvezide",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "Irbesartan / hydrochlorothiazide",
    "DecisionDate": "10/16/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Spain",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 153,
    "ClockStopElapsed": 63,
    "TotalTimeElapsed": 216
  },
  {
    "ApplicationNo": 255,
    "EUNumber": "EU/1/98/092",
    "EUNoShort": 92,
    "BrandName": "Prometax",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Rivastigmine",
    "DecisionDate": "12/04/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 4.8a(1)",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 53,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 53
  },
  {
    "ApplicationNo": 210,
    "EUNumber": "EU/1/98/089",
    "EUNoShort": 89,
    "BrandName": "Pritor",
    "MAH": "Bayer AG",
    "ActiveSubstance": "telmisartan",
    "DecisionDate": "12/11/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Italy",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 188,
    "ClockStopElapsed": 84,
    "TotalTimeElapsed": 272
  },
  {
    "ApplicationNo": 209,
    "EUNumber": "EU/1/98/090",
    "EUNoShort": 90,
    "BrandName": "Micardis",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "telmisartan",
    "DecisionDate": "12/16/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Italy",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 188,
    "ClockStopElapsed": 84,
    "TotalTimeElapsed": 272
  },
  {
    "ApplicationNo": 211,
    "EUNumber": "EU/1/98/091",
    "EUNoShort": 91,
    "BrandName": "Kinzalmono",
    "MAH": "Bayer AG",
    "ActiveSubstance": "telmisartan",
    "DecisionDate": "12/16/1998",
    "DecisionYear": "1998",
    "Period": "1995-2000",
    "Rapporteur": "Italy",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 188,
    "ClockStopElapsed": 84,
    "TotalTimeElapsed": 272
  },
  {
    "ApplicationNo": 181,
    "EUNumber": "EU/1/98/088",
    "EUNoShort": 88,
    "BrandName": "Triacelluvax",
    "MAH": "Chiron spa",
    "ActiveSubstance": "combined diphtheria, tetanus, and acellular pertussis vaccine",
    "DecisionDate": "01/11/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 188,
    "ClockStopElapsed": 209,
    "TotalTimeElapsed": 397
  },
  {
    "ApplicationNo": 197,
    "EUNumber": "EU/1/98/093",
    "EUNoShort": 93,
    "BrandName": "Forcaltonin",
    "MAH": "Unigene UK Limited",
    "ActiveSubstance": "Calcitonin (salmon)",
    "DecisionDate": "01/11/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Germany",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "H05",
    "ATCCodeL1": "H",
    "ATCNameL2": "Calcium homeostasis",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 147,
    "TotalTimeElapsed": 357
  },
  {
    "ApplicationNo": 229,
    "EUNumber": "EU/1/98/096",
    "EUNoShort": 96,
    "BrandName": "Temodal",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "temozolomide",
    "DecisionDate": "01/26/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Germany",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 60,
    "TotalTimeElapsed": 263
  },
  {
    "ApplicationNo": 223,
    "EUNumber": "EU/1/98/095",
    "EUNoShort": 95,
    "BrandName": "Emadine",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "emedastine",
    "DecisionDate": "01/27/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 186,
    "EUNumber": "EU/1/98/087",
    "EUNoShort": 87,
    "BrandName": "Infergen",
    "MAH": "Astellas Pharma Europe B.V.",
    "ActiveSubstance": "Interferon alfacon-1",
    "DecisionDate": "02/01/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 181,
    "TotalTimeElapsed": 363
  },
  {
    "ApplicationNo": 198,
    "EUNumber": "EU/1/99/098",
    "EUNoShort": 98,
    "BrandName": "Zenapax",
    "MAH": "Roche Registration Limited",
    "ActiveSubstance": "daclizumab",
    "DecisionDate": "02/26/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 214,
    "TotalTimeElapsed": 419
  },
  {
    "ApplicationNo": 228,
    "EUNumber": "EU/1/99/099",
    "EUNoShort": 99,
    "BrandName": "Zerene",
    "MAH": "Meda AB",
    "ActiveSubstance": "Zaleplon",
    "DecisionDate": "03/12/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Greece",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 113,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 227,
    "EUNumber": "EU/1/99/102",
    "EUNoShort": 102,
    "BrandName": "Sonata",
    "MAH": "Meda AB",
    "ActiveSubstance": "Zaleplon",
    "DecisionDate": "03/12/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Greece",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 113,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 212,
    "EUNumber": "EU/1/99/101",
    "EUNoShort": 101,
    "BrandName": "Regranex",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "becaplermin",
    "DecisionDate": "03/29/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "D03",
    "ATCCodeL1": "D",
    "ATCNameL2": "Preparations for treatment of wounds &amp; ulcers",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 188,
    "ClockStopElapsed": 203,
    "TotalTimeElapsed": 391
  },
  {
    "ApplicationNo": 206,
    "EUNumber": "EU/1/99/097",
    "EUNoShort": 97,
    "BrandName": "Beromun",
    "MAH": "BELPHARMA s.a.",
    "ActiveSubstance": "Tasonermin (Tumor Necrosis Factor alfa-1a)",
    "DecisionDate": "04/13/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 188,
    "ClockStopElapsed": 204,
    "TotalTimeElapsed": 392
  },
  {
    "ApplicationNo": 233,
    "EUNumber": "EU/1/99/100",
    "EUNoShort": 100,
    "BrandName": "Cetrotide",
    "MAH": "Merck Europe B.V.",
    "ActiveSubstance": "Cetrorelix (as acetate)",
    "DecisionDate": "04/13/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "H01",
    "ATCCodeL1": "H",
    "ATCNameL2": "Pituitary and hypothalamic hormones and analogues",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 173,
    "ClockStopElapsed": 121,
    "TotalTimeElapsed": 294
  },
  {
    "ApplicationNo": 232,
    "EUNumber": "EU/1/99/103",
    "EUNoShort": 103,
    "BrandName": "ReFacto AF",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "Moroctocog alfa",
    "DecisionDate": "04/13/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 146,
    "ClockStopElapsed": 148,
    "TotalTimeElapsed": 294
  },
  {
    "ApplicationNo": 231,
    "EUNumber": "EU/1/99/104",
    "EUNoShort": 104,
    "BrandName": "Procomvax",
    "MAH": "Sanofi Pasteur MSD, SNC",
    "ActiveSubstance": "Haemophilus b conjugate (Meningococcal Protein conjugate) and Hepatitis B vaccine",
    "DecisionDate": "05/07/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Germany",
    "CoRapporteur": "France",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 175,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 328
  },
  {
    "ApplicationNo": 192,
    "EUNumber": "EU/1/99/105",
    "EUNoShort": 105,
    "BrandName": "RotaShield",
    "MAH": "Wyeth-Lederle Vaccines S.A.",
    "ActiveSubstance": "Rotavirus vaccine",
    "DecisionDate": "05/07/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 175,
    "ClockStopElapsed": 393,
    "TotalTimeElapsed": 568
  },
  {
    "ApplicationNo": 247,
    "EUNumber": "EU/1/99/106",
    "EUNoShort": 106,
    "BrandName": "Cotronak",
    "MAH": "Schering-Plough Europe",
    "ActiveSubstance": "ribavirin",
    "DecisionDate": "05/07/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 185,
    "ClockStopElapsed": 57,
    "TotalTimeElapsed": 242
  },
  {
    "ApplicationNo": 246,
    "EUNumber": "EU/1/99/107",
    "EUNoShort": 107,
    "BrandName": "Rebetol",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "ribavirin",
    "DecisionDate": "05/07/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 185,
    "ClockStopElapsed": 57,
    "TotalTimeElapsed": 242
  },
  {
    "ApplicationNo": 249,
    "EUNumber": "EU/1/99/110",
    "EUNoShort": 110,
    "BrandName": "Sustiva",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "efavirenz",
    "DecisionDate": "05/28/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 183,
    "ClockStopElapsed": 27,
    "TotalTimeElapsed": 210
  },
  {
    "ApplicationNo": 250,
    "EUNumber": "EU/1/99/111",
    "EUNoShort": 111,
    "BrandName": "Stocrin",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "efavirenz",
    "DecisionDate": "05/28/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 183,
    "ClockStopElapsed": 27,
    "TotalTimeElapsed": 210
  },
  {
    "ApplicationNo": 230,
    "EUNumber": "EU/1/99/109",
    "EUNoShort": 109,
    "BrandName": "Integrilin",
    "MAH": "GlaxoSmithKline (Ireland) Limited",
    "ActiveSubstance": "Eptifibatide",
    "DecisionDate": "07/01/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 173,
    "ClockStopElapsed": 216,
    "TotalTimeElapsed": 389
  },
  {
    "ApplicationNo": 252,
    "EUNumber": "EU/1/99/112",
    "EUNoShort": 112,
    "BrandName": "Ziagen",
    "MAH": "ViiV Healthcare BV",
    "ActiveSubstance": "abacavir sulfate",
    "DecisionDate": "07/08/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 172,
    "ClockStopElapsed": 66,
    "TotalTimeElapsed": 238
  },
  {
    "ApplicationNo": 216,
    "EUNumber": "EU/1/99/113",
    "EUNoShort": 113,
    "BrandName": "Paxene",
    "MAH": "Norton Healthcare Limited",
    "ActiveSubstance": "paclitaxel",
    "DecisionDate": "07/19/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 179,
    "ClockStopElapsed": 251,
    "TotalTimeElapsed": 430
  },
  {
    "ApplicationNo": 242,
    "EUNumber": "EU/1/99/114",
    "EUNoShort": 114,
    "BrandName": "Zeffix",
    "MAH": "GlaxoSmithKline (Ireland) Limited",
    "ActiveSubstance": "Lamivudine",
    "DecisionDate": "07/29/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 160,
    "TotalTimeElapsed": 361
  },
  {
    "ApplicationNo": 244,
    "EUNumber": "EU/1/99/115",
    "EUNoShort": 115,
    "BrandName": "Vitravene",
    "MAH": "Novartis Ophtalmics Europe Ltd",
    "ActiveSubstance": "Fomivirsen",
    "DecisionDate": "07/29/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 141,
    "ClockStopElapsed": 154,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 257,
    "EUNumber": "EU/1/99/117",
    "EUNoShort": 117,
    "BrandName": "Synagis",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "palivizumab",
    "DecisionDate": "08/13/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J06",
    "ATCCodeL1": "J",
    "ATCNameL2": "Immune sera and immunoglobulins",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 174,
    "ClockStopElapsed": 95,
    "TotalTimeElapsed": 269
  },
  {
    "ApplicationNo": 240,
    "EUNumber": "EU/1/99/116",
    "EUNoShort": 116,
    "BrandName": "Remicade",
    "MAH": "Janssen Biologics B.V.",
    "ActiveSubstance": "infliximab",
    "DecisionDate": "08/13/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 185,
    "ClockStopElapsed": 259,
    "TotalTimeElapsed": 444
  },
  {
    "ApplicationNo": 236,
    "EUNumber": "EU/1/99/108",
    "EUNoShort": 108,
    "BrandName": "Ferriprox",
    "MAH": "Chiesi Farmaceutici S.p.A.",
    "ActiveSubstance": "Deferiprone",
    "DecisionDate": "08/25/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 175,
    "ClockStopElapsed": 160,
    "TotalTimeElapsed": 335
  },
  {
    "ApplicationNo": 235,
    "EUNumber": "EU/1/99/118",
    "EUNoShort": 118,
    "BrandName": "Arava",
    "MAH": "Sanofi-Aventis Deutschland GmbH",
    "ActiveSubstance": "leflunomide",
    "DecisionDate": "09/02/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 186,
    "ClockStopElapsed": 259,
    "TotalTimeElapsed": 445
  },
  {
    "ApplicationNo": 258,
    "EUNumber": "EU/1/99/119",
    "EUNoShort": 119,
    "BrandName": "NovoRapid",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "Insulin aspart",
    "DecisionDate": "09/07/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 28,
    "TotalTimeElapsed": 241
  },
  {
    "ApplicationNo": 238,
    "EUNumber": "EU/1/99/121",
    "EUNoShort": 121,
    "BrandName": "Tikosyn",
    "MAH": "Pfizer Limited",
    "ActiveSubstance": "Dofetilide",
    "DecisionDate": "11/29/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Denmark",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "C01",
    "ATCCodeL1": "C",
    "ATCNameL2": "Cardiac therapy",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 179,
    "ClockStopElapsed": 333,
    "TotalTimeElapsed": 512
  },
  {
    "ApplicationNo": 219,
    "EUNumber": "EU/1/99/120",
    "EUNoShort": 120,
    "BrandName": "Ammonaps",
    "MAH": "Immedica Pharma AB",
    "ActiveSubstance": "Sodium phenylbutyrate",
    "DecisionDate": "12/08/1999",
    "DecisionYear": "1999",
    "Period": "1995-2000",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Greece",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 189,
    "ClockStopElapsed": 481,
    "TotalTimeElapsed": 670
  },
  {
    "ApplicationNo": 253,
    "EUNumber": "EU/1/99/124",
    "EUNoShort": 124,
    "BrandName": "Tractocile",
    "MAH": "Ferring Pharmaceuticals A/S",
    "ActiveSubstance": "Atosiban",
    "DecisionDate": "01/20/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Italy",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "G02",
    "ATCCodeL1": "G",
    "ATCNameL2": "Other gynecologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 186,
    "ClockStopElapsed": 234,
    "TotalTimeElapsed": 420
  },
  {
    "ApplicationNo": 254,
    "EUNumber": "EU/1/99/123",
    "EUNoShort": 123,
    "BrandName": "Renagel",
    "MAH": "Genzyme Europe B.V.",
    "ActiveSubstance": "Sevelamer",
    "DecisionDate": "01/28/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Finland",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 199,
    "ClockStopElapsed": 213,
    "TotalTimeElapsed": 412
  },
  {
    "ApplicationNo": 287,
    "EUNumber": "EU/1/99/125",
    "EUNoShort": 125,
    "BrandName": "Zyprexa Velotab",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "Olanzapine",
    "DecisionDate": "02/03/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Finland",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 117,
    "ClockStopElapsed": 63,
    "TotalTimeElapsed": 180
  },
  {
    "ApplicationNo": 262,
    "EUNumber": "EU/1/99/126",
    "EUNoShort": 126,
    "BrandName": "Enbrel",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "Etanercept",
    "DecisionDate": "02/03/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 146,
    "TotalTimeElapsed": 359
  },
  {
    "ApplicationNo": 220,
    "EUNumber": "EU/1/99/122",
    "EUNoShort": 122,
    "BrandName": "Thyrogen",
    "MAH": "Genzyme Europe B.V.",
    "ActiveSubstance": "Thyrotropin alfa",
    "DecisionDate": "03/09/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "H01",
    "ATCCodeL1": "H",
    "ATCNameL2": "Pituitary and hypothalamic hormones and analogues",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 373,
    "TotalTimeElapsed": 581
  },
  {
    "ApplicationNo": 281,
    "EUNumber": "EU/1/99/127",
    "EUNoShort": 127,
    "BrandName": "IntronA",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "Interferon alfa-2b",
    "DecisionDate": "03/09/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 108,
    "ClockStopElapsed": 98,
    "TotalTimeElapsed": 206
  },
  {
    "ApplicationNo": 282,
    "EUNumber": "EU/1/99/128",
    "EUNoShort": 128,
    "BrandName": "Viraferon",
    "MAH": "Schering-Plough Europe",
    "ActiveSubstance": "Interferon alfa-2b",
    "DecisionDate": "03/09/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 43,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 43
  },
  {
    "ApplicationNo": 267,
    "EUNumber": "EU/1/00/129",
    "EUNoShort": 129,
    "BrandName": "Azopt",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Brinzolamide",
    "DecisionDate": "03/09/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Spain",
    "CoRapporteur": "France",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 178,
    "ClockStopElapsed": 154,
    "TotalTimeElapsed": 332
  },
  {
    "ApplicationNo": 274,
    "EUNumber": "EU/1/00/130",
    "EUNoShort": 130,
    "BrandName": "Orgalutran",
    "MAH": "N.V. Organon",
    "ActiveSubstance": "ganirelix",
    "DecisionDate": "05/17/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Finland",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "H01",
    "ATCCodeL1": "H",
    "ATCNameL2": "Pituitary and hypothalamic hormones and analogues",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 162,
    "ClockStopElapsed": 189,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 280,
    "EUNumber": "EU/1/00/131",
    "EUNoShort": 131,
    "BrandName": "PegIntron",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "Peginterferon alfa-2b",
    "DecisionDate": "05/25/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 189,
    "ClockStopElapsed": 139,
    "TotalTimeElapsed": 328
  },
  {
    "ApplicationNo": 329,
    "EUNumber": "EU/1/00/132",
    "EUNoShort": 132,
    "BrandName": "ViraferonPeg",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "Peginterferon alfa-2b",
    "DecisionDate": "05/29/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 108,
    "ClockStopElapsed": 98,
    "TotalTimeElapsed": 206
  },
  {
    "ApplicationNo": 284,
    "EUNumber": "EU/1/00/134",
    "EUNoShort": 134,
    "BrandName": "Lantus",
    "MAH": "Sanofi-Aventis Deutschland GmbH",
    "ActiveSubstance": "insulin glargine",
    "DecisionDate": "06/09/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 215,
    "ClockStopElapsed": 83,
    "TotalTimeElapsed": 298
  },
  {
    "ApplicationNo": 309,
    "EUNumber": "EU/1/00/133",
    "EUNoShort": 133,
    "BrandName": "Toujeo",
    "MAH": "Sanofi-Aventis Deutschland GmbH",
    "ActiveSubstance": "insulin glargine",
    "DecisionDate": "06/27/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 116,
    "ClockStopElapsed": 28,
    "TotalTimeElapsed": 144
  },
  {
    "ApplicationNo": 268,
    "EUNumber": "EU/1/00/137",
    "EUNoShort": 137,
    "BrandName": "Avandia",
    "MAH": "SmithKline Beecham Ltd",
    "ActiveSubstance": "Rosiglitazone",
    "DecisionDate": "07/11/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 186,
    "ClockStopElapsed": 119,
    "TotalTimeElapsed": 305
  },
  {
    "ApplicationNo": 270,
    "EUNumber": "EU/1/00/138",
    "EUNoShort": 138,
    "BrandName": "VENVIA",
    "MAH": "SmithKline Beecham plc",
    "ActiveSubstance": "Rosiglitazone",
    "DecisionDate": "07/11/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 186,
    "ClockStopElapsed": 119,
    "TotalTimeElapsed": 305
  },
  {
    "ApplicationNo": 269,
    "EUNumber": "EU/1/00/139",
    "EUNoShort": 139,
    "BrandName": "Nyracta",
    "MAH": "SmithKline Beecham plc",
    "ActiveSubstance": "Rosiglitazone",
    "DecisionDate": "07/11/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 186,
    "ClockStopElapsed": 119,
    "TotalTimeElapsed": 305
  },
  {
    "ApplicationNo": 297,
    "EUNumber": "EU/1/00/141",
    "EUNoShort": 141,
    "BrandName": "Myocet liposomal",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Doxorubicin",
    "DecisionDate": "07/13/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 167,
    "ClockStopElapsed": 91,
    "TotalTimeElapsed": 258
  },
  {
    "ApplicationNo": 266,
    "EUNumber": "EU/1/00/135",
    "EUNoShort": 135,
    "BrandName": "DaTSCAN",
    "MAH": "GE Healthcare B.V.",
    "ActiveSubstance": "Ioflupane (123I)",
    "DecisionDate": "07/27/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 178,
    "ClockStopElapsed": 272,
    "TotalTimeElapsed": 450
  },
  {
    "ApplicationNo": 305,
    "EUNumber": "EU/1/00/140",
    "EUNoShort": 140,
    "BrandName": "Visudyne",
    "MAH": "CHEPLAPHARM Arzneimittel GmbH",
    "ActiveSubstance": "verteporfin",
    "DecisionDate": "07/27/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "France",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 138,
    "ClockStopElapsed": 63,
    "TotalTimeElapsed": 201
  },
  {
    "ApplicationNo": 308,
    "EUNumber": "EU/1/00/142",
    "EUNoShort": 142,
    "BrandName": "NovoMix",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "Insulin aspart",
    "DecisionDate": "08/01/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 144,
    "ClockStopElapsed": 55,
    "TotalTimeElapsed": 199
  },
  {
    "ApplicationNo": 261,
    "EUNumber": "EU/1/00/136",
    "EUNoShort": 136,
    "BrandName": "Hepacare",
    "MAH": "Medeva Pharma Limited",
    "ActiveSubstance": "Triple antigen hepatitis B vaccine (recombinant)",
    "DecisionDate": "08/04/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 293,
    "TotalTimeElapsed": 503
  },
  {
    "ApplicationNo": 275,
    "EUNumber": "EU/1/00/143",
    "EUNoShort": 143,
    "BrandName": "KOGENATE Bayer",
    "MAH": "Bayer AG",
    "ActiveSubstance": "Recombinant coagulation factor VIII (octocog alfa)",
    "DecisionDate": "08/04/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Germany",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 201,
    "TotalTimeElapsed": 383
  },
  {
    "ApplicationNo": 276,
    "EUNumber": "EU/1/00/144",
    "EUNoShort": 144,
    "BrandName": "Helixate NexGen",
    "MAH": "Bayer AG",
    "ActiveSubstance": "Recombinant coagulation factor VIII (octocog alfa)",
    "DecisionDate": "08/04/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Germany",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 201,
    "TotalTimeElapsed": 383
  },
  {
    "ApplicationNo": 278,
    "EUNumber": "EU/1/00/145",
    "EUNoShort": 145,
    "BrandName": "Herceptin",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "trastuzumab",
    "DecisionDate": "08/28/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 147,
    "ClockStopElapsed": 305,
    "TotalTimeElapsed": 452
  },
  {
    "ApplicationNo": 277,
    "EUNumber": "EU/1/00/146",
    "EUNoShort": 146,
    "BrandName": "Keppra",
    "MAH": "UCB Pharma S.A.",
    "ActiveSubstance": "levetiracetam",
    "DecisionDate": "09/29/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 187,
    "ClockStopElapsed": 300,
    "TotalTimeElapsed": 487
  },
  {
    "ApplicationNo": 286,
    "EUNumber": "EU/1/00/151",
    "EUNoShort": 151,
    "BrandName": "Glustin",
    "MAH": "Takeda Pharma A/S",
    "ActiveSubstance": "pioglitazone",
    "DecisionDate": "10/10/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 178,
    "ClockStopElapsed": 251,
    "TotalTimeElapsed": 429
  },
  {
    "ApplicationNo": 279,
    "EUNumber": "EU/1/00/149",
    "EUNoShort": 149,
    "BrandName": "Panretin",
    "MAH": "Amdipharm Limited",
    "ActiveSubstance": "alitretinoin",
    "DecisionDate": "10/11/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 174,
    "ClockStopElapsed": 313,
    "TotalTimeElapsed": 487
  },
  {
    "ApplicationNo": 285,
    "EUNumber": "EU/1/00/150",
    "EUNoShort": 150,
    "BrandName": "Actos",
    "MAH": "Takeda Pharma A/S",
    "ActiveSubstance": "pioglitazone",
    "DecisionDate": "10/13/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 178,
    "ClockStopElapsed": 251,
    "TotalTimeElapsed": 429
  },
  {
    "ApplicationNo": 264,
    "EUNumber": "EU/1/00/148",
    "EUNoShort": 148,
    "BrandName": "Agenerase",
    "MAH": "Glaxo Group Limited",
    "ActiveSubstance": "amprenavir",
    "DecisionDate": "10/20/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Spain",
    "CoRapporteur": "Luxembourg",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 219,
    "ClockStopElapsed": 324,
    "TotalTimeElapsed": 543
  },
  {
    "ApplicationNo": 298,
    "EUNumber": "EU/1/00/147",
    "EUNoShort": 147,
    "BrandName": "Hexavac",
    "MAH": "Aventis Pasteur MSD",
    "ActiveSubstance": "diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted",
    "DecisionDate": "10/23/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Germany",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 333
  },
  {
    "ApplicationNo": 296,
    "EUNumber": "EU/1/00/152",
    "EUNoShort": 152,
    "BrandName": "Infanrix hexa",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type b (hib) conjugate vaccine (adsorbed)",
    "DecisionDate": "10/23/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 132,
    "TotalTimeElapsed": 333
  },
  {
    "ApplicationNo": 295,
    "EUNumber": "EU/1/00/153",
    "EUNoShort": 153,
    "BrandName": "Infanrix penta",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant (adsorbed), inactivated poliomyelitis vaccine",
    "DecisionDate": "10/23/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 132,
    "TotalTimeElapsed": 333
  },
  {
    "ApplicationNo": 263,
    "EUNumber": "EU/1/00/154",
    "EUNoShort": 154,
    "BrandName": "NeoSpect",
    "MAH": "CIS bio international",
    "ActiveSubstance": "Depreotide",
    "DecisionDate": "11/29/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 404,
    "TotalTimeElapsed": 608
  },
  {
    "ApplicationNo": 292,
    "EUNumber": "EU/1/00/155",
    "EUNoShort": 155,
    "BrandName": "Luveris",
    "MAH": "Merck Europe B.V.",
    "ActiveSubstance": "Lutropin alfa",
    "DecisionDate": "11/29/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Denmark",
    "CoRapporteur": "France",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 192,
    "ClockStopElapsed": 200,
    "TotalTimeElapsed": 392
  },
  {
    "ApplicationNo": 338,
    "EUNumber": "EU/1/00/156",
    "EUNoShort": 156,
    "BrandName": "Trizivir",
    "MAH": "ViiV Healthcare BV",
    "ActiveSubstance": "abacavir, lamivudine, zidovudine",
    "DecisionDate": "12/28/2000",
    "DecisionYear": "2000",
    "Period": "1995-2000",
    "Rapporteur": "Belgium",
    "CoRapporteur": "France",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 158,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 158
  },
  {
    "ApplicationNo": 310,
    "EUNumber": "EU/1/00/157",
    "EUNoShort": 157,
    "BrandName": "Azomyr",
    "MAH": "N.V. Organon",
    "ActiveSubstance": "desloratadine",
    "DecisionDate": "01/15/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "R06",
    "ATCCodeL1": "R",
    "ATCNameL2": "Antihistamines for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 159,
    "TotalTimeElapsed": 360
  },
  {
    "ApplicationNo": 311,
    "EUNumber": "EU/1/00/158",
    "EUNoShort": 158,
    "BrandName": "Opulis",
    "MAH": "Schering-Plough Europe",
    "ActiveSubstance": "desloratadine",
    "DecisionDate": "01/15/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "R06",
    "ATCCodeL1": "R",
    "ATCNameL2": "Antihistamines for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 159,
    "TotalTimeElapsed": 360
  },
  {
    "ApplicationNo": 312,
    "EUNumber": "EU/1/00/159",
    "EUNoShort": 159,
    "BrandName": "Allex",
    "MAH": "Schering-Plough Europe",
    "ActiveSubstance": "desloratadine",
    "DecisionDate": "01/15/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "R06",
    "ATCCodeL1": "R",
    "ATCNameL2": "Antihistamines for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 159,
    "TotalTimeElapsed": 360
  },
  {
    "ApplicationNo": 313,
    "EUNumber": "EU/1/00/160",
    "EUNoShort": 160,
    "BrandName": "Aerius",
    "MAH": "N.V. Organon",
    "ActiveSubstance": "desloratadine",
    "DecisionDate": "01/15/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "R06",
    "ATCCodeL1": "R",
    "ATCNameL2": "Antihistamines for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 159,
    "TotalTimeElapsed": 360
  },
  {
    "ApplicationNo": 314,
    "EUNumber": "EU/1/00/161",
    "EUNoShort": 161,
    "BrandName": "Neoclarityn",
    "MAH": "N.V. Organon",
    "ActiveSubstance": "desloratadine",
    "DecisionDate": "01/15/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "R06",
    "ATCCodeL1": "R",
    "ATCNameL2": "Antihistamines for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 159,
    "TotalTimeElapsed": 360
  },
  {
    "ApplicationNo": 301,
    "EUNumber": "EU/1/00/166",
    "EUNoShort": 166,
    "BrandName": "NeuroBloc",
    "MAH": "Sloan Pharma S.a.r.l.",
    "ActiveSubstance": "Botulinum Toxin Type B",
    "DecisionDate": "01/22/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "M03",
    "ATCCodeL1": "M",
    "ATCNameL2": "Muscle relaxants",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 187,
    "ClockStopElapsed": 229,
    "TotalTimeElapsed": 416
  },
  {
    "ApplicationNo": 362,
    "EUNumber": "EU/1/00/162",
    "EUNoShort": 162,
    "BrandName": "Prandin",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "Repaglinide",
    "DecisionDate": "01/29/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Luxembourg",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 4.8a(1)",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 91,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 91
  },
  {
    "ApplicationNo": 316,
    "EUNumber": "EU/1/00/163",
    "EUNoShort": 163,
    "BrandName": "Xeloda",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "capecitabine",
    "DecisionDate": "02/02/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Germany",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 159,
    "TotalTimeElapsed": 360
  },
  {
    "ApplicationNo": 320,
    "EUNumber": "EU/1/00/165",
    "EUNoShort": 165,
    "BrandName": "Ovitrelle",
    "MAH": "Merck Europe B.V.",
    "ActiveSubstance": "Choriogonadotrophin alfa",
    "DecisionDate": "02/02/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 174,
    "ClockStopElapsed": 186,
    "TotalTimeElapsed": 360
  },
  {
    "ApplicationNo": 323,
    "EUNumber": "EU/1/00/167",
    "EUNoShort": 167,
    "BrandName": "Prevenar",
    "MAH": "Pfizer Limited",
    "ActiveSubstance": "pneumoccocal saccharide conjugated vaccine, adsorbed",
    "DecisionDate": "02/02/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 125,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 315,
    "EUNumber": "EU/1/00/164",
    "EUNoShort": 164,
    "BrandName": "NutropinAq",
    "MAH": "Ipsen Pharma",
    "ActiveSubstance": "Somatropin",
    "DecisionDate": "02/16/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "H01",
    "ATCCodeL1": "H",
    "ATCNameL2": "Pituitary and hypothalamic hormones and analogues",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 174,
    "ClockStopElapsed": 186,
    "TotalTimeElapsed": 360
  },
  {
    "ApplicationNo": 307,
    "EUNumber": "EU/1/00/168",
    "EUNoShort": 168,
    "BrandName": "Tenecteplase Boehringer Ingelheim Pharma GmbH & Co. KG",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "tenecteplase",
    "DecisionDate": "02/23/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Germany",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 176,
    "ClockStopElapsed": 215,
    "TotalTimeElapsed": 391
  },
  {
    "ApplicationNo": 306,
    "EUNumber": "EU/1/00/169",
    "EUNoShort": 169,
    "BrandName": "Metalyse",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "tenecteplase",
    "DecisionDate": "02/23/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Germany",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 176,
    "ClockStopElapsed": 215,
    "TotalTimeElapsed": 391
  },
  {
    "ApplicationNo": 331,
    "EUNumber": "EU/1/00/170",
    "EUNoShort": 170,
    "BrandName": "Fasturtec",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "rasburicase",
    "DecisionDate": "02/23/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "France",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 273,
    "EUNumber": "EU/1/01/171",
    "EUNoShort": 171,
    "BrandName": "Rapamune",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "sirolimus",
    "DecisionDate": "03/13/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 214,
    "ClockStopElapsed": 393,
    "TotalTimeElapsed": 607
  },
  {
    "ApplicationNo": 325,
    "EUNumber": "EU/1/01/173",
    "EUNoShort": 173,
    "BrandName": "Vaniqa",
    "MAH": "Almirall, S.A.",
    "ActiveSubstance": "eflornithine",
    "DecisionDate": "03/20/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "D11",
    "ATCCodeL1": "D",
    "ATCNameL2": "Other dermatological preparations",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 157,
    "TotalTimeElapsed": 339
  },
  {
    "ApplicationNo": 336,
    "EUNumber": "EU/1/01/176",
    "EUNoShort": 176,
    "BrandName": "Zometa",
    "MAH": "Phoenix Labs Unlimited Company",
    "ActiveSubstance": "zoledronic acid",
    "DecisionDate": "03/20/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 146,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 368,
    "EUNumber": "EU/1/01/172",
    "EUNoShort": 172,
    "BrandName": "Kaletra",
    "MAH": "AbbVie Deutschland GmbH & Co. KG",
    "ActiveSubstance": "lopinavir / Ritonavir",
    "DecisionDate": "03/20/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "France",
    "CoRapporteur": "Luxembourg",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 145,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 145
  },
  {
    "ApplicationNo": 303,
    "EUNumber": "EU/1/01/177",
    "EUNoShort": 177,
    "BrandName": "SonoVue",
    "MAH": "Bracco International B.V.",
    "ActiveSubstance": "sulphur hexafluoride",
    "DecisionDate": "03/26/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "France",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "V08",
    "ATCCodeL1": "V",
    "ATCNameL2": "Contrast media",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 194,
    "ClockStopElapsed": 276,
    "TotalTimeElapsed": 470
  },
  {
    "ApplicationNo": 326,
    "EUNumber": "EU/1/01/178",
    "EUNoShort": 178,
    "BrandName": "Targretin",
    "MAH": "Eisai GmbH",
    "ActiveSubstance": "bexarotene",
    "DecisionDate": "03/29/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "France",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 197,
    "ClockStopElapsed": 159,
    "TotalTimeElapsed": 356
  },
  {
    "ApplicationNo": 335,
    "EUNumber": "EU/1/01/174",
    "EUNoShort": 174,
    "BrandName": "Starlix",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "nateglinide",
    "DecisionDate": "04/03/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 179,
    "ClockStopElapsed": 144,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 383,
    "EUNumber": "EU/1/01/175",
    "EUNoShort": 175,
    "BrandName": "Trazec",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "nateglinide",
    "DecisionDate": "04/03/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 58,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 58
  },
  {
    "ApplicationNo": 373,
    "EUNumber": "EU/1/01/183",
    "EUNoShort": 183,
    "BrandName": "HBVAXPRO",
    "MAH": "MSD VACCINS",
    "ActiveSubstance": "Recombinant Hepatitis B virus small surface antigen (HbsAg)",
    "DecisionDate": "04/27/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Germany",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 68,
    "ClockStopElapsed": 17,
    "TotalTimeElapsed": 85
  },
  {
    "ApplicationNo": 293,
    "EUNumber": "EU/1/01/179",
    "EUNoShort": 179,
    "BrandName": "Osigraft",
    "MAH": "Olympus Biotech International Limited",
    "ActiveSubstance": "eptotermin alfa",
    "DecisionDate": "05/17/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Finland",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 297,
    "TotalTimeElapsed": 498
  },
  {
    "ApplicationNo": 327,
    "EUNumber": "EU/1/01/180",
    "EUNoShort": 180,
    "BrandName": "Uprima",
    "MAH": "Abbott Laboratories Ltd",
    "ActiveSubstance": "apomorphine hydrochloride",
    "DecisionDate": "05/28/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 156,
    "ClockStopElapsed": 227,
    "TotalTimeElapsed": 383
  },
  {
    "ApplicationNo": 328,
    "EUNumber": "EU/1/01/181",
    "EUNoShort": 181,
    "BrandName": "Ixense",
    "MAH": "Takeda Europe R&D Centre Ltd",
    "ActiveSubstance": "apomorphine hydrochloride",
    "DecisionDate": "05/28/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 156,
    "ClockStopElapsed": 227,
    "TotalTimeElapsed": 383
  },
  {
    "ApplicationNo": 386,
    "EUNumber": "EU/1/01/182",
    "EUNoShort": 182,
    "BrandName": "Taluvian",
    "MAH": "Abbott SpA",
    "ActiveSubstance": "apomorphine hydrochloride",
    "DecisionDate": "05/28/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 26,
    "TotalTimeElapsed": 86
  },
  {
    "ApplicationNo": 333,
    "EUNumber": "EU/1/01/184",
    "EUNoShort": 184,
    "BrandName": "Nespo",
    "MAH": "Domp√© Biotec S.p.A.",
    "ActiveSubstance": "darbepoetin alfa",
    "DecisionDate": "06/08/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Germany",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "B03",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antianemic preparations",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 199,
    "TotalTimeElapsed": 401
  },
  {
    "ApplicationNo": 332,
    "EUNumber": "EU/1/01/185",
    "EUNoShort": 185,
    "BrandName": "Aranesp",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "darbepoetin alfa",
    "DecisionDate": "06/08/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Germany",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "B03",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antianemic preparations",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 199,
    "TotalTimeElapsed": 401
  },
  {
    "ApplicationNo": 348,
    "EUNumber": "EU/1/01/186",
    "EUNoShort": 186,
    "BrandName": "Nonafact",
    "MAH": "Sanquin Plasma Products B.V.",
    "ActiveSubstance": "Human coagulation factor IX",
    "DecisionDate": "07/03/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 171,
    "TotalTimeElapsed": 373
  },
  {
    "ApplicationNo": 353,
    "EUNumber": "EU/1/01/193",
    "EUNoShort": 193,
    "BrandName": "MabCampath",
    "MAH": "Genzyme Europe B.V.",
    "ActiveSubstance": "Alemtuzumab",
    "DecisionDate": "07/06/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 142,
    "TotalTimeElapsed": 345
  },
  {
    "ApplicationNo": 354,
    "EUNumber": "EU/1/01/191",
    "EUNoShort": 191,
    "BrandName": "Ketek",
    "MAH": "Aventis Pharma S.A.",
    "ActiveSubstance": "telithromycin",
    "DecisionDate": "07/09/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 164,
    "ClockStopElapsed": 181,
    "TotalTimeElapsed": 345
  },
  {
    "ApplicationNo": 355,
    "EUNumber": "EU/1/01/192",
    "EUNoShort": 192,
    "BrandName": "Levviax",
    "MAH": "Aventis Pharma S.A.",
    "ActiveSubstance": "telithromycin",
    "DecisionDate": "07/09/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 164,
    "ClockStopElapsed": 181,
    "TotalTimeElapsed": 345
  },
  {
    "ApplicationNo": 317,
    "EUNumber": "EU/1/01/187",
    "EUNoShort": 187,
    "BrandName": "DepoCyte",
    "MAH": "Pacira Limited",
    "ActiveSubstance": "Cytarabine",
    "DecisionDate": "07/11/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 176,
    "ClockStopElapsed": 313,
    "TotalTimeElapsed": 489
  },
  {
    "ApplicationNo": 334,
    "EUNumber": "EU/1/01/190",
    "EUNoShort": 190,
    "BrandName": "Ceprotin",
    "MAH": "Takeda Manufacturing Austria AG",
    "ActiveSubstance": "Protein C",
    "DecisionDate": "07/16/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Germany",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 185,
    "ClockStopElapsed": 243,
    "TotalTimeElapsed": 428
  },
  {
    "ApplicationNo": 337,
    "EUNumber": "EU/1/01/194",
    "EUNoShort": 194,
    "BrandName": "INOmax",
    "MAH": "Linde Healthcare AB",
    "ActiveSubstance": "Nitric oxide",
    "DecisionDate": "08/01/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "R07",
    "ATCCodeL1": "R",
    "ATCNameL2": "Other respiratory system products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 199,
    "ClockStopElapsed": 202,
    "TotalTimeElapsed": 401
  },
  {
    "ApplicationNo": 393,
    "EUNumber": "EU/1/01/195",
    "EUNoShort": 195,
    "BrandName": "Liprolog",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "Insulin lispro",
    "DecisionDate": "08/01/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 4.8a(1)",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 86,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 86
  },
  {
    "ApplicationNo": 370,
    "EUNumber": "EU/1/01/188",
    "EUNoShort": 188,
    "BrandName": "Fabrazyme",
    "MAH": "Genzyme Europe B.V.",
    "ActiveSubstance": "Agalsidase beta",
    "DecisionDate": "08/03/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 187,
    "ClockStopElapsed": 64,
    "TotalTimeElapsed": 251
  },
  {
    "ApplicationNo": 369,
    "EUNumber": "EU/1/01/189",
    "EUNoShort": 189,
    "BrandName": "Replagal",
    "MAH": "Shire Human Genetic Therapies AB",
    "ActiveSubstance": "Agalsidase alfa",
    "DecisionDate": "08/03/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 49,
    "TotalTimeElapsed": 249
  },
  {
    "ApplicationNo": 379,
    "EUNumber": "EU/1/01/196",
    "EUNoShort": 196,
    "BrandName": "CANCIDAS",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "caspofungin",
    "DecisionDate": "10/24/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J02",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycotics for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 59,
    "TotalTimeElapsed": 266
  },
  {
    "ApplicationNo": 318,
    "EUNumber": "EU/1/01/197",
    "EUNoShort": 197,
    "BrandName": "Foscan",
    "MAH": "biolitec Pharma Ltd",
    "ActiveSubstance": "temoporfin",
    "DecisionDate": "10/24/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 215,
    "ClockStopElapsed": 238,
    "TotalTimeElapsed": 453
  },
  {
    "ApplicationNo": 406,
    "EUNumber": "EU/1/01/198",
    "EUNoShort": 198,
    "BrandName": "Glivec",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Imatinib",
    "DecisionDate": "11/07/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "France",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 119,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 119
  },
  {
    "ApplicationNo": 390,
    "EUNumber": "EU/1/01/199",
    "EUNoShort": 199,
    "BrandName": "Travatan",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Travoprost",
    "DecisionDate": "11/27/2001",
    "DecisionYear": "2001",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 152,
    "ClockStopElapsed": 58,
    "TotalTimeElapsed": 210
  },
  {
    "ApplicationNo": 419,
    "EUNumber": "EU/1/01/200",
    "EUNoShort": 200,
    "BrandName": "Viread",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "tenofovir disoproxil fumarate",
    "DecisionDate": "02/05/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "France",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 83,
    "ClockStopElapsed": 63,
    "TotalTimeElapsed": 146
  },
  {
    "ApplicationNo": 374,
    "EUNumber": "EU/1/02/201",
    "EUNoShort": 201,
    "BrandName": "Protopic",
    "MAH": "Leo Pharma A/S",
    "ActiveSubstance": "Tacrolimus",
    "DecisionDate": "02/28/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "D11",
    "ATCCodeL1": "D",
    "ATCNameL2": "Other dermatological preparations",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 218,
    "TotalTimeElapsed": 422
  },
  {
    "ApplicationNo": 375,
    "EUNumber": "EU/1/02/202",
    "EUNoShort": 202,
    "BrandName": "Protopy",
    "MAH": "Astellas Pharma GmbH",
    "ActiveSubstance": "Tacrolimus",
    "DecisionDate": "02/28/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "D11",
    "ATCCodeL1": "D",
    "ATCNameL2": "Other dermatological preparations",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 218,
    "TotalTimeElapsed": 422
  },
  {
    "ApplicationNo": 388,
    "EUNumber": "EU/1/02/204",
    "EUNoShort": 204,
    "BrandName": "TRISENOX",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Arsenic trioxide",
    "DecisionDate": "03/05/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "France",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 51,
    "TotalTimeElapsed": 231
  },
  {
    "ApplicationNo": 363,
    "EUNumber": "EU/1/02/203",
    "EUNoShort": 203,
    "BrandName": "Kineret",
    "MAH": "Swedish Orphan Biovitrum AB (publ)",
    "ActiveSubstance": "Anakinra",
    "DecisionDate": "03/08/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 273,
    "TotalTimeElapsed": 477
  },
  {
    "ApplicationNo": 391,
    "EUNumber": "EU/1/02/205",
    "EUNoShort": 205,
    "BrandName": "Lumigan",
    "MAH": "Allergan Pharmaceuticals Ireland",
    "ActiveSubstance": "Bimatoprost",
    "DecisionDate": "03/08/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 192,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 319
  },
  {
    "ApplicationNo": 372,
    "EUNumber": "EU/1/02/211",
    "EUNoShort": 211,
    "BrandName": "Dynepo",
    "MAH": "Shire Pharmaceutical Contracts Ltd",
    "ActiveSubstance": "Epoetin delta",
    "DecisionDate": "03/18/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "B03",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antianemic preparations",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 206,
    "ClockStopElapsed": 238,
    "TotalTimeElapsed": 444
  },
  {
    "ApplicationNo": 387,
    "EUNumber": "EU/1/02/212",
    "EUNoShort": 212,
    "BrandName": "Vfend",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "voriconazole",
    "DecisionDate": "03/19/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "France",
    "ATCCodeL2": "J02",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycotics for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 169,
    "TotalTimeElapsed": 372
  },
  {
    "ApplicationNo": 403,
    "EUNumber": "EU/1/02/206",
    "EUNoShort": 206,
    "BrandName": "Arixtra",
    "MAH": "Mylan IRE Healthcare Limited",
    "ActiveSubstance": "Fondaparinux sodium",
    "DecisionDate": "03/21/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 78,
    "TotalTimeElapsed": 283
  },
  {
    "ApplicationNo": 404,
    "EUNumber": "EU/1/02/207",
    "EUNoShort": 207,
    "BrandName": "Quixidar",
    "MAH": "Glaxo Group Ltd",
    "ActiveSubstance": "Fondaparinux sodium",
    "DecisionDate": "03/21/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 78,
    "TotalTimeElapsed": 283
  },
  {
    "ApplicationNo": 380,
    "EUNumber": "EU/1/02/208",
    "EUNoShort": 208,
    "BrandName": "Xapit",
    "MAH": "Pharmacia Europe EEIG",
    "ActiveSubstance": "Parecoxib",
    "DecisionDate": "03/22/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "M01",
    "ATCCodeL1": "M",
    "ATCNameL2": "Antiinflammatory and antirheumatic products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 171,
    "TotalTimeElapsed": 375
  },
  {
    "ApplicationNo": 381,
    "EUNumber": "EU/1/02/209",
    "EUNoShort": 209,
    "BrandName": "Dynastat",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "Parecoxib",
    "DecisionDate": "03/22/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "M01",
    "ATCCodeL1": "M",
    "ATCNameL2": "Antiinflammatory and antirheumatic products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 171,
    "TotalTimeElapsed": 375
  },
  {
    "ApplicationNo": 382,
    "EUNumber": "EU/1/02/210",
    "EUNoShort": 210,
    "BrandName": "Rayzon",
    "MAH": "Pharmacia Europe EEIG",
    "ActiveSubstance": "Parecoxib",
    "DecisionDate": "03/22/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "M01",
    "ATCCodeL1": "M",
    "ATCNameL2": "Antiinflammatory and antirheumatic products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 171,
    "TotalTimeElapsed": 375
  },
  {
    "ApplicationNo": 389,
    "EUNumber": "EU/1/02/216",
    "EUNoShort": 216,
    "BrandName": "Invanz",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "Ertapenem",
    "DecisionDate": "04/18/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 212,
    "ClockStopElapsed": 169,
    "TotalTimeElapsed": 381
  },
  {
    "ApplicationNo": 413,
    "EUNumber": "EU/1/02/213",
    "EUNoShort": 213,
    "BrandName": "MicardisPlus",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "Telmisartan / hydrochlorothiazide",
    "DecisionDate": "04/19/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Italy",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 4.8a(2)",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 148,
    "ClockStopElapsed": 115,
    "TotalTimeElapsed": 263
  },
  {
    "ApplicationNo": 415,
    "EUNumber": "EU/1/02/214",
    "EUNoShort": 214,
    "BrandName": "Kinzalkomb",
    "MAH": "Bayer AG",
    "ActiveSubstance": "Telmisartan / hydrochlorothiazide",
    "DecisionDate": "04/19/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Italy",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 4.8a(2)",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 148,
    "ClockStopElapsed": 115,
    "TotalTimeElapsed": 263
  },
  {
    "ApplicationNo": 414,
    "EUNumber": "EU/1/02/215",
    "EUNoShort": 215,
    "BrandName": "PritorPlus",
    "MAH": "Bayer AG",
    "ActiveSubstance": "Telmisartan / hydrochlorothiazide",
    "DecisionDate": "04/22/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Italy",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 4.8a(2)",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 148,
    "ClockStopElapsed": 115,
    "TotalTimeElapsed": 263
  },
  {
    "ApplicationNo": 463,
    "EUNumber": "EU/1/02/219",
    "EUNoShort": 219,
    "BrandName": "Ebixa",
    "MAH": "H. Lundbeck A/S",
    "ActiveSubstance": "Memantine",
    "DecisionDate": "05/15/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 55,
    "ClockStopElapsed": 64,
    "TotalTimeElapsed": 119
  },
  {
    "ApplicationNo": 401,
    "EUNumber": "EU/1/02/220",
    "EUNoShort": 220,
    "BrandName": "Tracleer",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "bosentan",
    "DecisionDate": "05/15/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "France",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "C02",
    "ATCCodeL1": "C",
    "ATCNameL2": "Antihypertensives",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 187,
    "ClockStopElapsed": 167,
    "TotalTimeElapsed": 354
  },
  {
    "ApplicationNo": 407,
    "EUNumber": "EU/1/02/217",
    "EUNoShort": 217,
    "BrandName": "Opatanol",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Olopatadine",
    "DecisionDate": "05/17/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 223,
    "ClockStopElapsed": 101,
    "TotalTimeElapsed": 324
  },
  {
    "ApplicationNo": 378,
    "EUNumber": "EU/1/02/218",
    "EUNoShort": 218,
    "BrandName": "Axura",
    "MAH": "Merz Pharmaceuticals GmbH",
    "ActiveSubstance": "Memantine",
    "DecisionDate": "05/17/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 295,
    "TotalTimeElapsed": 505
  },
  {
    "ApplicationNo": 395,
    "EUNumber": "EU/1/02/221",
    "EUNoShort": 221,
    "BrandName": "Pegasys",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "peginterferon alfa-2a",
    "DecisionDate": "06/20/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 216,
    "TotalTimeElapsed": 421
  },
  {
    "ApplicationNo": 402,
    "EUNumber": "EU/1/02/222",
    "EUNoShort": 222,
    "BrandName": "Tamiflu",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "Oseltamivir",
    "DecisionDate": "06/20/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Finland",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 180,
    "TotalTimeElapsed": 384
  },
  {
    "ApplicationNo": 410,
    "EUNumber": "EU/1/02/223",
    "EUNoShort": 223,
    "BrandName": "Evra",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "Norelgestromin / Ethinyl estradiol",
    "DecisionDate": "08/22/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 147,
    "TotalTimeElapsed": 324
  },
  {
    "ApplicationNo": 420,
    "EUNumber": "EU/1/02/227",
    "EUNoShort": 227,
    "BrandName": "Neulasta",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "Pegfilgrastim",
    "DecisionDate": "08/22/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 191,
    "TotalTimeElapsed": 368
  },
  {
    "ApplicationNo": 422,
    "EUNumber": "EU/1/02/228",
    "EUNoShort": 228,
    "BrandName": "Neupopeg",
    "MAH": "Domp√© Biotec S.p.A.",
    "ActiveSubstance": "Pegfilgrastim",
    "DecisionDate": "08/22/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 191,
    "TotalTimeElapsed": 368
  },
  {
    "ApplicationNo": 396,
    "EUNumber": "EU/1/02/225",
    "EUNoShort": 225,
    "BrandName": "Xigris",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "Drotrecogin alfa (activated)",
    "DecisionDate": "08/22/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 211,
    "ClockStopElapsed": 270,
    "TotalTimeElapsed": 481
  },
  {
    "ApplicationNo": 426,
    "EUNumber": "EU/1/02/224",
    "EUNoShort": 224,
    "BrandName": "Ambirix",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)",
    "DecisionDate": "08/30/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 178,
    "ClockStopElapsed": 163,
    "TotalTimeElapsed": 341
  },
  {
    "ApplicationNo": 408,
    "EUNumber": "EU/1/02/226",
    "EUNoShort": 226,
    "BrandName": "InductOs",
    "MAH": "Medtronic BioPharma B.V.",
    "ActiveSubstance": "Dibotermin alfa",
    "DecisionDate": "09/09/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 224,
    "TotalTimeElapsed": 434
  },
  {
    "ApplicationNo": 427,
    "EUNumber": "EU/1/02/229",
    "EUNoShort": 229,
    "BrandName": "Actraphane",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "Insulin human (rDNA)",
    "DecisionDate": "10/07/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 105,
    "TotalTimeElapsed": 306
  },
  {
    "ApplicationNo": 424,
    "EUNumber": "EU/1/02/230",
    "EUNoShort": 230,
    "BrandName": "Actrapid",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "Insulin human (rDNA)",
    "DecisionDate": "10/07/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 133,
    "TotalTimeElapsed": 333
  },
  {
    "ApplicationNo": 428,
    "EUNumber": "EU/1/02/231",
    "EUNoShort": 231,
    "BrandName": "Mixtard",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "Insulin human (rDNA)",
    "DecisionDate": "10/07/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 105,
    "TotalTimeElapsed": 306
  },
  {
    "ApplicationNo": 423,
    "EUNumber": "EU/1/02/232",
    "EUNoShort": 232,
    "BrandName": "Velosulin",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "Insulin human (rDNA)",
    "DecisionDate": "10/07/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 133,
    "TotalTimeElapsed": 333
  },
  {
    "ApplicationNo": 441,
    "EUNumber": "EU/1/02/233",
    "EUNoShort": 233,
    "BrandName": "Insulatard",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "Insulin human (rDNA)",
    "DecisionDate": "10/07/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 78,
    "TotalTimeElapsed": 278
  },
  {
    "ApplicationNo": 442,
    "EUNumber": "EU/1/02/234",
    "EUNoShort": 234,
    "BrandName": "Protaphane",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "Insulin human (rDNA)",
    "DecisionDate": "10/07/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 78,
    "TotalTimeElapsed": 278
  },
  {
    "ApplicationNo": 440,
    "EUNumber": "EU/1/02/235",
    "EUNoShort": 235,
    "BrandName": "Monotard",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "Insulin human (rDNA)",
    "DecisionDate": "10/07/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 78,
    "TotalTimeElapsed": 278
  },
  {
    "ApplicationNo": 439,
    "EUNumber": "EU/1/02/236",
    "EUNoShort": 236,
    "BrandName": "Ultratard",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "Insulin human (rDNA)",
    "DecisionDate": "10/07/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 78,
    "TotalTimeElapsed": 278
  },
  {
    "ApplicationNo": 436,
    "EUNumber": "EU/1/02/237",
    "EUNoShort": 237,
    "BrandName": "Cialis",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "tadalafil",
    "DecisionDate": "11/12/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 166,
    "TotalTimeElapsed": 368
  },
  {
    "ApplicationNo": 409,
    "EUNumber": "EU/1/02/240",
    "EUNoShort": 240,
    "BrandName": "Somavert",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "Pegvisomant",
    "DecisionDate": "11/13/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "France",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "H01",
    "ATCCodeL1": "H",
    "ATCNameL2": "Pituitary and hypothalamic hormones and analogues",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 299,
    "TotalTimeElapsed": 476
  },
  {
    "ApplicationNo": 435,
    "EUNumber": "EU/1/02/238",
    "EUNoShort": 238,
    "BrandName": "Zavesca",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "Miglustat",
    "DecisionDate": "11/20/2002",
    "DecisionYear": "2002",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 168,
    "TotalTimeElapsed": 368
  },
  {
    "ApplicationNo": 445,
    "EUNumber": "EU/1/02/245",
    "EUNoShort": 245,
    "BrandName": "Theryttrex",
    "MAH": "MDS Nordion S.A.",
    "ActiveSubstance": "Yttrium (<sup>90</sup>Y) Chloride",
    "DecisionDate": "01/07/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "unknown",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 212,
    "ClockStopElapsed": 150,
    "TotalTimeElapsed": 362
  },
  {
    "ApplicationNo": 461,
    "EUNumber": "EU/1/02/246",
    "EUNoShort": 246,
    "BrandName": "Carbaglu",
    "MAH": "Recordati Rare Diseases",
    "ActiveSubstance": "Carglumic acid",
    "DecisionDate": "01/24/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 191,
    "ClockStopElapsed": 164,
    "TotalTimeElapsed": 355
  },
  {
    "ApplicationNo": 488,
    "EUNumber": "EU/1/03/249",
    "EUNoShort": 249,
    "BrandName": "Vivanza",
    "MAH": "Bayer AG",
    "ActiveSubstance": "Vardenafil",
    "DecisionDate": "03/04/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 96,
    "ClockStopElapsed": 115,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 475,
    "EUNumber": "EU/1/03/248",
    "EUNoShort": 248,
    "BrandName": "Levitra",
    "MAH": "Bayer AG",
    "ActiveSubstance": "Vardenafil",
    "DecisionDate": "03/06/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 115,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 485,
    "EUNumber": "EU/1/03/251",
    "EUNoShort": 251,
    "BrandName": "Hepsera",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "adefovir dipivoxil",
    "DecisionDate": "03/06/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "France",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 152,
    "ClockStopElapsed": 59,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 460,
    "EUNumber": "EU/1/03/250",
    "EUNoShort": 250,
    "BrandName": "Ytracis",
    "MAH": "CIS bio international",
    "ActiveSubstance": "Yttrium (<sup>90</sup>Y) Chloride",
    "DecisionDate": "03/24/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 176,
    "ClockStopElapsed": 209,
    "TotalTimeElapsed": 385
  },
  {
    "ApplicationNo": 431,
    "EUNumber": "EU/1/02/239",
    "EUNoShort": 239,
    "BrandName": "Bextra",
    "MAH": "Pharmacia Europe EEIG",
    "ActiveSubstance": "Valdecoxib",
    "DecisionDate": "03/27/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "M01",
    "ATCCodeL1": "M",
    "ATCNameL2": "Antiinflammatory and antirheumatic products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 165,
    "TotalTimeElapsed": 368
  },
  {
    "ApplicationNo": 432,
    "EUNumber": "EU/1/02/242",
    "EUNoShort": 242,
    "BrandName": "Valdyn",
    "MAH": "Pharmacia Europe EEIG",
    "ActiveSubstance": "Valdecoxib",
    "DecisionDate": "03/27/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "M01",
    "ATCCodeL1": "M",
    "ATCNameL2": "Antiinflammatory and antirheumatic products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 165,
    "TotalTimeElapsed": 368
  },
  {
    "ApplicationNo": 437,
    "EUNumber": "EU/1/02/244",
    "EUNoShort": 244,
    "BrandName": "Valdyn (ex Kudeq)",
    "MAH": "Pfizer Limited",
    "ActiveSubstance": "Valdecoxib",
    "DecisionDate": "03/27/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "M01",
    "ATCCodeL1": "M",
    "ATCNameL2": "Antiinflammatory and antirheumatic products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 165,
    "TotalTimeElapsed": 368
  },
  {
    "ApplicationNo": 514,
    "EUNumber": "EU/1/03/252",
    "EUNoShort": 252,
    "BrandName": "Fuzeon",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "Enfuvirtide",
    "DecisionDate": "05/27/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 139,
    "ClockStopElapsed": 9,
    "TotalTimeElapsed": 148
  },
  {
    "ApplicationNo": 425,
    "EUNumber": "EU/1/03/247",
    "EUNoShort": 247,
    "BrandName": "Forsteo",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "Teriparatide",
    "DecisionDate": "06/10/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "H05",
    "ATCCodeL1": "H",
    "ATCNameL2": "Calcium homeostasis",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 339,
    "TotalTimeElapsed": 546
  },
  {
    "ApplicationNo": 477,
    "EUNumber": "EU/1/03/253",
    "EUNoShort": 253,
    "BrandName": "Aldurazyme",
    "MAH": "Genzyme Europe B.V.",
    "ActiveSubstance": "Laronidase",
    "DecisionDate": "06/10/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 119,
    "TotalTimeElapsed": 324
  },
  {
    "ApplicationNo": 472,
    "EUNumber": "EU/1/03/254",
    "EUNoShort": 254,
    "BrandName": "Busilvex",
    "MAH": "Pierre Fabre M√©dicament",
    "ActiveSubstance": "busulfan",
    "DecisionDate": "07/09/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 4.8a(2)",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 173,
    "ClockStopElapsed": 180,
    "TotalTimeElapsed": 353
  },
  {
    "ApplicationNo": 482,
    "EUNumber": "EU/1/03/257",
    "EUNoShort": 257,
    "BrandName": "Trudexa",
    "MAH": "Abbott Laboratories Ltd",
    "ActiveSubstance": "Adalimumab",
    "DecisionDate": "09/01/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 181,
    "ClockStopElapsed": 209,
    "TotalTimeElapsed": 390
  },
  {
    "ApplicationNo": 481,
    "EUNumber": "EU/1/03/256",
    "EUNoShort": 256,
    "BrandName": "Humira",
    "MAH": "AbbVie Deutschland GmbH & Co. KG",
    "ActiveSubstance": "Adalimumab",
    "DecisionDate": "09/08/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 181,
    "ClockStopElapsed": 209,
    "TotalTimeElapsed": 390
  },
  {
    "ApplicationNo": 474,
    "EUNumber": "EU/1/03/255",
    "EUNoShort": 255,
    "BrandName": "Ventavis",
    "MAH": "Bayer AG",
    "ActiveSubstance": "Iloprost",
    "DecisionDate": "09/16/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "France",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 265,
    "TotalTimeElapsed": 474
  },
  {
    "ApplicationNo": 511,
    "EUNumber": "EU/1/03/260",
    "EUNoShort": 260,
    "BrandName": "Stalevo",
    "MAH": "Orion Corporation",
    "ActiveSubstance": "Levodopa,carbidopa,entacapone",
    "DecisionDate": "10/17/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "Finland",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 194,
    "ClockStopElapsed": 79,
    "TotalTimeElapsed": 273
  },
  {
    "ApplicationNo": 466,
    "EUNumber": "EU/1/03/259",
    "EUNoShort": 259,
    "BrandName": "Onsenal",
    "MAH": "Pfizer Limited",
    "ActiveSubstance": "Celecoxib",
    "DecisionDate": "10/17/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "Italy",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 369,
    "TotalTimeElapsed": 577
  },
  {
    "ApplicationNo": 522,
    "EUNumber": "EU/1/03/258",
    "EUNoShort": 258,
    "BrandName": "Avandamet",
    "MAH": "SmithKline Beecham Ltd",
    "ActiveSubstance": "rosiglitazone / metformin",
    "DecisionDate": "10/20/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 178,
    "ClockStopElapsed": 67,
    "TotalTimeElapsed": 245
  },
  {
    "ApplicationNo": 533,
    "EUNumber": "EU/1/03/261",
    "EUNoShort": 261,
    "BrandName": "Emtriva",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "Emtricitabine",
    "DecisionDate": "10/24/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 170,
    "ClockStopElapsed": 28,
    "TotalTimeElapsed": 198
  },
  {
    "ApplicationNo": 527,
    "EUNumber": "EU/1/03/262",
    "EUNoShort": 262,
    "BrandName": "Emend",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "aprepitant",
    "DecisionDate": "11/11/2003",
    "DecisionYear": "2003",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "A04",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antiemetics and antinauseants",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 64,
    "TotalTimeElapsed": 246
  },
  {
    "ApplicationNo": 547,
    "EUNumber": "EU/1/03/264",
    "EUNoShort": 264,
    "BrandName": "Zevalin",
    "MAH": "Ceft Biopharma s.r.o",
    "ActiveSubstance": "Ibritumomab tiuxetan",
    "DecisionDate": "01/16/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "V10",
    "ATCCodeL1": "V",
    "ATCNameL2": "Therapeutic radiopharmaceuticals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 153,
    "ClockStopElapsed": 28,
    "TotalTimeElapsed": 181
  },
  {
    "ApplicationNo": 501,
    "EUNumber": "EU/1/03/265",
    "EUNoShort": 265,
    "BrandName": "Bonviva",
    "MAH": "Atnahs Pharma Netherlands B.V.",
    "ActiveSubstance": "Ibandronic acid",
    "DecisionDate": "02/23/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 244,
    "TotalTimeElapsed": 451
  },
  {
    "ApplicationNo": 502,
    "EUNumber": "EU/1/03/266",
    "EUNoShort": 266,
    "BrandName": "Bondenza",
    "MAH": "Roche Registration Limited",
    "ActiveSubstance": "Ibandronic acid",
    "DecisionDate": "02/23/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 244,
    "TotalTimeElapsed": 451
  },
  {
    "ApplicationNo": 520,
    "EUNumber": "EU/1/03/271",
    "EUNoShort": 271,
    "BrandName": "Advate",
    "MAH": "Takeda Manufacturing Austria AG",
    "ActiveSubstance": "octocog alfa",
    "DecisionDate": "03/02/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Germany",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 156,
    "TotalTimeElapsed": 356
  },
  {
    "ApplicationNo": 494,
    "EUNumber": "EU/1/03/267",
    "EUNoShort": 267,
    "BrandName": "Reyataz",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "atazanavir sulphate",
    "DecisionDate": "03/02/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "France",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 326,
    "TotalTimeElapsed": 526
  },
  {
    "ApplicationNo": 512,
    "EUNumber": "EU/1/03/268",
    "EUNoShort": 268,
    "BrandName": "Cholestagel",
    "MAH": "CHEPLAPHARM Arzneimittel GmbH",
    "ActiveSubstance": "colesevelam hydrochloride",
    "DecisionDate": "03/10/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "C10",
    "ATCCodeL1": "C",
    "ATCNameL2": "Lipid modifying agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 204,
    "TotalTimeElapsed": 405
  },
  {
    "ApplicationNo": 540,
    "EUNumber": "EU/1/03/269",
    "EUNoShort": 269,
    "BrandName": "Faslodex",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "Fulvestrant",
    "DecisionDate": "03/10/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L02",
    "ATCCodeL1": "L",
    "ATCNameL2": "Endocrine therapy",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 176,
    "ClockStopElapsed": 54,
    "TotalTimeElapsed": 230
  },
  {
    "ApplicationNo": 493,
    "EUNumber": "EU/1/04/272",
    "EUNoShort": 272,
    "BrandName": "PhotoBarr",
    "MAH": "Pinnacle Biologics B.V.",
    "ActiveSubstance": "Porfimer sodium",
    "DecisionDate": "03/25/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Germany",
    "CoRapporteur": "France",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 197,
    "ClockStopElapsed": 321,
    "TotalTimeElapsed": 518
  },
  {
    "ApplicationNo": 504,
    "EUNumber": "EU/1/04/275",
    "EUNoShort": 275,
    "BrandName": "Litak",
    "MAH": "Lipomed GmbH",
    "ActiveSubstance": "Cladribine",
    "DecisionDate": "04/14/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 206,
    "ClockStopElapsed": 244,
    "TotalTimeElapsed": 450
  },
  {
    "ApplicationNo": 539,
    "EUNumber": "EU/1/04/274",
    "EUNoShort": 274,
    "BrandName": "VELCADE",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "bortezomib",
    "DecisionDate": "04/26/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Italy",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 183,
    "ClockStopElapsed": 148,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 476,
    "EUNumber": "EU/1/03/263",
    "EUNoShort": 263,
    "BrandName": "Dukoral",
    "MAH": "Valneva Sweden AB",
    "ActiveSubstance": "Oral cholera vaccine",
    "DecisionDate": "04/28/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 277,
    "TotalTimeElapsed": 478
  },
  {
    "ApplicationNo": 521,
    "EUNumber": "EU/1/04/273",
    "EUNoShort": 273,
    "BrandName": "Lysodren",
    "MAH": "HRA Pharma Rare Diseases",
    "ActiveSubstance": "Mitotane",
    "DecisionDate": "04/28/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 194,
    "ClockStopElapsed": 236,
    "TotalTimeElapsed": 430
  },
  {
    "ApplicationNo": 528,
    "EUNumber": "EU/1/04/278",
    "EUNoShort": 278,
    "BrandName": "Levemir",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "insulin detemir",
    "DecisionDate": "06/01/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 181,
    "ClockStopElapsed": 284,
    "TotalTimeElapsed": 465
  },
  {
    "ApplicationNo": 471,
    "EUNumber": "EU/1/04/276",
    "EUNoShort": 276,
    "BrandName": "Abilify",
    "MAH": "Otsuka Pharmaceutical Netherlands B.V.",
    "ActiveSubstance": "aripiprazole",
    "DecisionDate": "06/04/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Greece",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 217,
    "ClockStopElapsed": 577,
    "TotalTimeElapsed": 794
  },
  {
    "ApplicationNo": 505,
    "EUNumber": "EU/1/04/277",
    "EUNoShort": 277,
    "BrandName": "TachoSil",
    "MAH": "Takeda Austria GmbH",
    "ActiveSubstance": "Human Fibrinogen / Human Thrombin",
    "DecisionDate": "06/08/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 228,
    "ClockStopElapsed": 356,
    "TotalTimeElapsed": 584
  },
  {
    "ApplicationNo": 532,
    "EUNumber": "EU/1/03/270",
    "EUNoShort": 270,
    "BrandName": "Kentera",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Oxybutynin",
    "DecisionDate": "06/15/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 87,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 558,
    "EUNumber": "EU/1/04/281",
    "EUNoShort": 281,
    "BrandName": "Erbitux",
    "MAH": "Merck Europe B.V.",
    "ActiveSubstance": "cetuximab",
    "DecisionDate": "06/29/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 175,
    "ClockStopElapsed": 61,
    "TotalTimeElapsed": 236
  },
  {
    "ApplicationNo": 546,
    "EUNumber": "EU/1/04/279",
    "EUNoShort": 279,
    "BrandName": "Lyrica",
    "MAH": "Upjohn EESV",
    "ActiveSubstance": "pregabalin",
    "DecisionDate": "07/06/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 172,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 325
  },
  {
    "ApplicationNo": 534,
    "EUNumber": "EU/1/04/282",
    "EUNoShort": 282,
    "BrandName": "Telzir",
    "MAH": "ViiV Healthcare BV",
    "ActiveSubstance": "Fosamprenavir",
    "DecisionDate": "07/12/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "France",
    "CoRapporteur": "Luxembourg",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 207,
    "TotalTimeElapsed": 384
  },
  {
    "ApplicationNo": 549,
    "EUNumber": "EU/1/04/284",
    "EUNoShort": 284,
    "BrandName": "Pedea",
    "MAH": "Recordati Rare Diseases",
    "ActiveSubstance": "Ibuprofen",
    "DecisionDate": "07/29/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "C01",
    "ATCCodeL1": "C",
    "ATCNameL2": "Cardiac therapy",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 66,
    "TotalTimeElapsed": 276
  },
  {
    "ApplicationNo": 545,
    "EUNumber": "EU/1/04/280",
    "EUNoShort": 280,
    "BrandName": "Yentreve",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "duloxetine hydrochloride",
    "DecisionDate": "08/11/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 213,
    "TotalTimeElapsed": 395
  },
  {
    "ApplicationNo": 552,
    "EUNumber": "EU/1/04/283",
    "EUNoShort": 283,
    "BrandName": "Ariclaim",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "duloxetine hydrochloride",
    "DecisionDate": "08/11/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 233,
    "ClockStopElapsed": 161,
    "TotalTimeElapsed": 394
  },
  {
    "ApplicationNo": 562,
    "EUNumber": "EU/1/04/289",
    "EUNoShort": 289,
    "BrandName": "Angiox",
    "MAH": "The Medicines Company UK Ltd",
    "ActiveSubstance": "Bivalirudin",
    "DecisionDate": "09/20/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 181,
    "ClockStopElapsed": 129,
    "TotalTimeElapsed": 310
  },
  {
    "ApplicationNo": 564,
    "EUNumber": "EU/1/04/290",
    "EUNoShort": 290,
    "BrandName": "Alimta",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "pemetrexed",
    "DecisionDate": "09/20/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 108,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 542,
    "EUNumber": "EU/1/04/291",
    "EUNoShort": 291,
    "BrandName": "Raptiva",
    "MAH": "Serono Europe Limited",
    "ActiveSubstance": "Efalizumab",
    "DecisionDate": "09/20/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 183,
    "ClockStopElapsed": 303,
    "TotalTimeElapsed": 486
  },
  {
    "ApplicationNo": 561,
    "EUNumber": "EU/1/04/287",
    "EUNoShort": 287,
    "BrandName": "Osseor",
    "MAH": "Les Laboratoires Servier",
    "ActiveSubstance": "Strontium ranelate",
    "DecisionDate": "09/21/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 184,
    "ClockStopElapsed": 154,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 560,
    "EUNumber": "EU/1/04/288",
    "EUNoShort": 288,
    "BrandName": "Protelos",
    "MAH": "Les Laboratoires Servier",
    "ActiveSubstance": "Strontium ranelate",
    "DecisionDate": "09/21/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 184,
    "ClockStopElapsed": 154,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 557,
    "EUNumber": "EU/1/04/285",
    "EUNoShort": 285,
    "BrandName": "Apidra",
    "MAH": "Sanofi-Aventis Deutschland GmbH",
    "ActiveSubstance": "Insulin glulisine",
    "DecisionDate": "09/27/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 184,
    "ClockStopElapsed": 162,
    "TotalTimeElapsed": 346
  },
  {
    "ApplicationNo": 535,
    "EUNumber": "EU/1/04/286",
    "EUNoShort": 286,
    "BrandName": "Wilzin",
    "MAH": "Recordati Rare Diseases",
    "ActiveSubstance": "Zinc acetate dihydrate",
    "DecisionDate": "10/13/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 188,
    "ClockStopElapsed": 269,
    "TotalTimeElapsed": 457
  },
  {
    "ApplicationNo": 570,
    "EUNumber": "EU/1/04/292",
    "EUNoShort": 292,
    "BrandName": "Mimpara",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "Cinacalcet",
    "DecisionDate": "10/22/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "H05",
    "ATCCodeL1": "H",
    "ATCNameL2": "Calcium homeostasis",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 196,
    "ClockStopElapsed": 80,
    "TotalTimeElapsed": 276
  },
  {
    "ApplicationNo": 575,
    "EUNumber": "EU/1/04/293",
    "EUNoShort": 293,
    "BrandName": "Parareg",
    "MAH": "Domp√© Biotec S.p.A.",
    "ActiveSubstance": "Cinacalcet",
    "DecisionDate": "10/22/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "H05",
    "ATCCodeL1": "H",
    "ATCNameL2": "Calcium homeostasis",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 196,
    "ClockStopElapsed": 80,
    "TotalTimeElapsed": 276
  },
  {
    "ApplicationNo": 554,
    "EUNumber": "EU/1/04/294",
    "EUNoShort": 294,
    "BrandName": "Emselex",
    "MAH": "zr pharma& GmbH",
    "ActiveSubstance": "darifenacin hydrobromide",
    "DecisionDate": "10/22/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 181,
    "ClockStopElapsed": 221,
    "TotalTimeElapsed": 402
  },
  {
    "ApplicationNo": 480,
    "EUNumber": "EU/1/04/295",
    "EUNoShort": 295,
    "BrandName": "Xagrid",
    "MAH": "Shire Pharmaceuticals Ireland Limited",
    "ActiveSubstance": "anagrelide",
    "DecisionDate": "11/16/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "France",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 181,
    "ClockStopElapsed": 271,
    "TotalTimeElapsed": 452
  },
  {
    "ApplicationNo": 572,
    "EUNumber": "EU/1/04/296",
    "EUNoShort": 296,
    "BrandName": "Cymbalta",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "duloxetine hydrochloride",
    "DecisionDate": "12/17/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 113,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 573,
    "EUNumber": "EU/1/04/297",
    "EUNoShort": 297,
    "BrandName": "Nodetrip",
    "MAH": "Esteve Pharmaceuticals S.A.",
    "ActiveSubstance": "duloxetine hydrochloride",
    "DecisionDate": "12/17/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "Spain",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 113,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 581,
    "EUNumber": "EU/1/04/298",
    "EUNoShort": 298,
    "BrandName": "Kivexa",
    "MAH": "ViiV Healthcare BV",
    "ActiveSubstance": "abacavir / Lamivudine",
    "DecisionDate": "12/17/2004",
    "DecisionYear": "2004",
    "Period": "2001-2005",
    "Rapporteur": "France",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 175,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 293
  },
  {
    "ApplicationNo": 582,
    "EUNumber": "EU/1/04/300",
    "EUNoShort": 300,
    "BrandName": "Avastin",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "bevacizumab",
    "DecisionDate": "01/12/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 100,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 550,
    "EUNumber": "EU/1/04/299",
    "EUNoShort": 299,
    "BrandName": "Fendrix",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)",
    "DecisionDate": "02/02/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 168,
    "ClockStopElapsed": 363,
    "TotalTimeElapsed": 531
  },
  {
    "ApplicationNo": 556,
    "EUNumber": "EU/1/04/301",
    "EUNoShort": 301,
    "BrandName": "Quintanrix",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Diphtheria, tetanus, pertussis (whole cell), hepatitis B (rDNA) and Haemophilus type b conjugate vaccine (adsorbed)",
    "DecisionDate": "02/17/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 215,
    "ClockStopElapsed": 297,
    "TotalTimeElapsed": 512
  },
  {
    "ApplicationNo": 574,
    "EUNumber": "EU/1/04/304",
    "EUNoShort": 304,
    "BrandName": "Azilect",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "rasagiline",
    "DecisionDate": "02/21/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 180,
    "TotalTimeElapsed": 388
  },
  {
    "ApplicationNo": 594,
    "EUNumber": "EU/1/04/305",
    "EUNoShort": 305,
    "BrandName": "Truvada",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "emtricitabine / tenofovir disoproxil fumarate",
    "DecisionDate": "02/21/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 52,
    "TotalTimeElapsed": 234
  },
  {
    "ApplicationNo": 551,
    "EUNumber": "EU/1/04/302",
    "EUNoShort": 302,
    "BrandName": "Prialt",
    "MAH": "RIEMSER Pharma GmbH",
    "ActiveSubstance": "ziconotide",
    "DecisionDate": "02/21/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "N02",
    "ATCCodeL1": "N",
    "ATCNameL2": "Analgesics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 196,
    "ClockStopElapsed": 346,
    "TotalTimeElapsed": 542
  },
  {
    "ApplicationNo": 555,
    "EUNumber": "EU/1/04/303",
    "EUNoShort": 303,
    "BrandName": "Orfadin",
    "MAH": "Swedish Orphan Biovitrum International AB",
    "ActiveSubstance": "Nitisinone",
    "DecisionDate": "02/21/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Italy",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 197,
    "ClockStopElapsed": 289,
    "TotalTimeElapsed": 486
  },
  {
    "ApplicationNo": 577,
    "EUNumber": "EU/1/04/307",
    "EUNoShort": 307,
    "BrandName": "Zonegran",
    "MAH": "Eisai GmbH",
    "ActiveSubstance": "zonisamide",
    "DecisionDate": "03/10/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 185,
    "TotalTimeElapsed": 387
  },
  {
    "ApplicationNo": 563,
    "EUNumber": "EU/1/04/306",
    "EUNoShort": 306,
    "BrandName": "Aloxi",
    "MAH": "Helsinn Birex Pharmaceuticals Ltd",
    "ActiveSubstance": "Palonosetron",
    "DecisionDate": "03/22/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "A04",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antiemetics and antinauseants",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 206,
    "ClockStopElapsed": 279,
    "TotalTimeElapsed": 485
  },
  {
    "ApplicationNo": 595,
    "EUNumber": "EU/1/05/308",
    "EUNoShort": 308,
    "BrandName": "Aclasta",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "zoledronic acid",
    "DecisionDate": "04/15/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Iceland",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 181,
    "ClockStopElapsed": 67,
    "TotalTimeElapsed": 248
  },
  {
    "ApplicationNo": 619,
    "EUNumber": "EU/1/05/310",
    "EUNoShort": 310,
    "BrandName": "Fosavance",
    "MAH": "N.V. Organon",
    "ActiveSubstance": "Alendronate Sodium / Colecalciferol",
    "DecisionDate": "08/24/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 38,
    "TotalTimeElapsed": 220
  },
  {
    "ApplicationNo": 618,
    "EUNumber": "EU/1/05/311",
    "EUNoShort": 311,
    "BrandName": "Tarceva",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "Erlotinib",
    "DecisionDate": "09/19/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 193,
    "ClockStopElapsed": 83,
    "TotalTimeElapsed": 276
  },
  {
    "ApplicationNo": 601,
    "EUNumber": "EU/1/05/313",
    "EUNoShort": 313,
    "BrandName": "Ablavar",
    "MAH": "TMC Pharma Services Ltd",
    "ActiveSubstance": "Gadofosveset Trisodium",
    "DecisionDate": "10/03/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "V08",
    "ATCCodeL1": "V",
    "ATCNameL2": "Contrast media",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 185,
    "TotalTimeElapsed": 367
  },
  {
    "ApplicationNo": 593,
    "EUNumber": "EU/1/05/312",
    "EUNoShort": 312,
    "BrandName": "Xyrem",
    "MAH": "UCB Pharma S.A.",
    "ActiveSubstance": "Sodium oxybate",
    "DecisionDate": "10/13/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 198,
    "ClockStopElapsed": 253,
    "TotalTimeElapsed": 451
  },
  {
    "ApplicationNo": 609,
    "EUNumber": "EU/1/05/314",
    "EUNoShort": 314,
    "BrandName": "Kepivance",
    "MAH": "Swedish Orphan Biovitrum AB (publ)",
    "ActiveSubstance": "Palifermin",
    "DecisionDate": "10/25/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 217,
    "ClockStopElapsed": 156,
    "TotalTimeElapsed": 373
  },
  {
    "ApplicationNo": 597,
    "EUNumber": "EU/1/05/316",
    "EUNoShort": 316,
    "BrandName": "Procoralan",
    "MAH": "Les Laboratoires Servier",
    "ActiveSubstance": "Ivabradine",
    "DecisionDate": "10/25/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "C01",
    "ATCCodeL1": "C",
    "ATCNameL2": "Cardiac therapy",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 211,
    "ClockStopElapsed": 225,
    "TotalTimeElapsed": 436
  },
  {
    "ApplicationNo": 598,
    "EUNumber": "EU/1/05/317",
    "EUNoShort": 317,
    "BrandName": "Corlentor",
    "MAH": "Les Laboratoires Servier",
    "ActiveSubstance": "Ivabradine",
    "DecisionDate": "10/25/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "C01",
    "ATCCodeL1": "C",
    "ATCNameL2": "Cardiac therapy",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 211,
    "ClockStopElapsed": 225,
    "TotalTimeElapsed": 436
  },
  {
    "ApplicationNo": 606,
    "EUNumber": "EU/1/05/319",
    "EUNoShort": 319,
    "BrandName": "Xolair",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "omalizumab",
    "DecisionDate": "10/25/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 214,
    "ClockStopElapsed": 159,
    "TotalTimeElapsed": 373
  },
  {
    "ApplicationNo": 610,
    "EUNumber": "EU/1/05/320",
    "EUNoShort": 320,
    "BrandName": "Noxafil",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "Posaconazole",
    "DecisionDate": "10/25/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "J02",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycotics for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 219,
    "ClockStopElapsed": 154,
    "TotalTimeElapsed": 373
  },
  {
    "ApplicationNo": 611,
    "EUNumber": "EU/1/05/321",
    "EUNoShort": 321,
    "BrandName": "Posaconazole SP",
    "MAH": "SP Europe",
    "ActiveSubstance": "Posaconazole",
    "DecisionDate": "10/25/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "J02",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycotics for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 219,
    "ClockStopElapsed": 154,
    "TotalTimeElapsed": 373
  },
  {
    "ApplicationNo": 631,
    "EUNumber": "EU/1/05/315",
    "EUNoShort": 315,
    "BrandName": "APTIVUS",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "Tipranavir",
    "DecisionDate": "10/25/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 50,
    "TotalTimeElapsed": 254
  },
  {
    "ApplicationNo": 638,
    "EUNumber": "EU/1/05/318",
    "EUNoShort": 318,
    "BrandName": "Revatio",
    "MAH": "Upjohn EESV",
    "ActiveSubstance": "sildenafil",
    "DecisionDate": "10/28/2005",
    "DecisionYear": "2005",
    "Period": "2001-2005",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 2309/93",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "unknown",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 42,
    "TotalTimeElapsed": 219
  },
  {
    "ApplicationNo": 596,
    "EUNumber": "EU/1/05/322",
    "EUNoShort": 322,
    "BrandName": "Yttriga",
    "MAH": "Eckert & Ziegler Radiopharma GmbH",
    "ActiveSubstance": "Yttrium (<sup>90</sup>Y) Chloride",
    "DecisionDate": "01/19/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "V10",
    "ATCCodeL1": "V",
    "ATCNameL2": "Therapeutic radiopharmaceuticals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 216,
    "ClockStopElapsed": 207,
    "TotalTimeElapsed": 423
  },
  {
    "ApplicationNo": 637,
    "EUNumber": "EU/1/05/328",
    "EUNoShort": 328,
    "BrandName": "Cubicin",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "Daptomycin",
    "DecisionDate": "01/19/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 217,
    "ClockStopElapsed": 115,
    "TotalTimeElapsed": 332
  },
  {
    "ApplicationNo": 628,
    "EUNumber": "EU/1/05/329",
    "EUNoShort": 329,
    "BrandName": "Kiovig",
    "MAH": "Takeda Manufacturing Austria AG",
    "ActiveSubstance": "Human normal immunoglobulin (IVIg)",
    "DecisionDate": "01/19/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "J06",
    "ATCCodeL1": "J",
    "ATCNameL2": "Immune sera and immunoglobulins",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 191,
    "TotalTimeElapsed": 395
  },
  {
    "ApplicationNo": 612,
    "EUNumber": "EU/1/05/326",
    "EUNoShort": 326,
    "BrandName": "Ionsys",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "Fentanyl",
    "DecisionDate": "01/24/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "N02",
    "ATCCodeL1": "N",
    "ATCNameL2": "Analgesics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 199,
    "ClockStopElapsed": 252,
    "TotalTimeElapsed": 451
  },
  {
    "ApplicationNo": 588,
    "EUNumber": "EU/1/05/327",
    "EUNoShort": 327,
    "BrandName": "Exubera",
    "MAH": "Pfizer Limited",
    "ActiveSubstance": "Insulin human",
    "DecisionDate": "01/24/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 390,
    "TotalTimeElapsed": 598
  },
  {
    "ApplicationNo": 640,
    "EUNumber": "EU/1/05/324",
    "EUNoShort": 324,
    "BrandName": "Naglazyme",
    "MAH": "BioMarin International Limited",
    "ActiveSubstance": "galsulfase",
    "DecisionDate": "01/24/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 56,
    "TotalTimeElapsed": 269
  },
  {
    "ApplicationNo": 620,
    "EUNumber": "EU/1/05/325",
    "EUNoShort": 325,
    "BrandName": "Macugen",
    "MAH": "PharmaSwiss Cesk√° republika s.r.o.",
    "ActiveSubstance": "pegaptanib sodium",
    "DecisionDate": "01/31/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 216,
    "ClockStopElapsed": 170,
    "TotalTimeElapsed": 386
  },
  {
    "ApplicationNo": 626,
    "EUNumber": "EU/1/05/331",
    "EUNoShort": 331,
    "BrandName": "Neupro",
    "MAH": "UCB Pharma S.A.",
    "ActiveSubstance": "Rotigotine",
    "DecisionDate": "02/15/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 220,
    "TotalTimeElapsed": 422
  },
  {
    "ApplicationNo": 639,
    "EUNumber": "EU/1/05/330",
    "EUNoShort": 330,
    "BrandName": "Rotarix",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Rotavirus vaccine, live",
    "DecisionDate": "02/21/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 175,
    "ClockStopElapsed": 154,
    "TotalTimeElapsed": 329
  },
  {
    "ApplicationNo": 636,
    "EUNumber": "EU/1/06/333",
    "EUNoShort": 333,
    "BrandName": "Myozyme",
    "MAH": "Genzyme Europe B.V.",
    "ActiveSubstance": "alglucosidase alfa",
    "DecisionDate": "03/29/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Belgium",
    "CoRapporteur": "France",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 196,
    "ClockStopElapsed": 206,
    "TotalTimeElapsed": 402
  },
  {
    "ApplicationNo": 622,
    "EUNumber": "EU/1/05/323",
    "EUNoShort": 323,
    "BrandName": "ProQuad",
    "MAH": "MSD VACCINS",
    "ActiveSubstance": "Measles, Mumps, Rubella and Varicella Vaccine (Live)",
    "DecisionDate": "04/06/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 123,
    "TotalTimeElapsed": 332
  },
  {
    "ApplicationNo": 607,
    "EUNumber": "EU/1/06/332",
    "EUNoShort": 332,
    "BrandName": "Omnitrope",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "Somatropin",
    "DecisionDate": "04/12/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "H01",
    "ATCCodeL1": "H",
    "ATCNameL2": "Pituitary and hypothalamic hormones and analogues",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 147,
    "TotalTimeElapsed": 357
  },
  {
    "ApplicationNo": 602,
    "EUNumber": "EU/1/06/335",
    "EUNoShort": 335,
    "BrandName": "Valtropin",
    "MAH": "BioPartners GmbH",
    "ActiveSubstance": "Somatropin",
    "DecisionDate": "04/24/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "H01",
    "ATCCodeL1": "H",
    "ATCNameL2": "Pituitary and hypothalamic hormones and analogues",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 179,
    "ClockStopElapsed": 402,
    "TotalTimeElapsed": 581
  },
  {
    "ApplicationNo": 644,
    "EUNumber": "EU/1/06/336",
    "EUNoShort": 336,
    "BrandName": "Tygacil",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "Tigecycline",
    "DecisionDate": "04/24/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 210,
    "TotalTimeElapsed": 392
  },
  {
    "ApplicationNo": 665,
    "EUNumber": "EU/1/06/338",
    "EUNoShort": 338,
    "BrandName": "DuoTrav",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Travoprost / Timolol",
    "DecisionDate": "04/24/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 196,
    "ClockStopElapsed": 82,
    "TotalTimeElapsed": 278
  },
  {
    "ApplicationNo": 659,
    "EUNumber": "EU/1/06/339",
    "EUNoShort": 339,
    "BrandName": "Preotact",
    "MAH": "NPS Pharma Holdings Limited",
    "ActiveSubstance": "Parathyroid hormone",
    "DecisionDate": "04/24/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "H05",
    "ATCCodeL1": "H",
    "ATCNameL2": "Calcium homeostasis",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 224,
    "ClockStopElapsed": 105,
    "TotalTimeElapsed": 329
  },
  {
    "ApplicationNo": 604,
    "EUNumber": "EU/1/06/337",
    "EUNoShort": 337,
    "BrandName": "M-M-RVAXPRO",
    "MAH": "MSD VACCINS",
    "ActiveSubstance": "Measles, Mumps and Rubella Vaccine (Live)",
    "DecisionDate": "05/05/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 193,
    "ClockStopElapsed": 388,
    "TotalTimeElapsed": 581
  },
  {
    "ApplicationNo": 668,
    "EUNumber": "EU/1/06/340",
    "EUNoShort": 340,
    "BrandName": "Ganfort",
    "MAH": "Allergan Pharmaceuticals Ireland",
    "ActiveSubstance": "bimatoprost / timolol",
    "DecisionDate": "05/19/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 196,
    "ClockStopElapsed": 113,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 674,
    "EUNumber": "EU/1/06/341",
    "EUNoShort": 341,
    "BrandName": "Zostavax",
    "MAH": "MSD VACCINS",
    "ActiveSubstance": "shingles (herpes zoster) vaccine (live)",
    "DecisionDate": "05/19/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 79,
    "TotalTimeElapsed": 281
  },
  {
    "ApplicationNo": 613,
    "EUNumber": "EU/1/06/334",
    "EUNoShort": 334,
    "BrandName": "Evoltra",
    "MAH": "Genzyme Europe B.V.",
    "ActiveSubstance": "clofarabine",
    "DecisionDate": "05/29/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 344,
    "TotalTimeElapsed": 553
  },
  {
    "ApplicationNo": 666,
    "EUNumber": "EU/1/06/344",
    "EUNoShort": 344,
    "BrandName": "ACOMPLIA",
    "MAH": "Sanofi-Aventis",
    "ActiveSubstance": "Rimonabant",
    "DecisionDate": "06/19/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "A08",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antiobesity preparations, excluding diet products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 142,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 691,
    "EUNumber": "EU/1/06/345",
    "EUNoShort": 345,
    "BrandName": "Zimulti",
    "MAH": "Sanofi-Aventis",
    "ActiveSubstance": "Rimonabant",
    "DecisionDate": "06/19/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "A08",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antiobesity preparations, excluding diet products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 85,
    "ClockStopElapsed": 66,
    "TotalTimeElapsed": 151
  },
  {
    "ApplicationNo": 623,
    "EUNumber": "EU/1/06/343",
    "EUNoShort": 343,
    "BrandName": "Baraclude",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "entecavir",
    "DecisionDate": "06/26/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 343,
    "TotalTimeElapsed": 553
  },
  {
    "ApplicationNo": 603,
    "EUNumber": "EU/1/06/346",
    "EUNoShort": 346,
    "BrandName": "Tysabri",
    "MAH": "Biogen Netherlands B.V.",
    "ActiveSubstance": "Natalizumab",
    "DecisionDate": "06/27/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 176,
    "ClockStopElapsed": 496,
    "TotalTimeElapsed": 672
  },
  {
    "ApplicationNo": 669,
    "EUNumber": "EU/1/06/348",
    "EUNoShort": 348,
    "BrandName": "RotaTeq",
    "MAH": "MSD VACCINS",
    "ActiveSubstance": "Rotavirus vaccine (live, oral)",
    "DecisionDate": "06/27/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 190,
    "ClockStopElapsed": 154,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 675,
    "EUNumber": "EU/1/06/349",
    "EUNoShort": 349,
    "BrandName": "Avaglim",
    "MAH": "SmithKline Beecham Ltd",
    "ActiveSubstance": "Rosiglitazone / glimepiride",
    "DecisionDate": "06/27/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 112,
    "TotalTimeElapsed": 316
  },
  {
    "ApplicationNo": 690,
    "EUNumber": "EU/1/06/342",
    "EUNoShort": 342,
    "BrandName": "Nexavar",
    "MAH": "Bayer AG",
    "ActiveSubstance": "Sorafenib",
    "DecisionDate": "07/19/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 687,
    "EUNumber": "EU/1/06/347",
    "EUNoShort": 347,
    "BrandName": "Sutent",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "sunitinib",
    "DecisionDate": "07/19/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Italy",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 682,
    "EUNumber": "EU/1/06/350",
    "EUNoShort": 350,
    "BrandName": "Savene",
    "MAH": "Clinigen Healthcare B.V.",
    "ActiveSubstance": "Dexrazoxane",
    "DecisionDate": "07/28/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 84,
    "TotalTimeElapsed": 288
  },
  {
    "ApplicationNo": 630,
    "EUNumber": "EU/1/06/351",
    "EUNoShort": 351,
    "BrandName": "Livensa",
    "MAH": "Warner Chilcott Deutschland Gmbh",
    "ActiveSubstance": "testosterone",
    "DecisionDate": "07/28/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 353,
    "TotalTimeElapsed": 563
  },
  {
    "ApplicationNo": 634,
    "EUNumber": "EU/1/06/352",
    "EUNoShort": 352,
    "BrandName": "Intrinsa",
    "MAH": "Warner Chilcott UK Ltd",
    "ActiveSubstance": "testosterone",
    "DecisionDate": "07/28/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 353,
    "TotalTimeElapsed": 563
  },
  {
    "ApplicationNo": 655,
    "EUNumber": "EU/1/06/354",
    "EUNoShort": 354,
    "BrandName": "Competact",
    "MAH": "CHEPLAPHARM Arzneimittel GmbH",
    "ActiveSubstance": "Pioglitazone / metformin",
    "DecisionDate": "07/28/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 226,
    "TotalTimeElapsed": 430
  },
  {
    "ApplicationNo": 587,
    "EUNumber": "EU/1/06/355",
    "EUNoShort": 355,
    "BrandName": "ATryn",
    "MAH": "Laboratoire fran√ßais du Fractionnement et des Biotechnologies",
    "ActiveSubstance": "antithrombin alfa",
    "DecisionDate": "07/28/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 521,
    "TotalTimeElapsed": 728
  },
  {
    "ApplicationNo": 679,
    "EUNumber": "EU/1/06/353",
    "EUNoShort": 353,
    "BrandName": "Thelin",
    "MAH": "Pfizer Limited",
    "ActiveSubstance": "Sitaxentan sodium",
    "DecisionDate": "08/10/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "C02",
    "ATCCodeL1": "C",
    "ATCNameL2": "Antihypertensives",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 196,
    "ClockStopElapsed": 92,
    "TotalTimeElapsed": 288
  },
  {
    "ApplicationNo": 670,
    "EUNumber": "EU/1/06/356",
    "EUNoShort": 356,
    "BrandName": "Exjade",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "deferasirox",
    "DecisionDate": "08/28/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 174,
    "ClockStopElapsed": 202,
    "TotalTimeElapsed": 376
  },
  {
    "ApplicationNo": 703,
    "EUNumber": "EU/1/06/357",
    "EUNoShort": 357,
    "BrandName": "Gardasil",
    "MAH": "MSD VACCINS",
    "ActiveSubstance": "Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)",
    "DecisionDate": "09/20/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 732,
    "EUNumber": "EU/1/06/358",
    "EUNoShort": 358,
    "BrandName": "Silgard",
    "MAH": "Merck Sharp & Dohme Limited",
    "ActiveSubstance": "Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)",
    "DecisionDate": "09/20/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 117,
    "ClockStopElapsed": 28,
    "TotalTimeElapsed": 145
  },
  {
    "ApplicationNo": 654,
    "EUNumber": "EU/1/06/361",
    "EUNoShort": 361,
    "BrandName": "Luminity",
    "MAH": "Lantheus EU Limited",
    "ActiveSubstance": "perflutren",
    "DecisionDate": "09/20/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "V08",
    "ATCCodeL1": "V",
    "ATCNameL2": "Contrast media",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 314,
    "TotalTimeElapsed": 521
  },
  {
    "ApplicationNo": 697,
    "EUNumber": "EU/1/06/359",
    "EUNoShort": 359,
    "BrandName": "Suboxone",
    "MAH": "Indivior Europe Limited",
    "ActiveSubstance": "buprenorphine / naloxone",
    "DecisionDate": "09/26/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 196,
    "ClockStopElapsed": 78,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 699,
    "EUNumber": "EU/1/06/360",
    "EUNoShort": 360,
    "BrandName": "Champix",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "varenicline tartrate",
    "DecisionDate": "09/26/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 175,
    "ClockStopElapsed": 71,
    "TotalTimeElapsed": 246
  },
  {
    "ApplicationNo": 698,
    "EUNumber": "EU/1/06/362",
    "EUNoShort": 362,
    "BrandName": "Byetta",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "exenatide",
    "DecisionDate": "11/20/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 94,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 709,
    "EUNumber": "EU/1/06/363",
    "EUNoShort": 363,
    "BrandName": "Sprycel",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "Dasatinib",
    "DecisionDate": "11/20/2006",
    "DecisionYear": "2006",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 55,
    "TotalTimeElapsed": 232
  },
  {
    "ApplicationNo": 759,
    "EUNumber": "EU/1/06/364",
    "EUNoShort": 364,
    "BrandName": "Adrovance",
    "MAH": "N.V. Organon",
    "ActiveSubstance": "Alendronate sodium / Colecalciferol",
    "DecisionDate": "01/04/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 89,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 89
  },
  {
    "ApplicationNo": 664,
    "EUNumber": "EU/1/06/367",
    "EUNoShort": 367,
    "BrandName": "Diacomit",
    "MAH": "Biocodex",
    "ActiveSubstance": "Stiripentol",
    "DecisionDate": "01/04/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 317,
    "TotalTimeElapsed": 518
  },
  {
    "ApplicationNo": 680,
    "EUNumber": "EU/1/06/366",
    "EUNoShort": 366,
    "BrandName": "Tandemact",
    "MAH": "CHEPLAPHARM Arzneimittel GmbH",
    "ActiveSubstance": "Pioglitazone / Glimepiride",
    "DecisionDate": "01/08/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Ireland",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 196,
    "ClockStopElapsed": 231,
    "TotalTimeElapsed": 427
  },
  {
    "ApplicationNo": 700,
    "EUNumber": "EU/1/06/365",
    "EUNoShort": 365,
    "BrandName": "Elaprase",
    "MAH": "Shire Human Genetic Therapies AB",
    "ActiveSubstance": "Idursulfase",
    "DecisionDate": "01/08/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 87,
    "TotalTimeElapsed": 294
  },
  {
    "ApplicationNo": 776,
    "EUNumber": "EU/1/06/371",
    "EUNoShort": 371,
    "BrandName": "Dafiro",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "amlodipine / valsartan",
    "DecisionDate": "01/16/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 80,
    "ClockStopElapsed": 8,
    "TotalTimeElapsed": 88
  },
  {
    "ApplicationNo": 774,
    "EUNumber": "EU/1/06/372",
    "EUNoShort": 372,
    "BrandName": "Copalia",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "amlodipine / valsartan",
    "DecisionDate": "01/16/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 80,
    "ClockStopElapsed": 8,
    "TotalTimeElapsed": 88
  },
  {
    "ApplicationNo": 660,
    "EUNumber": "EU/1/06/378",
    "EUNoShort": 378,
    "BrandName": "Inovelon",
    "MAH": "Eisai GmbH",
    "ActiveSubstance": "Rufinamide",
    "DecisionDate": "01/16/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 339,
    "TotalTimeElapsed": 547
  },
  {
    "ApplicationNo": 761,
    "EUNumber": "EU/1/06/368",
    "EUNoShort": 368,
    "BrandName": "Insulin Human Winthrop",
    "MAH": "Sanofi-Aventis Deutschland GmbH",
    "ActiveSubstance": "Insulin human",
    "DecisionDate": "01/17/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 110,
    "ClockStopElapsed": 8,
    "TotalTimeElapsed": 118
  },
  {
    "ApplicationNo": 716,
    "EUNumber": "EU/1/06/370",
    "EUNoShort": 370,
    "BrandName": "Exforge",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "amlodipine / valsartan",
    "DecisionDate": "01/17/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 173,
    "ClockStopElapsed": 82,
    "TotalTimeElapsed": 255
  },
  {
    "ApplicationNo": 775,
    "EUNumber": "EU/1/06/373",
    "EUNoShort": 373,
    "BrandName": "Imprida",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "amlodipine / valsartan",
    "DecisionDate": "01/17/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 80,
    "ClockStopElapsed": 8,
    "TotalTimeElapsed": 88
  },
  {
    "ApplicationNo": 784,
    "EUNumber": "EU/1/06/369",
    "EUNoShort": 369,
    "BrandName": "Irbesartan HCT BMS",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "irbesartan / hydrochlorothiazide",
    "DecisionDate": "01/19/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 50,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 50
  },
  {
    "ApplicationNo": 786,
    "EUNumber": "EU/1/06/375",
    "EUNoShort": 375,
    "BrandName": "Irbesartan BMS",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "Irbesartan",
    "DecisionDate": "01/19/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 50,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 50
  },
  {
    "ApplicationNo": 785,
    "EUNumber": "EU/1/06/376",
    "EUNoShort": 376,
    "BrandName": "Irbesartan Zentiva",
    "MAH": "Zentiva k.s.",
    "ActiveSubstance": "Irbesartan",
    "DecisionDate": "01/19/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 50,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 50
  },
  {
    "ApplicationNo": 783,
    "EUNumber": "EU/1/06/377",
    "EUNoShort": 377,
    "BrandName": "Irbesartan HCT Zentiva",
    "MAH": "Zentiva k.s.",
    "ActiveSubstance": "irbesartan / hydrochlorothiazide",
    "DecisionDate": "01/19/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 50,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 50
  },
  {
    "ApplicationNo": 715,
    "EUNumber": "EU/1/06/374",
    "EUNoShort": 374,
    "BrandName": "Lucentis",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "ranibizumab",
    "DecisionDate": "01/22/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 195,
    "ClockStopElapsed": 65,
    "TotalTimeElapsed": 260
  },
  {
    "ApplicationNo": 707,
    "EUNumber": "EU/1/06/380",
    "EUNoShort": 380,
    "BrandName": "PREZISTA",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "darunavir",
    "DecisionDate": "02/12/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 112,
    "TotalTimeElapsed": 316
  },
  {
    "ApplicationNo": 678,
    "EUNumber": "EU/1/06/379",
    "EUNoShort": 379,
    "BrandName": "Cystadane",
    "MAH": "Recordati Rare Diseases",
    "ActiveSubstance": "Betaine anhydrous",
    "DecisionDate": "02/15/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 194,
    "ClockStopElapsed": 290,
    "TotalTimeElapsed": 484
  },
  {
    "ApplicationNo": 762,
    "EUNumber": "EU/1/07/382",
    "EUNoShort": 382,
    "BrandName": "Xelevia",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "sitagliptin",
    "DecisionDate": "03/21/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 85,
    "ClockStopElapsed": 44,
    "TotalTimeElapsed": 129
  },
  {
    "ApplicationNo": 722,
    "EUNumber": "EU/1/07/383",
    "EUNoShort": 383,
    "BrandName": "Januvia",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "sitagliptin",
    "DecisionDate": "03/21/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 301
  },
  {
    "ApplicationNo": 706,
    "EUNumber": "EU/1/06/381",
    "EUNoShort": 381,
    "BrandName": "Daronrix",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "A/Viet Nam/1194/2004 (H5N1) whole virus inactivated antigen",
    "DecisionDate": "03/21/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 142,
    "ClockStopElapsed": 174,
    "TotalTimeElapsed": 316
  },
  {
    "ApplicationNo": 808,
    "EUNumber": "EU/1/07/384",
    "EUNoShort": 384,
    "BrandName": "Docetaxel Zentiva",
    "MAH": "Zentiva k.s.",
    "ActiveSubstance": "Docetaxel",
    "DecisionDate": "04/20/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 723,
    "EUNumber": "EU/1/07/386",
    "EUNoShort": 386,
    "BrandName": "Toviaz",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "fesoterodine",
    "DecisionDate": "04/20/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 120,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 712,
    "EUNumber": "EU/1/07/387",
    "EUNoShort": 387,
    "BrandName": "Advagraf",
    "MAH": "Astellas Pharma Europe B.V.",
    "ActiveSubstance": "Tacrolimus",
    "DecisionDate": "04/23/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Lithuania",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 157,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 713,
    "EUNumber": "EU/1/07/388",
    "EUNoShort": 388,
    "BrandName": "Sebivo",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "telbivudine",
    "DecisionDate": "04/24/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 148,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 710,
    "EUNumber": "EU/1/07/385",
    "EUNoShort": 385,
    "BrandName": "Focetria",
    "MAH": "Novartis Vaccines and Diagnostics S.r.l.",
    "ActiveSubstance": "Pandemic influenza vaccine (H1N1) (surface antigen, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (X-181)",
    "DecisionDate": "05/02/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Italy",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 162,
    "ClockStopElapsed": 224,
    "TotalTimeElapsed": 386
  },
  {
    "ApplicationNo": 701,
    "EUNumber": "EU/1/07/389",
    "EUNoShort": 389,
    "BrandName": "Orencia",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "abatacept",
    "DecisionDate": "05/21/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Finland",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 245,
    "TotalTimeElapsed": 449
  },
  {
    "ApplicationNo": 757,
    "EUNumber": "EU/1/07/390",
    "EUNoShort": 390,
    "BrandName": "Altargo",
    "MAH": "Glaxo Group Ltd",
    "ActiveSubstance": "retapamulin",
    "DecisionDate": "05/24/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "D06",
    "ATCCodeL1": "D",
    "ATCNameL2": "Antibiotics and chemotherapeutics for dermatological use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 191,
    "ClockStopElapsed": 55,
    "TotalTimeElapsed": 246
  },
  {
    "ApplicationNo": 758,
    "EUNumber": "EU/1/07/394",
    "EUNoShort": 394,
    "BrandName": "Optaflu",
    "MAH": "Seqirus GmbH",
    "ActiveSubstance": "Influenza vaccine (surface antigen, inactivated, prepared in cell culture)",
    "DecisionDate": "06/01/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 79,
    "TotalTimeElapsed": 281
  },
  {
    "ApplicationNo": 717,
    "EUNumber": "EU/1/07/391",
    "EUNoShort": 391,
    "BrandName": "Revlimid",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "Lenalidomide",
    "DecisionDate": "06/14/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 199,
    "ClockStopElapsed": 159,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 791,
    "EUNumber": "EU/1/07/393",
    "EUNoShort": 393,
    "BrandName": "Soliris",
    "MAH": "Alexion Europe SAS",
    "ActiveSubstance": "Eculizumab",
    "DecisionDate": "06/20/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "France",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 147,
    "ClockStopElapsed": 36,
    "TotalTimeElapsed": 183
  },
  {
    "ApplicationNo": 746,
    "EUNumber": "EU/1/07/395",
    "EUNoShort": 395,
    "BrandName": "Invega",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "paliperidone",
    "DecisionDate": "06/25/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 135,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 714,
    "EUNumber": "EU/1/07/396",
    "EUNoShort": 396,
    "BrandName": "Pergoveris",
    "MAH": "Merck Europe B.V.",
    "ActiveSubstance": "follitropin alfa / lutropin alfa",
    "DecisionDate": "06/25/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 185,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 695,
    "EUNumber": "EU/1/07/392",
    "EUNoShort": 392,
    "BrandName": "Circadin",
    "MAH": "RAD Neurim Pharmaceuticals EEC SARL",
    "ActiveSubstance": "Melatonin",
    "DecisionDate": "06/29/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Greece",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 338,
    "TotalTimeElapsed": 547
  },
  {
    "ApplicationNo": 689,
    "EUNumber": "EU/1/07/397",
    "EUNoShort": 397,
    "BrandName": "Siklos",
    "MAH": "Addmedica",
    "ActiveSubstance": "hydroxycarbamide",
    "DecisionDate": "06/29/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Greece",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 339,
    "TotalTimeElapsed": 547
  },
  {
    "ApplicationNo": 739,
    "EUNumber": "EU/1/07/400",
    "EUNoShort": 400,
    "BrandName": "Mircera",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "methoxy polyethylene glycol-epoetin beta",
    "DecisionDate": "07/20/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "B03",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antianemic preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 176,
    "ClockStopElapsed": 189,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 745,
    "EUNumber": "EU/1/07/398",
    "EUNoShort": 398,
    "BrandName": "Optimark",
    "MAH": "Guerbet",
    "ActiveSubstance": "Gadoversetamide",
    "DecisionDate": "07/23/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "V08",
    "ATCCodeL1": "V",
    "ATCNameL2": "Contrast media",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 196,
    "ClockStopElapsed": 169,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 854,
    "EUNumber": "EU/1/07/401",
    "EUNoShort": 401,
    "BrandName": "alli",
    "MAH": "GlaxoSmithKline Dungarvan Limited",
    "ActiveSubstance": "Orlistat",
    "DecisionDate": "07/23/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Greece",
    "ATCCodeL2": "A08",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antiobesity preparations, excluding diet products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 772,
    "EUNumber": "EU/1/07/399",
    "EUNoShort": 399,
    "BrandName": "Aerinaze",
    "MAH": "N.V. Organon",
    "ActiveSubstance": "desloratadine; pseudoephedrine sulphate",
    "DecisionDate": "07/30/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "R06",
    "ATCCodeL1": "R",
    "ATCNameL2": "Antihistamines for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 196,
    "ClockStopElapsed": 85,
    "TotalTimeElapsed": 281
  },
  {
    "ApplicationNo": 704,
    "EUNumber": "EU/1/07/402",
    "EUNoShort": 402,
    "BrandName": "INCRELEX",
    "MAH": "Ipsen Pharma",
    "ActiveSubstance": "Mecasermin",
    "DecisionDate": "08/03/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Finland",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "H01",
    "ATCCodeL1": "H",
    "ATCNameL2": "Pituitary and hypothalamic hormones and analogues",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 304,
    "TotalTimeElapsed": 512
  },
  {
    "ApplicationNo": 780,
    "EUNumber": "EU/1/07/405",
    "EUNoShort": 405,
    "BrandName": "Rasilez",
    "MAH": "Noden Pharma DAC",
    "ActiveSubstance": "aliskiren",
    "DecisionDate": "08/22/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Italy",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 194,
    "ClockStopElapsed": 73,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 850,
    "EUNumber": "EU/1/07/406",
    "EUNoShort": 406,
    "BrandName": "Enviage",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "aliskiren",
    "DecisionDate": "08/22/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Italy",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 77,
    "ClockStopElapsed": 11,
    "TotalTimeElapsed": 88
  },
  {
    "ApplicationNo": 851,
    "EUNumber": "EU/1/07/407",
    "EUNoShort": 407,
    "BrandName": "Sprimeo",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "aliskiren",
    "DecisionDate": "08/22/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Italy",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 77,
    "ClockStopElapsed": 11,
    "TotalTimeElapsed": 88
  },
  {
    "ApplicationNo": 852,
    "EUNumber": "EU/1/07/408",
    "EUNoShort": 408,
    "BrandName": "Tekturna",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "aliskiren",
    "DecisionDate": "08/22/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Italy",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 77,
    "ClockStopElapsed": 11,
    "TotalTimeElapsed": 88
  },
  {
    "ApplicationNo": 853,
    "EUNumber": "EU/1/07/409",
    "EUNoShort": 409,
    "BrandName": "Riprazo",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "aliskiren",
    "DecisionDate": "08/22/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Italy",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 77,
    "ClockStopElapsed": 11,
    "TotalTimeElapsed": 88
  },
  {
    "ApplicationNo": 752,
    "EUNumber": "EU/1/07/403",
    "EUNoShort": 403,
    "BrandName": "Atriance",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "nelarabine",
    "DecisionDate": "08/22/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 162,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 781,
    "EUNumber": "EU/1/07/404",
    "EUNoShort": 404,
    "BrandName": "Flebogamma DIF",
    "MAH": "Instituto Grifols, S.A.",
    "ActiveSubstance": "Human normal immunoglobulin (IVIg)",
    "DecisionDate": "08/23/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "J06",
    "ATCCodeL1": "J",
    "ATCNameL2": "Immune sera and immunoglobulins",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 90,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 725,
    "EUNumber": "EU/1/07/410",
    "EUNoShort": 410,
    "BrandName": "Binocrit",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "epoetin alfa",
    "DecisionDate": "08/28/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "B03",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antianemic preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 244,
    "TotalTimeElapsed": 449
  },
  {
    "ApplicationNo": 726,
    "EUNumber": "EU/1/07/411",
    "EUNoShort": 411,
    "BrandName": "Epoetin alfa Hexal",
    "MAH": "Hexal AG",
    "ActiveSubstance": "epoetin alfa",
    "DecisionDate": "08/28/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "B03",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antianemic preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 244,
    "TotalTimeElapsed": 449
  },
  {
    "ApplicationNo": 727,
    "EUNumber": "EU/1/07/412",
    "EUNoShort": 412,
    "BrandName": "Abseamed",
    "MAH": "Medice Arzneimittel P√ºtter GmbH & Co KG",
    "ActiveSubstance": "epoetin alfa",
    "DecisionDate": "08/28/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "B03",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antianemic preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 244,
    "TotalTimeElapsed": 449
  },
  {
    "ApplicationNo": 744,
    "EUNumber": "EU/1/07/413",
    "EUNoShort": 413,
    "BrandName": "Gliolan",
    "MAH": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "ActiveSubstance": "5-aminolevulinic acid hydrochloride",
    "DecisionDate": "09/07/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 199,
    "ClockStopElapsed": 194,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 773,
    "EUNumber": "EU/1/07/417",
    "EUNoShort": 417,
    "BrandName": "Yondelis",
    "MAH": "Pharma Mar S.A.",
    "ActiveSubstance": "Trabectedin",
    "DecisionDate": "09/17/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 811,
    "EUNumber": "EU/1/07/418",
    "EUNoShort": 418,
    "BrandName": "Celsentri",
    "MAH": "ViiV Healthcare BV",
    "ActiveSubstance": "maraviroc",
    "DecisionDate": "09/18/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 169,
    "ClockStopElapsed": 35,
    "TotalTimeElapsed": 204
  },
  {
    "ApplicationNo": 788,
    "EUNumber": "EU/1/07/416",
    "EUNoShort": 416,
    "BrandName": "Ecalta",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "anidulafungin",
    "DecisionDate": "09/20/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "J02",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycotics for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 85,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 721,
    "EUNumber": "EU/1/07/419",
    "EUNoShort": 419,
    "BrandName": "Cervarix",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Human Papilloma Virus-16 and Human Papilloma Virus 18 L1 proteins",
    "DecisionDate": "09/20/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 275,
    "TotalTimeElapsed": 477
  },
  {
    "ApplicationNo": 771,
    "EUNumber": "EU/1/07/414",
    "EUNoShort": 414,
    "BrandName": "Galvus",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "vildagliptin",
    "DecisionDate": "09/26/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 792,
    "EUNumber": "EU/1/07/415",
    "EUNoShort": 415,
    "BrandName": "Zalasta",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "Olanzapine",
    "DecisionDate": "09/27/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Slovenia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 90,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 807,
    "EUNumber": "EU/1/07/425",
    "EUNoShort": 425,
    "BrandName": "Eucreas",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "vildagliptin / metformin hydrochloride",
    "DecisionDate": "11/14/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 62,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 793,
    "EUNumber": "EU/1/07/426",
    "EUNoShort": 426,
    "BrandName": "Olanzapine Cipla",
    "MAH": "Cipla (EU) Limited",
    "ActiveSubstance": "Olanzapine",
    "DecisionDate": "11/14/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 332
  },
  {
    "ApplicationNo": 798,
    "EUNumber": "EU/1/07/422",
    "EUNoShort": 422,
    "BrandName": "Tasigna",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Nilotinib",
    "DecisionDate": "11/19/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 130,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 799,
    "EUNumber": "EU/1/07/424",
    "EUNoShort": 424,
    "BrandName": "Torisel",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "Temsirolimus",
    "DecisionDate": "11/19/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 806,
    "EUNumber": "EU/1/07/420",
    "EUNoShort": 420,
    "BrandName": "Cyanokit",
    "MAH": "SERB S.A.",
    "ActiveSubstance": "hydroxocobalamin",
    "DecisionDate": "11/23/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 90,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 741,
    "EUNumber": "EU/1/07/423",
    "EUNoShort": 423,
    "BrandName": "Vectibix",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "panitumumab",
    "DecisionDate": "12/03/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 161,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 893,
    "EUNumber": "EU/1/07/421",
    "EUNoShort": 421,
    "BrandName": "Glubrava",
    "MAH": "Takeda Pharma A/S",
    "ActiveSubstance": "Pioglitazone / metformin hydrochloride",
    "DecisionDate": "12/11/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 59,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 59
  },
  {
    "ApplicationNo": 818,
    "EUNumber": "EU/1/07/433",
    "EUNoShort": 433,
    "BrandName": "Nevanac",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "nepafenac",
    "DecisionDate": "12/11/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 62,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 810,
    "EUNumber": "EU/1/07/427",
    "EUNoShort": 427,
    "BrandName": "Olanzapine Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Olanzapine",
    "DecisionDate": "12/12/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 797,
    "EUNumber": "EU/1/07/430",
    "EUNoShort": 430,
    "BrandName": "Atripla",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "efavirenz / emtricitabine / tenofovir disoproxil fumarate",
    "DecisionDate": "12/13/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "France",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 156,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 872,
    "EUNumber": "EU/1/07/431",
    "EUNoShort": 431,
    "BrandName": "Retacrit",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "epoetin zeta",
    "DecisionDate": "12/18/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "B03",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antianemic preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 85,
    "ClockStopElapsed": 66,
    "TotalTimeElapsed": 151
  },
  {
    "ApplicationNo": 760,
    "EUNumber": "EU/1/07/432",
    "EUNoShort": 432,
    "BrandName": "Silapo",
    "MAH": "STADA Arzneimittel AG",
    "ActiveSubstance": "epoetin zeta",
    "DecisionDate": "12/18/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "B03",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antianemic preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 254,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 860,
    "EUNumber": "EU/1/07/436",
    "EUNoShort": 436,
    "BrandName": "Isentress",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "raltegravir",
    "DecisionDate": "12/20/2007",
    "DecisionYear": "2007",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 141,
    "ClockStopElapsed": 35,
    "TotalTimeElapsed": 176
  },
  {
    "ApplicationNo": 910,
    "EUNumber": "EU/1/07/435",
    "EUNoShort": 435,
    "BrandName": "TESAVEL",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "sitagliptin",
    "DecisionDate": "01/10/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 778,
    "EUNumber": "EU/1/07/428",
    "EUNoShort": 428,
    "BrandName": "Abraxane",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "paclitaxel",
    "DecisionDate": "01/11/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 184,
    "TotalTimeElapsed": 386
  },
  {
    "ApplicationNo": 770,
    "EUNumber": "EU/1/07/434",
    "EUNoShort": 434,
    "BrandName": "Avamys",
    "MAH": "GlaxoSmithKline (Ireland) Limited",
    "ActiveSubstance": "Fluticasone furoate",
    "DecisionDate": "01/11/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Poland",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R01",
    "ATCCodeL1": "R",
    "ATCNameL2": "Nasal preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 226,
    "TotalTimeElapsed": 428
  },
  {
    "ApplicationNo": 743,
    "EUNumber": "EU/1/07/437",
    "EUNoShort": 437,
    "BrandName": "IVEMEND",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "fosaprepitant",
    "DecisionDate": "01/11/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "A04",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antiemetics and antinauseants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 197,
    "ClockStopElapsed": 343,
    "TotalTimeElapsed": 540
  },
  {
    "ApplicationNo": 884,
    "EUNumber": "EU/1/07/438",
    "EUNoShort": 438,
    "BrandName": "Myfenax",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Mycophenolate mofetil",
    "DecisionDate": "02/21/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 138,
    "ClockStopElapsed": 8,
    "TotalTimeElapsed": 146
  },
  {
    "ApplicationNo": 882,
    "EUNumber": "EU/1/07/439",
    "EUNoShort": 439,
    "BrandName": "Mycophenolate mofetil Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Mycophenolate mofetil",
    "DecisionDate": "02/21/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 138,
    "ClockStopElapsed": 8,
    "TotalTimeElapsed": 146
  },
  {
    "ApplicationNo": 829,
    "EUNumber": "EU/1/08/442",
    "EUNoShort": 442,
    "BrandName": "Pradaxa",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "dabigatran etexilate mesilate",
    "DecisionDate": "03/18/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "France",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 132,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 833,
    "EUNumber": "EU/1/08/441",
    "EUNoShort": 441,
    "BrandName": "Effentora",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "fentanyl citrate",
    "DecisionDate": "04/04/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "N02",
    "ATCCodeL1": "N",
    "ATCNameL2": "Analgesics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 105,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 823,
    "EUNumber": "EU/1/08/443",
    "EUNoShort": 443,
    "BrandName": "Thalidomide Celgene",
    "MAH": "Celgene Europe B.V.",
    "ActiveSubstance": "Thalidomide",
    "DecisionDate": "04/16/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 160,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 777,
    "EUNumber": "EU/1/08/447",
    "EUNoShort": 447,
    "BrandName": "Adenuric",
    "MAH": "Menarini International Operations Luxembourg S.A.",
    "ActiveSubstance": "febuxostat",
    "DecisionDate": "04/21/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Austria",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "M04",
    "ATCCodeL1": "M",
    "ATCNameL2": "Antigout preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 188,
    "ClockStopElapsed": 324,
    "TotalTimeElapsed": 512
  },
  {
    "ApplicationNo": 839,
    "EUNumber": "EU/1/08/451",
    "EUNoShort": 451,
    "BrandName": "Volibris",
    "MAH": "GlaxoSmithKline (Ireland) Limited",
    "ActiveSubstance": "Ambrisentan",
    "DecisionDate": "04/21/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "Czech Republic",
    "ATCCodeL2": "C02",
    "ATCCodeL1": "C",
    "ATCNameL2": "Antihypertensives",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 132,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 831,
    "EUNumber": "EU/1/08/446",
    "EUNoShort": 446,
    "BrandName": "Privigen",
    "MAH": "CSL Behring GmbH",
    "ActiveSubstance": "Human normal immunoglobulin (IVIg)",
    "DecisionDate": "04/25/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "J06",
    "ATCCodeL1": "J",
    "ATCNameL2": "Immune sera and immunoglobulins",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 188,
    "ClockStopElapsed": 177,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 734,
    "EUNumber": "EU/1/08/448",
    "EUNoShort": 448,
    "BrandName": "Mycamine",
    "MAH": "Astellas Pharma Europe B.V.",
    "ActiveSubstance": "micafungin",
    "DecisionDate": "04/25/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "J02",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycotics for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 435,
    "TotalTimeElapsed": 638
  },
  {
    "ApplicationNo": 822,
    "EUNumber": "EU/1/08/453",
    "EUNoShort": 453,
    "BrandName": "Prepandrix",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)",
    "DecisionDate": "05/14/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 189,
    "ClockStopElapsed": 204,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 832,
    "EUNumber": "EU/1/08/452",
    "EUNoShort": 452,
    "BrandName": "Pandemrix",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Pandemic influenza vaccine (H1N1) (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (X-179A)",
    "DecisionDate": "05/20/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 161,
    "ClockStopElapsed": 204,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 933,
    "EUNumber": "EU/1/08/454",
    "EUNoShort": 454,
    "BrandName": "Extavia",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Interferon beta-1b",
    "DecisionDate": "05/20/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 77,
    "ClockStopElapsed": 80,
    "TotalTimeElapsed": 157
  },
  {
    "ApplicationNo": 795,
    "EUNumber": "EU/1/07/440",
    "EUNoShort": 440,
    "BrandName": "Tyverb",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "lapatinib",
    "DecisionDate": "06/10/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 212,
    "TotalTimeElapsed": 414
  },
  {
    "ApplicationNo": 870,
    "EUNumber": "EU/1/08/463",
    "EUNoShort": 463,
    "BrandName": "Relistor",
    "MAH": "Bausch Health Ireland Limited",
    "ActiveSubstance": "methylnaltrexone bromide",
    "DecisionDate": "07/02/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "A06",
    "ATCCodeL1": "A",
    "ATCNameL2": "Laxatives",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 133,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 897,
    "EUNumber": "EU/1/08/458",
    "EUNoShort": 458,
    "BrandName": "Trevaclyn",
    "MAH": "Merck Sharp & Dohme Limited",
    "ActiveSubstance": "nicotinic acid / laropiprant",
    "DecisionDate": "07/03/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "C10",
    "ATCCodeL1": "C",
    "ATCNameL2": "Lipid modifying agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 176,
    "ClockStopElapsed": 77,
    "TotalTimeElapsed": 253
  },
  {
    "ApplicationNo": 889,
    "EUNumber": "EU/1/08/459",
    "EUNoShort": 459,
    "BrandName": "Tredaptive",
    "MAH": "Merck Sharp & Dohme Limited",
    "ActiveSubstance": "nicotinic acid / laropiprant",
    "DecisionDate": "07/03/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "C10",
    "ATCCodeL1": "C",
    "ATCNameL2": "Lipid modifying agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 77,
    "TotalTimeElapsed": 279
  },
  {
    "ApplicationNo": 903,
    "EUNumber": "EU/1/08/460",
    "EUNoShort": 460,
    "BrandName": "Pelzont",
    "MAH": "Merck Sharp & Dohme Limited",
    "ActiveSubstance": "nicotinic acid / laropiprant",
    "DecisionDate": "07/03/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "C10",
    "ATCCodeL1": "C",
    "ATCNameL2": "Lipid modifying agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 176,
    "ClockStopElapsed": 77,
    "TotalTimeElapsed": 253
  },
  {
    "ApplicationNo": 805,
    "EUNumber": "EU/1/08/462",
    "EUNoShort": 462,
    "BrandName": "Ranexa",
    "MAH": "Menarini International Operations Luxembourg S.A.",
    "ActiveSubstance": "ranolazine",
    "DecisionDate": "07/09/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "C01",
    "ATCCodeL1": "C",
    "ATCNameL2": "Cardiac therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 307,
    "TotalTimeElapsed": 484
  },
  {
    "ApplicationNo": 899,
    "EUNumber": "EU/1/08/461",
    "EUNoShort": 461,
    "BrandName": "Firazyr",
    "MAH": "Shire Pharmaceuticals Ireland Limited",
    "ActiveSubstance": "icatibant",
    "DecisionDate": "07/11/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "B06",
    "ATCCodeL1": "B",
    "ATCNameL2": "Other hematological agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 49,
    "TotalTimeElapsed": 253
  },
  {
    "ApplicationNo": 861,
    "EUNumber": "EU/1/08/455",
    "EUNoShort": 455,
    "BrandName": "Janumet",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "sitagliptin / metformin hydrochloride",
    "DecisionDate": "07/16/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 133,
    "TotalTimeElapsed": 340
  },
  {
    "ApplicationNo": 862,
    "EUNumber": "EU/1/08/456",
    "EUNoShort": 456,
    "BrandName": "Velmetia",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "sitagliptin / metformin hydrochloride",
    "DecisionDate": "07/16/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 133,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 896,
    "EUNumber": "EU/1/08/457",
    "EUNoShort": 457,
    "BrandName": "Efficib",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "sitagliptin / metformin hydrochloride",
    "DecisionDate": "07/16/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 120,
    "ClockStopElapsed": 133,
    "TotalTimeElapsed": 253
  },
  {
    "ApplicationNo": 974,
    "EUNumber": "EU/1/08/464",
    "EUNoShort": 464,
    "BrandName": "Clopidogrel BMS",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "07/16/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 975,
    "EUNumber": "EU/1/08/465",
    "EUNoShort": 465,
    "BrandName": "Clopidogrel Zentiva",
    "MAH": "Zentiva, k.s.",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "07/16/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 885,
    "EUNumber": "EU/1/08/466",
    "EUNoShort": 466,
    "BrandName": "Bridion",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "sugammadex",
    "DecisionDate": "07/25/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Finland",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 214,
    "ClockStopElapsed": 101,
    "TotalTimeElapsed": 315
  },
  {
    "ApplicationNo": 891,
    "EUNumber": "EU/1/08/467",
    "EUNoShort": 467,
    "BrandName": "Doribax",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "doripenem",
    "DecisionDate": "07/25/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 315
  },
  {
    "ApplicationNo": 900,
    "EUNumber": "EU/1/08/468",
    "EUNoShort": 468,
    "BrandName": "Intelence",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "etravirine",
    "DecisionDate": "08/28/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 178,
    "ClockStopElapsed": 138,
    "TotalTimeElapsed": 316
  },
  {
    "ApplicationNo": 863,
    "EUNumber": "EU/1/08/470",
    "EUNoShort": 470,
    "BrandName": "Vimpat",
    "MAH": "UCB Pharma S.A.",
    "ActiveSubstance": "lacosamide",
    "DecisionDate": "08/29/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 191,
    "TotalTimeElapsed": 400
  },
  {
    "ApplicationNo": 941,
    "EUNumber": "EU/1/08/469",
    "EUNoShort": 469,
    "BrandName": "Oprymea",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "pramipexole",
    "DecisionDate": "09/12/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 41,
    "TotalTimeElapsed": 218
  },
  {
    "ApplicationNo": 825,
    "EUNumber": "EU/1/08/444",
    "EUNoShort": 444,
    "BrandName": "Ratiograstim",
    "MAH": "ratiopharm GmbH",
    "ActiveSubstance": "filgrastim",
    "DecisionDate": "09/15/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Finland",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 156,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 827,
    "EUNumber": "EU/1/08/445",
    "EUNoShort": 445,
    "BrandName": "Tevagrastim",
    "MAH": "Teva GmbH",
    "ActiveSubstance": "filgrastim",
    "DecisionDate": "09/15/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Finland",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 156,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 824,
    "EUNumber": "EU/1/08/449",
    "EUNoShort": 449,
    "BrandName": "Filgrastim ratiopharm",
    "MAH": "ratiopharm GmbH",
    "ActiveSubstance": "filgrastim",
    "DecisionDate": "09/15/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Finland",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 156,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 826,
    "EUNumber": "EU/1/08/450",
    "EUNoShort": 450,
    "BrandName": "Biograstim",
    "MAH": "AbZ-Pharma GmbH",
    "ActiveSubstance": "filgrastim",
    "DecisionDate": "09/15/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Finland",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 156,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 1015,
    "EUNumber": "EU/1/08/478",
    "EUNoShort": 478,
    "BrandName": "Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)",
    "DecisionDate": "09/26/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 57,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 57
  },
  {
    "ApplicationNo": 944,
    "EUNumber": "EU/1/08/472",
    "EUNoShort": 472,
    "BrandName": "Xarelto",
    "MAH": "Bayer AG",
    "ActiveSubstance": "rivaroxaban",
    "DecisionDate": "09/30/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 181,
    "ClockStopElapsed": 63,
    "TotalTimeElapsed": 244
  },
  {
    "ApplicationNo": 1021,
    "EUNumber": "EU/1/08/476",
    "EUNoShort": 476,
    "BrandName": "Adcirca",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "tadalafil",
    "DecisionDate": "10/01/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 57,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 57
  },
  {
    "ApplicationNo": 898,
    "EUNumber": "EU/1/08/473",
    "EUNoShort": 473,
    "BrandName": "Evicel",
    "MAH": "Omrix Biopharmaceuticals N.V.",
    "ActiveSubstance": "human fibrinogen / human thrombin",
    "DecisionDate": "10/06/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 137,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 1019,
    "EUNumber": "EU/1/08/474",
    "EUNoShort": 474,
    "BrandName": "Alisade",
    "MAH": "Glaxo Group Ltd",
    "ActiveSubstance": "Fluticasone furoate",
    "DecisionDate": "10/06/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Poland",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R01",
    "ATCCodeL1": "R",
    "ATCNameL2": "Nasal preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 57,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 57
  },
  {
    "ApplicationNo": 961,
    "EUNumber": "EU/1/08/475",
    "EUNoShort": 475,
    "BrandName": "Olanzapine Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "Olanzapine",
    "DecisionDate": "10/07/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 796,
    "EUNumber": "EU/1/08/477",
    "EUNoShort": 477,
    "BrandName": "Ceplene",
    "MAH": "Noventia Pharma Srl",
    "ActiveSubstance": "Histamine dihydrochloride",
    "DecisionDate": "10/07/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 309,
    "TotalTimeElapsed": 511
  },
  {
    "ApplicationNo": 1007,
    "EUNumber": "EU/1/08/471",
    "EUNoShort": 471,
    "BrandName": "Duloxetine Boehringer Ingelheim",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "Duloxetine",
    "DecisionDate": "10/08/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 89,
    "ClockStopElapsed": 27,
    "TotalTimeElapsed": 116
  },
  {
    "ApplicationNo": 890,
    "EUNumber": "EU/1/08/479",
    "EUNoShort": 479,
    "BrandName": "Zypadhera",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "Olanzapine",
    "DecisionDate": "11/19/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Finland",
    "CoRapporteur": "France",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 198,
    "ClockStopElapsed": 235,
    "TotalTimeElapsed": 433
  },
  {
    "ApplicationNo": 1048,
    "EUNumber": "EU/1/08/485",
    "EUNoShort": 485,
    "BrandName": "Jalra",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "vildagliptin",
    "DecisionDate": "11/19/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 1051,
    "EUNumber": "EU/1/08/486",
    "EUNoShort": 486,
    "BrandName": "Xiliarx",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "vildagliptin",
    "DecisionDate": "11/19/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 960,
    "EUNumber": "EU/1/08/482",
    "EUNoShort": 482,
    "BrandName": "Azarga",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "brinzolamide / timolol",
    "DecisionDate": "11/25/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 97,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 962,
    "EUNumber": "EU/1/08/480",
    "EUNoShort": 480,
    "BrandName": "Ifirmasta",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "Irbesartan",
    "DecisionDate": "12/01/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 1049,
    "EUNumber": "EU/1/08/483",
    "EUNoShort": 483,
    "BrandName": "Zomarist",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "vildagliptin / metformin hydrochloride",
    "DecisionDate": "12/01/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 1050,
    "EUNumber": "EU/1/08/484",
    "EUNoShort": 484,
    "BrandName": "Icandra",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "vildagliptin / metformin hydrochloride",
    "DecisionDate": "12/01/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 943,
    "EUNumber": "EU/1/08/481",
    "EUNoShort": 481,
    "BrandName": "Kuvan",
    "MAH": "BioMarin International Limited",
    "ActiveSubstance": "sapropterin dihydrochloride",
    "DecisionDate": "12/02/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 107,
    "TotalTimeElapsed": 307
  },
  {
    "ApplicationNo": 978,
    "EUNumber": "EU/1/08/488",
    "EUNoShort": 488,
    "BrandName": "Vidaza",
    "MAH": "Bristol Myers Squibb Pharma EEIG",
    "ActiveSubstance": "Azacitidine",
    "DecisionDate": "12/17/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 198,
    "ClockStopElapsed": 69,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 940,
    "EUNumber": "EU/1/08/490",
    "EUNoShort": 490,
    "BrandName": "Pramipexole Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "pramipexole",
    "DecisionDate": "12/18/2008",
    "DecisionYear": "2008",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 196,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 964,
    "EUNumber": "EU/1/08/491",
    "EUNoShort": 491,
    "BrandName": "Rasilez HCT",
    "MAH": "Noden Pharma DAC",
    "ActiveSubstance": "aliskiren hemifumarate / hydrochlorothiazide",
    "DecisionDate": "01/16/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Italy",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 195,
    "ClockStopElapsed": 135,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 955,
    "EUNumber": "EU/1/08/492",
    "EUNoShort": 492,
    "BrandName": "RoActemra",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "tocilizumab",
    "DecisionDate": "01/16/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 125,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 958,
    "EUNumber": "EU/1/08/494",
    "EUNoShort": 494,
    "BrandName": "Stelara",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "ustekinumab",
    "DecisionDate": "01/16/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 123,
    "TotalTimeElapsed": 327
  },
  {
    "ApplicationNo": 942,
    "EUNumber": "EU/1/08/497",
    "EUNoShort": 497,
    "BrandName": "Nplate",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "romiplostim",
    "DecisionDate": "02/04/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 162,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 917,
    "EUNumber": "EU/1/08/495",
    "EUNoShort": 495,
    "BrandName": "Zarzio",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "Filgrastim",
    "DecisionDate": "02/06/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 216,
    "TotalTimeElapsed": 420
  },
  {
    "ApplicationNo": 918,
    "EUNumber": "EU/1/08/496",
    "EUNoShort": 496,
    "BrandName": "Filgrastim Hexal",
    "MAH": "Hexal AG",
    "ActiveSubstance": "Filgrastim",
    "DecisionDate": "02/06/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 216,
    "TotalTimeElapsed": 420
  },
  {
    "ApplicationNo": 986,
    "EUNumber": "EU/1/08/504",
    "EUNoShort": 504,
    "BrandName": "Firmagon",
    "MAH": "Ferring Pharmaceuticals A/S",
    "ActiveSubstance": "degarelix (as acetate)",
    "DecisionDate": "02/17/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L02",
    "ATCCodeL1": "L",
    "ATCNameL2": "Endocrine therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 195,
    "ClockStopElapsed": 72,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 819,
    "EUNumber": "EU/1/08/489",
    "EUNoShort": 489,
    "BrandName": "Opgenra",
    "MAH": "Olympus Biotech International Limited",
    "ActiveSubstance": "eptotermin alfa",
    "DecisionDate": "02/19/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Finland",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 289,
    "TotalTimeElapsed": 491
  },
  {
    "ApplicationNo": 916,
    "EUNumber": "EU/1/08/498",
    "EUNoShort": 498,
    "BrandName": "Thymanax",
    "MAH": "Servier (Ireland) Industries Limited",
    "ActiveSubstance": "agomelatine",
    "DecisionDate": "02/19/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Norway",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 217,
    "TotalTimeElapsed": 420
  },
  {
    "ApplicationNo": 915,
    "EUNumber": "EU/1/08/499",
    "EUNoShort": 499,
    "BrandName": "Valdoxan",
    "MAH": "Les Laboratoires Servier",
    "ActiveSubstance": "agomelatine",
    "DecisionDate": "02/19/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Norway",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 217,
    "TotalTimeElapsed": 420
  },
  {
    "ApplicationNo": 977,
    "EUNumber": "EU/1/08/500",
    "EUNoShort": 500,
    "BrandName": "Fablyn",
    "MAH": "Dr Friedrich Eberth Arzneimittel GmbH",
    "ActiveSubstance": "lasofoxifene",
    "DecisionDate": "02/24/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 120,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 957,
    "EUNumber": "EU/1/08/505",
    "EUNoShort": 505,
    "BrandName": "Intanza",
    "MAH": "Sanofi Pasteur Europe",
    "ActiveSubstance": "Influenza Vaccine (split virion, inactivated)",
    "DecisionDate": "02/24/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 966,
    "EUNumber": "EU/1/08/507",
    "EUNoShort": 507,
    "BrandName": "IDflu",
    "MAH": "Sanofi Pasteur SA",
    "ActiveSubstance": "Influenza Vaccine (split virion, inactivated)",
    "DecisionDate": "02/24/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 984,
    "EUNumber": "EU/1/08/503",
    "EUNoShort": 503,
    "BrandName": "Efient",
    "MAH": "Daiichi Sankyo Europe GmbH",
    "ActiveSubstance": "prasugrel",
    "DecisionDate": "02/25/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 91,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 982,
    "EUNumber": "EU/1/08/506",
    "EUNoShort": 506,
    "BrandName": "Celvapan",
    "MAH": "Nanotherapeutics Bohumil, s.r.o.",
    "ActiveSubstance": "Pandemic influenza vaccine (H1N1) (whole virion, Vero cell derived, inactivated) A/California/07/2009 (H1N1)v",
    "DecisionDate": "03/04/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 90,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 802,
    "EUNumber": "EU/1/08/502",
    "EUNoShort": 502,
    "BrandName": "Mepact",
    "MAH": "Takeda France SAS",
    "ActiveSubstance": "mifamurtide",
    "DecisionDate": "03/06/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "France",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 552,
    "TotalTimeElapsed": 757
  },
  {
    "ApplicationNo": 1042,
    "EUNumber": "EU/1/09/510",
    "EUNoShort": 510,
    "BrandName": "Fertavid",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "follitropin beta",
    "DecisionDate": "03/19/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 89,
    "ClockStopElapsed": 90,
    "TotalTimeElapsed": 179
  },
  {
    "ApplicationNo": 973,
    "EUNumber": "EU/1/09/508",
    "EUNoShort": 508,
    "BrandName": "Synflorix",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Pneumococcal polysaccharide conjugate vaccine (adsorbed)",
    "DecisionDate": "03/30/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 149,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 963,
    "EUNumber": "EU/1/08/501",
    "EUNoShort": 501,
    "BrandName": "Ixiaro",
    "MAH": "Valneva Austria GmbH",
    "ActiveSubstance": "Japanese Encephalitis vaccine (inactivated, adsorbed)",
    "DecisionDate": "03/31/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 119,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 1018,
    "EUNumber": "EU/1/09/509",
    "EUNoShort": 509,
    "BrandName": "Ribavirin Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Ribavirin",
    "DecisionDate": "03/31/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 36,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 913,
    "EUNumber": "EU/1/09/511",
    "EUNoShort": 511,
    "BrandName": "Conbriza",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "bazedoxifene",
    "DecisionDate": "04/17/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 309,
    "TotalTimeElapsed": 511
  },
  {
    "ApplicationNo": 1044,
    "EUNumber": "EU/1/09/513",
    "EUNoShort": 513,
    "BrandName": "Rivastigmine Teva",
    "MAH": "Teva Pharma B.V.",
    "ActiveSubstance": "Rivastigmine",
    "DecisionDate": "04/17/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 972,
    "EUNumber": "EU/1/09/512",
    "EUNoShort": 512,
    "BrandName": "Removab",
    "MAH": "Neovii Biotech GmbH",
    "ActiveSubstance": "Catumaxomab",
    "DecisionDate": "04/20/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 183,
    "TotalTimeElapsed": 386
  },
  {
    "ApplicationNo": 988,
    "EUNumber": "EU/1/09/514",
    "EUNoShort": 514,
    "BrandName": "Zebinix",
    "MAH": "Bial - Portela & C¬™, SA",
    "ActiveSubstance": "eslicarbazepine acetate",
    "DecisionDate": "04/21/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Czech Republic",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 125,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 987,
    "EUNumber": "EU/1/09/520",
    "EUNoShort": 520,
    "BrandName": "Exalief",
    "MAH": "Bial - Portela & C¬™, SA",
    "ActiveSubstance": "eslicarbazepine acetate",
    "DecisionDate": "04/21/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Czech Republic",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 125,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 1029,
    "EUNumber": "EU/1/09/525",
    "EUNoShort": 525,
    "BrandName": "Nimvastid",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "Rivastigmine",
    "DecisionDate": "05/11/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 198,
    "ClockStopElapsed": 69,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 1027,
    "EUNumber": "EU/1/09/522",
    "EUNoShort": 522,
    "BrandName": "ellaOne",
    "MAH": "Laboratoire HRA Pharma",
    "ActiveSubstance": "ulipristal acetate",
    "DecisionDate": "05/15/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 63,
    "TotalTimeElapsed": 266
  },
  {
    "ApplicationNo": 954,
    "EUNumber": "EU/1/09/523",
    "EUNoShort": 523,
    "BrandName": "Modigraf",
    "MAH": "Astellas Pharma Europe B.V.",
    "ActiveSubstance": "Tacrolimus",
    "DecisionDate": "05/15/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Lithuania",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 244,
    "TotalTimeElapsed": 449
  },
  {
    "ApplicationNo": 909,
    "EUNumber": "EU/1/09/524",
    "EUNoShort": 524,
    "BrandName": "Qutenza",
    "MAH": "Gr√ºnenthal GmbH",
    "ActiveSubstance": "Capsaicin",
    "DecisionDate": "05/15/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "N01",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anesthetics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 337,
    "TotalTimeElapsed": 539
  },
  {
    "ApplicationNo": 993,
    "EUNumber": "EU/1/09/521",
    "EUNoShort": 521,
    "BrandName": "Renvela",
    "MAH": "Genzyme Europe B.V.",
    "ActiveSubstance": "sevelamer (carbonate)",
    "DecisionDate": "06/10/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 154,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 1097,
    "EUNumber": "EU/1/09/515",
    "EUNoShort": 515,
    "BrandName": "CONTROLOC Control",
    "MAH": "Takeda GmbH",
    "ActiveSubstance": "pantoprazole",
    "DecisionDate": "06/12/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "A02",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs for acid related disorders",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 80,
    "ClockStopElapsed": 8,
    "TotalTimeElapsed": 88
  },
  {
    "ApplicationNo": 1098,
    "EUNumber": "EU/1/09/516",
    "EUNoShort": 516,
    "BrandName": "SOMAC Control",
    "MAH": "Takeda GmbH",
    "ActiveSubstance": "pantoprazole",
    "DecisionDate": "06/12/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "A02",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs for acid related disorders",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 80,
    "ClockStopElapsed": 8,
    "TotalTimeElapsed": 88
  },
  {
    "ApplicationNo": 1013,
    "EUNumber": "EU/1/09/517",
    "EUNoShort": 517,
    "BrandName": "PANTOZOL Control",
    "MAH": "Takeda GmbH",
    "ActiveSubstance": "pantoprazole",
    "DecisionDate": "06/12/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "A02",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs for acid related disorders",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 197,
    "ClockStopElapsed": 70,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 1099,
    "EUNumber": "EU/1/09/518",
    "EUNoShort": 518,
    "BrandName": "PANTECTA Control",
    "MAH": "Takeda GmbH",
    "ActiveSubstance": "pantoprazole",
    "DecisionDate": "06/12/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "A02",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs for acid related disorders",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 80,
    "ClockStopElapsed": 8,
    "TotalTimeElapsed": 88
  },
  {
    "ApplicationNo": 1100,
    "EUNumber": "EU/1/09/519",
    "EUNoShort": 519,
    "BrandName": "PANTOLOC Control",
    "MAH": "Takeda GmbH",
    "ActiveSubstance": "pantoprazole",
    "DecisionDate": "06/12/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "A02",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs for acid related disorders",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 80,
    "ClockStopElapsed": 8,
    "TotalTimeElapsed": 88
  },
  {
    "ApplicationNo": 1016,
    "EUNumber": "EU/1/09/526",
    "EUNoShort": 526,
    "BrandName": "Iressa",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "gefitinib",
    "DecisionDate": "06/24/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 119,
    "TotalTimeElapsed": 329
  },
  {
    "ApplicationNo": 1067,
    "EUNumber": "EU/1/09/530",
    "EUNoShort": 530,
    "BrandName": "Repaglinide Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Repaglinide",
    "DecisionDate": "06/29/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Hungary",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 1026,
    "EUNumber": "EU/1/09/529",
    "EUNoShort": 529,
    "BrandName": "Victoza",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "liraglutide",
    "DecisionDate": "06/30/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 98,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 1064,
    "EUNumber": "EU/1/09/527",
    "EUNoShort": 527,
    "BrandName": "Ribavirin Teva Pharma BV",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Ribavirin",
    "DecisionDate": "07/01/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 1014,
    "EUNumber": "EU/1/09/528",
    "EUNoShort": 528,
    "BrandName": "Peyona",
    "MAH": "Chiesi Farmaceutici S.p.A.",
    "ActiveSubstance": "Caffeine citrate",
    "DecisionDate": "07/02/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Austria",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10a",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 126,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 959,
    "EUNumber": "EU/1/09/531",
    "EUNoShort": 531,
    "BrandName": "Instanyl",
    "MAH": "Takeda Pharma A/S",
    "ActiveSubstance": "Fentanyl",
    "DecisionDate": "07/20/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "N02",
    "ATCCodeL1": "N",
    "ATCNameL2": "Analgesics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 279,
    "TotalTimeElapsed": 484
  },
  {
    "ApplicationNo": 1031,
    "EUNumber": "EU/1/09/536",
    "EUNoShort": 536,
    "BrandName": "Topotecan Actavis",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "topotecan",
    "DecisionDate": "07/24/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 206,
    "ClockStopElapsed": 132,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 920,
    "EUNumber": "EU/1/09/533",
    "EUNoShort": 533,
    "BrandName": "Vedrop",
    "MAH": "Recordati Rare Diseases",
    "ActiveSubstance": "tocofersolan",
    "DecisionDate": "07/24/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "A11",
    "ATCCodeL1": "A",
    "ATCNameL2": "Vitamins",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 273,
    "TotalTimeElapsed": 483
  },
  {
    "ApplicationNo": 1166,
    "EUNumber": "EU/1/09/532",
    "EUNoShort": 532,
    "BrandName": "Clopidogrel Acino",
    "MAH": "Acino AG",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "07/28/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 30,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 30
  },
  {
    "ApplicationNo": 1139,
    "EUNumber": "EU/1/09/534",
    "EUNoShort": 534,
    "BrandName": "Clopidogrel Hexal",
    "MAH": "Acino Pharma GmbH",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "07/28/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 87,
    "ClockStopElapsed": 9,
    "TotalTimeElapsed": 96
  },
  {
    "ApplicationNo": 1059,
    "EUNumber": "EU/1/09/535",
    "EUNoShort": 535,
    "BrandName": "Grepid",
    "MAH": "Pharmathen S.A.",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "07/28/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Slovenia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 78,
    "TotalTimeElapsed": 282
  },
  {
    "ApplicationNo": 1053,
    "EUNumber": "EU/1/09/540",
    "EUNoShort": 540,
    "BrandName": "Clopidogrel Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "07/28/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Slovenia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 78,
    "TotalTimeElapsed": 282
  },
  {
    "ApplicationNo": 1165,
    "EUNumber": "EU/1/09/541",
    "EUNoShort": 541,
    "BrandName": "Clopidogrel ratiopharm GmbH",
    "MAH": "Archie Samuel s.r.o.",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "07/28/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 30,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 30
  },
  {
    "ApplicationNo": 1054,
    "EUNumber": "EU/1/09/542",
    "EUNoShort": 542,
    "BrandName": "Clopidogrel 1A Pharma",
    "MAH": "Acino Pharma GmbH",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "07/28/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 78,
    "TotalTimeElapsed": 282
  },
  {
    "ApplicationNo": 1030,
    "EUNumber": "EU/1/09/537",
    "EUNoShort": 537,
    "BrandName": "Mozobil",
    "MAH": "Genzyme Europe B.V.",
    "ActiveSubstance": "Plerixafor",
    "DecisionDate": "07/31/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 131,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 1038,
    "EUNumber": "EU/1/09/538",
    "EUNoShort": 538,
    "BrandName": "Afinitor",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "everolimus",
    "DecisionDate": "08/03/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 206,
    "ClockStopElapsed": 104,
    "TotalTimeElapsed": 310
  },
  {
    "ApplicationNo": 980,
    "EUNumber": "EU/1/09/539",
    "EUNoShort": 539,
    "BrandName": "Samsca",
    "MAH": "Otsuka Pharmaceutical Netherlands B.V.",
    "ActiveSubstance": "tolvaptan",
    "DecisionDate": "08/03/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "C03",
    "ATCCodeL1": "C",
    "ATCNameL2": "Diuretics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 250,
    "TotalTimeElapsed": 457
  },
  {
    "ApplicationNo": 1174,
    "EUNumber": "EU/1/09/547",
    "EUNoShort": 547,
    "BrandName": "Clopidogrel Sandoz",
    "MAH": "Acino Pharma GmbH",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "09/21/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 21,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 21
  },
  {
    "ApplicationNo": 1175,
    "EUNumber": "EU/1/09/548",
    "EUNoShort": 548,
    "BrandName": "Clopidogrel Acino Pharma GmbH",
    "MAH": "Acino Pharma GmbH",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "09/21/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 55,
    "ClockStopElapsed": 8,
    "TotalTimeElapsed": 63
  },
  {
    "ApplicationNo": 983,
    "EUNumber": "EU/1/09/550",
    "EUNoShort": 550,
    "BrandName": "Javlor",
    "MAH": "Pierre Fabre M√©dicament",
    "ActiveSubstance": "vinflunine ditartrate",
    "DecisionDate": "09/21/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 196,
    "ClockStopElapsed": 288,
    "TotalTimeElapsed": 484
  },
  {
    "ApplicationNo": 1076,
    "EUNumber": "EU/1/09/551",
    "EUNoShort": 551,
    "BrandName": "Vizarsin",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "sildenafil",
    "DecisionDate": "09/21/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 197,
    "ClockStopElapsed": 49,
    "TotalTimeElapsed": 246
  },
  {
    "ApplicationNo": 1071,
    "EUNumber": "EU/1/09/552",
    "EUNoShort": 552,
    "BrandName": "Topotecan Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "topotecan",
    "DecisionDate": "09/21/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 69,
    "TotalTimeElapsed": 246
  },
  {
    "ApplicationNo": 1138,
    "EUNumber": "EU/1/09/558",
    "EUNoShort": 558,
    "BrandName": "Clopidogrel BGR",
    "MAH": "Laboratoires BIOGARAN",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "09/21/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 80,
    "ClockStopElapsed": 12,
    "TotalTimeElapsed": 92
  },
  {
    "ApplicationNo": 1134,
    "EUNumber": "EU/1/09/559",
    "EUNoShort": 559,
    "BrandName": "Clopidogrel Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "09/21/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 80,
    "ClockStopElapsed": 12,
    "TotalTimeElapsed": 92
  },
  {
    "ApplicationNo": 1132,
    "EUNumber": "EU/1/09/560",
    "EUNoShort": 560,
    "BrandName": "Clopidogrel DURA",
    "MAH": "Mylan dura GmbH",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "09/21/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 80,
    "ClockStopElapsed": 12,
    "TotalTimeElapsed": 92
  },
  {
    "ApplicationNo": 1133,
    "EUNumber": "EU/1/09/561",
    "EUNoShort": 561,
    "BrandName": "Clopidogrel Teva Pharma",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "09/21/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 80,
    "ClockStopElapsed": 12,
    "TotalTimeElapsed": 92
  },
  {
    "ApplicationNo": 1137,
    "EUNumber": "EU/1/09/562",
    "EUNoShort": 562,
    "BrandName": "Clopidogrel Krka d.d.",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "09/21/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 80,
    "ClockStopElapsed": 12,
    "TotalTimeElapsed": 92
  },
  {
    "ApplicationNo": 996,
    "EUNumber": "EU/1/09/543",
    "EUNoShort": 543,
    "BrandName": "Cayston",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "aztreonam",
    "DecisionDate": "09/21/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 154,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 1173,
    "EUNumber": "EU/1/09/554",
    "EUNoShort": 554,
    "BrandName": "Clopidogrel ratiopharm",
    "MAH": "Archie Samuel s.r.o.",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "09/23/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 21,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 21
  },
  {
    "ApplicationNo": 1136,
    "EUNumber": "EU/1/09/555",
    "EUNoShort": 555,
    "BrandName": "Clopidogrel TAD",
    "MAH": "TAD Pharma GmbH",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "09/23/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 80,
    "ClockStopElapsed": 12,
    "TotalTimeElapsed": 92
  },
  {
    "ApplicationNo": 1056,
    "EUNumber": "EU/1/09/556",
    "EUNoShort": 556,
    "BrandName": "Clopidogrel Krka",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "09/23/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 197,
    "ClockStopElapsed": 112,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 1135,
    "EUNumber": "EU/1/09/557",
    "EUNoShort": 557,
    "BrandName": "Clopidogrel Qualimed",
    "MAH": "Qualimed",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "09/23/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 80,
    "ClockStopElapsed": 12,
    "TotalTimeElapsed": 92
  },
  {
    "ApplicationNo": 1172,
    "EUNumber": "EU/1/09/549",
    "EUNoShort": 549,
    "BrandName": "Clopidogrel Acino Pharma",
    "MAH": "Acino Pharma GmbH",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "09/28/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 21,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 21
  },
  {
    "ApplicationNo": 1058,
    "EUNumber": "EU/1/09/553",
    "EUNoShort": 553,
    "BrandName": "Zyllt",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "09/28/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 197,
    "ClockStopElapsed": 112,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 1037,
    "EUNumber": "EU/1/09/544",
    "EUNoShort": 544,
    "BrandName": "Cimzia",
    "MAH": "UCB Pharma S.A.",
    "ActiveSubstance": "certolizumab pegol",
    "DecisionDate": "10/01/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 160,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 1039,
    "EUNumber": "EU/1/09/545",
    "EUNoShort": 545,
    "BrandName": "Onglyza",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "saxagliptin",
    "DecisionDate": "10/01/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 132,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 992,
    "EUNumber": "EU/1/09/546",
    "EUNoShort": 546,
    "BrandName": "Simponi",
    "MAH": "Janssen Biologics B.V.",
    "ActiveSubstance": "golimumab",
    "DecisionDate": "10/01/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 177,
    "ClockStopElapsed": 279,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 878,
    "EUNumber": "EU/1/09/563",
    "EUNoShort": 563,
    "BrandName": "ChondroCelect",
    "MAH": "TiGenix NV",
    "ActiveSubstance": "Characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins",
    "DecisionDate": "10/05/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "M09",
    "ATCCodeL1": "M",
    "ATCNameL2": "Other drugs for disorders of the musculo-skeletal system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 195,
    "ClockStopElapsed": 361,
    "TotalTimeElapsed": 556
  },
  {
    "ApplicationNo": 1065,
    "EUNumber": "EU/1/09/580",
    "EUNoShort": 580,
    "BrandName": "Enyglid",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "Repaglinide",
    "DecisionDate": "10/14/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 96,
    "TotalTimeElapsed": 305
  },
  {
    "ApplicationNo": 1161,
    "EUNumber": "EU/1/09/570",
    "EUNoShort": 570,
    "BrandName": "Imprida HCT",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "amlodipine besylate / valsartan / hydrochlorothiazide",
    "DecisionDate": "10/15/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 89,
    "ClockStopElapsed": 27,
    "TotalTimeElapsed": 116
  },
  {
    "ApplicationNo": 1012,
    "EUNumber": "EU/1/09/581",
    "EUNoShort": 581,
    "BrandName": "Resolor",
    "MAH": "Shire Pharmaceuticals Ireland Limited",
    "ActiveSubstance": "prucalopride",
    "DecisionDate": "10/15/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A06",
    "ATCCodeL1": "A",
    "ATCNameL2": "Laxatives",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 206,
    "ClockStopElapsed": 215,
    "TotalTimeElapsed": 421
  },
  {
    "ApplicationNo": 1189,
    "EUNumber": "EU/1/09/568",
    "EUNoShort": 568,
    "BrandName": "Clopidogrel Taw Pharma",
    "MAH": "Taw Pharma (Ireland) Limited",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "10/16/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Slovenia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 21,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 21
  },
  {
    "ApplicationNo": 1068,
    "EUNumber": "EU/1/09/569",
    "EUNoShort": 569,
    "BrandName": "Exforge HCT",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "amlodipine besylate / valsartan / hydrochlorothiazide",
    "DecisionDate": "10/16/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 206,
    "ClockStopElapsed": 96,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 1180,
    "EUNumber": "EU/1/09/572",
    "EUNoShort": 572,
    "BrandName": "Vantavo",
    "MAH": "N.V. Organon",
    "ActiveSubstance": "alendronic acid / colecalciferol",
    "DecisionDate": "10/16/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 1200,
    "EUNumber": "EU/1/09/571",
    "EUNoShort": 571,
    "BrandName": "Pandemic influenza vaccine H5N1 BAXTER",
    "MAH": "Ology Bioservices Ireland LTD",
    "ActiveSubstance": "Pandemic influenza vaccine (H5N1 whole virion, Vero cell derived, inactivated)",
    "DecisionDate": "10/16/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 13,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 13
  },
  {
    "ApplicationNo": 1208,
    "EUNumber": "EU/1/09/577",
    "EUNoShort": 577,
    "BrandName": "Foclivia",
    "MAH": "Seqirus S.r.l.,",
    "ActiveSubstance": "A/Viet Nam/1194/2004 (H5N1) virus surface inactivated antigen",
    "DecisionDate": "10/19/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Italy",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 9,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 9
  },
  {
    "ApplicationNo": 1206,
    "EUNumber": "EU/1/09/578",
    "EUNoShort": 578,
    "BrandName": "Adjupanrix",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Purified antigen fractions of inactivated split virions A/VietNam/1194/2004 NIBRG-14 (H5N1)",
    "DecisionDate": "10/19/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 8,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 8
  },
  {
    "ApplicationNo": 1036,
    "EUNumber": "EU/1/09/565",
    "EUNoShort": 565,
    "BrandName": "Biopoin",
    "MAH": "Teva GmbH",
    "ActiveSubstance": "epoetin theta",
    "DecisionDate": "10/23/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "B03",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antianemic preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 188,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 1113,
    "EUNumber": "EU/1/09/566",
    "EUNoShort": 566,
    "BrandName": "Lamivudine Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Lamivudine",
    "DecisionDate": "10/23/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 176,
    "ClockStopElapsed": 35,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 1109,
    "EUNumber": "EU/1/09/564",
    "EUNoShort": 564,
    "BrandName": "Ilaris",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Canakinumab",
    "DecisionDate": "10/23/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 176,
    "ClockStopElapsed": 35,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 1047,
    "EUNumber": "EU/1/09/582",
    "EUNoShort": 582,
    "BrandName": "Rilonacept Regeneron",
    "MAH": "Regeneron UK Limited",
    "ActiveSubstance": "Rilonacept",
    "DecisionDate": "10/23/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 197,
    "ClockStopElapsed": 168,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 1033,
    "EUNumber": "EU/1/09/573",
    "EUNoShort": 573,
    "BrandName": "Eporatio",
    "MAH": "ratiopharm GmbH",
    "ActiveSubstance": "epoetin theta",
    "DecisionDate": "10/29/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "B03",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antianemic preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 188,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 1093,
    "EUNumber": "EU/1/09/576",
    "EUNoShort": 576,
    "BrandName": "Irbesartan Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Irbesartan",
    "DecisionDate": "10/30/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 196,
    "ClockStopElapsed": 50,
    "TotalTimeElapsed": 246
  },
  {
    "ApplicationNo": 1160,
    "EUNumber": "EU/1/09/574",
    "EUNoShort": 574,
    "BrandName": "Dafiro HCT",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "amlodipine besylate / valsartan / hydrochlorothiazide",
    "DecisionDate": "11/04/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 89,
    "ClockStopElapsed": 27,
    "TotalTimeElapsed": 116
  },
  {
    "ApplicationNo": 1159,
    "EUNumber": "EU/1/09/575",
    "EUNoShort": 575,
    "BrandName": "Copalia HCT",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "amlodipine besylate / valsartan / hydrochlorothiazide",
    "DecisionDate": "11/04/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 89,
    "ClockStopElapsed": 27,
    "TotalTimeElapsed": 116
  },
  {
    "ApplicationNo": 1066,
    "EUNumber": "EU/1/09/579",
    "EUNoShort": 579,
    "BrandName": "Repaglinide Krka",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "Repaglinide",
    "DecisionDate": "11/04/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 206,
    "ClockStopElapsed": 96,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 1112,
    "EUNumber": "EU/1/09/583",
    "EUNoShort": 583,
    "BrandName": "Irbesartan / Hydrochlorothiazide Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "irbesartan / hydrochlorothiazide",
    "DecisionDate": "11/26/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 148,
    "ClockStopElapsed": 35,
    "TotalTimeElapsed": 183
  },
  {
    "ApplicationNo": 1043,
    "EUNumber": "EU/1/09/591",
    "EUNoShort": 591,
    "BrandName": "Multaq",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "dronedarone",
    "DecisionDate": "11/26/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "C01",
    "ATCCodeL1": "C",
    "ATCNameL2": "Cardiac therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 183,
    "ClockStopElapsed": 245,
    "TotalTimeElapsed": 428
  },
  {
    "ApplicationNo": 1073,
    "EUNumber": "EU/1/09/584",
    "EUNoShort": 584,
    "BrandName": "Sildenafil Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "sildenafil",
    "DecisionDate": "11/30/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 129,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 1210,
    "EUNumber": "EU/1/09/586",
    "EUNoShort": 586,
    "BrandName": "Oslif Breezhaler",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "indacaterol",
    "DecisionDate": "11/30/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 1114,
    "EUNumber": "EU/1/09/593",
    "EUNoShort": 593,
    "BrandName": "Onbrez Breezhaler",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "indacaterol",
    "DecisionDate": "11/30/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 178,
    "ClockStopElapsed": 61,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 1211,
    "EUNumber": "EU/1/09/594",
    "EUNoShort": 594,
    "BrandName": "Hirobriz Breezhaler",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "indacaterol",
    "DecisionDate": "11/30/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 1119,
    "EUNumber": "EU/1/09/598",
    "EUNoShort": 598,
    "BrandName": "Nevirapine Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "nevirapine",
    "DecisionDate": "11/30/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 59,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 1089,
    "EUNumber": "EU/1/09/600",
    "EUNoShort": 600,
    "BrandName": "Zutectra",
    "MAH": "Biotest Pharma GmbH",
    "ActiveSubstance": "Human Hepatitis B Immunoglobulin",
    "DecisionDate": "11/30/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "J06",
    "ATCCodeL1": "J",
    "ATCNameL2": "Immune sera and immunoglobulins",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 105,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 1085,
    "EUNumber": "EU/1/09/587",
    "EUNoShort": 587,
    "BrandName": "Olanzapine Glenmark",
    "MAH": "Glenmark Arzneimittel GmbH",
    "ActiveSubstance": "Olanzapine",
    "DecisionDate": "12/03/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 102,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 1086,
    "EUNumber": "EU/1/09/588",
    "EUNoShort": 588,
    "BrandName": "Olanzapine Glenmark Europe",
    "MAH": "Glenmark Arzneimittel GmbH",
    "ActiveSubstance": "Olanzapine",
    "DecisionDate": "12/03/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 102,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 1104,
    "EUNumber": "EU/1/09/590",
    "EUNoShort": 590,
    "BrandName": "Prevenar 13",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)",
    "DecisionDate": "12/09/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 70,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 1088,
    "EUNumber": "EU/1/09/592",
    "EUNoShort": 592,
    "BrandName": "Olazax Disperzi",
    "MAH": "Glenmark Pharmaceuticals s.r.o.",
    "ActiveSubstance": "Olanzapine",
    "DecisionDate": "12/10/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 102,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 1090,
    "EUNumber": "EU/1/09/595",
    "EUNoShort": 595,
    "BrandName": "Sildenafil Actavis",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "Sildenafil",
    "DecisionDate": "12/10/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 159,
    "TotalTimeElapsed": 367
  },
  {
    "ApplicationNo": 1111,
    "EUNumber": "EU/1/09/596",
    "EUNoShort": 596,
    "BrandName": "Lamivudine Teva Pharma B.V.",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Lamivudine",
    "DecisionDate": "12/10/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 176,
    "ClockStopElapsed": 35,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 1181,
    "EUNumber": "EU/1/09/585",
    "EUNoShort": 585,
    "BrandName": "Rivastigmine 1 A Pharma",
    "MAH": "1 A Pharma GmbH",
    "ActiveSubstance": "Rivastigmine",
    "DecisionDate": "12/11/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 30,
    "ClockStopElapsed": 93,
    "TotalTimeElapsed": 123
  },
  {
    "ApplicationNo": 1182,
    "EUNumber": "EU/1/09/589",
    "EUNoShort": 589,
    "BrandName": "Rivastigmine HEXAL",
    "MAH": "Hexal AG",
    "ActiveSubstance": "Rivastigmine",
    "DecisionDate": "12/11/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 30,
    "ClockStopElapsed": 93,
    "TotalTimeElapsed": 123
  },
  {
    "ApplicationNo": 1087,
    "EUNumber": "EU/1/09/597",
    "EUNoShort": 597,
    "BrandName": "Olazax",
    "MAH": "Glenmark Pharmaceuticals s.r.o.",
    "ActiveSubstance": "Olanzapine",
    "DecisionDate": "12/11/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 102,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 1183,
    "EUNumber": "EU/1/09/599",
    "EUNoShort": 599,
    "BrandName": "Rivastigmine Sandoz",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "Rivastigmine",
    "DecisionDate": "12/11/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 30,
    "ClockStopElapsed": 93,
    "TotalTimeElapsed": 123
  },
  {
    "ApplicationNo": 1080,
    "EUNumber": "EU/1/09/603",
    "EUNoShort": 603,
    "BrandName": "Sildenafil ratiopharm",
    "MAH": "ratiopharm GmbH",
    "ActiveSubstance": "Sildenafil",
    "DecisionDate": "12/23/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 206,
    "ClockStopElapsed": 159,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 1032,
    "EUNumber": "EU/1/09/601",
    "EUNoShort": 601,
    "BrandName": "Firdapse",
    "MAH": "SERB S.A.",
    "ActiveSubstance": "amifampridine",
    "DecisionDate": "12/23/2009",
    "DecisionYear": "2009",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 196,
    "ClockStopElapsed": 288,
    "TotalTimeElapsed": 484
  },
  {
    "ApplicationNo": 1129,
    "EUNumber": "EU/1/09/604",
    "EUNoShort": 604,
    "BrandName": "Leflunomide Zentiva",
    "MAH": "Zentiva k.s.",
    "ActiveSubstance": "leflunomide",
    "DecisionDate": "01/08/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 31,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 1045,
    "EUNumber": "EU/1/09/602",
    "EUNoShort": 602,
    "BrandName": "Scintimun",
    "MAH": "CIS bio international",
    "ActiveSubstance": "besilesomab",
    "DecisionDate": "01/11/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 253,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 1124,
    "EUNumber": "EU/1/09/605",
    "EUNoShort": 605,
    "BrandName": "Temomedac",
    "MAH": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "ActiveSubstance": "temozolomide",
    "DecisionDate": "01/25/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 57,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 1106,
    "EUNumber": "EU/1/09/609",
    "EUNoShort": 609,
    "BrandName": "Elonva",
    "MAH": "N.V. Organon",
    "ActiveSubstance": "corifollitropin alfa",
    "DecisionDate": "01/25/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 125,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 1146,
    "EUNumber": "EU/1/09/610",
    "EUNoShort": 610,
    "BrandName": "Telmisartan Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "telmisartan",
    "DecisionDate": "01/26/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Hungary",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 59,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 1107,
    "EUNumber": "EU/1/09/611",
    "EUNoShort": 611,
    "BrandName": "Docetaxel Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Docetaxel",
    "DecisionDate": "01/26/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 123,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 1126,
    "EUNumber": "EU/1/09/606",
    "EUNoShort": 606,
    "BrandName": "Temozolomide Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "temozolomide",
    "DecisionDate": "01/28/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 57,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 1209,
    "EUNumber": "EU/1/09/607",
    "EUNoShort": 607,
    "BrandName": "Silodyx",
    "MAH": "Recordati Ireland Ltd",
    "ActiveSubstance": "silodosin",
    "DecisionDate": "01/29/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 85,
    "ClockStopElapsed": 33,
    "TotalTimeElapsed": 118
  },
  {
    "ApplicationNo": 1092,
    "EUNumber": "EU/1/09/608",
    "EUNoShort": 608,
    "BrandName": "Urorec",
    "MAH": "Recordati Ireland Ltd",
    "ActiveSubstance": "silodosin",
    "DecisionDate": "01/29/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 160,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 1110,
    "EUNumber": "EU/1/10/612",
    "EUNoShort": 612,
    "BrandName": "Revolade",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Eltrombopag",
    "DecisionDate": "03/11/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 199,
    "ClockStopElapsed": 159,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 1055,
    "EUNumber": "EU/1/10/613",
    "EUNoShort": 613,
    "BrandName": "ImmunoGam",
    "MAH": "Cangene Europe Limited",
    "ActiveSubstance": "Human Hepatitis B Immunoglobulin",
    "DecisionDate": "03/15/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J06",
    "ATCCodeL1": "J",
    "ATCNameL2": "Immune sera and immunoglobulins",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 279,
    "TotalTimeElapsed": 484
  },
  {
    "ApplicationNo": 1095,
    "EUNumber": "EU/1/10/614",
    "EUNoShort": 614,
    "BrandName": "Menveo",
    "MAH": "GSK Vaccines S.r.l.",
    "ActiveSubstance": "Meningococcal Group A, C, W135 and Y Conjugate Vaccine",
    "DecisionDate": "03/15/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 188,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 1125,
    "EUNumber": "EU/1/10/615",
    "EUNoShort": 615,
    "BrandName": "Temozolomide Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "temozolomide",
    "DecisionDate": "03/15/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Portugal",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 87,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 1127,
    "EUNumber": "EU/1/10/616",
    "EUNoShort": 616,
    "BrandName": "Temozolomide HEXAL",
    "MAH": "Hexal AG",
    "ActiveSubstance": "temozolomide",
    "DecisionDate": "03/15/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 87,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 1128,
    "EUNumber": "EU/1/10/617",
    "EUNoShort": 617,
    "BrandName": "Temozolomide Sandoz",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "temozolomide",
    "DecisionDate": "03/15/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 87,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 1143,
    "EUNumber": "EU/1/10/619",
    "EUNoShort": 619,
    "BrandName": "DuoPlavin",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "clopidogrel / acetylsalicylic acid",
    "DecisionDate": "03/15/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 172,
    "ClockStopElapsed": 95,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 1235,
    "EUNumber": "EU/1/10/620",
    "EUNoShort": 620,
    "BrandName": "Ristfor",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "sitagliptin / metformin hydrochloride",
    "DecisionDate": "03/15/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 61,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 61
  },
  {
    "ApplicationNo": 1234,
    "EUNumber": "EU/1/10/621",
    "EUNoShort": 621,
    "BrandName": "Ristaben",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "sitagliptin",
    "DecisionDate": "03/15/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 61,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 61
  },
  {
    "ApplicationNo": 1046,
    "EUNumber": "EU/1/10/622",
    "EUNoShort": 622,
    "BrandName": "Tepadina",
    "MAH": "ADIENNE S.r.l.S.U.",
    "ActiveSubstance": "Thiotepa",
    "DecisionDate": "03/15/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10a",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 206,
    "ClockStopElapsed": 306,
    "TotalTimeElapsed": 512
  },
  {
    "ApplicationNo": 1144,
    "EUNumber": "EU/1/10/623",
    "EUNoShort": 623,
    "BrandName": "Clopidogrel/Acetylsalicylic acid Zentiva",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "clopidogrel / acetylsalicylic acid",
    "DecisionDate": "03/15/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 172,
    "ClockStopElapsed": 95,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 1201,
    "EUNumber": "EU/1/10/624",
    "EUNoShort": 624,
    "BrandName": "Arepanrix",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Pandemic influenza vaccine (H1N1) (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (X-179A)",
    "DecisionDate": "03/23/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 1,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 1
  },
  {
    "ApplicationNo": 1184,
    "EUNumber": "EU/1/10/626",
    "EUNoShort": 626,
    "BrandName": "Ribavirin BioPartners",
    "MAH": "BioPartners GmbH",
    "ActiveSubstance": "Ribavirin",
    "DecisionDate": "04/06/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 59,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 1131,
    "EUNumber": "EU/1/10/625",
    "EUNoShort": 625,
    "BrandName": "Arzerra",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Ofatumumab",
    "DecisionDate": "04/19/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 188,
    "ClockStopElapsed": 142,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 1075,
    "EUNumber": "EU/1/10/627",
    "EUNoShort": 627,
    "BrandName": "Raloxifene Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Raloxifene hydrochloride",
    "DecisionDate": "04/29/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 283,
    "TotalTimeElapsed": 484
  },
  {
    "ApplicationNo": 1074,
    "EUNumber": "EU/1/10/630",
    "EUNoShort": 630,
    "BrandName": "Docefrez",
    "MAH": "Sun Pharmaceutical Industries Europe BV",
    "ActiveSubstance": "Docetaxel",
    "DecisionDate": "05/10/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 240,
    "ClockStopElapsed": 244,
    "TotalTimeElapsed": 484
  },
  {
    "ApplicationNo": 1120,
    "EUNumber": "EU/1/10/618",
    "EUNoShort": 618,
    "BrandName": "Prolia",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "denosumab",
    "DecisionDate": "05/26/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 212,
    "ClockStopElapsed": 111,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 1196,
    "EUNumber": "EU/1/10/632",
    "EUNoShort": 632,
    "BrandName": "Tolura",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "telmisartan",
    "DecisionDate": "06/04/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Hungary",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 199,
    "ClockStopElapsed": 40,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 1142,
    "EUNumber": "EU/1/10/631",
    "EUNoShort": 631,
    "BrandName": "Nivestim",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "Filgrastim",
    "DecisionDate": "06/08/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Finland",
    "CoRapporteur": "Czech Republic",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 148,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 1202,
    "EUNumber": "EU/1/10/629",
    "EUNoShort": 629,
    "BrandName": "Humenza",
    "MAH": "Sanofi Pasteur SA",
    "ActiveSubstance": "Pandemic influenza vaccine (H1N1) (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (X-179A)",
    "DecisionDate": "06/08/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 34,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 34
  },
  {
    "ApplicationNo": 1192,
    "EUNumber": "EU/1/10/633",
    "EUNoShort": 633,
    "BrandName": "Topotecan Hospira",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "topotecan",
    "DecisionDate": "06/10/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 57,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 1185,
    "EUNumber": "EU/1/10/634",
    "EUNoShort": 634,
    "BrandName": "Ribavirin Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "Ribavirin",
    "DecisionDate": "06/10/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 198,
    "ClockStopElapsed": 97,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 1178,
    "EUNumber": "EU/1/10/635",
    "EUNoShort": 635,
    "BrandName": "Olanzapine Apotex",
    "MAH": "Apotex Europe B.V.",
    "ActiveSubstance": "Olanzapine",
    "DecisionDate": "06/10/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 199,
    "ClockStopElapsed": 96,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 1141,
    "EUNumber": "EU/1/10/628",
    "EUNoShort": 628,
    "BrandName": "Votrient",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Pazopanib hydrochloride",
    "DecisionDate": "06/14/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 183,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 1179,
    "EUNumber": "EU/1/10/636",
    "EUNoShort": 636,
    "BrandName": "Daxas",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "roflumilast",
    "DecisionDate": "07/05/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Spain",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 120,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 1227,
    "EUNumber": "EU/1/10/637",
    "EUNoShort": 637,
    "BrandName": "Leflunomide medac",
    "MAH": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "ActiveSubstance": "leflunomide",
    "DecisionDate": "07/27/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 59,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 1140,
    "EUNumber": "EU/1/10/638",
    "EUNoShort": 638,
    "BrandName": "Ozurdex",
    "MAH": "Allergan Pharmaceuticals Ireland",
    "ActiveSubstance": "dexamethasone",
    "DecisionDate": "07/27/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 211,
    "TotalTimeElapsed": 421
  },
  {
    "ApplicationNo": 1249,
    "EUNumber": "EU/1/10/646",
    "EUNoShort": 646,
    "BrandName": "VPRIV",
    "MAH": "Shire Pharmaceuticals Ireland Limited",
    "ActiveSubstance": "Velaglucerase alfa",
    "DecisionDate": "08/26/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 33,
    "TotalTimeElapsed": 183
  },
  {
    "ApplicationNo": 1164,
    "EUNumber": "EU/1/10/644",
    "EUNoShort": 644,
    "BrandName": "PecFent",
    "MAH": "Kyowa Kirin Holdings B.V.",
    "ActiveSubstance": "Fentanyl",
    "DecisionDate": "08/31/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "France",
    "ATCCodeL2": "N02",
    "ATCCodeL1": "N",
    "ATCNameL2": "Analgesics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 1177,
    "EUNumber": "EU/1/10/640",
    "EUNoShort": 640,
    "BrandName": "Sycrest",
    "MAH": "Organon N.V.",
    "ActiveSubstance": "asenapine",
    "DecisionDate": "09/01/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 183,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 1215,
    "EUNumber": "EU/1/10/645",
    "EUNoShort": 645,
    "BrandName": "Brinavess",
    "MAH": "Correvio",
    "ActiveSubstance": "vernakalant hydrochloride",
    "DecisionDate": "09/01/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "C01",
    "ATCCodeL1": "C",
    "ATCNameL2": "Cardiac therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 100,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 1176,
    "EUNumber": "EU/1/10/643",
    "EUNoShort": 643,
    "BrandName": "Rapiscan",
    "MAH": "GE Healthcare AS",
    "ActiveSubstance": "regadenoson",
    "DecisionDate": "09/06/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "C01",
    "ATCCodeL1": "C",
    "ATCNameL2": "Cardiac therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 184,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 1195,
    "EUNumber": "EU/1/10/642",
    "EUNoShort": 642,
    "BrandName": "Ibandronic Acid Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Ibandronic acid",
    "DecisionDate": "09/17/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 120,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 120
  },
  {
    "ApplicationNo": 1168,
    "EUNumber": "EU/1/10/639",
    "EUNoShort": 639,
    "BrandName": "Telmisartan Actavis",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "telmisartan",
    "DecisionDate": "09/30/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 156,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 1218,
    "EUNumber": "EU/1/10/647",
    "EUNoShort": 647,
    "BrandName": "Myclausen",
    "MAH": "Passauer Pharma GmbH",
    "ActiveSubstance": "mycophenolate mofetil",
    "DecisionDate": "10/07/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 122,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 1224,
    "EUNumber": "EU/1/10/648",
    "EUNoShort": 648,
    "BrandName": "Twynsta",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "telmisartan / amlodipine",
    "DecisionDate": "10/07/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 92,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 1223,
    "EUNumber": "EU/1/10/641",
    "EUNoShort": 641,
    "BrandName": "Ruconest",
    "MAH": "Pharming Group N.V.",
    "ActiveSubstance": "Conestat alfa",
    "DecisionDate": "10/28/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "B06",
    "ATCCodeL1": "B",
    "ATCNameL2": "Other hematological agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 64,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 2254,
    "EUNumber": "EU/1/10/650",
    "EUNoShort": 650,
    "BrandName": "Clopidogrel Teva Generics B.V.",
    "MAH": "Teva Generics B.V.",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "10/28/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Belgium",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 2255,
    "EUNumber": "EU/1/10/651",
    "EUNoShort": 651,
    "BrandName": "Clopidogrel HCS",
    "MAH": "HCS bvba",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "10/28/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Belgium",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 2035,
    "EUNumber": "EU/1/10/654",
    "EUNoShort": 654,
    "BrandName": "Leflunomide ratiopharm",
    "MAH": "ratiopharm GmbH",
    "ActiveSubstance": "leflunomide",
    "DecisionDate": "11/29/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Germany",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 120,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 120
  },
  {
    "ApplicationNo": 2269,
    "EUNumber": "EU/1/10/657",
    "EUNoShort": 657,
    "BrandName": "Prepandemic Influenza",
    "MAH": "Novartis Vaccines and Diagnostics S.r.l.",
    "ActiveSubstance": "Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)",
    "DecisionDate": "11/29/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Italy",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 64,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 2094,
    "EUNumber": "EU/1/10/658",
    "EUNoShort": 658,
    "BrandName": "Aflunov",
    "MAH": "Seqirus S.r.l.",
    "ActiveSubstance": "Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)",
    "DecisionDate": "11/29/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Italy",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 64,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 1241,
    "EUNumber": "EU/1/10/655",
    "EUNoShort": 655,
    "BrandName": "Brilique",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "ticagrelor",
    "DecisionDate": "12/03/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 206,
    "ClockStopElapsed": 103,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 2303,
    "EUNumber": "EU/1/10/656",
    "EUNoShort": 656,
    "BrandName": "Possia",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "ticagrelor",
    "DecisionDate": "12/03/2010",
    "DecisionYear": "2010",
    "Period": "2006-2010",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 87,
    "ClockStopElapsed": 33,
    "TotalTimeElapsed": 120
  },
  {
    "ApplicationNo": 2282,
    "EUNumber": "EU/1/10/660",
    "EUNoShort": 660,
    "BrandName": "Potactasol",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "topotecan",
    "DecisionDate": "01/06/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 2025,
    "EUNumber": "EU/1/10/659",
    "EUNoShort": 659,
    "BrandName": "Iasibon",
    "MAH": "Pharmathen S.A.",
    "ActiveSubstance": "Ibandronic acid",
    "DecisionDate": "01/21/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 68,
    "TotalTimeElapsed": 273
  },
  {
    "ApplicationNo": 2032,
    "EUNumber": "EU/1/10/662",
    "EUNoShort": 662,
    "BrandName": "Docetaxel Teva Pharma",
    "MAH": "Teva Pharma B.V.",
    "ActiveSubstance": "Docetaxel",
    "DecisionDate": "01/21/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 1101,
    "EUNumber": "EU/1/10/661",
    "EUNoShort": 661,
    "BrandName": "FLUENZ",
    "MAH": "MedImmune, LLC",
    "ActiveSubstance": "influenza vaccine (live attenuated, nasal)",
    "DecisionDate": "01/27/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 454,
    "TotalTimeElapsed": 664
  },
  {
    "ApplicationNo": 2075,
    "EUNumber": "EU/1/10/665",
    "EUNoShort": 665,
    "BrandName": "Entacapone Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "entacapone",
    "DecisionDate": "02/18/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 152,
    "ClockStopElapsed": 24,
    "TotalTimeElapsed": 176
  },
  {
    "ApplicationNo": 1236,
    "EUNumber": "EU/1/10/663",
    "EUNoShort": 663,
    "BrandName": "Lamivudine / Zidovudine Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Lamivudine / Zidovudine",
    "DecisionDate": "02/28/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 183,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 2399,
    "EUNumber": "EU/1/11/666",
    "EUNoShort": 666,
    "BrandName": "Libertek",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "roflumilast",
    "DecisionDate": "02/28/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 2154,
    "EUNumber": "EU/1/11/667",
    "EUNoShort": 667,
    "BrandName": "Esbriet",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "Pirfenidone",
    "DecisionDate": "02/28/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 87,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 2398,
    "EUNumber": "EU/1/11/668",
    "EUNoShort": 668,
    "BrandName": "Daliresp",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "roflumilast",
    "DecisionDate": "02/28/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 2048,
    "EUNumber": "EU/1/11/671",
    "EUNoShort": 671,
    "BrandName": "Xiapex",
    "MAH": "Swedish Orphan Biovitrum AB (publ)",
    "ActiveSubstance": "collagenase clostridium histolyticum",
    "DecisionDate": "02/28/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "France",
    "ATCCodeL2": "M09",
    "ATCCodeL1": "M",
    "ATCNameL2": "Other drugs for disorders of the musculo-skeletal system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 119,
    "TotalTimeElapsed": 329
  },
  {
    "ApplicationNo": 1212,
    "EUNumber": "EU/1/10/664",
    "EUNoShort": 664,
    "BrandName": "Pumarix",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)",
    "DecisionDate": "03/04/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 91,
    "ClockStopElapsed": 365,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 2105,
    "EUNumber": "EU/1/11/672",
    "EUNoShort": 672,
    "BrandName": "Xeplion",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "paliperidone",
    "DecisionDate": "03/04/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 178,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 2302,
    "EUNumber": "EU/1/11/673",
    "EUNoShort": 673,
    "BrandName": "Ifirmacombi",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "Irbesartan / hydrochlorothiazide",
    "DecisionDate": "03/04/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 24,
    "TotalTimeElapsed": 204
  },
  {
    "ApplicationNo": 2356,
    "EUNumber": "EU/1/11/675",
    "EUNoShort": 675,
    "BrandName": "Leflunomide Teva",
    "MAH": "Teva Pharma B.V.",
    "ActiveSubstance": "leflunomide",
    "DecisionDate": "03/10/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 55,
    "ClockStopElapsed": 30,
    "TotalTimeElapsed": 85
  },
  {
    "ApplicationNo": 1242,
    "EUNumber": "EU/1/11/669",
    "EUNoShort": 669,
    "BrandName": "Teysuno",
    "MAH": "Nordic Group B.V.",
    "ActiveSubstance": "Tegafur / gimeracil / oteracil",
    "DecisionDate": "03/14/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 183,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 1222,
    "EUNumber": "EU/1/11/674",
    "EUNoShort": 674,
    "BrandName": "Repso",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "leflunomide",
    "DecisionDate": "03/14/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 239,
    "TotalTimeElapsed": 449
  },
  {
    "ApplicationNo": 2018,
    "EUNumber": "EU/1/11/676",
    "EUNoShort": 676,
    "BrandName": "JEVTANA",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "cabazitaxel",
    "DecisionDate": "03/17/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 31,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 2202,
    "EUNumber": "EU/1/11/677",
    "EUNoShort": 677,
    "BrandName": "Gilenya",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Fingolimod",
    "DecisionDate": "03/17/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 181,
    "ClockStopElapsed": 183,
    "TotalTimeElapsed": 364
  },
  {
    "ApplicationNo": 2084,
    "EUNumber": "EU/1/11/678",
    "EUNoShort": 678,
    "BrandName": "HALAVEN",
    "MAH": "Eisai GmbH",
    "ActiveSubstance": "eribulin",
    "DecisionDate": "03/17/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 59,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 1245,
    "EUNumber": "EU/1/11/681",
    "EUNoShort": 681,
    "BrandName": "Trobalt",
    "MAH": "Glaxo Group Ltd",
    "ActiveSubstance": "retigabine",
    "DecisionDate": "03/28/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 218,
    "TotalTimeElapsed": 428
  },
  {
    "ApplicationNo": 2420,
    "EUNumber": "EU/1/11/680",
    "EUNoShort": 680,
    "BrandName": "Riprazo HCT",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "aliskiren / hydrochlorothiazide",
    "DecisionDate": "04/13/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Italy",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 1243,
    "EUNumber": "EU/1/11/679",
    "EUNoShort": 679,
    "BrandName": "Pravafenix",
    "MAH": "LABORATOIRES SMB SA",
    "ActiveSubstance": "fenofibrate / pravastatin",
    "DecisionDate": "04/14/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "C10",
    "ATCCodeL1": "C",
    "ATCNameL2": "Lipid modifying agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 218,
    "TotalTimeElapsed": 428
  },
  {
    "ApplicationNo": 2073,
    "EUNumber": "EU/1/11/686",
    "EUNoShort": 686,
    "BrandName": "Rasilamlo",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "aliskiren / amlodipine",
    "DecisionDate": "04/14/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Italy",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 213,
    "TotalTimeElapsed": 421
  },
  {
    "ApplicationNo": 2127,
    "EUNumber": "EU/1/11/687",
    "EUNoShort": 687,
    "BrandName": "Hizentra",
    "MAH": "CSL Behring GmbH",
    "ActiveSubstance": "human normal immunoglobulin",
    "DecisionDate": "04/14/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "France",
    "ATCCodeL2": "J06",
    "ATCCodeL1": "J",
    "ATCNameL2": "Immune sera and immunoglobulins",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 120,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 2108,
    "EUNumber": "EU/1/11/682",
    "EUNoShort": 682,
    "BrandName": "Methylthioninium chloride Proveblue",
    "MAH": "Provepharm S.A.S.",
    "ActiveSubstance": "methylthioninium chloride",
    "DecisionDate": "05/06/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 182,
    "TotalTimeElapsed": 392
  },
  {
    "ApplicationNo": 2148,
    "EUNumber": "EU/1/11/691",
    "EUNoShort": 691,
    "BrandName": "Eliquis",
    "MAH": "Bristol-Myers Squibb/Pfizer EEIG",
    "ActiveSubstance": "apixaban",
    "DecisionDate": "05/18/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 148,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 1198,
    "EUNumber": "EU/1/11/692",
    "EUNoShort": 692,
    "BrandName": "Yellox",
    "MAH": "Bausch Health Ireland Limited",
    "ActiveSubstance": "bromfenac",
    "DecisionDate": "05/18/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 393,
    "TotalTimeElapsed": 603
  },
  {
    "ApplicationNo": 1207,
    "EUNumber": "EU/1/11/688",
    "EUNoShort": 688,
    "BrandName": "Cinryze",
    "MAH": "Shire Services BVBA",
    "ActiveSubstance": "C1 inhibitor, human",
    "DecisionDate": "06/15/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "B06",
    "ATCCodeL1": "B",
    "ATCNameL2": "Other hematological agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 157,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 1226,
    "EUNumber": "EU/1/10/649",
    "EUNoShort": 649,
    "BrandName": "Clopidogrel Teva Pharma B.V.",
    "MAH": "Teva Pharma B.V.",
    "ActiveSubstance": "Clopidogrel",
    "DecisionDate": "06/16/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 92,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 2036,
    "EUNumber": "EU/1/11/693",
    "EUNoShort": 693,
    "BrandName": "Rivastigmine Actavis",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "Rivastigmine",
    "DecisionDate": "06/16/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 113,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 2380,
    "EUNumber": "EU/1/11/695",
    "EUNoShort": 695,
    "BrandName": "Leganto",
    "MAH": "UCB Pharma S.A.",
    "ActiveSubstance": "Rotigotine",
    "DecisionDate": "06/16/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 2098,
    "EUNumber": "EU/1/11/694",
    "EUNoShort": 694,
    "BrandName": "NULOJIX",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "belatacept",
    "DecisionDate": "06/17/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Lithuania",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 204,
    "TotalTimeElapsed": 414
  },
  {
    "ApplicationNo": 2020,
    "EUNumber": "EU/1/11/696",
    "EUNoShort": 696,
    "BrandName": "Bydureon",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "exenatide",
    "DecisionDate": "06/17/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 183,
    "ClockStopElapsed": 203,
    "TotalTimeElapsed": 386
  },
  {
    "ApplicationNo": 2421,
    "EUNumber": "EU/1/11/683",
    "EUNoShort": 683,
    "BrandName": "Sprimeo HCT",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "aliskiren / hydrochlorothiazide",
    "DecisionDate": "06/23/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Italy",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 2198,
    "EUNumber": "EU/1/11/697",
    "EUNoShort": 697,
    "BrandName": "Temozolomide SUN",
    "MAH": "Sun Pharmaceutical Industries Europe BV",
    "ActiveSubstance": "temozolomide",
    "DecisionDate": "07/13/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 92,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 2213,
    "EUNumber": "EU/1/11/698",
    "EUNoShort": 698,
    "BrandName": "YERVOY",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "ipilimumab",
    "DecisionDate": "07/13/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 148,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 2015,
    "EUNumber": "EU/1/11/700",
    "EUNoShort": 700,
    "BrandName": "Benlysta",
    "MAH": "GlaxoSmithKline (Ireland) Limited",
    "ActiveSubstance": "belimumab",
    "DecisionDate": "07/13/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 120,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 2173,
    "EUNumber": "EU/1/11/703",
    "EUNoShort": 703,
    "BrandName": "Xgeva",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "denosumab",
    "DecisionDate": "07/13/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 120,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 2332,
    "EUNumber": "EU/1/11/704",
    "EUNoShort": 704,
    "BrandName": "Victrelis",
    "MAH": "Merck Sharp & Dohme Limited",
    "ActiveSubstance": "boceprevir",
    "DecisionDate": "07/18/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 145,
    "ClockStopElapsed": 10,
    "TotalTimeElapsed": 155
  },
  {
    "ApplicationNo": 2155,
    "EUNumber": "EU/1/10/652",
    "EUNoShort": 652,
    "BrandName": "TOBI Podhaler",
    "MAH": "Mylan IRE Healthcare Ltd",
    "ActiveSubstance": "Tobramycin",
    "DecisionDate": "07/20/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 64,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 2097,
    "EUNumber": "EU/1/11/699",
    "EUNoShort": 699,
    "BrandName": "Fampyra",
    "MAH": "Biogen Netherlands B.V.",
    "ActiveSubstance": "fampridine",
    "DecisionDate": "07/20/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 155,
    "TotalTimeElapsed": 364
  },
  {
    "ApplicationNo": 2367,
    "EUNumber": "EU/1/11/685",
    "EUNoShort": 685,
    "BrandName": "Ibandronic acid Sandoz",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "Ibandronic acid",
    "DecisionDate": "07/26/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 1213,
    "EUNumber": "EU/1/11/690",
    "EUNoShort": 690,
    "BrandName": "Zoely",
    "MAH": "Theramex Ireland Limited",
    "ActiveSubstance": "nomegestrol / estradiol",
    "DecisionDate": "07/27/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 365,
    "TotalTimeElapsed": 575
  },
  {
    "ApplicationNo": 2440,
    "EUNumber": "EU/1/11/708",
    "EUNoShort": 708,
    "BrandName": "Entacapone Orion",
    "MAH": "Orion Corporation",
    "ActiveSubstance": "entacapone",
    "DecisionDate": "08/18/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Finland",
    "CoRapporteur": "Luxembourg",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 2441,
    "EUNumber": "EU/1/11/706",
    "EUNoShort": 706,
    "BrandName": "Levodopa/Carbidopa/Entacapone Orion",
    "MAH": "Orion Corporation",
    "ActiveSubstance": "Levodopa,carbidopa,entacapone",
    "DecisionDate": "08/24/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Finland",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 2110,
    "EUNumber": "EU/1/11/707",
    "EUNoShort": 707,
    "BrandName": "Trajenta",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "linagliptin",
    "DecisionDate": "08/24/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 2316,
    "EUNumber": "EU/1/11/701",
    "EUNoShort": 701,
    "BrandName": "Levetiracetam Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "levetiracetam",
    "DecisionDate": "08/26/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 31,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 2244,
    "EUNumber": "EU/1/11/702",
    "EUNoShort": 702,
    "BrandName": "Levetiracetam ratiopharm",
    "MAH": "ratiopharm GmbH",
    "ActiveSubstance": "levetiracetam",
    "DecisionDate": "08/26/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Belgium",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 31,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 1240,
    "EUNumber": "EU/1/11/705",
    "EUNoShort": 705,
    "BrandName": "Vibativ",
    "MAH": "Theravance Biopharma Ireland Limited",
    "ActiveSubstance": "telavancin",
    "DecisionDate": "09/02/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 337,
    "TotalTimeElapsed": 547
  },
  {
    "ApplicationNo": 2311,
    "EUNumber": "EU/1/11/710",
    "EUNoShort": 710,
    "BrandName": "Votubia",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Everolimus",
    "DecisionDate": "09/02/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 2321,
    "EUNumber": "EU/1/11/714",
    "EUNoShort": 714,
    "BrandName": "Zytiga",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "abiraterone",
    "DecisionDate": "09/05/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L02",
    "ATCCodeL1": "L",
    "ATCNameL2": "Endocrine therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 33,
    "TotalTimeElapsed": 183
  },
  {
    "ApplicationNo": 2267,
    "EUNumber": "EU/1/11/709",
    "EUNoShort": 709,
    "BrandName": "Buccolam",
    "MAH": "Laboratorios Lesvi, S.L.",
    "ActiveSubstance": "midazolam",
    "DecisionDate": "09/05/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 64,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 2268,
    "EUNumber": "EU/1/11/718",
    "EUNoShort": 718,
    "BrandName": "Dexdor",
    "MAH": "Orion Corporation",
    "ActiveSubstance": "dexmedetomidine",
    "DecisionDate": "09/16/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 73,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 2313,
    "EUNumber": "EU/1/11/720",
    "EUNoShort": 720,
    "BrandName": "Incivo",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "telaprevir",
    "DecisionDate": "09/19/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 33,
    "TotalTimeElapsed": 183
  },
  {
    "ApplicationNo": 2291,
    "EUNumber": "EU/1/11/728",
    "EUNoShort": 728,
    "BrandName": "Pramipexole Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "pramipexole",
    "DecisionDate": "09/30/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Norway",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 46,
    "TotalTimeElapsed": 246
  },
  {
    "ApplicationNo": 2024,
    "EUNumber": "EU/1/11/711",
    "EUNoShort": 711,
    "BrandName": "Matever",
    "MAH": "Pharmathen S.A.",
    "ActiveSubstance": "levetiracetam",
    "DecisionDate": "10/03/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 206,
    "ClockStopElapsed": 68,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 2290,
    "EUNumber": "EU/1/11/712",
    "EUNoShort": 712,
    "BrandName": "Levetiracetam Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "levetiracetam",
    "DecisionDate": "10/03/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Belgium",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 46,
    "TotalTimeElapsed": 246
  },
  {
    "ApplicationNo": 2355,
    "EUNumber": "EU/1/11/713",
    "EUNoShort": 713,
    "BrandName": "Levetiracetam Actavis",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "levetiracetam",
    "DecisionDate": "10/03/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 64,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 2511,
    "EUNumber": "EU/1/11/719",
    "EUNoShort": 719,
    "BrandName": "Telmisartan Teva Pharma",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "telmisartan",
    "DecisionDate": "10/03/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Hungary",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 1199,
    "EUNumber": "EU/1/11/716",
    "EUNoShort": 716,
    "BrandName": "Eurartesim",
    "MAH": "Alfasigma S.p.A.",
    "ActiveSubstance": "piperaquine tetraphosphate/artenimol",
    "DecisionDate": "10/27/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "P01",
    "ATCCodeL1": "P",
    "ATCNameL2": "Antiprotozoals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 492,
    "TotalTimeElapsed": 701
  },
  {
    "ApplicationNo": 2185,
    "EUNumber": "EU/1/11/715",
    "EUNoShort": 715,
    "BrandName": "Plenadren",
    "MAH": "Shire Services BVBA",
    "ActiveSubstance": "hydrocortisone",
    "DecisionDate": "11/03/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "H02",
    "ATCCodeL1": "H",
    "ATCNameL2": "Corticosteroids for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 183,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 2068,
    "EUNumber": "EU/1/11/689",
    "EUNoShort": 689,
    "BrandName": "IOA",
    "MAH": "Merck Sharp & Dohme Limited",
    "ActiveSubstance": "nomegestrol / estradiol",
    "DecisionDate": "11/16/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 239,
    "TotalTimeElapsed": 449
  },
  {
    "ApplicationNo": 2294,
    "EUNumber": "EU/1/11/717",
    "EUNoShort": 717,
    "BrandName": "Vyndaqel",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "tafamidis",
    "DecisionDate": "11/16/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 2017,
    "EUNumber": "EU/1/11/730",
    "EUNoShort": 730,
    "BrandName": "Rasitrio",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "aliskiren / amlodipine / hydrochlorothiazide",
    "DecisionDate": "11/22/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Italy",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 274,
    "TotalTimeElapsed": 484
  },
  {
    "ApplicationNo": 2118,
    "EUNumber": "EU/1/11/729",
    "EUNoShort": 729,
    "BrandName": "Onduarp",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "telmisartan / amlodipine",
    "DecisionDate": "11/24/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 55,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 55
  },
  {
    "ApplicationNo": 2059,
    "EUNumber": "EU/1/11/731",
    "EUNoShort": 731,
    "BrandName": "Komboglyze",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "saxagliptin / metformin",
    "DecisionDate": "11/24/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 400
  },
  {
    "ApplicationNo": 2419,
    "EUNumber": "EU/1/11/732",
    "EUNoShort": 732,
    "BrandName": "Desloratadine Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "desloratadine",
    "DecisionDate": "11/24/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Hungary",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "R06",
    "ATCCodeL1": "R",
    "ATCNameL2": "Antihistamines for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 31,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 2264,
    "EUNumber": "EU/1/11/736",
    "EUNoShort": 736,
    "BrandName": "EDURANT",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "rilpivirine",
    "DecisionDate": "11/28/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 155,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 2312,
    "EUNumber": "EU/1/11/737",
    "EUNoShort": 737,
    "BrandName": "Eviplera",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "emtricitabine / rilpivirine (as hydrochloride) / tenofovir disoproxil (as fumarate)",
    "DecisionDate": "11/28/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 155,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 2310,
    "EUNumber": "EU/1/11/739",
    "EUNoShort": 739,
    "BrandName": "Dasselta",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "desloratadine",
    "DecisionDate": "11/28/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Hungary",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "R06",
    "ATCCodeL1": "R",
    "ATCNameL2": "Antihistamines for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 31,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 2087,
    "EUNumber": "EU/1/11/733",
    "EUNoShort": 733,
    "BrandName": "Dificlir",
    "MAH": "Tillotts Pharma GmbH",
    "ActiveSubstance": "fidaxomicin",
    "DecisionDate": "12/05/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "A07",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antidiarrheals, intestinal antiinflammatory/antiinfective agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 400
  },
  {
    "ApplicationNo": 2305,
    "EUNumber": "EU/1/11/738",
    "EUNoShort": 738,
    "BrandName": "Levetiracetam Actavis Group",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "levetiracetam",
    "DecisionDate": "12/05/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 71,
    "TotalTimeElapsed": 281
  },
  {
    "ApplicationNo": 2293,
    "EUNumber": "EU/1/11/734",
    "EUNoShort": 734,
    "BrandName": "Edarbi",
    "MAH": "Takeda Pharma A/S",
    "ActiveSubstance": "azilsartan medoxomil",
    "DecisionDate": "12/07/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 2517,
    "EUNumber": "EU/1/11/735",
    "EUNoShort": 735,
    "BrandName": "Ipreziv",
    "MAH": "Takeda Pharma A/S",
    "ActiveSubstance": "azilsartan medoxomil",
    "DecisionDate": "12/07/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 32,
    "TotalTimeElapsed": 92
  },
  {
    "ApplicationNo": 2204,
    "EUNumber": "EU/1/11/740",
    "EUNoShort": 740,
    "BrandName": "Ameluz",
    "MAH": "Biofrontera Bioscience GmbH",
    "ActiveSubstance": "5-Aminolaevulinic acid",
    "DecisionDate": "12/14/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 183,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 2051,
    "EUNumber": "EU/1/11/741",
    "EUNoShort": 741,
    "BrandName": "Levetiracetam SUN",
    "MAH": "Sun Pharmaceutical Industries Europe BV",
    "ActiveSubstance": "levetiracetam",
    "DecisionDate": "12/14/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Greece",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 164,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 2318,
    "EUNumber": "EU/1/11/743",
    "EUNoShort": 743,
    "BrandName": "Repaglinide Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "Repaglinide",
    "DecisionDate": "12/22/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Hungary",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 129,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 2261,
    "EUNumber": "EU/1/11/744",
    "EUNoShort": 744,
    "BrandName": "Topotecan Eagle",
    "MAH": "Eagle Laboratories Limited",
    "ActiveSubstance": "topotecan",
    "DecisionDate": "12/22/2011",
    "DecisionYear": "2011",
    "Period": "2011-2015",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 274,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 2352,
    "EUNumber": "EU/1/11/742",
    "EUNoShort": 742,
    "BrandName": "Efavirenz Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "efavirenz",
    "DecisionDate": "01/09/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 108,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 2435,
    "EUNumber": "EU/1/11/745",
    "EUNoShort": 745,
    "BrandName": "Desloratadine Actavis",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "desloratadine",
    "DecisionDate": "01/13/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Hungary",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "R06",
    "ATCCodeL1": "R",
    "ATCNameL2": "Antihistamines for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 66,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 2404,
    "EUNumber": "EU/1/11/746",
    "EUNoShort": 746,
    "BrandName": "Desloratadine ratiopharm",
    "MAH": "ratiopharm GmbH",
    "ActiveSubstance": "desloratadine",
    "DecisionDate": "01/13/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Belgium",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "R06",
    "ATCCodeL1": "R",
    "ATCNameL2": "Antihistamines for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 66,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 2317,
    "EUNumber": "EU/1/11/748",
    "EUNoShort": 748,
    "BrandName": "Docetaxel Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "Docetaxel",
    "DecisionDate": "01/31/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 246,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 1225,
    "EUNumber": "EU/1/11/747",
    "EUNoShort": 747,
    "BrandName": "Colobreathe",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Colistimethate sodium",
    "DecisionDate": "02/13/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 211,
    "TotalTimeElapsed": 421
  },
  {
    "ApplicationNo": 2409,
    "EUNumber": "EU/1/12/751",
    "EUNoShort": 751,
    "BrandName": "Zelboraf",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "vemurafenib",
    "DecisionDate": "02/17/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 23,
    "TotalTimeElapsed": 203
  },
  {
    "ApplicationNo": 2089,
    "EUNumber": "EU/1/12/752",
    "EUNoShort": 752,
    "BrandName": "Vepacel",
    "MAH": "Ology Bioservices Ireland LTD",
    "ActiveSubstance": "Prepandemic influenza vaccine (A/H5N1) (whole virion, Vero cell derived, inactivated)",
    "DecisionDate": "02/17/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 183,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 2315,
    "EUNumber": "EU/1/11/749",
    "EUNoShort": 749,
    "BrandName": "Caprelsa",
    "MAH": "Genzyme Europe B.V.",
    "ActiveSubstance": "vandetanib",
    "DecisionDate": "02/17/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 211,
    "TotalTimeElapsed": 421
  },
  {
    "ApplicationNo": 2041,
    "EUNumber": "EU/1/12/750",
    "EUNoShort": 750,
    "BrandName": "Esmya",
    "MAH": "Gedeon Richter Plc.",
    "ActiveSubstance": "Ulipristal Acetate",
    "DecisionDate": "02/23/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 233,
    "ClockStopElapsed": 132,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 2022,
    "EUNumber": "EU/1/11/727",
    "EUNoShort": 727,
    "BrandName": "Xaluprine",
    "MAH": "Nova Laboratories Ireland Limited",
    "ActiveSubstance": "Mercaptopurine",
    "DecisionDate": "03/09/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 165,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 2021,
    "EUNumber": "EU/1/12/754",
    "EUNoShort": 754,
    "BrandName": "Sepioglin",
    "MAH": "Vaia S.A.",
    "ActiveSubstance": "pioglitazone",
    "DecisionDate": "03/09/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Ireland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 2324,
    "EUNumber": "EU/1/12/755",
    "EUNoShort": 755,
    "BrandName": "Pioglitazone Actavis",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "pioglitazone",
    "DecisionDate": "03/15/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Ireland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 2558,
    "EUNumber": "EU/1/12/756",
    "EUNoShort": 756,
    "BrandName": "Glidipion",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "pioglitazone",
    "DecisionDate": "03/15/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Ireland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 32,
    "TotalTimeElapsed": 92
  },
  {
    "ApplicationNo": 2309,
    "EUNumber": "EU/1/11/721",
    "EUNoShort": 721,
    "BrandName": "Paglitaz",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "pioglitazone",
    "DecisionDate": "03/21/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Ireland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 46,
    "TotalTimeElapsed": 246
  },
  {
    "ApplicationNo": 2277,
    "EUNumber": "EU/1/11/722",
    "EUNoShort": 722,
    "BrandName": "Pioglitazone Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "pioglitazone",
    "DecisionDate": "03/21/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Ireland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 46,
    "TotalTimeElapsed": 246
  },
  {
    "ApplicationNo": 2453,
    "EUNumber": "EU/1/11/723",
    "EUNoShort": 723,
    "BrandName": "Pioglitazone Krka",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "pioglitazone",
    "DecisionDate": "03/21/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Ireland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 200,
    "ClockStopElapsed": 46,
    "TotalTimeElapsed": 246
  },
  {
    "ApplicationNo": 2297,
    "EUNumber": "EU/1/12/757",
    "EUNoShort": 757,
    "BrandName": "Pioglitazone Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "pioglitazone",
    "DecisionDate": "03/26/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Ireland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 2410,
    "EUNumber": "EU/1/12/758",
    "EUNoShort": 758,
    "BrandName": "Pioglitazone Teva Pharma",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "pioglitazone",
    "DecisionDate": "03/26/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Ireland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 92,
    "ClockStopElapsed": 59,
    "TotalTimeElapsed": 151
  },
  {
    "ApplicationNo": 1252,
    "EUNumber": "EU/1/12/760",
    "EUNoShort": 760,
    "BrandName": "Bronchitol",
    "MAH": "Pharmaxis Europe Limited",
    "ActiveSubstance": "Mannitol",
    "DecisionDate": "04/13/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "R05",
    "ATCCodeL1": "R",
    "ATCNameL2": "Cough and cold preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 0,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 841
  },
  {
    "ApplicationNo": 2510,
    "EUNumber": "EU/1/12/765",
    "EUNoShort": 765,
    "BrandName": "Sabervel",
    "MAH": "Pharmathen S.A.",
    "ActiveSubstance": "Irbesartan",
    "DecisionDate": "04/13/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 66,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 2488,
    "EUNumber": "EU/1/12/759",
    "EUNoShort": 759,
    "BrandName": "Zoledronic acid Actavis",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "zoledronic acid",
    "DecisionDate": "04/20/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 57,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 2362,
    "EUNumber": "EU/1/12/761",
    "EUNoShort": 761,
    "BrandName": "Capecitabine Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "capecitabine",
    "DecisionDate": "04/20/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 120,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 2386,
    "EUNumber": "EU/1/12/762",
    "EUNoShort": 762,
    "BrandName": "Capecitabine Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "capecitabine",
    "DecisionDate": "04/20/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 120,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 2605,
    "EUNumber": "EU/1/12/763",
    "EUNoShort": 763,
    "BrandName": "Ecansya",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "capecitabine",
    "DecisionDate": "04/20/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 89,
    "ClockStopElapsed": 31,
    "TotalTimeElapsed": 120
  },
  {
    "ApplicationNo": 2296,
    "EUNumber": "EU/1/12/766",
    "EUNoShort": 766,
    "BrandName": "SANCUSO",
    "MAH": "Kyowa Kirin Holdings B.V.",
    "ActiveSubstance": "granisetron",
    "DecisionDate": "04/20/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Lithuania",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A04",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antiemetics and antinauseants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 247,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 2226,
    "EUNumber": "EU/1/12/767",
    "EUNoShort": 767,
    "BrandName": "Nimenrix",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "Meningococcal group A, C, W-135 and Y conjugate vaccine",
    "DecisionDate": "04/20/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 120,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 2052,
    "EUNumber": "EU/1/12/753",
    "EUNoShort": 753,
    "BrandName": "Signifor",
    "MAH": "Recordati Rare Diseases",
    "ActiveSubstance": "pasireotide",
    "DecisionDate": "04/24/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "H01",
    "ATCCodeL1": "H",
    "ATCNameL2": "Pituitary and hypothalamic hormones and analogues",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 214,
    "ClockStopElapsed": 242,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 2622,
    "EUNumber": "EU/1/12/768",
    "EUNoShort": 768,
    "BrandName": "Riluzole Zentiva",
    "MAH": "Zentiva k.s.",
    "ActiveSubstance": "Riluzole",
    "DecisionDate": "05/07/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 2055,
    "EUNumber": "EU/1/12/764",
    "EUNoShort": 764,
    "BrandName": "Pixuvri",
    "MAH": "Les Laboratoires Servier",
    "ActiveSubstance": "pixantrone",
    "DecisionDate": "05/10/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 255,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 2539,
    "EUNumber": "EU/1/12/769",
    "EUNoShort": 769,
    "BrandName": "Docetaxel Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "Docetaxel",
    "DecisionDate": "05/22/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 66,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 2325,
    "EUNumber": "EU/1/12/770",
    "EUNoShort": 770,
    "BrandName": "Docetaxel Kabi",
    "MAH": "Fresenius Kabi Deutschland GmbH",
    "ActiveSubstance": "Docetaxel",
    "DecisionDate": "05/22/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 66,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 2215,
    "EUNumber": "EU/1/12/774",
    "EUNoShort": 774,
    "BrandName": "Rienso",
    "MAH": "Takeda Pharma A/S",
    "ActiveSubstance": "Ferumoxytol",
    "DecisionDate": "06/15/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Lithuania",
    "ATCCodeL2": "B03",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antianemic preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 458,
    "TotalTimeElapsed": 666
  },
  {
    "ApplicationNo": 2211,
    "EUNumber": "EU/1/12/778",
    "EUNoShort": 778,
    "BrandName": "Eklira Genuair",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "aclidinium bromide",
    "DecisionDate": "07/20/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 73,
    "TotalTimeElapsed": 281
  },
  {
    "ApplicationNo": 2279,
    "EUNumber": "EU/1/12/780",
    "EUNoShort": 780,
    "BrandName": "Jentadueto",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "linagliptin/metformin hydrochloride",
    "DecisionDate": "07/20/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 101,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 2706,
    "EUNumber": "EU/1/12/781",
    "EUNoShort": 781,
    "BrandName": "Bretaris Genuair",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "aclidinium bromide",
    "DecisionDate": "07/20/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 84,
    "ClockStopElapsed": 7,
    "TotalTimeElapsed": 91
  },
  {
    "ApplicationNo": 2494,
    "EUNumber": "EU/1/12/782",
    "EUNoShort": 782,
    "BrandName": "Kalydeco",
    "MAH": "Vertex Pharmaceuticals (Ireland) Limited",
    "ActiveSubstance": "ivacaftor",
    "DecisionDate": "07/23/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "R07",
    "ATCCodeL1": "R",
    "ATCNameL2": "Other respiratory system products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 40,
    "TotalTimeElapsed": 190
  },
  {
    "ApplicationNo": 2434,
    "EUNumber": "EU/1/12/776",
    "EUNoShort": 776,
    "BrandName": "Fycompa",
    "MAH": "Eisai GmbH",
    "ActiveSubstance": "Perampanel",
    "DecisionDate": "07/23/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 129,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 2359,
    "EUNumber": "EU/1/12/779",
    "EUNoShort": 779,
    "BrandName": "Zoledronic acid medac",
    "MAH": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "ActiveSubstance": "zoledronic acid",
    "DecisionDate": "08/03/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 157,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 2439,
    "EUNumber": "EU/1/12/771",
    "EUNoShort": 771,
    "BrandName": "Zoledronic acid Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "zoledronic acid",
    "DecisionDate": "08/16/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 85,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 2437,
    "EUNumber": "EU/1/12/772",
    "EUNoShort": 772,
    "BrandName": "Zoledronic acid Teva Pharma",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "zoledronic acid",
    "DecisionDate": "08/16/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 85,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 2464,
    "EUNumber": "EU/1/12/773",
    "EUNoShort": 773,
    "BrandName": "Jakavi",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "ruxolitinib",
    "DecisionDate": "08/23/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 94,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 2387,
    "EUNumber": "EU/1/12/783",
    "EUNoShort": 783,
    "BrandName": "Zyclara",
    "MAH": "Meda AB",
    "ActiveSubstance": "imiquimod",
    "DecisionDate": "08/23/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "D06",
    "ATCCodeL1": "D",
    "ATCNameL2": "Antibiotics and chemotherapeutics for dermatological use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 136,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 2136,
    "EUNumber": "EU/1/12/784",
    "EUNoShort": 784,
    "BrandName": "Cuprymina",
    "MAH": "A.C.O.M. -ADVANCED CENTER ONCOLOGY MACERATA -S.R.L.",
    "ActiveSubstance": "Copper <sup>64</sup>Cu chloride",
    "DecisionDate": "08/23/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "NA",
    "ATCCodeL1": "N",
    "ATCNameL2": "NA",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 409,
    "TotalTimeElapsed": 610
  },
  {
    "ApplicationNo": 2252,
    "EUNumber": "EU/1/12/785",
    "EUNoShort": 785,
    "BrandName": "Zinforo",
    "MAH": "Pfizer Ireland Pharmaceuticals",
    "ActiveSubstance": "ceftaroline fosamil",
    "DecisionDate": "08/23/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 318,
    "TotalTimeElapsed": 519
  },
  {
    "ApplicationNo": 2482,
    "EUNumber": "EU/1/12/786",
    "EUNoShort": 786,
    "BrandName": "Zoledronic acid Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "zoledronic acid",
    "DecisionDate": "08/23/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 192,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 2345,
    "EUNumber": "EU/1/12/787",
    "EUNoShort": 787,
    "BrandName": "Revestive",
    "MAH": "Shire Pharmaceuticals Ireland Limited",
    "ActiveSubstance": "teduglutide",
    "DecisionDate": "08/30/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 255,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 2284,
    "EUNumber": "EU/1/12/775",
    "EUNoShort": 775,
    "BrandName": "NovoThirteen",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "catridecacog",
    "DecisionDate": "09/03/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 157,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 2406,
    "EUNumber": "EU/1/12/777",
    "EUNoShort": 777,
    "BrandName": "Inlyta",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "Axitinib",
    "DecisionDate": "09/03/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Norway",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 155,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 2221,
    "EUNumber": "EU/1/12/792",
    "EUNoShort": 792,
    "BrandName": "Dacogen",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "Decitabine",
    "DecisionDate": "09/20/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 183,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 2430,
    "EUNumber": "EU/1/12/788",
    "EUNoShort": 788,
    "BrandName": "Seebri Breezhaler",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "glycopyrronium bromide",
    "DecisionDate": "09/28/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 73,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 2691,
    "EUNumber": "EU/1/12/789",
    "EUNoShort": 789,
    "BrandName": "Enurev Breezhaler",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "glycopyrronium bromide",
    "DecisionDate": "09/28/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 183,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 183
  },
  {
    "ApplicationNo": 2690,
    "EUNumber": "EU/1/12/790",
    "EUNoShort": 790,
    "BrandName": "Tovanor Breezhaler",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "glycopyrronium bromide",
    "DecisionDate": "09/28/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 183,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 183
  },
  {
    "ApplicationNo": 2489,
    "EUNumber": "EU/1/12/793",
    "EUNoShort": 793,
    "BrandName": "XALKORI",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "crizotinib",
    "DecisionDate": "10/23/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 136,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 2145,
    "EUNumber": "EU/1/12/791",
    "EUNoShort": 791,
    "BrandName": "Glybera",
    "MAH": "uniQure biopharma B.V.",
    "ActiveSubstance": "Alipogene tiparvovec",
    "DecisionDate": "10/25/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "unknown",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "C10",
    "ATCCodeL1": "C",
    "ATCNameL2": "Lipid modifying agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 0,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 638
  },
  {
    "ApplicationNo": 2455,
    "EUNumber": "EU/1/12/794",
    "EUNoShort": 794,
    "BrandName": "ADCETRIS",
    "MAH": "Takeda Pharma A/S",
    "ActiveSubstance": "Brentuximab vedotin",
    "DecisionDate": "10/25/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 2322,
    "EUNumber": "EU/1/12/795",
    "EUNoShort": 795,
    "BrandName": "Forxiga",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "dapagliflozin",
    "DecisionDate": "11/12/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 248,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 2275,
    "EUNumber": "EU/1/12/796",
    "EUNoShort": 796,
    "BrandName": "Picato",
    "MAH": "LEO Laboratories Ltd",
    "ActiveSubstance": "ingenol mebutate",
    "DecisionDate": "11/15/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "D06",
    "ATCCodeL1": "D",
    "ATCNameL2": "Antibiotics and chemotherapeutics for dermatological use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 400
  },
  {
    "ApplicationNo": 2638,
    "EUNumber": "EU/1/12/798",
    "EUNoShort": 798,
    "BrandName": "Ibandronic acid Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "Ibandronic acid",
    "DecisionDate": "11/19/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 59,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 2365,
    "EUNumber": "EU/1/12/800",
    "EUNoShort": 800,
    "BrandName": "Zoledronic acid Hospira",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "zoledronic acid",
    "DecisionDate": "11/19/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 246,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 2568,
    "EUNumber": "EU/1/12/802",
    "EUNoShort": 802,
    "BrandName": "Capecitabine medac",
    "MAH": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "ActiveSubstance": "capecitabine",
    "DecisionDate": "11/19/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 129,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 2392,
    "EUNumber": "EU/1/12/797",
    "EUNoShort": 797,
    "BrandName": "Eylea",
    "MAH": "Bayer AG",
    "ActiveSubstance": "aflibercept",
    "DecisionDate": "11/22/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 246,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 2711,
    "EUNumber": "EU/1/12/799",
    "EUNoShort": 799,
    "BrandName": "Memantine Merz",
    "MAH": "Merz Pharmaceuticals GmbH",
    "ActiveSubstance": "Memantine",
    "DecisionDate": "11/22/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Belgium",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 2490,
    "EUNumber": "EU/1/12/801",
    "EUNoShort": 801,
    "BrandName": "Constella",
    "MAH": "Allergan Pharmaceuticals International Limited",
    "ActiveSubstance": "linaclotide",
    "DecisionDate": "11/26/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "A06",
    "ATCCodeL1": "A",
    "ATCNameL2": "Laxatives",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 2246,
    "EUNumber": "EU/1/12/803",
    "EUNoShort": 803,
    "BrandName": "NexoBrid",
    "MAH": "MediWound Germany GmbH",
    "ActiveSubstance": "Concentrate of proteolytic enzymes enriched in bromelain",
    "DecisionDate": "12/18/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "D03",
    "ATCCodeL1": "D",
    "ATCNameL2": "Preparations for treatment of wounds &amp; ulcers",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 463,
    "TotalTimeElapsed": 673
  },
  {
    "ApplicationNo": 2388,
    "EUNumber": "EU/1/12/809",
    "EUNoShort": 809,
    "BrandName": "Betmiga",
    "MAH": "Astellas Pharma Europe B.V.",
    "ActiveSubstance": "mirabegron",
    "DecisionDate": "12/20/2012",
    "DecisionYear": "2012",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 192,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 2585,
    "EUNumber": "EU/1/12/808",
    "EUNoShort": 808,
    "BrandName": "Imatinib Teva",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "imatinib",
    "DecisionDate": "01/08/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 101,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 2208,
    "EUNumber": "EU/1/12/810",
    "EUNoShort": 810,
    "BrandName": "Krystexxa",
    "MAH": "Crealta Pharmaceuticals Ireland Limited",
    "ActiveSubstance": "pegloticase",
    "DecisionDate": "01/08/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "M04",
    "ATCCodeL1": "M",
    "ATCNameL2": "Antigout preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 311,
    "TotalTimeElapsed": 512
  },
  {
    "ApplicationNo": 2422,
    "EUNumber": "EU/1/12/805",
    "EUNoShort": 805,
    "BrandName": "Amyvid",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "Florbetapir (<sup>18</sup>F)",
    "DecisionDate": "01/14/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 65,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 2333,
    "EUNumber": "EU/1/12/812",
    "EUNoShort": 812,
    "BrandName": "Bexsero",
    "MAH": "GlaxoSmithKline Vaccines S.r.l.",
    "ActiveSubstance": "Meningococcal group B Vaccine (rDNA, component, adsorbed)",
    "DecisionDate": "01/14/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 465,
    "TotalTimeElapsed": 666
  },
  {
    "ApplicationNo": 2377,
    "EUNumber": "EU/1/12/804",
    "EUNoShort": 804,
    "BrandName": "BindRen",
    "MAH": "Mitsubishi Tanabe Pharma Europe Ltd",
    "ActiveSubstance": "colestilan",
    "DecisionDate": "01/21/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Lithuania",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 155,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 2499,
    "EUNumber": "EU/1/12/806",
    "EUNoShort": 806,
    "BrandName": "Ryzodeg",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "Insulin degludec/insulin aspart",
    "DecisionDate": "01/21/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 164,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 2498,
    "EUNumber": "EU/1/12/807",
    "EUNoShort": 807,
    "BrandName": "Tresiba",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "Insulin degludec",
    "DecisionDate": "01/21/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 164,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 2445,
    "EUNumber": "EU/1/12/811",
    "EUNoShort": 811,
    "BrandName": "Lyxumia",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "lixisenatide",
    "DecisionDate": "02/01/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 214,
    "ClockStopElapsed": 164,
    "TotalTimeElapsed": 378
  },
  {
    "ApplicationNo": 2532,
    "EUNumber": "EU/1/12/814",
    "EUNoShort": 814,
    "BrandName": "ZALTRAP",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "aflibercept",
    "DecisionDate": "02/01/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 120,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 2400,
    "EUNumber": "EU/1/13/823",
    "EUNoShort": 823,
    "BrandName": "Adasuve",
    "MAH": "Ferrer Internacional S.A.",
    "ActiveSubstance": "loxapine",
    "DecisionDate": "02/20/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 170,
    "ClockStopElapsed": 162,
    "TotalTimeElapsed": 332
  },
  {
    "ApplicationNo": 2583,
    "EUNumber": "EU/1/12/815",
    "EUNoShort": 815,
    "BrandName": "Selincro",
    "MAH": "H. Lundbeck A/S",
    "ActiveSubstance": "nalmefene",
    "DecisionDate": "02/25/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 157,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 2547,
    "EUNumber": "EU/1/13/813",
    "EUNoShort": 813,
    "BrandName": "Perjeta",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "pertuzumab",
    "DecisionDate": "03/04/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 157,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 2676,
    "EUNumber": "EU/1/13/817",
    "EUNoShort": 817,
    "BrandName": "Actelsar HCT",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "telmisartan / hydrochlorothiazide",
    "DecisionDate": "03/13/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 27,
    "TotalTimeElapsed": 237
  },
  {
    "ApplicationNo": 2381,
    "EUNumber": "EU/1/13/819",
    "EUNoShort": 819,
    "BrandName": "JETREA",
    "MAH": "Inceptua AB",
    "ActiveSubstance": "ocriplasmin",
    "DecisionDate": "03/13/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 244,
    "TotalTimeElapsed": 454
  },
  {
    "ApplicationNo": 2549,
    "EUNumber": "EU/1/13/821",
    "EUNoShort": 821,
    "BrandName": "Tolucombi",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "telmisartan/hydrochlorothiazide",
    "DecisionDate": "03/13/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 27,
    "TotalTimeElapsed": 237
  },
  {
    "ApplicationNo": 2373,
    "EUNumber": "EU/1/13/818",
    "EUNoShort": 818,
    "BrandName": "Bosulif",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "Bosutinib",
    "DecisionDate": "03/27/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 307,
    "TotalTimeElapsed": 517
  },
  {
    "ApplicationNo": 2594,
    "EUNumber": "EU/1/13/825",
    "EUNoShort": 825,
    "BrandName": "Imatinib Actavis",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "Imatinib",
    "DecisionDate": "04/17/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Iceland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 216,
    "TotalTimeElapsed": 426
  },
  {
    "ApplicationNo": 2702,
    "EUNumber": "EU/1/13/828",
    "EUNoShort": 828,
    "BrandName": "Hexacima",
    "MAH": "Sanofi Pasteur",
    "ActiveSubstance": "Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and <i>Haemophilus influenzae</i> type b conjugate vaccine (adsorbed)",
    "DecisionDate": "04/17/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 117,
    "ClockStopElapsed": 39,
    "TotalTimeElapsed": 156
  },
  {
    "ApplicationNo": 2796,
    "EUNumber": "EU/1/13/829",
    "EUNoShort": 829,
    "BrandName": "Hexyon",
    "MAH": "Sanofi Pasteur",
    "ActiveSubstance": "diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and <i>Haemophilus influenzae</i> type b conjugate vaccine (adsorbed)",
    "DecisionDate": "04/17/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 116,
    "ClockStopElapsed": 39,
    "TotalTimeElapsed": 155
  },
  {
    "ApplicationNo": 2680,
    "EUNumber": "EU/1/13/824",
    "EUNoShort": 824,
    "BrandName": "Nemdatine",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "Memantine",
    "DecisionDate": "04/22/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 36,
    "TotalTimeElapsed": 244
  },
  {
    "ApplicationNo": 2630,
    "EUNumber": "EU/1/13/826",
    "EUNoShort": 826,
    "BrandName": "Memantine LEK",
    "MAH": "Pharmathen S.A.",
    "ActiveSubstance": "Memantine",
    "DecisionDate": "04/22/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 65,
    "TotalTimeElapsed": 247
  },
  {
    "ApplicationNo": 2660,
    "EUNumber": "EU/1/13/827",
    "EUNoShort": 827,
    "BrandName": "Memantine Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "Memantine",
    "DecisionDate": "04/22/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 37,
    "TotalTimeElapsed": 219
  },
  {
    "ApplicationNo": 2658,
    "EUNumber": "EU/1/13/820",
    "EUNoShort": 820,
    "BrandName": "Marixino",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "Memantine",
    "DecisionDate": "04/29/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 30,
    "TotalTimeElapsed": 212
  },
  {
    "ApplicationNo": 2669,
    "EUNumber": "EU/1/13/835",
    "EUNoShort": 835,
    "BrandName": "Voriconazole Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "voriconazole",
    "DecisionDate": "05/16/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J02",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycotics for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 93,
    "TotalTimeElapsed": 275
  },
  {
    "ApplicationNo": 2491,
    "EUNumber": "EU/1/13/840",
    "EUNoShort": 840,
    "BrandName": "HyQvia",
    "MAH": "Baxalta Innovations GmbH",
    "ActiveSubstance": "human normal immunoglobulin",
    "DecisionDate": "05/16/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "J06",
    "ATCCodeL1": "J",
    "ATCNameL2": "Immune sera and immunoglobulins",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 316,
    "TotalTimeElapsed": 517
  },
  {
    "ApplicationNo": 2574,
    "EUNumber": "EU/1/13/830",
    "EUNoShort": 830,
    "BrandName": "Stribild",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as fumarate)",
    "DecisionDate": "05/24/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 253,
    "TotalTimeElapsed": 454
  },
  {
    "ApplicationNo": 2671,
    "EUNumber": "EU/1/13/836",
    "EUNoShort": 836,
    "BrandName": "Memantine ratiopharm",
    "MAH": "ratiopharm GmbH",
    "ActiveSubstance": "memantine",
    "DecisionDate": "06/13/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Belgium",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 62,
    "TotalTimeElapsed": 272
  },
  {
    "ApplicationNo": 2050,
    "EUNumber": "EU/1/13/831",
    "EUNoShort": 831,
    "BrandName": "Capecitabine SUN",
    "MAH": "Sun Pharmaceutical Industries Europe BV",
    "ActiveSubstance": "Capecitabine",
    "DecisionDate": "06/21/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 307
  },
  {
    "ApplicationNo": 2581,
    "EUNumber": "EU/1/13/841",
    "EUNoShort": 841,
    "BrandName": "Spedra",
    "MAH": "Menarini International Operations Luxembourg S.A.",
    "ActiveSubstance": "avanafil",
    "DecisionDate": "06/21/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 188,
    "TotalTimeElapsed": 398
  },
  {
    "ApplicationNo": 2639,
    "EUNumber": "EU/1/13/846",
    "EUNoShort": 846,
    "BrandName": "Xtandi",
    "MAH": "Astellas Pharma Europe B.V.",
    "ActiveSubstance": "enzalutamide",
    "DecisionDate": "06/21/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L02",
    "ATCCodeL1": "L",
    "ATCNameL2": "Endocrine therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 41,
    "TotalTimeElapsed": 251
  },
  {
    "ApplicationNo": 2644,
    "EUNumber": "EU/1/13/832",
    "EUNoShort": 832,
    "BrandName": "Stayveer",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "bosentan",
    "DecisionDate": "06/24/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "C02",
    "ATCCodeL1": "C",
    "ATCNameL2": "Antihypertensives",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 61,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 61
  },
  {
    "ApplicationNo": 2560,
    "EUNumber": "EU/1/13/833",
    "EUNoShort": 833,
    "BrandName": "Nuedexta",
    "MAH": "Jenson Pharmaceutical Services Ltd",
    "ActiveSubstance": "Dextromethorphan / quinidine",
    "DecisionDate": "06/24/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 316,
    "TotalTimeElapsed": 524
  },
  {
    "ApplicationNo": 2522,
    "EUNumber": "EU/1/13/847",
    "EUNoShort": 847,
    "BrandName": "MACI",
    "MAH": "Vericel Denmark ApS",
    "ActiveSubstance": "Matrix applied characterised autologous cultured chondrocytes",
    "DecisionDate": "06/27/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "unknown",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "M09",
    "ATCCodeL1": "M",
    "ATCNameL2": "Other drugs for disorders of the musculo-skeletal system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 375,
    "TotalTimeElapsed": 580
  },
  {
    "ApplicationNo": 2695,
    "EUNumber": "EU/1/13/839",
    "EUNoShort": 839,
    "BrandName": "Iclusig",
    "MAH": "Incyte Biosciences Distribution B.V.",
    "ActiveSubstance": "ponatinib",
    "DecisionDate": "07/01/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 152,
    "ClockStopElapsed": 32,
    "TotalTimeElapsed": 184
  },
  {
    "ApplicationNo": 2681,
    "EUNumber": "EU/1/13/845",
    "EUNoShort": 845,
    "BrandName": "Imatinib Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "Imatinib",
    "DecisionDate": "07/01/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 307
  },
  {
    "ApplicationNo": 2602,
    "EUNumber": "EU/1/13/848",
    "EUNoShort": 848,
    "BrandName": "Erivedge",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "vismodegib",
    "DecisionDate": "07/12/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 281,
    "TotalTimeElapsed": 489
  },
  {
    "ApplicationNo": 2556,
    "EUNumber": "EU/1/13/856",
    "EUNoShort": 856,
    "BrandName": "Lonquex",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "lipegfilgrastim",
    "DecisionDate": "07/25/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 314,
    "TotalTimeElapsed": 524
  },
  {
    "ApplicationNo": 2500,
    "EUNumber": "EU/1/13/822",
    "EUNoShort": 822,
    "BrandName": "PHEBURANE",
    "MAH": "Eurocept International BV",
    "ActiveSubstance": "Sodium Phenylbutyrate",
    "DecisionDate": "07/31/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Ireland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 125,
    "TotalTimeElapsed": 335
  },
  {
    "ApplicationNo": 2329,
    "EUNumber": "EU/1/13/852",
    "EUNoShort": 852,
    "BrandName": "Atosiban SUN",
    "MAH": "Sun Pharmaceutical Industries Europe BV",
    "ActiveSubstance": "atosiban",
    "DecisionDate": "07/31/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "G02",
    "ATCCodeL1": "G",
    "ATCNameL2": "Other gynecologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 72,
    "TotalTimeElapsed": 254
  },
  {
    "ApplicationNo": 2578,
    "EUNumber": "EU/1/13/851",
    "EUNoShort": 851,
    "BrandName": "Lojuxta",
    "MAH": "Amryt Pharmaceuticals DAC",
    "ActiveSubstance": "Lomitapide",
    "DecisionDate": "07/31/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "C10",
    "ATCCodeL1": "C",
    "ATCNameL2": "Lipid modifying agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 223,
    "TotalTimeElapsed": 433
  },
  {
    "ApplicationNo": 2596,
    "EUNumber": "EU/1/13/855",
    "EUNoShort": 855,
    "BrandName": "Imvanex",
    "MAH": "Bavarian Nordic A/S",
    "ActiveSubstance": "modified vaccinia ankara virus",
    "DecisionDate": "07/31/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 224,
    "TotalTimeElapsed": 433
  },
  {
    "ApplicationNo": 2196,
    "EUNumber": "EU/1/13/849",
    "EUNoShort": 849,
    "BrandName": "Somatropin Biopartners",
    "MAH": "BioPartners GmbH",
    "ActiveSubstance": "somatropin",
    "DecisionDate": "08/05/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "H01",
    "ATCCodeL1": "H",
    "ATCNameL2": "Pituitary and hypothalamic hormones and analogues",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 252,
    "TotalTimeElapsed": 461
  },
  {
    "ApplicationNo": 2682,
    "EUNumber": "EU/1/13/850",
    "EUNoShort": 850,
    "BrandName": "Imnovid",
    "MAH": "Bristol Myers Squibb Pharma EEIG",
    "ActiveSubstance": "Pomalidomide",
    "DecisionDate": "08/05/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 132,
    "TotalTimeElapsed": 342
  },
  {
    "ApplicationNo": 2493,
    "EUNumber": "EU/1/13/857",
    "EUNoShort": 857,
    "BrandName": "Voncento",
    "MAH": "CSL Behring GmbH",
    "ActiveSubstance": "human coagulation factor VIII / human von Willebrand factor",
    "DecisionDate": "08/12/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 314,
    "TotalTimeElapsed": 524
  },
  {
    "ApplicationNo": 2573,
    "EUNumber": "EU/1/13/858",
    "EUNoShort": 858,
    "BrandName": "Stivarga",
    "MAH": "Bayer AG",
    "ActiveSubstance": "regorafenib",
    "DecisionDate": "08/26/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 188,
    "TotalTimeElapsed": 398
  },
  {
    "ApplicationNo": 2514,
    "EUNumber": "EU/1/13/838",
    "EUNoShort": 838,
    "BrandName": "AUBAGIO",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "Teriflunomide",
    "DecisionDate": "08/26/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 391
  },
  {
    "ApplicationNo": 2618,
    "EUNumber": "EU/1/13/860",
    "EUNoShort": 860,
    "BrandName": "Nexium Control",
    "MAH": "GlaxoSmithKline Dungarvan Limited",
    "ActiveSubstance": "esomeprazole",
    "DecisionDate": "08/26/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Lithuania",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "A02",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs for acid related disorders",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 132,
    "TotalTimeElapsed": 342
  },
  {
    "ApplicationNo": 2604,
    "EUNumber": "EU/1/13/865",
    "EUNoShort": 865,
    "BrandName": "Tafinlar",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "DABRAFENIB",
    "DecisionDate": "08/26/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "unknown",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 104,
    "TotalTimeElapsed": 314
  },
  {
    "ApplicationNo": 2559,
    "EUNumber": "EU/1/13/866",
    "EUNoShort": 866,
    "BrandName": "Cholib",
    "MAH": "Mylan IRE Healthcare Ltd",
    "ActiveSubstance": "fenofibrate / simvastatin",
    "DecisionDate": "08/26/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C10",
    "ATCCodeL1": "C",
    "ATCNameL2": "Lipid modifying agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 316,
    "TotalTimeElapsed": 517
  },
  {
    "ApplicationNo": 2465,
    "EUNumber": "EU/1/13/861",
    "EUNoShort": 861,
    "BrandName": "Procysbi",
    "MAH": "Chiesi Farmaceutici S.p.A.",
    "ActiveSubstance": "mercaptamine (cysteamine bitartrate)",
    "DecisionDate": "09/06/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 260,
    "TotalTimeElapsed": 461
  },
  {
    "ApplicationNo": 2513,
    "EUNumber": "EU/1/13/867",
    "EUNoShort": 867,
    "BrandName": "Provenge",
    "MAH": "Dendreon UK Limited",
    "ActiveSubstance": "Autologous peripheral blood mononuclear cells activated with PAP-GM-CSF (Sipuleucel-T)",
    "DecisionDate": "09/06/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "unknown",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 284,
    "TotalTimeElapsed": 485
  },
  {
    "ApplicationNo": 2576,
    "EUNumber": "EU/1/13/853",
    "EUNoShort": 853,
    "BrandName": "Remsima",
    "MAH": "Celltrion Healthcare Hungary Kft.",
    "ActiveSubstance": "Infliximab",
    "DecisionDate": "09/10/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 260,
    "TotalTimeElapsed": 461
  },
  {
    "ApplicationNo": 2778,
    "EUNumber": "EU/1/13/854",
    "EUNoShort": 854,
    "BrandName": "Inflectra",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "Infliximab",
    "DecisionDate": "09/10/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 89,
    "ClockStopElapsed": 260,
    "TotalTimeElapsed": 349
  },
  {
    "ApplicationNo": 3718,
    "EUNumber": "EU/1/13/869",
    "EUNoShort": 869,
    "BrandName": "Lemtrada",
    "MAH": "Sanofi Belgium",
    "ActiveSubstance": "Alemtuzumab",
    "DecisionDate": "09/12/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 84,
    "ClockStopElapsed": 76,
    "TotalTimeElapsed": 160
  },
  {
    "ApplicationNo": 1250,
    "EUNumber": "EU/1/13/870",
    "EUNoShort": 870,
    "BrandName": "Orphacol",
    "MAH": "Laboratoires CTRS",
    "ActiveSubstance": "Cholic acid",
    "DecisionDate": "09/12/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "A05",
    "ATCCodeL1": "A",
    "ATCNameL2": "Bile and liver therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 10a",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 183,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 2178,
    "EUNumber": "EU/1/13/842",
    "EUNoShort": 842,
    "BrandName": "Incresync",
    "MAH": "Takeda Pharma A/S",
    "ActiveSubstance": "alogliptin / pioglitazone",
    "DecisionDate": "09/19/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 160,
    "TotalTimeElapsed": 370
  },
  {
    "ApplicationNo": 2654,
    "EUNumber": "EU/1/13/843",
    "EUNoShort": 843,
    "BrandName": "Vipdomet",
    "MAH": "Takeda Pharma A/S",
    "ActiveSubstance": "alogliptin / metformin",
    "DecisionDate": "09/19/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 160,
    "TotalTimeElapsed": 370
  },
  {
    "ApplicationNo": 2182,
    "EUNumber": "EU/1/13/844",
    "EUNoShort": 844,
    "BrandName": "Vipidia",
    "MAH": "Takeda Pharma A/S",
    "ActiveSubstance": "alogliptin",
    "DecisionDate": "09/19/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 188,
    "TotalTimeElapsed": 398
  },
  {
    "ApplicationNo": 2679,
    "EUNumber": "EU/1/13/862",
    "EUNoShort": 862,
    "BrandName": "Ultibro Breezhaler",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "indacaterol/glycopyrronium bromide",
    "DecisionDate": "09/19/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 71,
    "TotalTimeElapsed": 272
  },
  {
    "ApplicationNo": 3755,
    "EUNumber": "EU/1/13/863",
    "EUNoShort": 863,
    "BrandName": "Xoterna Breezhaler",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "indacaterol/glycopyrronium bromide",
    "DecisionDate": "09/19/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 51,
    "ClockStopElapsed": 69,
    "TotalTimeElapsed": 120
  },
  {
    "ApplicationNo": 2572,
    "EUNumber": "EU/1/13/872",
    "EUNoShort": 872,
    "BrandName": "Tybost",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "cobicistat",
    "DecisionDate": "09/19/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 216,
    "TotalTimeElapsed": 426
  },
  {
    "ApplicationNo": 2515,
    "EUNumber": "EU/1/13/868",
    "EUNoShort": 868,
    "BrandName": "EVARREST",
    "MAH": "Omrix Biopharmaceuticals N.V.",
    "ActiveSubstance": "Human fibrinogen/Human thrombin",
    "DecisionDate": "09/25/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 260,
    "TotalTimeElapsed": 461
  },
  {
    "ApplicationNo": 2692,
    "EUNumber": "EU/1/13/876",
    "EUNoShort": 876,
    "BrandName": "Imatinib Medac",
    "MAH": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "ActiveSubstance": "Imatinib",
    "DecisionDate": "09/25/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 93,
    "TotalTimeElapsed": 275
  },
  {
    "ApplicationNo": 2280,
    "EUNumber": "EU/1/13/879",
    "EUNoShort": 879,
    "BrandName": "Giotrif",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "afatinib",
    "DecisionDate": "09/25/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 97,
    "TotalTimeElapsed": 307
  },
  {
    "ApplicationNo": 2608,
    "EUNumber": "EU/1/13/871",
    "EUNoShort": 871,
    "BrandName": "Ovaleap",
    "MAH": "Theramex Ireland Limited",
    "ActiveSubstance": "Follitropin alfa",
    "DecisionDate": "09/27/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 279,
    "TotalTimeElapsed": 489
  },
  {
    "ApplicationNo": 2150,
    "EUNumber": "EU/1/13/877",
    "EUNoShort": 877,
    "BrandName": "Grastofil",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "filgrastim",
    "DecisionDate": "10/18/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 216,
    "TotalTimeElapsed": 426
  },
  {
    "ApplicationNo": 2393,
    "EUNumber": "EU/1/13/878",
    "EUNoShort": 878,
    "BrandName": "Defitelio",
    "MAH": "Gentium S.r.I.",
    "ActiveSubstance": "defibrotide",
    "DecisionDate": "10/18/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 0,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 792
  },
  {
    "ApplicationNo": 2785,
    "EUNumber": "EU/1/13/859",
    "EUNoShort": 859,
    "BrandName": "Corbilta",
    "MAH": "Orion Corporation",
    "ActiveSubstance": "levodopa / carbidopa / entacapone",
    "DecisionDate": "11/11/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Finland",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 92,
    "ClockStopElapsed": 53,
    "TotalTimeElapsed": 145
  },
  {
    "ApplicationNo": 2653,
    "EUNumber": "EU/1/13/873",
    "EUNoShort": 873,
    "BrandName": "Xofigo",
    "MAH": "Bayer AG",
    "ActiveSubstance": "Radium Ra 223 dichloride",
    "DecisionDate": "11/13/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "V10",
    "ATCCodeL1": "V",
    "ATCNameL2": "Therapeutic radiopharmaceuticals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 183,
    "ClockStopElapsed": 50,
    "TotalTimeElapsed": 233
  },
  {
    "ApplicationNo": 2577,
    "EUNumber": "EU/1/13/883",
    "EUNoShort": 883,
    "BrandName": "Vitekta",
    "MAH": "Gilead Sciences International Limited",
    "ActiveSubstance": "elvitegravir",
    "DecisionDate": "11/13/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "unknown",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 244,
    "TotalTimeElapsed": 454
  },
  {
    "ApplicationNo": 2673,
    "EUNumber": "EU/1/13/886",
    "EUNoShort": 886,
    "BrandName": "Relvar Ellipta",
    "MAH": "GlaxoSmithKline (Ireland) Limited",
    "ActiveSubstance": "fluticasone furoate/vilanterol",
    "DecisionDate": "11/13/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 216,
    "TotalTimeElapsed": 426
  },
  {
    "ApplicationNo": 2719,
    "EUNumber": "EU/1/13/888",
    "EUNoShort": 888,
    "BrandName": "NovoEight",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "turoctocog alfa",
    "DecisionDate": "11/13/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 90,
    "TotalTimeElapsed": 300
  },
  {
    "ApplicationNo": 2693,
    "EUNumber": "EU/1/13/881",
    "EUNoShort": 881,
    "BrandName": "Fortacin",
    "MAH": "Recordati Ireland Ltd",
    "ActiveSubstance": "lidocaine / prilocaine",
    "DecisionDate": "11/15/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "N01",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anesthetics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 244,
    "TotalTimeElapsed": 454
  },
  {
    "ApplicationNo": 2755,
    "EUNumber": "EU/1/13/882",
    "EUNoShort": 882,
    "BrandName": "ABILIFY MAINTENA",
    "MAH": "Otsuka Pharmaceutical Netherlands B.V.",
    "ActiveSubstance": "Aripiprazole",
    "DecisionDate": "11/15/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Greece",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 55,
    "TotalTimeElapsed": 265
  },
  {
    "ApplicationNo": 2649,
    "EUNumber": "EU/1/13/884",
    "EUNoShort": 884,
    "BrandName": "Invokana",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "canagliflozin",
    "DecisionDate": "11/15/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 216,
    "TotalTimeElapsed": 426
  },
  {
    "ApplicationNo": 2389,
    "EUNumber": "EU/1/13/885",
    "EUNoShort": 885,
    "BrandName": "Kadcyla",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "Trastuzumab emtansine",
    "DecisionDate": "11/15/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 363
  },
  {
    "ApplicationNo": 2766,
    "EUNumber": "EU/1/13/880",
    "EUNoShort": 880,
    "BrandName": "Memantine Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "memantine",
    "DecisionDate": "12/04/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 363
  },
  {
    "ApplicationNo": 2617,
    "EUNumber": "EU/1/13/887",
    "EUNoShort": 887,
    "BrandName": "Fluenz Tetra",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "influenza vaccine (live attenuated, nasal)",
    "DecisionDate": "12/04/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 328
  },
  {
    "ApplicationNo": 2717,
    "EUNumber": "EU/1/13/891",
    "EUNoShort": 891,
    "BrandName": "Brintellix",
    "MAH": "H. Lundbeck A/S",
    "ActiveSubstance": "vortioxetine",
    "DecisionDate": "12/18/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 188,
    "TotalTimeElapsed": 398
  },
  {
    "ApplicationNo": 2697,
    "EUNumber": "EU/1/13/893",
    "EUNoShort": 893,
    "BrandName": "Opsumit",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "macitentan",
    "DecisionDate": "12/20/2013",
    "DecisionYear": "2013",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "C02",
    "ATCCodeL1": "C",
    "ATCNameL2": "Antihypertensives",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 335
  },
  {
    "ApplicationNo": 2783,
    "EUNumber": "EU/1/13/889",
    "EUNoShort": 889,
    "BrandName": "Levetiracetam Hospira",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "levetiracetam",
    "DecisionDate": "01/08/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Latvia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 92,
    "TotalTimeElapsed": 300
  },
  {
    "ApplicationNo": 2798,
    "EUNumber": "EU/1/13/894",
    "EUNoShort": 894,
    "BrandName": "Sovaldi",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "sofosbuvir",
    "DecisionDate": "01/16/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 152,
    "ClockStopElapsed": 32,
    "TotalTimeElapsed": 184
  },
  {
    "ApplicationNo": 2667,
    "EUNumber": "EU/1/13/834",
    "EUNoShort": 834,
    "BrandName": "Zoledronic acid Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "zoledronic acid",
    "DecisionDate": "01/16/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 335,
    "TotalTimeElapsed": 545
  },
  {
    "ApplicationNo": 2753,
    "EUNumber": "EU/1/13/892",
    "EUNoShort": 892,
    "BrandName": "Tivicay",
    "MAH": "ViiV Healthcare BV",
    "ActiveSubstance": "dolutegravir",
    "DecisionDate": "01/16/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 92,
    "TotalTimeElapsed": 293
  },
  {
    "ApplicationNo": 2672,
    "EUNumber": "EU/1/13/900",
    "EUNoShort": 900,
    "BrandName": "Xigduo",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "dapagliflozin/metformin",
    "DecisionDate": "01/16/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 328
  },
  {
    "ApplicationNo": 2601,
    "EUNumber": "EU/1/13/837",
    "EUNoShort": 837,
    "BrandName": "Tecfidera",
    "MAH": "Biogen Netherlands B.V.",
    "ActiveSubstance": "Dimethyl fumarate",
    "DecisionDate": "01/30/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 162,
    "TotalTimeElapsed": 363
  },
  {
    "ApplicationNo": 2738,
    "EUNumber": "EU/1/13/905",
    "EUNoShort": 905,
    "BrandName": "Izba",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "travoprost",
    "DecisionDate": "02/20/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 111,
    "TotalTimeElapsed": 320
  },
  {
    "ApplicationNo": 2553,
    "EUNumber": "EU/1/13/906",
    "EUNoShort": 906,
    "BrandName": "Neuraceq",
    "MAH": "Life Radiopharma Berlin GmbH",
    "ActiveSubstance": "florbetaben (<sup>18</sup>F)",
    "DecisionDate": "02/20/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 111,
    "TotalTimeElapsed": 321
  },
  {
    "ApplicationNo": 2642,
    "EUNumber": "EU/1/13/904",
    "EUNoShort": 904,
    "BrandName": "Mirvaso",
    "MAH": "Galderma International",
    "ActiveSubstance": "brimonidine",
    "DecisionDate": "02/21/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "D11",
    "ATCCodeL1": "D",
    "ATCNameL2": "Other dermatological preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 111,
    "TotalTimeElapsed": 321
  },
  {
    "ApplicationNo": 2614,
    "EUNumber": "EU/1/13/901",
    "EUNoShort": 901,
    "BrandName": "Sirturo",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "bedaquiline",
    "DecisionDate": "03/05/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J04",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycobacterials",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 244,
    "TotalTimeElapsed": 454
  },
  {
    "ApplicationNo": 2735,
    "EUNumber": "EU/1/13/908",
    "EUNoShort": 908,
    "BrandName": "Eperzan",
    "MAH": "GlaxoSmithKline Trading Services Limited",
    "ActiveSubstance": "albiglutide",
    "DecisionDate": "03/21/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 90,
    "TotalTimeElapsed": 303
  },
  {
    "ApplicationNo": 2713,
    "EUNumber": "EU/1/14/913",
    "EUNoShort": 913,
    "BrandName": "Latuda",
    "MAH": "Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. S.p.A.",
    "ActiveSubstance": "lurasidone",
    "DecisionDate": "03/21/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 244,
    "TotalTimeElapsed": 454
  },
  {
    "ApplicationNo": 2640,
    "EUNumber": "EU/1/13/890",
    "EUNoShort": 890,
    "BrandName": "Cometriq",
    "MAH": "Ipsen Pharma",
    "ActiveSubstance": "cabozantinib",
    "DecisionDate": "03/21/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 181,
    "TotalTimeElapsed": 391
  },
  {
    "ApplicationNo": 2737,
    "EUNumber": "EU/1/13/907",
    "EUNoShort": 907,
    "BrandName": "Adempas",
    "MAH": "Bayer AG",
    "ActiveSubstance": "riociguat",
    "DecisionDate": "03/27/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "C02",
    "ATCCodeL1": "C",
    "ATCNameL2": "Antihypertensives",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 2615,
    "EUNumber": "EU/1/13/909",
    "EUNoShort": 909,
    "BrandName": "Bemfola",
    "MAH": "Gedeon Richter Plc.",
    "ActiveSubstance": "follitropin alfa",
    "DecisionDate": "03/27/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 216,
    "TotalTimeElapsed": 426
  },
  {
    "ApplicationNo": 2805,
    "EUNumber": "EU/1/14/912",
    "EUNoShort": 912,
    "BrandName": "Zoledronic acid Teva Generics",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "Zoledronic Acid",
    "DecisionDate": "03/27/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 30,
    "TotalTimeElapsed": 212
  },
  {
    "ApplicationNo": 3824,
    "EUNumber": "EU/1/14/911",
    "EUNoShort": 911,
    "BrandName": "Rivastigmine 3M Health Care Ltd.",
    "MAH": "3M Health Care Limited",
    "ActiveSubstance": "rivastigmine",
    "DecisionDate": "04/03/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 61,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 61
  },
  {
    "ApplicationNo": 2081,
    "EUNumber": "EU/1/13/895",
    "EUNoShort": 895,
    "BrandName": "Kolbam",
    "MAH": "Retrophin Europe Limited",
    "ActiveSubstance": "cholic acid",
    "DecisionDate": "04/04/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "A05",
    "ATCCodeL1": "A",
    "ATCNameL2": "Bile and liver therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 370,
    "TotalTimeElapsed": 552
  },
  {
    "ApplicationNo": 2709,
    "EUNumber": "EU/1/13/896",
    "EUNoShort": 896,
    "BrandName": "Granupas",
    "MAH": "Eurocept International B.V.",
    "ActiveSubstance": "Para-aminosalicylic acid",
    "DecisionDate": "04/07/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "J04",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycobacterials",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10a",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 218,
    "ClockStopElapsed": 398,
    "TotalTimeElapsed": 616
  },
  {
    "ApplicationNo": 3880,
    "EUNumber": "EU/1/14/916",
    "EUNoShort": 916,
    "BrandName": "Pregabalin Pfizer",
    "MAH": "Upjohn EESV",
    "ActiveSubstance": "pregabalin",
    "DecisionDate": "04/10/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 61,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 61
  },
  {
    "ApplicationNo": 3875,
    "EUNumber": "EU/1/14/917",
    "EUNoShort": 917,
    "BrandName": "Ulunar Breezhaler",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "indacaterol/glycopyrronium bromide",
    "DecisionDate": "04/23/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 61,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 61
  },
  {
    "ApplicationNo": 2656,
    "EUNumber": "EU/1/14/918",
    "EUNoShort": 918,
    "BrandName": "Vokanamet",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "canagliflozin / metformin hydrochloride",
    "DecisionDate": "04/23/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 2621,
    "EUNumber": "EU/1/14/919",
    "EUNoShort": 919,
    "BrandName": "Hemangiol",
    "MAH": "Pierre Fabre Dermatologie",
    "ActiveSubstance": "propranolol",
    "DecisionDate": "04/23/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "C07",
    "ATCCodeL1": "C",
    "ATCNameL2": "Beta blocking agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 2779,
    "EUNumber": "EU/1/14/914",
    "EUNoShort": 914,
    "BrandName": "Vimizim",
    "MAH": "BioMarin International Limited",
    "ActiveSubstance": "elosulfase alfa",
    "DecisionDate": "04/28/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 62,
    "TotalTimeElapsed": 275
  },
  {
    "ApplicationNo": 2348,
    "EUNumber": "EU/1/14/920",
    "EUNoShort": 920,
    "BrandName": "DuoResp Spiromax",
    "MAH": "Teva Pharma B.V.",
    "ActiveSubstance": "budesonide / formoterol",
    "DecisionDate": "04/28/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 3890,
    "EUNumber": "EU/1/14/921",
    "EUNoShort": 921,
    "BrandName": "BiResp Spiromax",
    "MAH": "Teva Pharma B.V.",
    "ActiveSubstance": "budesonide / formoterol",
    "DecisionDate": "04/28/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 32,
    "ClockStopElapsed": 31,
    "TotalTimeElapsed": 63
  },
  {
    "ApplicationNo": 2809,
    "EUNumber": "EU/1/14/922",
    "EUNoShort": 922,
    "BrandName": "Incruse Ellipta",
    "MAH": "GlaxoSmithKline (Ireland) Limited",
    "ActiveSubstance": "umeclidinium bromide",
    "DecisionDate": "04/28/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 71,
    "TotalTimeElapsed": 275
  },
  {
    "ApplicationNo": 2552,
    "EUNumber": "EU/1/13/875",
    "EUNoShort": 875,
    "BrandName": "Deltyba",
    "MAH": "Otsuka Novel Products GmbH",
    "ActiveSubstance": "delamanid",
    "DecisionDate": "04/28/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "J04",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycobacterials",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 0,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 701
  },
  {
    "ApplicationNo": 2745,
    "EUNumber": "EU/1/14/929",
    "EUNoShort": 929,
    "BrandName": "Revinty Ellipta",
    "MAH": "GlaxoSmithKline (Ireland) Limited",
    "ActiveSubstance": "fluticasone furoate / vilanterol",
    "DecisionDate": "05/02/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 61,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 61
  },
  {
    "ApplicationNo": 2751,
    "EUNumber": "EU/1/14/898",
    "EUNoShort": 898,
    "BrandName": "Anoro Ellipta",
    "MAH": "GlaxoSmithKline (Ireland) Limited",
    "ActiveSubstance": "umeclidinium bromide / vilanterol trifenatate",
    "DecisionDate": "05/08/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 205,
    "ClockStopElapsed": 182,
    "TotalTimeElapsed": 387
  },
  {
    "ApplicationNo": 3754,
    "EUNumber": "EU/1/14/899",
    "EUNoShort": 899,
    "BrandName": "Laventair Ellipta",
    "MAH": "GlaxoSmithKline (Ireland) Limited",
    "ActiveSubstance": "umeclidinium bromide / vilanterol trifenatate",
    "DecisionDate": "05/08/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 149,
    "ClockStopElapsed": 182,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 2777,
    "EUNumber": "EU/1/14/924",
    "EUNoShort": 924,
    "BrandName": "OLYSIO",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "simeprevir",
    "DecisionDate": "05/14/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 90,
    "TotalTimeElapsed": 303
  },
  {
    "ApplicationNo": 3708,
    "EUNumber": "EU/1/14/928",
    "EUNoShort": 928,
    "BrandName": "Sylvant",
    "MAH": "EUSA Pharma (Netherlands) B.V.",
    "ActiveSubstance": "siltuximab",
    "DecisionDate": "05/22/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 152,
    "ClockStopElapsed": 25,
    "TotalTimeElapsed": 177
  },
  {
    "ApplicationNo": 3717,
    "EUNumber": "EU/1/14/915",
    "EUNoShort": 915,
    "BrandName": "Ebilfumin",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "oseltamivir",
    "DecisionDate": "05/22/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 303
  },
  {
    "ApplicationNo": 2782,
    "EUNumber": "EU/1/14/923",
    "EUNoShort": 923,
    "BrandName": "Entyvio",
    "MAH": "Takeda Pharma A/S",
    "ActiveSubstance": "vedolizumab",
    "DecisionDate": "05/22/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 149,
    "TotalTimeElapsed": 359
  },
  {
    "ApplicationNo": 2677,
    "EUNumber": "EU/1/14/930",
    "EUNoShort": 930,
    "BrandName": "Jardiance",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "Empagliflozin",
    "DecisionDate": "05/22/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 146,
    "TotalTimeElapsed": 359
  },
  {
    "ApplicationNo": 2643,
    "EUNumber": "EU/1/14/931",
    "EUNoShort": 931,
    "BrandName": "Mekinist",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "trametinib",
    "DecisionDate": "06/30/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 205,
    "TotalTimeElapsed": 415
  },
  {
    "ApplicationNo": 3698,
    "EUNumber": "EU/1/14/933",
    "EUNoShort": 933,
    "BrandName": "Simbrinza",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Brinzolamide / Brimonidine tartrate",
    "DecisionDate": "07/18/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 303
  },
  {
    "ApplicationNo": 2827,
    "EUNumber": "EU/1/14/934",
    "EUNoShort": 934,
    "BrandName": "Plegridy",
    "MAH": "Biogen Netherlands B.V.",
    "ActiveSubstance": "peginterferon beta-1a",
    "DecisionDate": "07/18/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 2655,
    "EUNumber": "EU/1/14/935",
    "EUNoShort": 935,
    "BrandName": "Envarsus",
    "MAH": "Chiesi Farmaceutici S.p.A.",
    "ActiveSubstance": "tacrolimus",
    "DecisionDate": "07/18/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 2813,
    "EUNumber": "EU/1/14/936",
    "EUNoShort": 936,
    "BrandName": "Nuwiq",
    "MAH": "Octapharma AB",
    "ActiveSubstance": "simoctocog alfa",
    "DecisionDate": "07/22/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 2799,
    "EUNumber": "EU/1/14/937",
    "EUNoShort": 937,
    "BrandName": "Gazyvaro",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "obinutuzumab",
    "DecisionDate": "07/23/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "France",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 162,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 2720,
    "EUNumber": "EU/1/13/902",
    "EUNoShort": 902,
    "BrandName": "Translarna",
    "MAH": "PTC Therapeutics International Limited",
    "ActiveSubstance": "ataluren",
    "DecisionDate": "07/31/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "M09",
    "ATCCodeL1": "M",
    "ATCNameL2": "Other drugs for disorders of the musculo-skeletal system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 0,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 547
  },
  {
    "ApplicationNo": 3768,
    "EUNumber": "EU/1/14/939",
    "EUNoShort": 939,
    "BrandName": "Daklinza",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "daclatasvir",
    "DecisionDate": "08/22/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 152,
    "ClockStopElapsed": 31,
    "TotalTimeElapsed": 183
  },
  {
    "ApplicationNo": 2557,
    "EUNumber": "EU/1/14/941",
    "EUNoShort": 941,
    "BrandName": "Vizamyl",
    "MAH": "GE Healthcare AS",
    "ActiveSubstance": "flutemetamol (18F)",
    "DecisionDate": "08/22/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 335,
    "TotalTimeElapsed": 548
  },
  {
    "ApplicationNo": 2705,
    "EUNumber": "EU/1/14/943",
    "EUNoShort": 943,
    "BrandName": "Velphoro",
    "MAH": "Vifor Fresenius Medical Care Renal Pharma France",
    "ActiveSubstance": "mixture of polynuclear iron(iii)-oxyhydroxide, sucrose and starches",
    "DecisionDate": "08/26/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Lithuania",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 211,
    "ClockStopElapsed": 302,
    "TotalTimeElapsed": 513
  },
  {
    "ApplicationNo": 2754,
    "EUNumber": "EU/1/14/940",
    "EUNoShort": 940,
    "BrandName": "Triumeq",
    "MAH": "ViiV Healthcare BV",
    "ActiveSubstance": "dolutegravir / abacavir / lamivudine",
    "DecisionDate": "09/01/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 37,
    "TotalTimeElapsed": 219
  },
  {
    "ApplicationNo": 2272,
    "EUNumber": "EU/1/14/942",
    "EUNoShort": 942,
    "BrandName": "Clopidogrel / Acetylsalicylic acid Teva",
    "MAH": "Teva Pharma B.V.",
    "ActiveSubstance": "clopidogrel / acetylsalicylic acid",
    "DecisionDate": "09/01/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 212,
    "ClockStopElapsed": 98,
    "TotalTimeElapsed": 310
  },
  {
    "ApplicationNo": 2835,
    "EUNumber": "EU/1/14/944",
    "EUNoShort": 944,
    "BrandName": "Abasaglar",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "Insulin glargine",
    "DecisionDate": "09/09/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 199,
    "ClockStopElapsed": 167,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 3843,
    "EUNumber": "EU/1/14/938",
    "EUNoShort": 938,
    "BrandName": "Zydelig",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "idelalisib",
    "DecisionDate": "09/18/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 43,
    "TotalTimeElapsed": 247
  },
  {
    "ApplicationNo": 3956,
    "EUNumber": "EU/1/14/946",
    "EUNoShort": 946,
    "BrandName": "Accofil",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "Filgrastim",
    "DecisionDate": "09/18/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 61,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 61
  },
  {
    "ApplicationNo": 2647,
    "EUNumber": "EU/1/14/947",
    "EUNoShort": 947,
    "BrandName": "Xultophy",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "insulin degludec / liraglutide",
    "DecisionDate": "09/18/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 394
  },
  {
    "ApplicationNo": 2806,
    "EUNumber": "EU/1/14/951",
    "EUNoShort": 951,
    "BrandName": "Busulfan Fresenius Kabi",
    "MAH": "Fresenius Kabi Deutschland GmbH",
    "ActiveSubstance": "busulfan",
    "DecisionDate": "09/22/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 125,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 3791,
    "EUNumber": "EU/1/14/945",
    "EUNoShort": 945,
    "BrandName": "IMBRUVICA",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "Ibrutinib",
    "DecisionDate": "10/21/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 43,
    "TotalTimeElapsed": 247
  },
  {
    "ApplicationNo": 3850,
    "EUNumber": "EU/1/14/958",
    "EUNoShort": 958,
    "BrandName": "Harvoni",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "ledipasvir/sofosbuvir",
    "DecisionDate": "11/17/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 152,
    "ClockStopElapsed": 32,
    "TotalTimeElapsed": 184
  },
  {
    "ApplicationNo": 3906,
    "EUNumber": "EU/1/14/965",
    "EUNoShort": 965,
    "BrandName": "Ketoconazole HRA",
    "MAH": "HRA Pharma Rare Diseases",
    "ActiveSubstance": "ketoconazole",
    "DecisionDate": "11/19/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "J02",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycotics for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10a",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 152,
    "ClockStopElapsed": 60,
    "TotalTimeElapsed": 212
  },
  {
    "ApplicationNo": 3951,
    "EUNumber": "EU/1/14/948",
    "EUNoShort": 948,
    "BrandName": "Budesonide/Formoterol Teva",
    "MAH": "Teva Pharma B.V.",
    "ActiveSubstance": "budesonide / formoterol",
    "DecisionDate": "11/19/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 32,
    "ClockStopElapsed": 31,
    "TotalTimeElapsed": 63
  },
  {
    "ApplicationNo": 3952,
    "EUNumber": "EU/1/14/949",
    "EUNoShort": 949,
    "BrandName": "Vylaer Spiromax",
    "MAH": "Teva Pharma B.V.",
    "ActiveSubstance": "budesonide / formoterol",
    "DecisionDate": "11/19/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 154,
    "ClockStopElapsed": 30,
    "TotalTimeElapsed": 184
  },
  {
    "ApplicationNo": 3953,
    "EUNumber": "EU/1/14/950",
    "EUNoShort": 950,
    "BrandName": "Budesonide/Formoterol Teva Pharma B.V.",
    "MAH": "Teva Pharma B.V.",
    "ActiveSubstance": "budesonide / formoterol",
    "DecisionDate": "11/19/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 154,
    "ClockStopElapsed": 30,
    "TotalTimeElapsed": 184
  },
  {
    "ApplicationNo": 2085,
    "EUNumber": "EU/1/14/955",
    "EUNoShort": 955,
    "BrandName": "Lymphoseek",
    "MAH": "Navidea Biopharmaceuticals Europe Ltd.",
    "ActiveSubstance": "tilmanocept",
    "DecisionDate": "11/19/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 391,
    "TotalTimeElapsed": 604
  },
  {
    "ApplicationNo": 3969,
    "EUNumber": "EU/1/14/963",
    "EUNoShort": 963,
    "BrandName": "Brimica Genuair",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "aclidinium bromide / formoterol fumarate dihydrate",
    "DecisionDate": "11/19/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 116,
    "ClockStopElapsed": 97,
    "TotalTimeElapsed": 213
  },
  {
    "ApplicationNo": 3745,
    "EUNumber": "EU/1/14/964",
    "EUNoShort": 964,
    "BrandName": "Duaklir Genuair",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "aclidinium bromide / formoterol fumarate dihydrate",
    "DecisionDate": "11/19/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 97,
    "TotalTimeElapsed": 310
  },
  {
    "ApplicationNo": 2819,
    "EUNumber": "EU/1/14/967",
    "EUNoShort": 967,
    "BrandName": "Rezolsta",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "Darunavir/Cobicistat",
    "DecisionDate": "11/19/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "unknown",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 125,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 2569,
    "EUNumber": "EU/1/14/954",
    "EUNoShort": 954,
    "BrandName": "Vargatef",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "nintedanib",
    "DecisionDate": "11/21/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 125,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 2825,
    "EUNumber": "EU/1/14/956",
    "EUNoShort": 956,
    "BrandName": "Trulicity",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "dulaglutide",
    "DecisionDate": "11/21/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 125,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 3787,
    "EUNumber": "EU/1/14/961",
    "EUNoShort": 961,
    "BrandName": "Tadalafil Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "tadalafil",
    "DecisionDate": "11/21/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Iceland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 92,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 4066,
    "EUNumber": "EU/1/14/971",
    "EUNoShort": 971,
    "BrandName": "Trevicta",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "paliperidone",
    "DecisionDate": "12/05/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 61,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 61
  },
  {
    "ApplicationNo": 2810,
    "EUNumber": "EU/1/14/962",
    "EUNoShort": 962,
    "BrandName": "Moventig",
    "MAH": "Kyowa Kirin Holdings B.V.",
    "ActiveSubstance": "naloxegol",
    "DecisionDate": "12/08/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "A06",
    "ATCCodeL1": "A",
    "ATCNameL2": "Laxatives",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 4000,
    "EUNumber": "EU/1/14/972",
    "EUNoShort": 972,
    "BrandName": "Duloxetine Lilly",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "duloxetine",
    "DecisionDate": "12/08/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 122,
    "ClockStopElapsed": 30,
    "TotalTimeElapsed": 152
  },
  {
    "ApplicationNo": 3726,
    "EUNumber": "EU/1/14/959",
    "EUNoShort": 959,
    "BrandName": "Lynparza",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "Olaparib",
    "DecisionDate": "12/16/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 394
  },
  {
    "ApplicationNo": 2314,
    "EUNumber": "EU/1/14/960",
    "EUNoShort": 960,
    "BrandName": "DUAVIVE",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "oestrogens conjugated / bazedoxifene",
    "DecisionDate": "12/16/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 201,
    "ClockStopElapsed": 624,
    "TotalTimeElapsed": 825
  },
  {
    "ApplicationNo": 2829,
    "EUNumber": "EU/1/14/957",
    "EUNoShort": 957,
    "BrandName": "Cyramza",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "ramucirumab",
    "DecisionDate": "12/19/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Iceland",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 3771,
    "EUNumber": "EU/1/14/970",
    "EUNoShort": 970,
    "BrandName": "Rixubis",
    "MAH": "Baxalta Innovations GmbH",
    "ActiveSubstance": "nonacog gamma",
    "DecisionDate": "12/19/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Austria",
    "CoRapporteur": "France",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 2548,
    "EUNumber": "EU/1/14/969",
    "EUNoShort": 969,
    "BrandName": "SCENESSE",
    "MAH": "Clinuvel Europe Limited",
    "ActiveSubstance": "afamelanotide",
    "DecisionDate": "12/22/2014",
    "DecisionYear": "2014",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "D02",
    "ATCCodeL1": "D",
    "ATCNameL2": "Emollients and protectives",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 743,
    "TotalTimeElapsed": 953
  },
  {
    "ApplicationNo": 3957,
    "EUNumber": "EU/1/14/977",
    "EUNoShort": 977,
    "BrandName": "Rasagiline ratiopharm",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "rasagiline",
    "DecisionDate": "01/12/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 61,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 61
  },
  {
    "ApplicationNo": 3821,
    "EUNumber": "EU/1/14/979",
    "EUNoShort": 979,
    "BrandName": "Ofev",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "Nintedanib",
    "DecisionDate": "01/15/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Ireland",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 152,
    "ClockStopElapsed": 25,
    "TotalTimeElapsed": 177
  },
  {
    "ApplicationNo": 3839,
    "EUNumber": "EU/1/14/982",
    "EUNoShort": 982,
    "BrandName": "Viekirax",
    "MAH": "AbbVie Deutschland GmbH & Co. KG",
    "ActiveSubstance": "ombitasvir / paritaprevir / ritonavir",
    "DecisionDate": "01/15/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 152,
    "ClockStopElapsed": 25,
    "TotalTimeElapsed": 177
  },
  {
    "ApplicationNo": 3837,
    "EUNumber": "EU/1/14/983",
    "EUNoShort": 983,
    "BrandName": "Exviera",
    "MAH": "AbbVie Deutschland GmbH & Co. KG",
    "ActiveSubstance": "dasabuvir",
    "DecisionDate": "01/15/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 152,
    "ClockStopElapsed": 25,
    "TotalTimeElapsed": 177
  },
  {
    "ApplicationNo": 3971,
    "EUNumber": "EU/1/14/952",
    "EUNoShort": 952,
    "BrandName": "Sevelamer carbonate Winthrop",
    "MAH": "Genzyme Europe B.V.",
    "ActiveSubstance": "Sevelamer carbonate",
    "DecisionDate": "01/15/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 94,
    "ClockStopElapsed": 23,
    "TotalTimeElapsed": 117
  },
  {
    "ApplicationNo": 2780,
    "EUNumber": "EU/1/14/978",
    "EUNoShort": 978,
    "BrandName": "Senshio",
    "MAH": "Shionogi B.V.",
    "ActiveSubstance": "ospemifene",
    "DecisionDate": "01/15/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "France",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 391,
    "TotalTimeElapsed": 604
  },
  {
    "ApplicationNo": 3729,
    "EUNumber": "EU/1/14/980",
    "EUNoShort": 980,
    "BrandName": "Cosentyx",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "secukinumab",
    "DecisionDate": "01/15/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Finland",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 3746,
    "EUNumber": "EU/1/14/981",
    "EUNoShort": 981,
    "BrandName": "Otezla",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "apremilast",
    "DecisionDate": "01/15/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Ireland",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 117,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 3724,
    "EUNumber": "EU/1/14/974",
    "EUNoShort": 974,
    "BrandName": "Cerdelga",
    "MAH": "Genzyme Europe B.V.",
    "ActiveSubstance": "eliglustat",
    "DecisionDate": "01/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 181,
    "TotalTimeElapsed": 394
  },
  {
    "ApplicationNo": 2814,
    "EUNumber": "EU/1/14/976",
    "EUNoShort": 976,
    "BrandName": "Zontivity",
    "MAH": "Merck Sharp & Dohme Limited",
    "ActiveSubstance": "vorapaxar",
    "DecisionDate": "01/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 117,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 2450,
    "EUNumber": "EU/1/14/987",
    "EUNoShort": 987,
    "BrandName": "Holoclar",
    "MAH": "Holostem Terapie Avanzate S.r.l.",
    "ActiveSubstance": "Ex vivo expanded autologous human corneal epithelial cells containing stem cells",
    "DecisionDate": "02/17/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "unknown",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 424,
    "TotalTimeElapsed": 632
  },
  {
    "ApplicationNo": 4006,
    "EUNumber": "EU/1/14/975",
    "EUNoShort": 975,
    "BrandName": "Clopidogrel ratiopharm",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "clopidogrel",
    "DecisionDate": "02/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Slovenia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 114,
    "ClockStopElapsed": 31,
    "TotalTimeElapsed": 145
  },
  {
    "ApplicationNo": 2840,
    "EUNumber": "EU/1/14/986",
    "EUNoShort": 986,
    "BrandName": "Xydalba",
    "MAH": "Allergan Pharmaceuticals International Limited",
    "ActiveSubstance": "Dalbavancin",
    "DecisionDate": "02/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 145,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 2396,
    "EUNumber": "EU/1/14/984",
    "EUNoShort": 984,
    "BrandName": "Xadago",
    "MAH": "Zambon S.p.A.",
    "ActiveSubstance": "safinamide",
    "DecisionDate": "02/24/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 154,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 3968,
    "EUNumber": "EU/1/14/953",
    "EUNoShort": 953,
    "BrandName": "Tasermity",
    "MAH": "Genzyme Europe B.V.",
    "ActiveSubstance": "sevelamer hydrochloride",
    "DecisionDate": "02/26/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Finland",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 122,
    "ClockStopElapsed": 23,
    "TotalTimeElapsed": 145
  },
  {
    "ApplicationNo": 2633,
    "EUNumber": "EU/1/14/932",
    "EUNoShort": 932,
    "BrandName": "Vantobra",
    "MAH": "PARI Pharma GmbH",
    "ActiveSubstance": "Tobramycin",
    "DecisionDate": "03/18/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 372,
    "TotalTimeElapsed": 582
  },
  {
    "ApplicationNo": 2807,
    "EUNumber": "EU/1/14/985",
    "EUNoShort": 985,
    "BrandName": "Raplixa",
    "MAH": "Mallinckrodt Pharmaceuticals Ireland Limited",
    "ActiveSubstance": "human fibrinogen / human thrombin",
    "DecisionDate": "03/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 216,
    "TotalTimeElapsed": 429
  },
  {
    "ApplicationNo": 3785,
    "EUNumber": "EU/1/15/989",
    "EUNoShort": 989,
    "BrandName": "Orbactiv",
    "MAH": "Menarini International Operations Luxembourg S.A.",
    "ActiveSubstance": "oritavancin",
    "DecisionDate": "03/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 2066,
    "EUNumber": "EU/1/15/990",
    "EUNoShort": 990,
    "BrandName": "IKERVIS",
    "MAH": "Santen Oy",
    "ActiveSubstance": "Ciclosporin",
    "DecisionDate": "03/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 212,
    "ClockStopElapsed": 181,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 2846,
    "EUNumber": "EU/1/15/991",
    "EUNoShort": 991,
    "BrandName": "Sivextro",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "tedizolid phosphate",
    "DecisionDate": "03/23/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 3780,
    "EUNumber": "EU/1/15/992",
    "EUNoShort": 992,
    "BrandName": "Saxenda",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "liraglutide",
    "DecisionDate": "03/23/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 212,
    "ClockStopElapsed": 154,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 3773,
    "EUNumber": "EU/1/15/994",
    "EUNoShort": 994,
    "BrandName": "Kengrexal",
    "MAH": "Chiesi Farmaceutici S.p.A.",
    "ActiveSubstance": "cangrelor",
    "DecisionDate": "03/23/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 180,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 2789,
    "EUNumber": "EU/1/14/973",
    "EUNoShort": 973,
    "BrandName": "Quinsair",
    "MAH": "Chiesi Farmaceutici S.p.A.",
    "ActiveSubstance": "levofloxacin",
    "DecisionDate": "03/26/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Czech Republic",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 154,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 3687,
    "EUNumber": "EU/1/14/988",
    "EUNoShort": 988,
    "BrandName": "Mysimba",
    "MAH": "Orexigen Therapeutics Ireland Limited",
    "ActiveSubstance": "naltrexone / bupropion",
    "DecisionDate": "03/26/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Denmark",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "A08",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antiobesity preparations, excluding diet products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 209,
    "TotalTimeElapsed": 422
  },
  {
    "ApplicationNo": 3823,
    "EUNumber": "EU/1/15/995",
    "EUNoShort": 995,
    "BrandName": "DUTREBIS",
    "MAH": "Merck Sharp & Dohme Limited",
    "ActiveSubstance": "lamivudine / raltegravir",
    "DecisionDate": "03/26/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 90,
    "TotalTimeElapsed": 303
  },
  {
    "ApplicationNo": 3910,
    "EUNumber": "EU/1/15/996",
    "EUNoShort": 996,
    "BrandName": "Ristempa",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "pegfilgrastim",
    "DecisionDate": "04/13/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 92,
    "ClockStopElapsed": 67,
    "TotalTimeElapsed": 159
  },
  {
    "ApplicationNo": 3819,
    "EUNumber": "EU/1/15/999",
    "EUNoShort": 999,
    "BrandName": "Zykadia",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "ceritinib",
    "DecisionDate": "05/06/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 125,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 2788,
    "EUNumber": "EU/1/15/1000",
    "EUNoShort": 1000,
    "BrandName": "Jinarc",
    "MAH": "Otsuka Pharmaceutical Netherlands B.V.",
    "ActiveSubstance": "tolvaptan",
    "DecisionDate": "05/27/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "C03",
    "ATCCodeL1": "C",
    "ATCNameL2": "Diuretics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 215,
    "TotalTimeElapsed": 428
  },
  {
    "ApplicationNo": 3728,
    "EUNumber": "EU/1/15/1001",
    "EUNoShort": 1001,
    "BrandName": "Akynzeo",
    "MAH": "Helsinn Birex Pharmaceuticals Ltd",
    "ActiveSubstance": "‚Äònetupitant/palonosetron‚Äô or ‚Äòfosnetupitant/palonosetron‚Äô",
    "DecisionDate": "05/27/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Ireland",
    "CoRapporteur": "France",
    "ATCCodeL2": "A04",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antiemetics and antinauseants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 216,
    "TotalTimeElapsed": 429
  },
  {
    "ApplicationNo": 3770,
    "EUNumber": "EU/1/15/1003",
    "EUNoShort": 1003,
    "BrandName": "Synjardy",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "empagliflozin / metformin",
    "DecisionDate": "05/27/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 65,
    "TotalTimeElapsed": 247
  },
  {
    "ApplicationNo": 3737,
    "EUNumber": "EU/1/15/1004",
    "EUNoShort": 1004,
    "BrandName": "Voriconazole Hikma",
    "MAH": "Hikma Farmac√™utica (Portugal), S.A.",
    "ActiveSubstance": "voriconazole",
    "DecisionDate": "05/27/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Latvia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J02",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycotics for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 3727,
    "EUNumber": "EU/1/15/1002",
    "EUNoShort": 1002,
    "BrandName": "Lenvima",
    "MAH": "Eisai GmbH",
    "ActiveSubstance": "lenvatinib",
    "DecisionDate": "05/28/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Belgium",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 152,
    "ClockStopElapsed": 32,
    "TotalTimeElapsed": 184
  },
  {
    "ApplicationNo": 3852,
    "EUNumber": "EU/1/15/1007",
    "EUNoShort": 1007,
    "BrandName": "Gardasil 9",
    "MAH": "MSD VACCINS",
    "ActiveSubstance": "human papillomavirus 9-valent vaccine (recombinant, adsorbed)",
    "DecisionDate": "06/10/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 3985,
    "EUNumber": "EU/1/15/1014",
    "EUNoShort": 1014,
    "BrandName": "OPDIVO",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "nivolumab",
    "DecisionDate": "06/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 175,
    "ClockStopElapsed": 37,
    "TotalTimeElapsed": 212
  },
  {
    "ApplicationNo": 2629,
    "EUNumber": "EU/1/15/993",
    "EUNoShort": 993,
    "BrandName": "Lixiana",
    "MAH": "Daiichi Sankyo Europe GmbH",
    "ActiveSubstance": "edoxaban",
    "DecisionDate": "06/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 209,
    "TotalTimeElapsed": 422
  },
  {
    "ApplicationNo": 3981,
    "EUNumber": "EU/1/15/1010",
    "EUNoShort": 1010,
    "BrandName": "Duloxetine Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "Duloxetine",
    "DecisionDate": "06/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 8,
    "TotalTimeElapsed": 212
  },
  {
    "ApplicationNo": 4010,
    "EUNumber": "EU/1/15/1011",
    "EUNoShort": 1011,
    "BrandName": "Pregabalin Sandoz",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "pregabalin",
    "DecisionDate": "06/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 43,
    "TotalTimeElapsed": 247
  },
  {
    "ApplicationNo": 4070,
    "EUNumber": "EU/1/15/1012",
    "EUNoShort": 1012,
    "BrandName": "Pregabalin Sandoz GmbH",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "pregabalin",
    "DecisionDate": "06/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 43,
    "TotalTimeElapsed": 247
  },
  {
    "ApplicationNo": 2749,
    "EUNumber": "EU/1/15/1013",
    "EUNoShort": 1013,
    "BrandName": "Lumark",
    "MAH": "IDB Holland B.V.",
    "ActiveSubstance": "lutetium, isotope of mass 177",
    "DecisionDate": "06/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "V10",
    "ATCCodeL1": "V",
    "ATCNameL2": "Therapeutic radiopharmaceuticals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10a",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 209,
    "TotalTimeElapsed": 422
  },
  {
    "ApplicationNo": 4078,
    "EUNumber": "EU/1/15/997",
    "EUNoShort": 997,
    "BrandName": "Pregabalin Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "pregabalin",
    "DecisionDate": "06/25/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 247
  },
  {
    "ApplicationNo": 3962,
    "EUNumber": "EU/1/15/998",
    "EUNoShort": 998,
    "BrandName": "Pregabalin Mylan Pharma",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "pregabalin",
    "DecisionDate": "06/25/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 247
  },
  {
    "ApplicationNo": 3899,
    "EUNumber": "EU/1/15/1009",
    "EUNoShort": 1009,
    "BrandName": "Aripiprazole Zentiva",
    "MAH": "Zentiva, k.s.",
    "ActiveSubstance": "aripiprazole",
    "DecisionDate": "06/25/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 62,
    "TotalTimeElapsed": 275
  },
  {
    "ApplicationNo": 3803,
    "EUNumber": "EU/1/15/1005",
    "EUNoShort": 1005,
    "BrandName": "Aripiprazole Mylan Pharma",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "aripiprazole",
    "DecisionDate": "06/30/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Norway",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 62,
    "TotalTimeElapsed": 275
  },
  {
    "ApplicationNo": 3870,
    "EUNumber": "EU/1/15/1008",
    "EUNoShort": 1008,
    "BrandName": "Hetlioz",
    "MAH": "Vanda Pharmaceuticals Netherlands B.V.,",
    "ActiveSubstance": "tasimelteon",
    "DecisionDate": "07/03/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 3904,
    "EUNumber": "EU/1/15/1025",
    "EUNoShort": 1025,
    "BrandName": "EVOTAZ",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "atazanavir / cobicistat",
    "DecisionDate": "07/13/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Portugal",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 90,
    "TotalTimeElapsed": 303
  },
  {
    "ApplicationNo": 3766,
    "EUNumber": "EU/1/15/1016",
    "EUNoShort": 1016,
    "BrandName": "Repatha",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "evolocumab",
    "DecisionDate": "07/17/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C10",
    "ATCCodeL1": "C",
    "ATCNameL2": "Lipid modifying agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 36,
    "TotalTimeElapsed": 240
  },
  {
    "ApplicationNo": 3900,
    "EUNumber": "EU/1/15/1021",
    "EUNoShort": 1021,
    "BrandName": "Pregabalin Zentiva",
    "MAH": "Zentiva, k.s.",
    "ActiveSubstance": "pregabalin",
    "DecisionDate": "07/17/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 62,
    "TotalTimeElapsed": 275
  },
  {
    "ApplicationNo": 3820,
    "EUNumber": "EU/1/15/1024",
    "EUNoShort": 1024,
    "BrandName": "KEYTRUDA",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "pembrolizumab",
    "DecisionDate": "07/17/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Italy",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 3984,
    "EUNumber": "EU/1/15/1019",
    "EUNoShort": 1019,
    "BrandName": "Bortezomib Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "bortezomib",
    "DecisionDate": "07/20/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 3840,
    "EUNumber": "EU/1/15/1026",
    "EUNoShort": 1026,
    "BrandName": "Nivolumab BMS",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "nivolumab",
    "DecisionDate": "07/20/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 58,
    "TotalTimeElapsed": 240
  },
  {
    "ApplicationNo": 3702,
    "EUNumber": "EU/1/15/1018",
    "EUNoShort": 1018,
    "BrandName": "Omidria",
    "MAH": "Omeros Ireland Limited",
    "ActiveSubstance": "phenylephrine / ketorolac",
    "DecisionDate": "07/28/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 394,
    "TotalTimeElapsed": 604
  },
  {
    "ApplicationNo": 2800,
    "EUNumber": "EU/1/15/1022",
    "EUNoShort": 1022,
    "BrandName": "Unituxin",
    "MAH": "United Therapeutics Europe Ltd",
    "ActiveSubstance": "dinutuximab",
    "DecisionDate": "08/14/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 299,
    "TotalTimeElapsed": 512
  },
  {
    "ApplicationNo": 2839,
    "EUNumber": "EU/1/15/1030",
    "EUNoShort": 1030,
    "BrandName": "Odomzo",
    "MAH": "Sun Pharmaceutical Industries Europe BV",
    "ActiveSubstance": "sonidegib",
    "DecisionDate": "08/14/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 181,
    "TotalTimeElapsed": 394
  },
  {
    "ApplicationNo": 2739,
    "EUNumber": "EU/1/15/1006",
    "EUNoShort": 1006,
    "BrandName": "Respreeza",
    "MAH": "CSL Behring GmbH",
    "ActiveSubstance": "human alpha1-proteinase inhibitor",
    "DecisionDate": "08/20/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 334,
    "TotalTimeElapsed": 547
  },
  {
    "ApplicationNo": 3935,
    "EUNumber": "EU/1/15/1028",
    "EUNoShort": 1028,
    "BrandName": "Duloxetine Zentiva",
    "MAH": "Zentiva, k.s.",
    "ActiveSubstance": "duloxetine",
    "DecisionDate": "08/20/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 62,
    "TotalTimeElapsed": 275
  },
  {
    "ApplicationNo": 4008,
    "EUNumber": "EU/1/15/1029",
    "EUNoShort": 1029,
    "BrandName": "Aripiprazole Sandoz",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "Aripiprazole",
    "DecisionDate": "08/20/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 125,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 4004,
    "EUNumber": "EU/1/15/1033",
    "EUNoShort": 1033,
    "BrandName": "Kanuma",
    "MAH": "Alexion Europe SAS",
    "ActiveSubstance": "sebelipase alfa",
    "DecisionDate": "08/28/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 152,
    "ClockStopElapsed": 32,
    "TotalTimeElapsed": 184
  },
  {
    "ApplicationNo": 3925,
    "EUNumber": "EU/1/15/1017",
    "EUNoShort": 1017,
    "BrandName": "Taxespira",
    "MAH": "Hospira UK Limited",
    "ActiveSubstance": "docetaxel",
    "DecisionDate": "08/28/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 211,
    "ClockStopElapsed": 155,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 3725,
    "EUNumber": "EU/1/15/1023",
    "EUNoShort": 1023,
    "BrandName": "Farydak",
    "MAH": "Secura Bio Limited",
    "ActiveSubstance": "panobinostat",
    "DecisionDate": "08/28/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 217,
    "ClockStopElapsed": 177,
    "TotalTimeElapsed": 394
  },
  {
    "ApplicationNo": 4024,
    "EUNumber": "EU/1/15/1027",
    "EUNoShort": 1027,
    "BrandName": "Pregabalin Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "pregabalin",
    "DecisionDate": "08/28/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Finland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 211,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 310
  },
  {
    "ApplicationNo": 3794,
    "EUNumber": "EU/1/15/1015",
    "EUNoShort": 1015,
    "BrandName": "Strensiq",
    "MAH": "Alexion Europe SAS",
    "ActiveSubstance": "asfotase alfa",
    "DecisionDate": "08/28/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 211,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 4187,
    "EUNumber": "EU/1/15/1041",
    "EUNoShort": 1041,
    "BrandName": "Ivabradine Anpharm",
    "MAH": "ANPHARM Przedsiebiorstwo Farmaceutyczne S.A.",
    "ActiveSubstance": "ivabradine",
    "DecisionDate": "09/08/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "C01",
    "ATCCodeL1": "C",
    "ATCNameL2": "Cardiac therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 3834,
    "EUNumber": "EU/1/15/1020",
    "EUNoShort": 1020,
    "BrandName": "Raxone",
    "MAH": "Santhera Pharmaceuticals (Deutschland) GmbH",
    "ActiveSubstance": "idebenone",
    "DecisionDate": "09/08/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Malta",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 211,
    "ClockStopElapsed": 183,
    "TotalTimeElapsed": 394
  },
  {
    "ApplicationNo": 4114,
    "EUNumber": "EU/1/15/1034",
    "EUNoShort": 1034,
    "BrandName": "Pemetrexed Lilly",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "pemetrexed",
    "DecisionDate": "09/14/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 30,
    "TotalTimeElapsed": 212
  },
  {
    "ApplicationNo": 3759,
    "EUNumber": "EU/1/15/1040",
    "EUNoShort": 1040,
    "BrandName": "Intuniv",
    "MAH": "Shire Pharmaceuticals Ireland Limited",
    "ActiveSubstance": "guanfacine",
    "DecisionDate": "09/17/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "C02",
    "ATCCodeL1": "C",
    "ATCNameL2": "Antihypertensives",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 206,
    "ClockStopElapsed": 279,
    "TotalTimeElapsed": 485
  },
  {
    "ApplicationNo": 3772,
    "EUNumber": "EU/1/15/1032",
    "EUNoShort": 1032,
    "BrandName": "Zerbaxa",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "ceftolozane / tazobactam",
    "DecisionDate": "09/18/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 125,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 4011,
    "EUNumber": "EU/1/15/1037",
    "EUNoShort": 1037,
    "BrandName": "Pemetrexed Sandoz",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "pemetrexed",
    "DecisionDate": "09/18/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Norway",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 64,
    "TotalTimeElapsed": 268
  },
  {
    "ApplicationNo": 2784,
    "EUNumber": "EU/1/15/1042",
    "EUNoShort": 1042,
    "BrandName": "Zalviso",
    "MAH": "Gr√ºnenthal GmbH",
    "ActiveSubstance": "Sufentanil",
    "DecisionDate": "09/18/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Austria",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "N01",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anesthetics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 3882,
    "EUNumber": "EU/1/15/1031",
    "EUNoShort": 1031,
    "BrandName": "Praluent",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "alirocumab",
    "DecisionDate": "09/23/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C10",
    "ATCCodeL1": "C",
    "ATCNameL2": "Lipid modifying agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 30,
    "TotalTimeElapsed": 212
  },
  {
    "ApplicationNo": 3776,
    "EUNumber": "EU/1/15/1039",
    "EUNoShort": 1039,
    "BrandName": "Fexeric",
    "MAH": "Akebia Europe Limited",
    "ActiveSubstance": "ferric citrate coordination complex",
    "DecisionDate": "09/23/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Lithuania",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 272,
    "TotalTimeElapsed": 485
  },
  {
    "ApplicationNo": 2734,
    "EUNumber": "EU/1/15/1036",
    "EUNoShort": 1036,
    "BrandName": "Cresemba",
    "MAH": "Basilea Pharmaceutica Deutschland GmbH",
    "ActiveSubstance": "isavuconazole",
    "DecisionDate": "10/15/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "J02",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycotics for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 125,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 4161,
    "EUNumber": "EU/1/15/1052",
    "EUNoShort": 1052,
    "BrandName": "Edistride",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "dapagliflozin",
    "DecisionDate": "11/09/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 2792,
    "EUNumber": "EU/1/15/1035",
    "EUNoShort": 1035,
    "BrandName": "OBIZUR",
    "MAH": "Baxalta Innovations GmbH",
    "ActiveSubstance": "susoctocog alfa",
    "DecisionDate": "11/11/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 4021,
    "EUNumber": "EU/1/15/1045",
    "EUNoShort": 1045,
    "BrandName": "Aripiprazole Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "aripiprazole",
    "DecisionDate": "11/16/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 188,
    "TotalTimeElapsed": 401
  },
  {
    "ApplicationNo": 4162,
    "EUNumber": "EU/1/15/1051",
    "EUNoShort": 1051,
    "BrandName": "Ebymect",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "dapagliflozin / metformin",
    "DecisionDate": "11/16/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 4062,
    "EUNumber": "EU/1/15/1058",
    "EUNoShort": 1058,
    "BrandName": "Entresto",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "sacubitril / valsartan",
    "DecisionDate": "11/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 66,
    "TotalTimeElapsed": 246
  },
  {
    "ApplicationNo": 3954,
    "EUNumber": "EU/1/15/1059",
    "EUNoShort": 1059,
    "BrandName": "Orkambi",
    "MAH": "Vertex Pharmaceuticals (Ireland) Limited",
    "ActiveSubstance": "Lumacaftor/Ivacaftor",
    "DecisionDate": "11/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "R07",
    "ATCCodeL1": "R",
    "ATCNameL2": "Other respiratory system products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 90,
    "TotalTimeElapsed": 303
  },
  {
    "ApplicationNo": 3790,
    "EUNumber": "EU/1/15/1060",
    "EUNoShort": 1060,
    "BrandName": "Kyprolis",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "carfilzomib",
    "DecisionDate": "11/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Spain",
    "CoRapporteur": "France",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 61,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 2611,
    "EUNumber": "EU/1/15/1044",
    "EUNoShort": 1044,
    "BrandName": "Numient",
    "MAH": "Amneal Pharma Europe Ltd",
    "ActiveSubstance": "levodopa / carbidopa",
    "DecisionDate": "11/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 90,
    "TotalTimeElapsed": 303
  },
  {
    "ApplicationNo": 3964,
    "EUNumber": "EU/1/15/1046",
    "EUNoShort": 1046,
    "BrandName": "Elocta",
    "MAH": "Swedish Orphan Biovitrum AB (publ)",
    "ActiveSubstance": "efmoroctocog alfa",
    "DecisionDate": "11/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 2715,
    "EUNumber": "EU/1/15/1050",
    "EUNoShort": 1050,
    "BrandName": "IONSYS",
    "MAH": "Incline Therapeutics Europe Ltd",
    "ActiveSubstance": "fentanyl",
    "DecisionDate": "11/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "N02",
    "ATCCodeL1": "N",
    "ATCNameL2": "Analgesics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 4014,
    "EUNumber": "EU/1/15/1054",
    "EUNoShort": 1054,
    "BrandName": "Cinacalcet Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "cinacalcet",
    "DecisionDate": "11/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "H05",
    "ATCCodeL1": "H",
    "ATCNameL2": "Calcium homeostasis",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 66,
    "TotalTimeElapsed": 246
  },
  {
    "ApplicationNo": 4042,
    "EUNumber": "EU/1/15/1061",
    "EUNoShort": 1061,
    "BrandName": "Genvoya",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide",
    "DecisionDate": "11/19/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 62,
    "TotalTimeElapsed": 275
  },
  {
    "ApplicationNo": 3986,
    "EUNumber": "EU/1/15/1056",
    "EUNoShort": 1056,
    "BrandName": "Praxbind",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "idarucizumab",
    "DecisionDate": "11/20/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Germany",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 33,
    "TotalTimeElapsed": 183
  },
  {
    "ApplicationNo": 3960,
    "EUNumber": "EU/1/15/1048",
    "EUNoShort": 1048,
    "BrandName": "Cotellic",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "cobimetinib",
    "DecisionDate": "11/20/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 153,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 3970,
    "EUNumber": "EU/1/15/1057",
    "EUNoShort": 1057,
    "BrandName": "Pemetrexed Hospira",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "pemetrexed",
    "DecisionDate": "11/20/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 3731,
    "EUNumber": "EU/1/15/1047",
    "EUNoShort": 1047,
    "BrandName": "BLINCYTO",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "blinatumomab",
    "DecisionDate": "11/23/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "France",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 3905,
    "EUNumber": "EU/1/15/1038",
    "EUNoShort": 1038,
    "BrandName": "Pemetrexed medac",
    "MAH": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "ActiveSubstance": "Pemetrexed",
    "DecisionDate": "11/27/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Belgium",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 3822,
    "EUNumber": "EU/1/15/1062",
    "EUNoShort": 1062,
    "BrandName": "Ravicti",
    "MAH": "Immedica Pharma AB",
    "ActiveSubstance": "Glycerol phenylbutyrate",
    "DecisionDate": "11/27/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 244,
    "TotalTimeElapsed": 457
  },
  {
    "ApplicationNo": 3860,
    "EUNumber": "EU/1/15/1043",
    "EUNoShort": 1043,
    "BrandName": "Nucala",
    "MAH": "GlaxoSmithKline Trading Services Limited",
    "ActiveSubstance": "mepolizumab",
    "DecisionDate": "12/02/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 90,
    "TotalTimeElapsed": 303
  },
  {
    "ApplicationNo": 3788,
    "EUNumber": "EU/1/15/1055",
    "EUNoShort": 1055,
    "BrandName": "Ciambra",
    "MAH": "Menarini International Operations Luxembourg S.A.",
    "ActiveSubstance": "pemetrexed",
    "DecisionDate": "12/02/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "Latvia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 2771,
    "EUNumber": "EU/1/15/1064",
    "EUNoShort": 1064,
    "BrandName": "Imlygic",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "talimogene laherparepvec",
    "DecisionDate": "12/16/2015",
    "DecisionYear": "2015",
    "Period": "2011-2015",
    "Rapporteur": "unknown",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 236,
    "ClockStopElapsed": 158,
    "TotalTimeElapsed": 394
  },
  {
    "ApplicationNo": 4104,
    "EUNumber": "EU/1/15/1065",
    "EUNoShort": 1065,
    "BrandName": "Eptifibatide Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "eptifibatide",
    "DecisionDate": "01/11/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 4025,
    "EUNumber": "EU/1/15/1067",
    "EUNoShort": 1067,
    "BrandName": "Lopinavir/Ritonavir Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "lopinavir / ritonavir",
    "DecisionDate": "01/14/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 3938,
    "EUNumber": "EU/1/15/1069",
    "EUNoShort": 1069,
    "BrandName": "Episalvan",
    "MAH": "Amryt GMBH",
    "ActiveSubstance": "birch bark extract",
    "DecisionDate": "01/14/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Latvia",
    "ATCCodeL2": "D03",
    "ATCCodeL1": "D",
    "ATCNameL2": "Preparations for treatment of wounds &amp; ulcers",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 174,
    "TotalTimeElapsed": 387
  },
  {
    "ApplicationNo": 3789,
    "EUNumber": "EU/1/15/1070",
    "EUNoShort": 1070,
    "BrandName": "Oncaspar",
    "MAH": "Les Laboratoires Servier",
    "ActiveSubstance": "pegaspargase",
    "DecisionDate": "01/14/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 272,
    "TotalTimeElapsed": 485
  },
  {
    "ApplicationNo": 2661,
    "EUNumber": "EU/1/15/1072",
    "EUNoShort": 1072,
    "BrandName": "Spectrila",
    "MAH": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "ActiveSubstance": "asparaginase",
    "DecisionDate": "01/14/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 490,
    "TotalTimeElapsed": 694
  },
  {
    "ApplicationNo": 3898,
    "EUNumber": "EU/1/15/1073",
    "EUNoShort": 1073,
    "BrandName": "Briviact",
    "MAH": "UCB Pharma S.A.",
    "ActiveSubstance": "brivaracetam",
    "DecisionDate": "01/14/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 4007,
    "EUNumber": "EU/1/15/1074",
    "EUNoShort": 1074,
    "BrandName": "Benepali",
    "MAH": "Samsung Bioepis NL B.V.",
    "ActiveSubstance": "etanercept",
    "DecisionDate": "01/14/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 4109,
    "EUNumber": "EU/1/15/1063",
    "EUNoShort": 1063,
    "BrandName": "Armisarte",
    "MAH": "Actavis Group PTC ehf.",
    "ActiveSubstance": "pemetrexed",
    "DecisionDate": "01/18/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 64,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 4072,
    "EUNumber": "EU/1/15/1071",
    "EUNoShort": 1071,
    "BrandName": "Pemetrexed Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "pemetrexed",
    "DecisionDate": "01/18/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 146,
    "TotalTimeElapsed": 359
  },
  {
    "ApplicationNo": 4124,
    "EUNumber": "EU/1/16/1086",
    "EUNoShort": 1086,
    "BrandName": "TAGRISSO",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "osimertinib",
    "DecisionDate": "02/02/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 26,
    "TotalTimeElapsed": 176
  },
  {
    "ApplicationNo": 4134,
    "EUNumber": "EU/1/15/1081",
    "EUNoShort": 1081,
    "BrandName": "Caspofungin Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "caspofungin",
    "DecisionDate": "02/11/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Norway",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J02",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycotics for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 55,
    "TotalTimeElapsed": 268
  },
  {
    "ApplicationNo": 3982,
    "EUNumber": "EU/1/15/1079",
    "EUNoShort": 1079,
    "BrandName": "Vaxelis",
    "MAH": "MCM Vaccine B.V.",
    "ActiveSubstance": "Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)",
    "DecisionDate": "02/15/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 3886,
    "EUNumber": "EU/1/15/1084",
    "EUNoShort": 1084,
    "BrandName": "Portrazza",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "necitumumab",
    "DecisionDate": "02/15/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 155,
    "TotalTimeElapsed": 359
  },
  {
    "ApplicationNo": 2733,
    "EUNumber": "EU/1/15/1075",
    "EUNoShort": 1075,
    "BrandName": "Feraccru",
    "MAH": "Norgine B.V.",
    "ActiveSubstance": "ferric maltol",
    "DecisionDate": "02/18/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "B03",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antianemic preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 149,
    "TotalTimeElapsed": 359
  },
  {
    "ApplicationNo": 3825,
    "EUNumber": "EU/1/15/1076",
    "EUNoShort": 1076,
    "BrandName": "Kovaltry",
    "MAH": "Bayer AG",
    "ActiveSubstance": "octocog alfa",
    "DecisionDate": "02/18/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 146,
    "TotalTimeElapsed": 359
  },
  {
    "ApplicationNo": 4147,
    "EUNumber": "EU/1/15/1077",
    "EUNoShort": 1077,
    "BrandName": "Iblias",
    "MAH": "Bayer AG",
    "ActiveSubstance": "octocog alfa",
    "DecisionDate": "02/18/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 217,
    "ClockStopElapsed": 146,
    "TotalTimeElapsed": 363
  },
  {
    "ApplicationNo": 3932,
    "EUNumber": "EU/1/15/1080",
    "EUNoShort": 1080,
    "BrandName": "Zurampic",
    "MAH": "Gr√ºnenthal GmbH",
    "ActiveSubstance": "lesinurad",
    "DecisionDate": "02/18/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "M04",
    "ATCCodeL1": "M",
    "ATCNameL2": "Antigout preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 213,
    "ClockStopElapsed": 118,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 3855,
    "EUNumber": "EU/1/16/1087",
    "EUNoShort": 1087,
    "BrandName": "Coagadex",
    "MAH": "BPL Bioproducts Laboratory GmbH",
    "ActiveSubstance": "human coagulation factor X",
    "DecisionDate": "03/16/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 40,
    "TotalTimeElapsed": 190
  },
  {
    "ApplicationNo": 4071,
    "EUNumber": "EU/1/15/1053",
    "EUNoShort": 1053,
    "BrandName": "Neofordex",
    "MAH": "Laboratoires CTRS",
    "ActiveSubstance": "dexamethasone",
    "DecisionDate": "03/16/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "H02",
    "ATCCodeL1": "H",
    "ATCNameL2": "Corticosteroids for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 106,
    "ClockStopElapsed": 281,
    "TotalTimeElapsed": 387
  },
  {
    "ApplicationNo": 4037,
    "EUNumber": "EU/1/16/1092",
    "EUNoShort": 1092,
    "BrandName": "Amlodipine/Valsartan Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "amlodipine/valsartan",
    "DecisionDate": "03/22/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Poland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 212,
    "ClockStopElapsed": 126,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 2616,
    "EUNumber": "EU/1/15/1068",
    "EUNoShort": 1068,
    "BrandName": "Wakix",
    "MAH": "Bioprojet Pharma",
    "ActiveSubstance": "Pitolisant hydrochloride",
    "DecisionDate": "03/31/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 204,
    "ClockStopElapsed": 337,
    "TotalTimeElapsed": 541
  },
  {
    "ApplicationNo": 4127,
    "EUNumber": "EU/1/16/1093",
    "EUNoShort": 1093,
    "BrandName": "Zonisamide Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "zonisamide",
    "DecisionDate": "03/31/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Portugal",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 38,
    "TotalTimeElapsed": 218
  },
  {
    "ApplicationNo": 4064,
    "EUNumber": "EU/1/16/1090",
    "EUNoShort": 1090,
    "BrandName": "Rasagiline Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "rasagiline",
    "DecisionDate": "04/04/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Iceland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 212,
    "ClockStopElapsed": 98,
    "TotalTimeElapsed": 310
  },
  {
    "ApplicationNo": 4069,
    "EUNumber": "EU/1/16/1100",
    "EUNoShort": 1100,
    "BrandName": "Palonosetron Hospira",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "palonosetron",
    "DecisionDate": "04/08/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Iceland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A04",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antiemetics and antinauseants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 94,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 4094,
    "EUNumber": "EU/1/16/1099",
    "EUNoShort": 1099,
    "BrandName": "Descovy",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "emtricitabine / tenofovir alafenamide",
    "DecisionDate": "04/21/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 64,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 3943,
    "EUNumber": "EU/1/15/1085",
    "EUNoShort": 1085,
    "BrandName": "Taltz",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "ixekizumab",
    "DecisionDate": "04/25/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 64,
    "TotalTimeElapsed": 274
  },
  {
    "ApplicationNo": 3897,
    "EUNumber": "EU/1/16/1096",
    "EUNoShort": 1096,
    "BrandName": "Lonsurf",
    "MAH": "Les Laboratoires Servier",
    "ActiveSubstance": "trifluridine / tipiracil",
    "DecisionDate": "04/25/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 212,
    "ClockStopElapsed": 126,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 3967,
    "EUNumber": "EU/1/16/1088",
    "EUNoShort": 1088,
    "BrandName": "Empliciti",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "elotuzumab",
    "DecisionDate": "05/11/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 40,
    "TotalTimeElapsed": 190
  },
  {
    "ApplicationNo": 3955,
    "EUNumber": "EU/1/16/1095",
    "EUNoShort": 1095,
    "BrandName": "IDELVION",
    "MAH": "CSL Behring GmbH",
    "ActiveSubstance": "albutrepenonacog alfa",
    "DecisionDate": "05/11/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 212,
    "ClockStopElapsed": 126,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 3774,
    "EUNumber": "EU/1/15/1083",
    "EUNoShort": 1083,
    "BrandName": "Uptravi",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "selexipag",
    "DecisionDate": "05/12/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 219,
    "ClockStopElapsed": 182,
    "TotalTimeElapsed": 401
  },
  {
    "ApplicationNo": 4142,
    "EUNumber": "EU/1/16/1098",
    "EUNoShort": 1098,
    "BrandName": "ALPROLIX",
    "MAH": "Swedish Orphan Biovitrum AB (publ)",
    "ActiveSubstance": "eftrenonacog alfa",
    "DecisionDate": "05/12/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 43,
    "TotalTimeElapsed": 246
  },
  {
    "ApplicationNo": 4077,
    "EUNumber": "EU/1/16/1101",
    "EUNoShort": 1101,
    "BrandName": "Darzalex",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "daratumumab",
    "DecisionDate": "05/20/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 34,
    "TotalTimeElapsed": 184
  },
  {
    "ApplicationNo": 3963,
    "EUNumber": "EU/1/16/1089",
    "EUNoShort": 1089,
    "BrandName": "Pandemic influenza vaccine H5N1 AstraZeneca",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "Pandemic influenza vaccine (H5N1) (live attenuated, nasal)",
    "DecisionDate": "05/20/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 211,
    "ClockStopElapsed": 163,
    "TotalTimeElapsed": 374
  },
  {
    "ApplicationNo": 4059,
    "EUNumber": "EU/1/15/1082",
    "EUNoShort": 1082,
    "BrandName": "Galafold",
    "MAH": "Amicus Therapeutics Europe Limited",
    "ActiveSubstance": "migalastat",
    "DecisionDate": "05/26/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Czech Republic",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 79,
    "TotalTimeElapsed": 282
  },
  {
    "ApplicationNo": 3854,
    "EUNumber": "EU/1/16/1097",
    "EUNoShort": 1097,
    "BrandName": "Strimvelis",
    "MAH": "Orchard Therapeutics (Netherlands) B.V.",
    "ActiveSubstance": "autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence",
    "DecisionDate": "05/26/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "unknown",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 100,
    "TotalTimeElapsed": 310
  },
  {
    "ApplicationNo": 4343,
    "EUNumber": "EU/1/16/1103",
    "EUNoShort": 1103,
    "BrandName": "Neparvis",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "sacubitril / valsartan",
    "DecisionDate": "05/26/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "C09",
    "ATCCodeL1": "C",
    "ATCNameL2": "Agents acting on the renin-angiotensin system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 4129,
    "EUNumber": "EU/1/16/1104",
    "EUNoShort": 1104,
    "BrandName": "Palonosetron Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "palonosetron",
    "DecisionDate": "05/26/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A04",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antiemetics and antinauseants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 100,
    "TotalTimeElapsed": 310
  },
  {
    "ApplicationNo": 4020,
    "EUNumber": "EU/1/16/1106",
    "EUNoShort": 1106,
    "BrandName": "Flixabi",
    "MAH": "Samsung Bioepis NL B.V.",
    "ActiveSubstance": "infliximab",
    "DecisionDate": "05/26/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 212,
    "ClockStopElapsed": 162,
    "TotalTimeElapsed": 374
  },
  {
    "ApplicationNo": 4156,
    "EUNumber": "EU/1/16/1112",
    "EUNoShort": 1112,
    "BrandName": "Odefsey",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "emtricitabine / rilpivirine / tenofovir alafenamide",
    "DecisionDate": "06/21/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 50,
    "TotalTimeElapsed": 253
  },
  {
    "ApplicationNo": 2790,
    "EUNumber": "EU/1/15/1066",
    "EUNoShort": 1066,
    "BrandName": "Ongentys",
    "MAH": "Bial - Portela & C¬™, SA",
    "ActiveSubstance": "opicapone",
    "DecisionDate": "06/24/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 212,
    "ClockStopElapsed": 280,
    "TotalTimeElapsed": 492
  },
  {
    "ApplicationNo": 4027,
    "EUNumber": "EU/1/16/1109",
    "EUNoShort": 1109,
    "BrandName": "Zavicefta",
    "MAH": "Pfizer Ireland Pharmaceuticals",
    "ActiveSubstance": "ceftazidime/avibactam",
    "DecisionDate": "06/24/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 2070,
    "EUNumber": "EU/1/16/1113",
    "EUNoShort": 1113,
    "BrandName": "Enzepi",
    "MAH": "Allergan Pharmaceuticals International Limited",
    "ActiveSubstance": "pancreas powder",
    "DecisionDate": "06/29/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A09",
    "ATCCodeL1": "A",
    "ATCNameL2": "Digestives, incl enzymes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 211,
    "ClockStopElapsed": 218,
    "TotalTimeElapsed": 429
  },
  {
    "ApplicationNo": 3862,
    "EUNumber": "EU/1/16/1107",
    "EUNoShort": 1107,
    "BrandName": "Zinbryta",
    "MAH": "Biogen Idec Limited",
    "ActiveSubstance": "daclizumab beta",
    "DecisionDate": "07/01/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Portugal",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 192,
    "TotalTimeElapsed": 401
  },
  {
    "ApplicationNo": 4210,
    "EUNumber": "EU/1/16/1116",
    "EUNoShort": 1116,
    "BrandName": "Epclusa",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "sofosbuvir/velpatasvir",
    "DecisionDate": "07/06/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 25,
    "TotalTimeElapsed": 175
  },
  {
    "ApplicationNo": 3999,
    "EUNumber": "EU/1/16/1105",
    "EUNoShort": 1105,
    "BrandName": "EndolucinBeta",
    "MAH": "ITM Medical Isotopes GmbH",
    "ActiveSubstance": "Lutetium (<sup>177</sup> Lu) chloride",
    "DecisionDate": "07/06/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "V10",
    "ATCCodeL1": "V",
    "ATCNameL2": "Therapeutic radiopharmaceuticals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 4057,
    "EUNumber": "EU/1/16/1108",
    "EUNoShort": 1108,
    "BrandName": "Qtern",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "saxagliptin / dapagliflozin",
    "DecisionDate": "07/15/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 162,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 4126,
    "EUNumber": "EU/1/16/1119",
    "EUNoShort": 1119,
    "BrandName": "Zepatier",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "elbasvir / grazoprevir",
    "DecisionDate": "07/22/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 4076,
    "EUNumber": "EU/1/16/1102",
    "EUNoShort": 1102,
    "BrandName": "Bortezomib SUN",
    "MAH": "Sun Pharmaceutical Industries Europe BV",
    "ActiveSubstance": "bortezomib",
    "DecisionDate": "07/22/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Croatia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 211,
    "ClockStopElapsed": 218,
    "TotalTimeElapsed": 429
  },
  {
    "ApplicationNo": 4207,
    "EUNumber": "EU/1/16/1114",
    "EUNoShort": 1114,
    "BrandName": "Bortezomib Hospira",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "bortezomib",
    "DecisionDate": "07/22/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 36,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 3895,
    "EUNumber": "EU/1/16/1115",
    "EUNoShort": 1115,
    "BrandName": "Pemetrexed Fresenius Kabi",
    "MAH": "Fresenius Kabi Deutschland GmbH",
    "ActiveSubstance": "pemetrexed",
    "DecisionDate": "07/22/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Norway",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 3912,
    "EUNumber": "EU/1/16/1125",
    "EUNoShort": 1125,
    "BrandName": "Cinqaero",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "reslizumab",
    "DecisionDate": "08/16/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 2752,
    "EUNumber": "EU/1/16/1122",
    "EUNoShort": 1122,
    "BrandName": "Aerivio Spiromax",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "salmeterol/fluticasone propionate",
    "DecisionDate": "08/18/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Malta",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 155,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 4267,
    "EUNumber": "EU/1/16/1123",
    "EUNoShort": 1123,
    "BrandName": "Airexar Spiromax",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "salmeterol/fluticasone propionate",
    "DecisionDate": "08/18/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Malta",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 209,
    "ClockStopElapsed": 155,
    "TotalTimeElapsed": 364
  },
  {
    "ApplicationNo": 3983,
    "EUNumber": "EU/1/16/1124",
    "EUNoShort": 1124,
    "BrandName": "Nordimet",
    "MAH": "Nordic Group B.V.",
    "ActiveSubstance": "methotrexate",
    "DecisionDate": "08/18/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Portugal",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 2801,
    "EUNumber": "EU/1/16/1121",
    "EUNoShort": 1121,
    "BrandName": "Zalmoxis",
    "MAH": "MolMed S.p.A.",
    "ActiveSubstance": "Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (<U+0394>LNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2)",
    "DecisionDate": "08/18/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "unknown",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 206,
    "ClockStopElapsed": 615,
    "TotalTimeElapsed": 821
  },
  {
    "ApplicationNo": 4048,
    "EUNumber": "EU/1/16/1091",
    "EUNoShort": 1091,
    "BrandName": "Atazanavir Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "atazanavir",
    "DecisionDate": "08/22/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Norway",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 212,
    "ClockStopElapsed": 308,
    "TotalTimeElapsed": 520
  },
  {
    "ApplicationNo": 4224,
    "EUNumber": "EU/1/16/1128",
    "EUNoShort": 1128,
    "BrandName": "Kisplyx",
    "MAH": "Eisai GmbH",
    "ActiveSubstance": "lenvatinib",
    "DecisionDate": "08/25/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 26,
    "TotalTimeElapsed": 176
  },
  {
    "ApplicationNo": 4163,
    "EUNumber": "EU/1/16/1136",
    "EUNoShort": 1136,
    "BrandName": "CABOMETYX",
    "MAH": "Ipsen Pharma",
    "ActiveSubstance": "cabozantinib",
    "DecisionDate": "09/09/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 26,
    "TotalTimeElapsed": 176
  },
  {
    "ApplicationNo": 4120,
    "EUNumber": "EU/1/16/1127",
    "EUNoShort": 1127,
    "BrandName": "Tenofovir disoproxil Zentiva",
    "MAH": "Zentiva, k.s.",
    "ActiveSubstance": "tenofovir disoproxil",
    "DecisionDate": "09/15/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 85,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 3795,
    "EUNumber": "EU/1/16/1131",
    "EUNoShort": 1131,
    "BrandName": "Thorinane",
    "MAH": "Techdow Pharma Netherlands B.V.",
    "ActiveSubstance": "enoxaparin sodium",
    "DecisionDate": "09/15/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 211,
    "ClockStopElapsed": 274,
    "TotalTimeElapsed": 485
  },
  {
    "ApplicationNo": 4264,
    "EUNumber": "EU/1/16/1132",
    "EUNoShort": 1132,
    "BrandName": "Inhixa",
    "MAH": "Techdow Pharma Netherlands B.V.",
    "ActiveSubstance": "enoxaparin sodium",
    "DecisionDate": "09/15/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 119,
    "ClockStopElapsed": 274,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 4186,
    "EUNumber": "EU/1/16/1134",
    "EUNoShort": 1134,
    "BrandName": "Mysildecard",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "sildenafil",
    "DecisionDate": "09/15/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 51,
    "TotalTimeElapsed": 231
  },
  {
    "ApplicationNo": 3883,
    "EUNumber": "EU/1/16/1135",
    "EUNoShort": 1135,
    "BrandName": "Sialanar",
    "MAH": "Proveca Pharma Limited",
    "ActiveSubstance": "glycopyrronium bromide",
    "DecisionDate": "09/15/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Czech Republic",
    "ATCCodeL2": "A03",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs for functional gastrointestinal disorders",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10a",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 239,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 429
  },
  {
    "ApplicationNo": 4098,
    "EUNumber": "EU/1/16/1126",
    "EUNoShort": 1126,
    "BrandName": "Truberzi",
    "MAH": "Allergan Pharmaceuticals International Limited",
    "ActiveSubstance": "eluxadoline",
    "DecisionDate": "09/19/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "A07",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antidiarrheals, intestinal antiinflammatory/antiinfective agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 211,
    "TotalTimeElapsed": 421
  },
  {
    "ApplicationNo": 4125,
    "EUNumber": "EU/1/16/1130",
    "EUNoShort": 1130,
    "BrandName": "Onivyde pegylated liposomal",
    "MAH": "Les Laboratoires Servier",
    "ActiveSubstance": "irinotecan",
    "DecisionDate": "10/14/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 211,
    "TotalTimeElapsed": 421
  },
  {
    "ApplicationNo": 4216,
    "EUNumber": "EU/1/16/1143",
    "EUNoShort": 1143,
    "BrandName": "Lartruvo",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "olaratumab",
    "DecisionDate": "11/09/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 54,
    "TotalTimeElapsed": 204
  },
  {
    "ApplicationNo": 3853,
    "EUNumber": "EU/1/16/1147",
    "EUNoShort": 1147,
    "BrandName": "IBRANCE",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "palbociclib",
    "DecisionDate": "11/09/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 183,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 4137,
    "EUNumber": "EU/1/16/1148",
    "EUNoShort": 1148,
    "BrandName": "Emtricitabine/Tenofovir disoproxil Zentiva",
    "MAH": "Zentiva, k.s.",
    "ActiveSubstance": "emtricitabine / tenofovir disoproxil",
    "DecisionDate": "11/09/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 113,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 3995,
    "EUNumber": "EU/1/16/1142",
    "EUNoShort": 1142,
    "BrandName": "Parsabiv",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "etelcalcetide",
    "DecisionDate": "11/11/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "H05",
    "ATCCodeL1": "H",
    "ATCNameL2": "Calcium homeostasis",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 4117,
    "EUNumber": "EU/1/16/1144",
    "EUNoShort": 1144,
    "BrandName": "Ivabradine Zentiva",
    "MAH": "Zentiva, k.s.",
    "ActiveSubstance": "ivabradine",
    "DecisionDate": "11/11/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C01",
    "ATCCodeL1": "C",
    "ATCNameL2": "Cardiac therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 77,
    "TotalTimeElapsed": 287
  },
  {
    "ApplicationNo": 4217,
    "EUNumber": "EU/1/16/1145",
    "EUNoShort": 1145,
    "BrandName": "Ivabradine JensonR",
    "MAH": "JensonR+ Limited",
    "ActiveSubstance": "ivabradine",
    "DecisionDate": "11/11/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Poland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C01",
    "ATCCodeL1": "C",
    "ATCNameL2": "Cardiac therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 107,
    "TotalTimeElapsed": 287
  },
  {
    "ApplicationNo": 3833,
    "EUNumber": "EU/1/16/1146",
    "EUNoShort": 1146,
    "BrandName": "Glyxambi",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "empagliflozin/linagliptin",
    "DecisionDate": "11/11/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 113,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 4289,
    "EUNumber": "EU/1/16/1137",
    "EUNoShort": 1137,
    "BrandName": "Granpidam",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "sildenafil",
    "DecisionDate": "11/14/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Iceland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 107,
    "TotalTimeElapsed": 287
  },
  {
    "ApplicationNo": 3844,
    "EUNumber": "EU/1/16/1094",
    "EUNoShort": 1094,
    "BrandName": "Ninlaro",
    "MAH": "Takeda Pharma A/S",
    "ActiveSubstance": "ixazomib",
    "DecisionDate": "11/21/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 174,
    "ClockStopElapsed": 107,
    "TotalTimeElapsed": 281
  },
  {
    "ApplicationNo": 4106,
    "EUNumber": "EU/1/16/1138",
    "EUNoShort": 1138,
    "BrandName": "Venclyxto",
    "MAH": "AbbVie Deutschland GmbH & Co. KG",
    "ActiveSubstance": "venetoclax",
    "DecisionDate": "12/05/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 107,
    "TotalTimeElapsed": 315
  },
  {
    "ApplicationNo": 4049,
    "EUNumber": "EU/1/16/1129",
    "EUNoShort": 1129,
    "BrandName": "Tenofovir disoproxil Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "Tenofovir disoproxil",
    "DecisionDate": "12/08/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Lithuania",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 211,
    "TotalTimeElapsed": 421
  },
  {
    "ApplicationNo": 4140,
    "EUNumber": "EU/1/16/1141",
    "EUNoShort": 1141,
    "BrandName": "SomaKit TOC",
    "MAH": "Advanced Accelerator Applications",
    "ActiveSubstance": "edotreotide",
    "DecisionDate": "12/08/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10a",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 148,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 4215,
    "EUNumber": "EU/1/16/1151",
    "EUNoShort": 1151,
    "BrandName": "Emtricitabine/Tenofovir disoproxil Krka",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "emtricitabine / tenofovir disoproxil",
    "DecisionDate": "12/08/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 85,
    "TotalTimeElapsed": 288
  },
  {
    "ApplicationNo": 3994,
    "EUNumber": "EU/1/16/1150",
    "EUNoShort": 1150,
    "BrandName": "Rekovelle",
    "MAH": "Ferring Pharmaceuticals A/S",
    "ActiveSubstance": "follitropin delta",
    "DecisionDate": "12/12/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 4093,
    "EUNumber": "EU/1/16/1139",
    "EUNoShort": 1139,
    "BrandName": "Ocaliva",
    "MAH": "Intercept Pharma International Limited",
    "ActiveSubstance": "obeticholic acid",
    "DecisionDate": "12/12/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "A05",
    "ATCCodeL1": "A",
    "ATCNameL2": "Bile and liver therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 274,
    "TotalTimeElapsed": 477
  },
  {
    "ApplicationNo": 4050,
    "EUNumber": "EU/1/16/1133",
    "EUNoShort": 1133,
    "BrandName": "Emtricitabine/Tenofovir disoproxil Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "emtricitabine / tenofovir disoproxil",
    "DecisionDate": "12/16/2016",
    "DecisionYear": "2016",
    "Period": "2016-2020",
    "Rapporteur": "Lithuania",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 239,
    "TotalTimeElapsed": 449
  },
  {
    "ApplicationNo": 4068,
    "EUNumber": "EU/1/16/1140",
    "EUNoShort": 1140,
    "BrandName": "Darunavir Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "darunavir",
    "DecisionDate": "01/04/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 239,
    "TotalTimeElapsed": 449
  },
  {
    "ApplicationNo": 4075,
    "EUNumber": "EU/1/16/1158",
    "EUNoShort": 1158,
    "BrandName": "AFSTYLA",
    "MAH": "CSL Behring GmbH",
    "ActiveSubstance": "lonoctocog alfa",
    "DecisionDate": "01/04/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 316
  },
  {
    "ApplicationNo": 3916,
    "EUNumber": "EU/1/16/1159",
    "EUNoShort": 1159,
    "BrandName": "Terrosa",
    "MAH": "Gedeon Richter Plc.",
    "ActiveSubstance": "teriparatide",
    "DecisionDate": "01/04/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "H05",
    "ATCCodeL1": "H",
    "ATCNameL2": "Calcium homeostasis",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 316
  },
  {
    "ApplicationNo": 4101,
    "EUNumber": "EU/1/16/1162",
    "EUNoShort": 1162,
    "BrandName": "Lusduna",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "insulin glargine",
    "DecisionDate": "01/04/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 316
  },
  {
    "ApplicationNo": 4297,
    "EUNumber": "EU/1/16/1153",
    "EUNoShort": 1153,
    "BrandName": "Talmanco",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "tadalafil",
    "DecisionDate": "01/09/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 78,
    "TotalTimeElapsed": 288
  },
  {
    "ApplicationNo": 4169,
    "EUNumber": "EU/1/16/1154",
    "EUNoShort": 1154,
    "BrandName": "Vemlidy",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "tenofovir alafenamide",
    "DecisionDate": "01/09/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 50,
    "TotalTimeElapsed": 260
  },
  {
    "ApplicationNo": 4046,
    "EUNumber": "EU/1/16/1160",
    "EUNoShort": 1160,
    "BrandName": "Fiasp",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "insulin aspart",
    "DecisionDate": "01/09/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 316
  },
  {
    "ApplicationNo": 4243,
    "EUNumber": "EU/1/16/1157",
    "EUNoShort": 1157,
    "BrandName": "Suliqua",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "insulin glargine / lixisenatide",
    "DecisionDate": "01/11/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 29,
    "TotalTimeElapsed": 232
  },
  {
    "ApplicationNo": 4368,
    "EUNumber": "EU/1/16/1161",
    "EUNoShort": 1161,
    "BrandName": "Movymia",
    "MAH": "STADA Arzneimittel AG",
    "ActiveSubstance": "teriparatide",
    "DecisionDate": "01/11/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "H05",
    "ATCCodeL1": "H",
    "ATCNameL2": "Calcium homeostasis",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 225,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 331
  },
  {
    "ApplicationNo": 4136,
    "EUNumber": "EU/1/16/1156",
    "EUNoShort": 1156,
    "BrandName": "ZINPLAVA",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "bezlotoxumab",
    "DecisionDate": "01/18/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J06",
    "ATCCodeL1": "J",
    "ATCNameL2": "Immune sera and immunoglobulins",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 133,
    "TotalTimeElapsed": 343
  },
  {
    "ApplicationNo": 3769,
    "EUNumber": "EU/1/15/1049",
    "EUNoShort": 1049,
    "BrandName": "Cystadrops",
    "MAH": "Recordati Rare Diseases",
    "ActiveSubstance": "mercaptamine",
    "DecisionDate": "01/19/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 212,
    "ClockStopElapsed": 539,
    "TotalTimeElapsed": 751
  },
  {
    "ApplicationNo": 4167,
    "EUNumber": "EU/1/16/1165",
    "EUNoShort": 1165,
    "BrandName": "LIFMIOR",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "etanercept",
    "DecisionDate": "02/13/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 120,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 120
  },
  {
    "ApplicationNo": 4459,
    "EUNumber": "EU/1/16/1168",
    "EUNoShort": 1168,
    "BrandName": "Vihuma",
    "MAH": "Octapharma AB",
    "ActiveSubstance": "simoctocog alfa",
    "DecisionDate": "02/13/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 4085,
    "EUNumber": "EU/1/16/1170",
    "EUNoShort": 1170,
    "BrandName": "Olumiant",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "baricitinib",
    "DecisionDate": "02/13/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 85,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 4164,
    "EUNumber": "EU/1/16/1169",
    "EUNoShort": 1169,
    "BrandName": "Alecensa",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "alectinib",
    "DecisionDate": "02/16/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 232,
    "TotalTimeElapsed": 442
  },
  {
    "ApplicationNo": 4112,
    "EUNumber": "EU/1/16/1167",
    "EUNoShort": 1167,
    "BrandName": "Truxima",
    "MAH": "Celltrion Healthcare Hungary Kft.",
    "ActiveSubstance": "rituximab",
    "DecisionDate": "02/17/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 204,
    "TotalTimeElapsed": 414
  },
  {
    "ApplicationNo": 4277,
    "EUNumber": "EU/1/16/1166",
    "EUNoShort": 1166,
    "BrandName": "Pregabalin Zentiva k.s",
    "MAH": "Zentiva, k.s.",
    "ActiveSubstance": "pregabalin",
    "DecisionDate": "02/27/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 120,
    "ClockStopElapsed": 87,
    "TotalTimeElapsed": 207
  },
  {
    "ApplicationNo": 2826,
    "EUNumber": "EU/1/16/1171",
    "EUNoShort": 1171,
    "BrandName": "Ledaga",
    "MAH": "Helsinn Birex Pharmaceuticals Ltd.",
    "ActiveSubstance": "chlormethine",
    "DecisionDate": "03/03/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 358,
    "TotalTimeElapsed": 568
  },
  {
    "ApplicationNo": 4654,
    "EUNumber": "EU/1/17/1174",
    "EUNoShort": 1174,
    "BrandName": "Rolufta Ellipta",
    "MAH": "GlaxoSmithKline Trading Services Limited",
    "ActiveSubstance": "umeclidinium",
    "DecisionDate": "03/20/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 4373,
    "EUNumber": "EU/1/16/1163",
    "EUNoShort": 1163,
    "BrandName": "SOLYMBIC",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "adalimumab",
    "DecisionDate": "03/22/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 4212,
    "EUNumber": "EU/1/16/1164",
    "EUNoShort": 1164,
    "BrandName": "AMGEVITA",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "adalimumab",
    "DecisionDate": "03/22/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 4310,
    "EUNumber": "EU/1/17/1175",
    "EUNoShort": 1175,
    "BrandName": "Daptomycin Hospira",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "daptomycin",
    "DecisionDate": "03/22/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Iceland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 4016,
    "EUNumber": "EU/1/17/1176",
    "EUNoShort": 1176,
    "BrandName": "Yargesa",
    "MAH": "Piramal Critical Care B.V.",
    "ActiveSubstance": "miglustat",
    "DecisionDate": "03/22/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 211,
    "ClockStopElapsed": 463,
    "TotalTimeElapsed": 674
  },
  {
    "ApplicationNo": 4666,
    "EUNumber": "EU/1/17/1177",
    "EUNoShort": 1177,
    "BrandName": "Tadalafil Lilly",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "tadalafil",
    "DecisionDate": "03/22/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 4214,
    "EUNumber": "EU/1/17/1178",
    "EUNoShort": 1178,
    "BrandName": "Xeljanz",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "Tofacitinib",
    "DecisionDate": "03/22/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 3756,
    "EUNumber": "EU/1/17/1172",
    "EUNoShort": 1172,
    "BrandName": "Jylamvo",
    "MAH": "Therakind (Europe) Limited",
    "ActiveSubstance": "methotrexate",
    "DecisionDate": "03/29/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Portugal",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 211,
    "ClockStopElapsed": 463,
    "TotalTimeElapsed": 674
  },
  {
    "ApplicationNo": 4061,
    "EUNumber": "EU/1/16/1110",
    "EUNoShort": 1110,
    "BrandName": "Chenodeoxycholic acid Leadiant",
    "MAH": "Leadiant GmbH",
    "ActiveSubstance": "chenodeoxycholic acid",
    "DecisionDate": "04/10/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Greece",
    "ATCCodeL2": "A05",
    "ATCCodeL1": "A",
    "ATCNameL2": "Bile and liver therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 113,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 4339,
    "EUNumber": "EU/1/16/1152",
    "EUNoShort": 1152,
    "BrandName": "Roteas",
    "MAH": "Berlin-Chemie AG",
    "ActiveSubstance": "edoxaban",
    "DecisionDate": "04/20/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 90,
    "ClockStopElapsed": 75,
    "TotalTimeElapsed": 165
  },
  {
    "ApplicationNo": 4196,
    "EUNumber": "EU/1/17/1180",
    "EUNoShort": 1180,
    "BrandName": "Varuby",
    "MAH": "TESARO Bio Netherlands B.V.",
    "ActiveSubstance": "rolapitant",
    "DecisionDate": "04/20/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "A04",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antiemetics and antinauseants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 4488,
    "EUNumber": "EU/1/17/1183",
    "EUNoShort": 1183,
    "BrandName": "Pemetrexed Pfizer",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "pemetrexed",
    "DecisionDate": "04/24/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 128,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 255
  },
  {
    "ApplicationNo": 3861,
    "EUNumber": "EU/1/15/1078",
    "EUNoShort": 1078,
    "BrandName": "Natpar",
    "MAH": "Shire Pharmaceuticals Ireland Limited",
    "ActiveSubstance": "parathyroid hormone",
    "DecisionDate": "04/24/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "H05",
    "ATCCodeL1": "H",
    "ATCNameL2": "Calcium homeostasis",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 212,
    "ClockStopElapsed": 609,
    "TotalTimeElapsed": 821
  },
  {
    "ApplicationNo": 4686,
    "EUNumber": "EU/1/17/1182",
    "EUNoShort": 1182,
    "BrandName": "Emtricitabine /Tenofovir disoproxil Krka d.d.",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "emtricitabine / tenofovir disoproxil",
    "DecisionDate": "04/28/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 3918,
    "EUNumber": "EU/1/17/1191",
    "EUNoShort": 1191,
    "BrandName": "Qarziba",
    "MAH": "EUSA Pharma (Netherlands) B.V.",
    "ActiveSubstance": "dinutuximab beta",
    "DecisionDate": "05/08/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 463,
    "TotalTimeElapsed": 666
  },
  {
    "ApplicationNo": 4197,
    "EUNumber": "EU/1/17/1186",
    "EUNoShort": 1186,
    "BrandName": "Axumin",
    "MAH": "Blue Earth Diagnostics Ireland Ltd",
    "ActiveSubstance": "fluciclovine (<sup>18</sup>F)",
    "DecisionDate": "05/22/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 239,
    "TotalTimeElapsed": 449
  },
  {
    "ApplicationNo": 4241,
    "EUNumber": "EU/1/17/1190",
    "EUNoShort": 1190,
    "BrandName": "Ivabradine Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "ivabradine",
    "DecisionDate": "05/22/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Greece",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C01",
    "ATCCodeL1": "C",
    "ATCNameL2": "Cardiac therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 266,
    "TotalTimeElapsed": 476
  },
  {
    "ApplicationNo": 4051,
    "EUNumber": "EU/1/17/1187",
    "EUNoShort": 1187,
    "BrandName": "Trumenba",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "meningococcal group B vaccine (recombinant, adsorbed)",
    "DecisionDate": "05/24/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 4312,
    "EUNumber": "EU/1/17/1188",
    "EUNoShort": 1188,
    "BrandName": "Spinraza",
    "MAH": "Biogen Netherlands B.V.",
    "ActiveSubstance": "nusinersen",
    "DecisionDate": "05/30/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Portugal",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "M09",
    "ATCCodeL1": "M",
    "ATCNameL2": "Other drugs for disorders of the musculo-skeletal system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 145,
    "ClockStopElapsed": 32,
    "TotalTimeElapsed": 177
  },
  {
    "ApplicationNo": 4065,
    "EUNumber": "EU/1/17/1192",
    "EUNoShort": 1192,
    "BrandName": "Brineura",
    "MAH": "BioMarin International Limited",
    "ActiveSubstance": "cerliponase alfa",
    "DecisionDate": "05/30/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 69,
    "TotalTimeElapsed": 219
  },
  {
    "ApplicationNo": 4246,
    "EUNumber": "EU/1/17/1189",
    "EUNoShort": 1189,
    "BrandName": "Elmiron",
    "MAH": "bene-Arzneimittel GmbH",
    "ActiveSubstance": "pentosan polysulfate sodium",
    "DecisionDate": "06/02/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "Lithuania",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10a",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 4178,
    "EUNumber": "EU/1/17/1193",
    "EUNoShort": 1193,
    "BrandName": "Refixia",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "nonacog beta pegol",
    "DecisionDate": "06/02/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "France",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 213,
    "TotalTimeElapsed": 421
  },
  {
    "ApplicationNo": 4729,
    "EUNumber": "EU/1/17/1184",
    "EUNoShort": 1184,
    "BrandName": "Riximyo",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "rituximab",
    "DecisionDate": "06/15/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 100,
    "ClockStopElapsed": 27,
    "TotalTimeElapsed": 127
  },
  {
    "ApplicationNo": 3903,
    "EUNumber": "EU/1/17/1185",
    "EUNoShort": 1185,
    "BrandName": "Rixathon",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "rituximab",
    "DecisionDate": "06/15/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 128,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 4374,
    "EUNumber": "EU/1/17/1194",
    "EUNoShort": 1194,
    "BrandName": "Febuxostat Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "febuxostat",
    "DecisionDate": "06/15/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Latvia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "M04",
    "ATCCodeL1": "M",
    "ATCNameL2": "Antigout preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 128,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 4192,
    "EUNumber": "EU/1/17/1195",
    "EUNoShort": 1195,
    "BrandName": "Erelzi",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "etanercept",
    "DecisionDate": "06/23/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 295,
    "TotalTimeElapsed": 505
  },
  {
    "ApplicationNo": 4254,
    "EUNumber": "EU/1/17/1196",
    "EUNoShort": 1196,
    "BrandName": "Kevzara",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "sarilumab",
    "DecisionDate": "06/23/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 72,
    "TotalTimeElapsed": 282
  },
  {
    "ApplicationNo": 2157,
    "EUNumber": "EU/1/17/1201",
    "EUNoShort": 1201,
    "BrandName": "Skilarence",
    "MAH": "Almirall, S.A.",
    "ActiveSubstance": "dimethyl fumarate",
    "DecisionDate": "06/23/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 268,
    "TotalTimeElapsed": 478
  },
  {
    "ApplicationNo": 4019,
    "EUNumber": "EU/1/17/1202",
    "EUNoShort": 1202,
    "BrandName": "Ucedane",
    "MAH": "Eurocept International B.V.",
    "ActiveSubstance": "carglumic acid",
    "DecisionDate": "06/23/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Greece",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 128,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 4119,
    "EUNumber": "EU/1/17/1200",
    "EUNoShort": 1200,
    "BrandName": "Besponsa",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "inotuzumab ozogamicin",
    "DecisionDate": "06/29/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 128,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 4209,
    "EUNumber": "EU/1/17/1197",
    "EUNoShort": 1197,
    "BrandName": "OXERVATE",
    "MAH": "Domp√© farmaceutici S.p.A.",
    "ActiveSubstance": "cenegermin",
    "DecisionDate": "07/06/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 143,
    "ClockStopElapsed": 33,
    "TotalTimeElapsed": 176
  },
  {
    "ApplicationNo": 2736,
    "EUNumber": "EU/1/17/1181",
    "EUNoShort": 1181,
    "BrandName": "Spherox",
    "MAH": "CO.DON AG",
    "ActiveSubstance": "spheroids of human autologous matrix-associated chondrocytes",
    "DecisionDate": "07/10/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "unknown",
    "CoRapporteur": "unknown",
    "ATCCodeL2": "M09",
    "ATCCodeL1": "M",
    "ATCNameL2": "Other drugs for disorders of the musculo-skeletal system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 202,
    "ClockStopElapsed": 1402,
    "TotalTimeElapsed": 1604
  },
  {
    "ApplicationNo": 4723,
    "EUNumber": "EU/1/17/1205",
    "EUNoShort": 1205,
    "BrandName": "Blitzima",
    "MAH": "Celltrion Healthcare Hungary Kft.",
    "ActiveSubstance": "rituximab",
    "DecisionDate": "07/13/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 4724,
    "EUNumber": "EU/1/17/1206",
    "EUNoShort": 1206,
    "BrandName": "Rituzena",
    "MAH": "Celltrion Healthcare Hungary Kft.",
    "ActiveSubstance": "rituximab",
    "DecisionDate": "07/13/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 4725,
    "EUNumber": "EU/1/17/1207",
    "EUNoShort": 1207,
    "BrandName": "Ritemvia",
    "MAH": "Celltrion Healthcare Hungary Kft.",
    "ActiveSubstance": "rituximab",
    "DecisionDate": "07/13/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 2770,
    "EUNumber": "EU/1/17/1209",
    "EUNoShort": 1209,
    "BrandName": "Reagila",
    "MAH": "Gedeon Richter Plc.",
    "ActiveSubstance": "cariprazine",
    "DecisionDate": "07/13/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 211,
    "TotalTimeElapsed": 421
  },
  {
    "ApplicationNo": 3959,
    "EUNumber": "EU/1/16/1155",
    "EUNoShort": 1155,
    "BrandName": "Kyntheum",
    "MAH": "Leo Pharma A/S",
    "ActiveSubstance": "brodalumab",
    "DecisionDate": "07/17/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 329,
    "TotalTimeElapsed": 532
  },
  {
    "ApplicationNo": 4257,
    "EUNumber": "EU/1/17/1208",
    "EUNoShort": 1208,
    "BrandName": "Trimbow",
    "MAH": "Chiesi Farmaceutici S.p.A.",
    "ActiveSubstance": "beclometasone / formoterol / glycopyrronium bromide",
    "DecisionDate": "07/17/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 24,
    "TotalTimeElapsed": 204
  },
  {
    "ApplicationNo": 4250,
    "EUNumber": "EU/1/17/1210",
    "EUNoShort": 1210,
    "BrandName": "Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva",
    "MAH": "Zentiva, k.s.",
    "ActiveSubstance": "efavirenz / emtricitabine / tenofovir disoproxil",
    "DecisionDate": "07/17/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 4180,
    "EUNumber": "EU/1/17/1179",
    "EUNoShort": 1179,
    "BrandName": "Veltassa",
    "MAH": "Vifor Fresenius Medical Care Renal Pharma France",
    "ActiveSubstance": "patiromer",
    "DecisionDate": "07/19/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 162,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 4303,
    "EUNumber": "EU/1/17/1203",
    "EUNoShort": 1203,
    "BrandName": "Insulin lispro Sanofi",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "insulin lispro",
    "DecisionDate": "07/19/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Finland",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 29,
    "TotalTimeElapsed": 232
  },
  {
    "ApplicationNo": 4430,
    "EUNumber": "EU/1/17/1213",
    "EUNoShort": 1213,
    "BrandName": "Maviret",
    "MAH": "AbbVie Deutschland GmbH & Co. KG",
    "ActiveSubstance": "glecaprevir / pibrentasvir",
    "DecisionDate": "07/26/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 122,
    "ClockStopElapsed": 32,
    "TotalTimeElapsed": 154
  },
  {
    "ApplicationNo": 4350,
    "EUNumber": "EU/1/17/1223",
    "EUNoShort": 1223,
    "BrandName": "Vosevi",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "sofosbuvir / velpatasvir / voxilaprevir",
    "DecisionDate": "07/26/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 122,
    "ClockStopElapsed": 32,
    "TotalTimeElapsed": 154
  },
  {
    "ApplicationNo": 4230,
    "EUNumber": "EU/1/17/1212",
    "EUNoShort": 1212,
    "BrandName": "MAVENCLAD",
    "MAH": "Merck Europe B.V.",
    "ActiveSubstance": "cladribine",
    "DecisionDate": "08/22/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 4213,
    "EUNumber": "EU/1/17/1221",
    "EUNoShort": 1221,
    "BrandName": "Kisqali",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "ribociclib",
    "DecisionDate": "08/22/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 57,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 4131,
    "EUNumber": "EU/1/17/1215",
    "EUNoShort": 1215,
    "BrandName": "Fotivda",
    "MAH": "EUSA Pharma (Netherlands) B.V.",
    "ActiveSubstance": "tivozanib",
    "DecisionDate": "08/24/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Portugal",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 248,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 4279,
    "EUNumber": "EU/1/17/1216",
    "EUNoShort": 1216,
    "BrandName": "Imraldi",
    "MAH": "Samsung Bioepis NL B.V.",
    "ActiveSubstance": "adalimumab",
    "DecisionDate": "08/24/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Finland",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 4281,
    "EUNumber": "EU/1/17/1217",
    "EUNoShort": 1217,
    "BrandName": "Nitisinone MDK",
    "MAH": "MendeliKABS Europe Limited",
    "ActiveSubstance": "nitisinone",
    "DecisionDate": "08/24/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Estonia",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 246,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 4005,
    "EUNumber": "EU/1/17/1199",
    "EUNoShort": 1199,
    "BrandName": "Cuprior",
    "MAH": "Orphalan",
    "ActiveSubstance": "trientine",
    "DecisionDate": "09/05/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 268,
    "TotalTimeElapsed": 478
  },
  {
    "ApplicationNo": 4240,
    "EUNumber": "EU/1/17/1222",
    "EUNoShort": 1222,
    "BrandName": "Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "Efavirenz / emtricitabine / tenofovir disoproxil",
    "DecisionDate": "09/05/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Portugal",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 4095,
    "EUNumber": "EU/1/17/1218",
    "EUNoShort": 1218,
    "BrandName": "Rydapt",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "Midostaurin",
    "DecisionDate": "09/18/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 3937,
    "EUNumber": "EU/1/17/1224",
    "EUNoShort": 1224,
    "BrandName": "Xermelo",
    "MAH": "Ipsen Pharma",
    "ActiveSubstance": "telotristat",
    "DecisionDate": "09/18/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Czech Republic",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 162,
    "TotalTimeElapsed": 372
  },
  {
    "ApplicationNo": 4377,
    "EUNumber": "EU/1/17/1227",
    "EUNoShort": 1227,
    "BrandName": "Entecavir Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "entecavir",
    "DecisionDate": "09/18/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 4443,
    "EUNumber": "EU/1/17/1230",
    "EUNoShort": 1230,
    "BrandName": "Lacosamide Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "lacosamide",
    "DecisionDate": "09/18/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 92,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 4338,
    "EUNumber": "EU/1/17/1214",
    "EUNoShort": 1214,
    "BrandName": "Bavencio",
    "MAH": "Merck Europe B.V.",
    "ActiveSubstance": "avelumab",
    "DecisionDate": "09/18/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 64,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 4143,
    "EUNumber": "EU/1/17/1220",
    "EUNoShort": 1220,
    "BrandName": "Tecentriq",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "atezolizumab",
    "DecisionDate": "09/21/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 220,
    "TotalTimeElapsed": 428
  },
  {
    "ApplicationNo": 4391,
    "EUNumber": "EU/1/17/1225",
    "EUNoShort": 1225,
    "BrandName": "Symtuza",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "darunavir / cobicistat / emtricitabine / tenofovir alafenamide",
    "DecisionDate": "09/21/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "France",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 85,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 4123,
    "EUNumber": "EU/1/17/1226",
    "EUNoShort": 1226,
    "BrandName": "Lutathera",
    "MAH": "Advanced Accelerator Applications",
    "ActiveSubstance": "lutetium (<sup>177</sup>Lu) oxodotreotide",
    "DecisionDate": "09/26/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "V10",
    "ATCCodeL1": "V",
    "ATCNameL2": "Therapeutic radiopharmaceuticals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 218,
    "TotalTimeElapsed": 428
  },
  {
    "ApplicationNo": 4458,
    "EUNumber": "EU/1/17/1211",
    "EUNoShort": 1211,
    "BrandName": "Entecavir Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "entecavir",
    "DecisionDate": "09/26/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Poland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 4390,
    "EUNumber": "EU/1/17/1229",
    "EUNoShort": 1229,
    "BrandName": "Dupixent",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "dupilumab",
    "DecisionDate": "09/26/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "D11",
    "ATCCodeL1": "D",
    "ATCNameL2": "Other dermatological preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 59,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 4182,
    "EUNumber": "EU/1/17/1228",
    "EUNoShort": 1228,
    "BrandName": "TOOKAD",
    "MAH": "Steba Biotech S.A",
    "ActiveSubstance": "padeliporfin",
    "DecisionDate": "11/10/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Portugal",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 386,
    "TotalTimeElapsed": 596
  },
  {
    "ApplicationNo": 4366,
    "EUNumber": "EU/1/17/1232",
    "EUNoShort": 1232,
    "BrandName": "Miglustat Gen.Orph",
    "MAH": "Gen.Orph",
    "ActiveSubstance": "Miglustat",
    "DecisionDate": "11/10/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 183,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 4407,
    "EUNumber": "EU/1/17/1233",
    "EUNoShort": 1233,
    "BrandName": "Zubsolv",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "buprenorphine / naloxone",
    "DecisionDate": "11/10/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Czech Republic",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 113,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 4271,
    "EUNumber": "EU/1/17/1234",
    "EUNoShort": 1234,
    "BrandName": "Tremfya",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "Guselkumab",
    "DecisionDate": "11/10/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Hungary",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 56,
    "TotalTimeElapsed": 266
  },
  {
    "ApplicationNo": 4325,
    "EUNumber": "EU/1/17/1238",
    "EUNoShort": 1238,
    "BrandName": "Nyxoid",
    "MAH": "Mundipharma Corporation (Ireland) Limited",
    "ActiveSubstance": "naloxone",
    "DecisionDate": "11/10/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Latvia",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 92,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 4446,
    "EUNumber": "EU/1/17/1239",
    "EUNoShort": 1239,
    "BrandName": "VeraSeal",
    "MAH": "Instituto Grifols, S.A.",
    "ActiveSubstance": "human fibrinogen / human thrombin",
    "DecisionDate": "11/10/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 86,
    "TotalTimeElapsed": 266
  },
  {
    "ApplicationNo": 4319,
    "EUNumber": "EU/1/17/1240",
    "EUNoShort": 1240,
    "BrandName": "Cyltezo",
    "MAH": "Boehringer Ingelheim International GmbH",
    "ActiveSubstance": "adalimumab",
    "DecisionDate": "11/10/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 85,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 4549,
    "EUNumber": "EU/1/17/1242",
    "EUNoShort": 1242,
    "BrandName": "Ritonavir Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "ritonavir",
    "DecisionDate": "11/10/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 56,
    "TotalTimeElapsed": 266
  },
  {
    "ApplicationNo": 4363,
    "EUNumber": "EU/1/17/1236",
    "EUNoShort": 1236,
    "BrandName": "Trelegy Ellipta",
    "MAH": "GlaxoSmithKline Trading Services Limited",
    "ActiveSubstance": "fluticasone furoate/umeclidinium/vilanterol",
    "DecisionDate": "11/15/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 63,
    "TotalTimeElapsed": 266
  },
  {
    "ApplicationNo": 4781,
    "EUNumber": "EU/1/17/1237",
    "EUNoShort": 1237,
    "BrandName": "Elebrato Ellipta",
    "MAH": "GlaxoSmithKline Trading Services Limited",
    "ActiveSubstance": "fluticasone furoate/umeclidinium/vilanterol",
    "DecisionDate": "11/15/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 112,
    "ClockStopElapsed": 63,
    "TotalTimeElapsed": 175
  },
  {
    "ApplicationNo": 4323,
    "EUNumber": "EU/1/17/1241",
    "EUNoShort": 1241,
    "BrandName": "Ontruzant",
    "MAH": "Samsung Bioepis NL B.V.",
    "ActiveSubstance": "trastuzumab",
    "DecisionDate": "11/15/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 4748,
    "EUNumber": "EU/1/17/1243",
    "EUNoShort": 1243,
    "BrandName": "Imatinib Teva B.V.",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "imatinib",
    "DecisionDate": "11/15/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 120,
    "ClockStopElapsed": 24,
    "TotalTimeElapsed": 144
  },
  {
    "ApplicationNo": 4249,
    "EUNumber": "EU/1/17/1235",
    "EUNoShort": 1235,
    "BrandName": "Zejula",
    "MAH": "GlaxoSmithKline (Ireland) Limited",
    "ActiveSubstance": "niraparib",
    "DecisionDate": "11/16/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Norway",
    "CoRapporteur": "France",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 113,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 4435,
    "EUNumber": "EU/1/17/1244",
    "EUNoShort": 1244,
    "BrandName": "Tacforius",
    "MAH": "Teva B.V.",
    "ActiveSubstance": "tacrolimus",
    "DecisionDate": "12/08/2017",
    "DecisionYear": "2017",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 84,
    "TotalTimeElapsed": 294
  },
  {
    "ApplicationNo": 4536,
    "EUNumber": "EU/1/17/1245",
    "EUNoShort": 1245,
    "BrandName": "PREVYMIS",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "letermovir",
    "DecisionDate": "01/08/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 166,
    "ClockStopElapsed": 38,
    "TotalTimeElapsed": 204
  },
  {
    "ApplicationNo": 4655,
    "EUNumber": "EU/1/17/1254",
    "EUNoShort": 1254,
    "BrandName": "Jorveza",
    "MAH": "Dr Falk Pharma GmbH",
    "ActiveSubstance": "budesonide",
    "DecisionDate": "01/08/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Czech Republic",
    "ATCCodeL2": "A07",
    "ATCCodeL1": "A",
    "ATCNameL2": "Antidiarrheals, intestinal antiinflammatory/antiinfective agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 122,
    "ClockStopElapsed": 26,
    "TotalTimeElapsed": 148
  },
  {
    "ApplicationNo": 4043,
    "EUNumber": "EU/1/17/1231",
    "EUNoShort": 1231,
    "BrandName": "Ocrevus",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "ocrelizumab",
    "DecisionDate": "01/08/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 337,
    "TotalTimeElapsed": 540
  },
  {
    "ApplicationNo": 4195,
    "EUNumber": "EU/1/17/1247",
    "EUNoShort": 1247,
    "BrandName": "ADYNOVI",
    "MAH": "Baxalta Innovations GmbH",
    "ActiveSubstance": "rurioctocog alfa pegol",
    "DecisionDate": "01/08/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 393,
    "TotalTimeElapsed": 596
  },
  {
    "ApplicationNo": 4433,
    "EUNumber": "EU/1/17/1252",
    "EUNoShort": 1252,
    "BrandName": "Fasenra",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "benralizumab",
    "DecisionDate": "01/08/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 112,
    "TotalTimeElapsed": 322
  },
  {
    "ApplicationNo": 4649,
    "EUNumber": "EU/1/17/1253",
    "EUNoShort": 1253,
    "BrandName": "Fulvestrant Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "fulvestrant",
    "DecisionDate": "01/08/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Latvia",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L02",
    "ATCCodeL1": "L",
    "ATCNameL2": "Endocrine therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 112,
    "TotalTimeElapsed": 322
  },
  {
    "ApplicationNo": 4138,
    "EUNumber": "EU/1/17/1255",
    "EUNoShort": 1255,
    "BrandName": "Intrarosa",
    "MAH": "Endoceutics S.A.",
    "ActiveSubstance": "prasterone",
    "DecisionDate": "01/08/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 442,
    "TotalTimeElapsed": 652
  },
  {
    "ApplicationNo": 4728,
    "EUNumber": "EU/1/17/1246",
    "EUNoShort": 1246,
    "BrandName": "Mvasi",
    "MAH": "Amgen Technology (Ireland) UC",
    "ActiveSubstance": "bevacizumab",
    "DecisionDate": "01/15/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Norway",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 112,
    "TotalTimeElapsed": 322
  },
  {
    "ApplicationNo": 4891,
    "EUNumber": "EU/1/17/1248",
    "EUNoShort": 1248,
    "BrandName": "Darunavir Krka d.d.",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "darunavir",
    "DecisionDate": "01/18/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 93,
    "ClockStopElapsed": 26,
    "TotalTimeElapsed": 119
  },
  {
    "ApplicationNo": 4273,
    "EUNumber": "EU/1/17/1249",
    "EUNoShort": 1249,
    "BrandName": "Darunavir Krka",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "darunavir",
    "DecisionDate": "01/26/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 4174,
    "EUNumber": "EU/1/17/1251",
    "EUNoShort": 1251,
    "BrandName": "Ozempic",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "semaglutide",
    "DecisionDate": "02/08/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 154,
    "TotalTimeElapsed": 357
  },
  {
    "ApplicationNo": 4274,
    "EUNumber": "EU/1/17/1263",
    "EUNoShort": 1263,
    "BrandName": "Efavirenz/Emtricitabine/Tenofovir disoproxil Krka",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "efavirenz / emtricitabine / tenofovir disoproxil",
    "DecisionDate": "02/08/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Malta",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 31,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 2575,
    "EUNumber": "EU/1/17/1257",
    "EUNoShort": 1257,
    "BrandName": "Herzuma",
    "MAH": "Celltrion Healthcare Hungary Kft.",
    "ActiveSubstance": "trastuzumab",
    "DecisionDate": "02/09/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 211,
    "TotalTimeElapsed": 414
  },
  {
    "ApplicationNo": 4416,
    "EUNumber": "EU/1/17/1260",
    "EUNoShort": 1260,
    "BrandName": "Alkindi",
    "MAH": "Diurnal Europe B.V.",
    "ActiveSubstance": "hydrocortisone",
    "DecisionDate": "02/09/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Iceland",
    "ATCCodeL2": "H02",
    "ATCCodeL1": "H",
    "ATCNameL2": "Corticosteroids for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 147,
    "TotalTimeElapsed": 357
  },
  {
    "ApplicationNo": 4585,
    "EUNumber": "EU/1/17/1256",
    "EUNoShort": 1256,
    "BrandName": "Anagrelide Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "anagrelide",
    "DecisionDate": "02/15/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 147,
    "TotalTimeElapsed": 357
  },
  {
    "ApplicationNo": 4275,
    "EUNumber": "EU/1/17/1262",
    "EUNoShort": 1262,
    "BrandName": "CRYSVITA",
    "MAH": "Kyowa Kirin Holdings B.V.",
    "ActiveSubstance": "Burosumab",
    "DecisionDate": "02/19/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 147,
    "TotalTimeElapsed": 357
  },
  {
    "ApplicationNo": 4406,
    "EUNumber": "EU/1/18/1271",
    "EUNoShort": 1271,
    "BrandName": "Hemlibra",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "emicizumab",
    "DecisionDate": "02/23/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "France",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 143,
    "ClockStopElapsed": 54,
    "TotalTimeElapsed": 197
  },
  {
    "ApplicationNo": 4315,
    "EUNumber": "EU/1/18/1267",
    "EUNoShort": 1267,
    "BrandName": "Steglatro",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "ertugliflozin",
    "DecisionDate": "03/21/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 4336,
    "EUNumber": "EU/1/18/1272",
    "EUNoShort": 1272,
    "BrandName": "Shingrix",
    "MAH": "GlaxoSmithKline Biologicals S.A.",
    "ActiveSubstance": "herpes zoster vaccine (recombinant, adjuvanted)",
    "DecisionDate": "03/21/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 196,
    "TotalTimeElapsed": 399
  },
  {
    "ApplicationNo": 4029,
    "EUNumber": "EU/1/17/1173",
    "EUNoShort": 1173,
    "BrandName": "Lokelma",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "sodium zirconium cyclosilicate",
    "DecisionDate": "03/22/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Lithuania",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 218,
    "TotalTimeElapsed": 421
  },
  {
    "ApplicationNo": 3922,
    "EUNumber": "EU/1/17/1258",
    "EUNoShort": 1258,
    "BrandName": "Lamzede",
    "MAH": "Chiesi Farmaceutici S.p.A.",
    "ActiveSubstance": "velmanase alfa",
    "DecisionDate": "03/23/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 281,
    "TotalTimeElapsed": 484
  },
  {
    "ApplicationNo": 4258,
    "EUNumber": "EU/1/17/1261",
    "EUNoShort": 1261,
    "BrandName": "Alofisel",
    "MAH": "Takeda Pharma A/S",
    "ActiveSubstance": "Darvadstrocel",
    "DecisionDate": "03/23/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 421,
    "TotalTimeElapsed": 631
  },
  {
    "ApplicationNo": 4314,
    "EUNumber": "EU/1/18/1265",
    "EUNoShort": 1265,
    "BrandName": "Segluromet",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "ertugliflozin / metformin hydrochloride",
    "DecisionDate": "03/23/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 4313,
    "EUNumber": "EU/1/18/1266",
    "EUNoShort": 1266,
    "BrandName": "Steglujan",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "ertugliflozin / sitagliptin",
    "DecisionDate": "03/23/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 4280,
    "EUNumber": "EU/1/18/1270",
    "EUNoShort": 1270,
    "BrandName": "Semglee",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "Insulin glargine",
    "DecisionDate": "03/23/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 246,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 4299,
    "EUNumber": "EU/1/18/1269",
    "EUNoShort": 1269,
    "BrandName": "Alpivab",
    "MAH": "BioCryst Ireland Limited",
    "ActiveSubstance": "peramivir",
    "DecisionDate": "04/13/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 197,
    "TotalTimeElapsed": 400
  },
  {
    "ApplicationNo": 4204,
    "EUNumber": "EU/1/18/1277",
    "EUNoShort": 1277,
    "BrandName": "Mylotarg",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "gemtuzumab ozogamicin",
    "DecisionDate": "04/19/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 217,
    "TotalTimeElapsed": 427
  },
  {
    "ApplicationNo": 4836,
    "EUNumber": "EU/1/18/1275",
    "EUNoShort": 1275,
    "BrandName": "Riarify",
    "MAH": "Chiesi Farmaceutici S.p.A.",
    "ActiveSubstance": "beclometasone / formoterol / glycopyrronium bromide",
    "DecisionDate": "04/23/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 4702,
    "EUNumber": "EU/1/18/1274",
    "EUNoShort": 1274,
    "BrandName": "Trydonis",
    "MAH": "Chiesi Farmaceutici S.p.A.",
    "ActiveSubstance": "beclometasone / formoterol / glycopyrronium bromide",
    "DecisionDate": "04/26/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 4644,
    "EUNumber": "EU/1/18/1273",
    "EUNoShort": 1273,
    "BrandName": "Prasugrel Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "prasugrel",
    "DecisionDate": "05/16/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 4361,
    "EUNumber": "EU/1/18/1281",
    "EUNoShort": 1281,
    "BrandName": "KANJINTI",
    "MAH": "Amgen Europe B.V.",
    "ActiveSubstance": "trastuzumab",
    "DecisionDate": "05/16/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 162,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 4427,
    "EUNumber": "EU/1/18/1282",
    "EUNoShort": 1282,
    "BrandName": "Juluca",
    "MAH": "ViiV Healthcare B.V.",
    "ActiveSubstance": "dolutegravir / rilpivirine",
    "DecisionDate": "05/16/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 71,
    "TotalTimeElapsed": 281
  },
  {
    "ApplicationNo": 4647,
    "EUNumber": "EU/1/18/1280",
    "EUNoShort": 1280,
    "BrandName": "Zessly",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "infliximab",
    "DecisionDate": "05/18/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 3958,
    "EUNumber": "EU/1/18/1283",
    "EUNoShort": 1283,
    "BrandName": "Pemetrexed Krka",
    "MAH": "KRKA, d.d.",
    "ActiveSubstance": "pemetrexed",
    "DecisionDate": "05/22/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Iceland",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 71,
    "TotalTimeElapsed": 281
  },
  {
    "ApplicationNo": 4379,
    "EUNumber": "EU/1/18/1279",
    "EUNoShort": 1279,
    "BrandName": "AMGLIDIA",
    "MAH": "AMMTeK",
    "ActiveSubstance": "glibenclamide",
    "DecisionDate": "05/24/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 304,
    "TotalTimeElapsed": 484
  },
  {
    "ApplicationNo": 4272,
    "EUNumber": "EU/1/17/1250",
    "EUNoShort": 1250,
    "BrandName": "Rubraca",
    "MAH": "Clovis Oncology Ireland Limited",
    "ActiveSubstance": "rucaparib",
    "DecisionDate": "05/24/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 281,
    "TotalTimeElapsed": 484
  },
  {
    "ApplicationNo": 4449,
    "EUNumber": "EU/1/18/1289",
    "EUNoShort": 1289,
    "BrandName": "Biktarvy",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "bictegravir / emtricitabine / tenofovir alafenamide",
    "DecisionDate": "06/21/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 78,
    "TotalTimeElapsed": 288
  },
  {
    "ApplicationNo": 4335,
    "EUNumber": "EU/1/18/1284",
    "EUNoShort": 1284,
    "BrandName": "Dzuveo",
    "MAH": "FGK Representative Service GmbH",
    "ActiveSubstance": "sufentanil",
    "DecisionDate": "06/25/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Iceland",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "N01",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anesthetics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 400
  },
  {
    "ApplicationNo": 4411,
    "EUNumber": "EU/1/17/1219",
    "EUNoShort": 1219,
    "BrandName": "Verkazia",
    "MAH": "Santen Oy",
    "ActiveSubstance": "ciclosporin",
    "DecisionDate": "07/06/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "France",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 145,
    "ClockStopElapsed": 37,
    "TotalTimeElapsed": 182
  },
  {
    "ApplicationNo": 4782,
    "EUNumber": "EU/1/18/1296",
    "EUNoShort": 1296,
    "BrandName": "Tegsedi",
    "MAH": "Akcea Therapeutics Ireland Ltd",
    "ActiveSubstance": "inotersen",
    "DecisionDate": "07/06/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 143,
    "ClockStopElapsed": 47,
    "TotalTimeElapsed": 190
  },
  {
    "ApplicationNo": 4326,
    "EUNumber": "EU/1/18/1278",
    "EUNoShort": 1278,
    "BrandName": "Carmustine Obvius",
    "MAH": "Obvius Investment B.V.",
    "ActiveSubstance": "carmustine",
    "DecisionDate": "07/19/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Latvia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 470,
    "TotalTimeElapsed": 680
  },
  {
    "ApplicationNo": 4320,
    "EUNumber": "EU/1/18/1286",
    "EUNoShort": 1286,
    "BrandName": "Hyrimoz",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "adalimumab",
    "DecisionDate": "07/26/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 176,
    "TotalTimeElapsed": 379
  },
  {
    "ApplicationNo": 4865,
    "EUNumber": "EU/1/18/1287",
    "EUNoShort": 1287,
    "BrandName": "Hefiya",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "adalimumab",
    "DecisionDate": "07/26/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 82,
    "ClockStopElapsed": 75,
    "TotalTimeElapsed": 157
  },
  {
    "ApplicationNo": 4866,
    "EUNumber": "EU/1/18/1288",
    "EUNoShort": 1288,
    "BrandName": "Halimatoz",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "adalimumab",
    "DecisionDate": "07/26/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 89,
    "ClockStopElapsed": 75,
    "TotalTimeElapsed": 164
  },
  {
    "ApplicationNo": 4582,
    "EUNumber": "EU/1/18/1290",
    "EUNoShort": 1290,
    "BrandName": "Nityr",
    "MAH": "Cycle Pharmaceuticals (Europe) Ltd",
    "ActiveSubstance": "nitisinone",
    "DecisionDate": "07/26/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 260,
    "TotalTimeElapsed": 463
  },
  {
    "ApplicationNo": 4447,
    "EUNumber": "EU/1/18/1293",
    "EUNoShort": 1293,
    "BrandName": "Aimovig",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "erenumab",
    "DecisionDate": "07/26/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "N02",
    "ATCCodeL1": "N",
    "ATCNameL2": "Analgesics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 148,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 3841,
    "EUNumber": "EU/1/18/1294",
    "EUNoShort": 1294,
    "BrandName": "RXULTI",
    "MAH": "Otsuka Pharmaceutical Netherlands B.V.",
    "ActiveSubstance": "brexpiprazole",
    "DecisionDate": "07/26/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Italy",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 225,
    "TotalTimeElapsed": 435
  },
  {
    "ApplicationNo": 4463,
    "EUNumber": "EU/1/18/1295",
    "EUNoShort": 1295,
    "BrandName": "Trazimera",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "trastuzumab",
    "DecisionDate": "07/26/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 120,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 4218,
    "EUNumber": "EU/1/18/1276",
    "EUNoShort": 1276,
    "BrandName": "Myalepta",
    "MAH": "Amryt Pharmaceuticals DAC",
    "ActiveSubstance": "metreleptin",
    "DecisionDate": "07/30/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 288,
    "TotalTimeElapsed": 498
  },
  {
    "ApplicationNo": 4282,
    "EUNumber": "EU/1/18/1308",
    "EUNoShort": 1308,
    "BrandName": "Vyxeos liposomal",
    "MAH": "Jazz Pharmaceuticals Ireland Ltd",
    "ActiveSubstance": "daunorubicin / cytarabine",
    "DecisionDate": "08/23/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 166,
    "ClockStopElapsed": 52,
    "TotalTimeElapsed": 218
  },
  {
    "ApplicationNo": 4438,
    "EUNumber": "EU/1/18/1301",
    "EUNoShort": 1301,
    "BrandName": "Mepsevii",
    "MAH": "Ultragenyx Germany GmbH",
    "ActiveSubstance": "vestronidase alfa",
    "DecisionDate": "08/23/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "France",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 197,
    "TotalTimeElapsed": 407
  },
  {
    "ApplicationNo": 4412,
    "EUNumber": "EU/1/18/1300",
    "EUNoShort": 1300,
    "BrandName": "Duzallo",
    "MAH": "Gr√ºnenthal GmbH",
    "ActiveSubstance": "allopurinol / lesinurad",
    "DecisionDate": "08/23/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Czech Republic",
    "ATCCodeL2": "M04",
    "ATCCodeL1": "M",
    "ATCNameL2": "Antigout preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 4090,
    "EUNumber": "EU/1/18/1297",
    "EUNoShort": 1297,
    "BrandName": "Kymriah",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "tisagenlecleucel",
    "DecisionDate": "08/23/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Norway",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "yes",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 172,
    "ClockStopElapsed": 74,
    "TotalTimeElapsed": 246
  },
  {
    "ApplicationNo": 4480,
    "EUNumber": "EU/1/18/1299",
    "EUNoShort": 1299,
    "BrandName": "Yescarta",
    "MAH": "Kite Pharma EU B.V.",
    "ActiveSubstance": "axicabtagene ciloleucel",
    "DecisionDate": "08/23/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "yes",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 4699,
    "EUNumber": "EU/1/18/1320",
    "EUNoShort": 1320,
    "BrandName": "Onpattro",
    "MAH": "Alnylam Netherlands B.V.",
    "ActiveSubstance": "patisiran",
    "DecisionDate": "08/27/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 143,
    "ClockStopElapsed": 40,
    "TotalTimeElapsed": 183
  },
  {
    "ApplicationNo": 5017,
    "EUNumber": "EU/1/18/1309",
    "EUNoShort": 1309,
    "BrandName": "Ulipristal Acetate Gedeon Richter",
    "MAH": "Gedeon Richter Plc.",
    "ActiveSubstance": "Ulipristal Acetate",
    "DecisionDate": "08/27/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "G03",
    "ATCCodeL1": "G",
    "ATCNameL2": "Sex hormones and modulators of the genital system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 4454,
    "EUNumber": "EU/1/18/1298",
    "EUNoShort": 1298,
    "BrandName": "VEYVONDI",
    "MAH": "Baxalta Innovations GmbH",
    "ActiveSubstance": "vonicog alfa",
    "DecisionDate": "08/31/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 176,
    "TotalTimeElapsed": 379
  },
  {
    "ApplicationNo": 4426,
    "EUNumber": "EU/1/18/1305",
    "EUNoShort": 1305,
    "BrandName": "Cablivi",
    "MAH": "Ablynx N.V.",
    "ActiveSubstance": "caplacizumab",
    "DecisionDate": "08/31/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 288,
    "TotalTimeElapsed": 491
  },
  {
    "ApplicationNo": 4030,
    "EUNumber": "EU/1/18/1311",
    "EUNoShort": 1311,
    "BrandName": "Nerlynx",
    "MAH": "Pierre Fabre M√©dicament",
    "ActiveSubstance": "neratinib",
    "DecisionDate": "08/31/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 346,
    "TotalTimeElapsed": 554
  },
  {
    "ApplicationNo": 4429,
    "EUNumber": "EU/1/18/1319",
    "EUNoShort": 1319,
    "BrandName": "Hulio",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "adalimumab",
    "DecisionDate": "09/17/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 225,
    "TotalTimeElapsed": 435
  },
  {
    "ApplicationNo": 4514,
    "EUNumber": "EU/1/18/1323",
    "EUNoShort": 1323,
    "BrandName": "Ilumetri",
    "MAH": "Almirall, S.A.",
    "ActiveSubstance": "tildrakizumab",
    "DecisionDate": "09/17/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 281,
    "TotalTimeElapsed": 491
  },
  {
    "ApplicationNo": 4534,
    "EUNumber": "EU/1/18/1302",
    "EUNoShort": 1302,
    "BrandName": "Kigabeq",
    "MAH": "ORPHELIA Pharma SAS",
    "ActiveSubstance": "vigabatrin",
    "DecisionDate": "09/20/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Poland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 4710,
    "EUNumber": "EU/1/18/1310",
    "EUNoShort": 1310,
    "BrandName": "Deferiprone Lipomed",
    "MAH": "Lipomed GmbH",
    "ActiveSubstance": "Deferiprone",
    "DecisionDate": "09/20/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Poland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 169,
    "TotalTimeElapsed": 379
  },
  {
    "ApplicationNo": 4237,
    "EUNumber": "EU/1/18/1312",
    "EUNoShort": 1312,
    "BrandName": "Xerava",
    "MAH": "PAION Deutschland GmbH",
    "ActiveSubstance": "Eravacycline",
    "DecisionDate": "09/20/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 4580,
    "EUNumber": "EU/1/18/1314",
    "EUNoShort": 1314,
    "BrandName": "Braftovi",
    "MAH": "Pierre Fabre M√©dicament",
    "ActiveSubstance": "encorafenib",
    "DecisionDate": "09/20/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 4579,
    "EUNumber": "EU/1/18/1315",
    "EUNoShort": 1315,
    "BrandName": "Mektovi",
    "MAH": "Pierre Fabre M√©dicament",
    "ActiveSubstance": "binimetinib",
    "DecisionDate": "09/20/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 4857,
    "EUNumber": "EU/1/18/1316",
    "EUNoShort": 1316,
    "BrandName": "Lenalidomide Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "lenalidomide",
    "DecisionDate": "09/20/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Poland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 4425,
    "EUNumber": "EU/1/18/1318",
    "EUNoShort": 1318,
    "BrandName": "Slenyto",
    "MAH": "RAD Neurim Pharmaceuticals EEC SARL",
    "ActiveSubstance": "melatonin",
    "DecisionDate": "09/20/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Czech Republic",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 225,
    "TotalTimeElapsed": 435
  },
  {
    "ApplicationNo": 4413,
    "EUNumber": "EU/1/18/1303",
    "EUNoShort": 1303,
    "BrandName": "Udenyca",
    "MAH": "ERA Consulting GmbH",
    "ActiveSubstance": "pegfilgrastim",
    "DecisionDate": "09/21/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 407,
    "TotalTimeElapsed": 610
  },
  {
    "ApplicationNo": 3961,
    "EUNumber": "EU/1/18/1313",
    "EUNoShort": 1313,
    "BrandName": "Pelgraz",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "pegfilgrastim",
    "DecisionDate": "09/21/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Czech Republic",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 225,
    "TotalTimeElapsed": 435
  },
  {
    "ApplicationNo": 4771,
    "EUNumber": "EU/1/18/1322",
    "EUNoShort": 1322,
    "BrandName": "Imfinzi",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "durvalumab",
    "DecisionDate": "09/21/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 92,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 4302,
    "EUNumber": "EU/1/18/1307",
    "EUNoShort": 1307,
    "BrandName": "Verzenios",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "abemaciclib",
    "DecisionDate": "09/27/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 4826,
    "EUNumber": "EU/1/18/1321",
    "EUNoShort": 1321,
    "BrandName": "Gefitinib Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "gefitinib",
    "DecisionDate": "09/27/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Croatia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 4682,
    "EUNumber": "EU/1/18/1306",
    "EUNoShort": 1306,
    "BrandName": "Symkevi",
    "MAH": "Vertex Pharmaceuticals (Ireland) Limited",
    "ActiveSubstance": "tezacaftor/ivacaftor",
    "DecisionDate": "10/31/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "R07",
    "ATCCodeL1": "R",
    "ATCNameL2": "Other respiratory system products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 4648,
    "EUNumber": "EU/1/18/1330",
    "EUNoShort": 1330,
    "BrandName": "Emgality",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "galcanezumab",
    "DecisionDate": "11/14/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Italy",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "N02",
    "ATCCodeL1": "N",
    "ATCNameL2": "Analgesics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 92,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 4154,
    "EUNumber": "EU/1/18/1292",
    "EUNoShort": 1292,
    "BrandName": "Apealea",
    "MAH": "Oasmia Pharmaceutical AB",
    "ActiveSubstance": "paclitaxel",
    "DecisionDate": "11/20/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 729,
    "TotalTimeElapsed": 939
  },
  {
    "ApplicationNo": 4700,
    "EUNumber": "EU/1/18/1328",
    "EUNoShort": 1328,
    "BrandName": "Pelmeg",
    "MAH": "Mundipharma Corporation (Ireland) Limited",
    "ActiveSubstance": "pegfilgrastim",
    "DecisionDate": "11/20/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 148,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 4915,
    "EUNumber": "EU/1/18/1329",
    "EUNoShort": 1329,
    "BrandName": "Fulphila",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "pegfilgrastim",
    "DecisionDate": "11/20/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "France",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 122,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 4669,
    "EUNumber": "EU/1/18/1334",
    "EUNoShort": 1334,
    "BrandName": "Vaborem",
    "MAH": "Menarini International Operations Luxembourg S.A.",
    "ActiveSubstance": "meropenem/vaborbactam",
    "DecisionDate": "11/20/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 225,
    "TotalTimeElapsed": 435
  },
  {
    "ApplicationNo": 4651,
    "EUNumber": "EU/1/18/1336",
    "EUNoShort": 1336,
    "BrandName": "Buvidal",
    "MAH": "Camurus AB",
    "ActiveSubstance": "buprenorphine",
    "DecisionDate": "11/20/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 148,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 4806,
    "EUNumber": "EU/1/18/1340",
    "EUNoShort": 1340,
    "BrandName": "TAKHZYRO",
    "MAH": "Shire Pharmaceuticals Ireland Limited",
    "ActiveSubstance": "lanadelumab",
    "DecisionDate": "11/22/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "B06",
    "ATCCodeL1": "B",
    "ATCNameL2": "Other hematological agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 143,
    "ClockStopElapsed": 61,
    "TotalTimeElapsed": 204
  },
  {
    "ApplicationNo": 4248,
    "EUNumber": "EU/1/18/1264",
    "EUNoShort": 1264,
    "BrandName": "Alunbrig",
    "MAH": "Takeda Pharma A/S",
    "ActiveSubstance": "brigatinib",
    "DecisionDate": "11/22/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 365,
    "TotalTimeElapsed": 575
  },
  {
    "ApplicationNo": 4054,
    "EUNumber": "EU/1/18/1324",
    "EUNoShort": 1324,
    "BrandName": "Jivi",
    "MAH": "Bayer AG",
    "ActiveSubstance": "damoctocog alfa pegol",
    "DecisionDate": "11/22/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 148,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 4802,
    "EUNumber": "EU/1/18/1327",
    "EUNoShort": 1327,
    "BrandName": "Ziextenzo",
    "MAH": "Sandoz GmbH",
    "ActiveSubstance": "pegfilgrastim",
    "DecisionDate": "11/22/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Romania",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 120,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 4451,
    "EUNumber": "EU/1/18/1331",
    "EUNoShort": 1331,
    "BrandName": "Luxturna",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "voretigene neparvovec",
    "DecisionDate": "11/22/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "unknown",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 400
  },
  {
    "ApplicationNo": 4747,
    "EUNumber": "EU/1/18/1332",
    "EUNoShort": 1332,
    "BrandName": "Pifeltro",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "doravirine",
    "DecisionDate": "11/22/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 92,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 4746,
    "EUNumber": "EU/1/18/1333",
    "EUNoShort": 1333,
    "BrandName": "Delstrigo",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "doravirine / lamivudine / tenofovir disoproxil",
    "DecisionDate": "11/22/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 92,
    "TotalTimeElapsed": 302
  },
  {
    "ApplicationNo": 4232,
    "EUNumber": "EU/1/18/1335",
    "EUNoShort": 1335,
    "BrandName": "Poteligeo",
    "MAH": "Kyowa Kirin Holdings B.V.",
    "ActiveSubstance": "Mogamulizumab",
    "DecisionDate": "11/22/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 120,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 4814,
    "EUNumber": "EU/1/18/1326",
    "EUNoShort": 1326,
    "BrandName": "Flucelvax Tetra",
    "MAH": "Seqirus Netherlands B.V.",
    "ActiveSubstance": "influenza vaccine (surface antigen, inactivated, prepared in cell cultures)",
    "DecisionDate": "12/12/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "France",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 122,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 4171,
    "EUNumber": "EU/1/18/1338",
    "EUNoShort": 1338,
    "BrandName": "Dengvaxia",
    "MAH": "Sanofi Pasteur",
    "ActiveSubstance": "dengue tetravalent vaccine (live, attenuated)",
    "DecisionDate": "12/12/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 731,
    "TotalTimeElapsed": 939
  },
  {
    "ApplicationNo": 4916,
    "EUNumber": "EU/1/18/1341",
    "EUNoShort": 1341,
    "BrandName": "Ogivri",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "trastuzumab",
    "DecisionDate": "12/12/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 330
  },
  {
    "ApplicationNo": 4584,
    "EUNumber": "EU/1/18/1325",
    "EUNoShort": 1325,
    "BrandName": "Namuscla",
    "MAH": "Lupin Europe GmbH",
    "ActiveSubstance": "Mexiletine",
    "DecisionDate": "12/18/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "C01",
    "ATCCodeL1": "C",
    "ATCNameL2": "Cardiac therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 220,
    "TotalTimeElapsed": 428
  },
  {
    "ApplicationNo": 4245,
    "EUNumber": "EU/1/18/1339",
    "EUNoShort": 1339,
    "BrandName": "Bevespi Aerosphere",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "glycopyrronium bromide / formoterol",
    "DecisionDate": "12/18/2018",
    "DecisionYear": "2018",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 253,
    "TotalTimeElapsed": 463
  },
  {
    "ApplicationNo": 4964,
    "EUNumber": "EU/1/18/1343",
    "EUNoShort": 1343,
    "BrandName": "Silodosin Recordati",
    "MAH": "Recordati Ireland Ltd",
    "ActiveSubstance": "silodosin",
    "DecisionDate": "01/07/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Croatia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "G04",
    "ATCCodeL1": "G",
    "ATCNameL2": "Urologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 120,
    "ClockStopElapsed": 80,
    "TotalTimeElapsed": 200
  },
  {
    "ApplicationNo": 4660,
    "EUNumber": "EU/1/18/1337",
    "EUNoShort": 1337,
    "BrandName": "Macimorelin Consilient Health",
    "MAH": "Consilient Health Ltd",
    "ActiveSubstance": "macimorelin",
    "DecisionDate": "01/11/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "France",
    "ATCCodeL2": "V04",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 148,
    "TotalTimeElapsed": 358
  },
  {
    "ApplicationNo": 4452,
    "EUNumber": "EU/1/18/1342",
    "EUNoShort": 1342,
    "BrandName": "Erleada",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "apalutamide",
    "DecisionDate": "01/14/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Latvia",
    "ATCCodeL2": "L02",
    "ATCCodeL1": "L",
    "ATCNameL2": "Endocrine therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 50,
    "TotalTimeElapsed": 260
  },
  {
    "ApplicationNo": 4697,
    "EUNumber": "EU/1/18/1344",
    "EUNoShort": 1344,
    "BrandName": "Zirabev",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "bevacizumab",
    "DecisionDate": "02/14/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Norway",
    "CoRapporteur": "France",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 85,
    "TotalTimeElapsed": 288
  },
  {
    "ApplicationNo": 4128,
    "EUNumber": "EU/1/18/1352",
    "EUNoShort": 1352,
    "BrandName": "Besremi",
    "MAH": "AOP Orphan Pharmaceuticals AG",
    "ActiveSubstance": "ropeginterferon alfa-2b",
    "DecisionDate": "02/15/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "France",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 456,
    "TotalTimeElapsed": 659
  },
  {
    "ApplicationNo": 4256,
    "EUNumber": "EU/1/18/1291",
    "EUNoShort": 1291,
    "BrandName": "Rizmoic",
    "MAH": "Shionogi B.V.",
    "ActiveSubstance": "naldemedine",
    "DecisionDate": "02/18/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A06",
    "ATCCodeL1": "A",
    "ATCNameL2": "Laxatives",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 421,
    "TotalTimeElapsed": 631
  },
  {
    "ApplicationNo": 4904,
    "EUNumber": "EU/1/18/1346",
    "EUNoShort": 1346,
    "BrandName": "Miglustat Dipharma",
    "MAH": "Dipharma B.V.",
    "ActiveSubstance": "miglustat",
    "DecisionDate": "02/18/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Slovakia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 57,
    "TotalTimeElapsed": 260
  },
  {
    "ApplicationNo": 4720,
    "EUNumber": "EU/1/18/1348",
    "EUNoShort": 1348,
    "BrandName": "Mulpleo",
    "MAH": "Shionogi B.V.",
    "ActiveSubstance": "lusutrombopag",
    "DecisionDate": "02/18/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 316
  },
  {
    "ApplicationNo": 5086,
    "EUNumber": "EU/1/18/1350",
    "EUNoShort": 1350,
    "BrandName": "Tobramycin PARI",
    "MAH": "PARI Pharma GmbH",
    "ActiveSubstance": "tobramycin",
    "DecisionDate": "02/18/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 90,
    "ClockStopElapsed": 26,
    "TotalTimeElapsed": 116
  },
  {
    "ApplicationNo": 4859,
    "EUNumber": "EU/1/19/1353",
    "EUNoShort": 1353,
    "BrandName": "Atazanavir Krka",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "atazanavir",
    "DecisionDate": "03/25/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 4773,
    "EUNumber": "EU/1/18/1347",
    "EUNoShort": 1347,
    "BrandName": "Febuxostat Krka",
    "MAH": "KRKA d d., Novo mesto",
    "ActiveSubstance": "febuxostat",
    "DecisionDate": "03/28/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "M04",
    "ATCCodeL1": "M",
    "ATCNameL2": "Antigout preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 43,
    "TotalTimeElapsed": 253
  },
  {
    "ApplicationNo": 4833,
    "EUNumber": "EU/1/19/1358",
    "EUNoShort": 1358,
    "BrandName": "AJOVY",
    "MAH": "Teva GmbH",
    "ActiveSubstance": "fremanezumab",
    "DecisionDate": "03/28/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "N02",
    "ATCCodeL1": "N",
    "ATCNameL2": "Analgesics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 155,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 4779,
    "EUNumber": "EU/1/19/1354",
    "EUNoShort": 1354,
    "BrandName": "Vizimpro",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "dacomitinib",
    "DecisionDate": "04/02/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 4475,
    "EUNumber": "EU/1/19/1356",
    "EUNoShort": 1356,
    "BrandName": "Idacio",
    "MAH": "Fresenius Kabi Deutschland GmbH",
    "ActiveSubstance": "adalimumab",
    "DecisionDate": "04/02/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Lithuania",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 225,
    "TotalTimeElapsed": 435
  },
  {
    "ApplicationNo": 5158,
    "EUNumber": "EU/1/19/1357",
    "EUNoShort": 1357,
    "BrandName": "Kromeya",
    "MAH": "Fresenius Kabi Deutschland GmbH",
    "ActiveSubstance": "adalimumab",
    "DecisionDate": "04/02/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Lithuania",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 90,
    "ClockStopElapsed": 47,
    "TotalTimeElapsed": 137
  },
  {
    "ApplicationNo": 4102,
    "EUNumber": "EU/1/18/1349",
    "EUNoShort": 1349,
    "BrandName": "Dectova",
    "MAH": "GlaxoSmithKline Trading Services Limited",
    "ActiveSubstance": "zanamivir",
    "DecisionDate": "04/26/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Norway",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 225,
    "TotalTimeElapsed": 428
  },
  {
    "ApplicationNo": 4759,
    "EUNumber": "EU/1/19/1361",
    "EUNoShort": 1361,
    "BrandName": "Skyrizi",
    "MAH": "AbbVie Deutschland GmbH & Co. KG",
    "ActiveSubstance": "risankizumab",
    "DecisionDate": "04/26/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 78,
    "TotalTimeElapsed": 281
  },
  {
    "ApplicationNo": 4889,
    "EUNumber": "EU/1/19/1363",
    "EUNoShort": 1363,
    "BrandName": "Zynquista",
    "MAH": "Guidehouse Germany GmbH",
    "ActiveSubstance": "sotagliflozin",
    "DecisionDate": "04/26/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 4108,
    "EUNumber": "EU/1/18/1345",
    "EUNoShort": 1345,
    "BrandName": "Ondexxya",
    "MAH": "Alexion Europe S.A.S.",
    "ActiveSubstance": "andexanet alfa",
    "DecisionDate": "04/26/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 715,
    "TotalTimeElapsed": 925
  },
  {
    "ApplicationNo": 4744,
    "EUNumber": "EU/1/19/1362",
    "EUNoShort": 1362,
    "BrandName": "Palynziq",
    "MAH": "BioMarin International Limited",
    "ActiveSubstance": "pegvaliase",
    "DecisionDate": "05/03/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "France",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 4538,
    "EUNumber": "EU/1/19/1360",
    "EUNoShort": 1360,
    "BrandName": "Waylivra",
    "MAH": "Akcea Therapeutics Ireland Limited",
    "ActiveSubstance": "volanesorsen",
    "DecisionDate": "05/03/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "C10",
    "ATCCodeL1": "C",
    "ATCNameL2": "Lipid modifying agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 351,
    "TotalTimeElapsed": 561
  },
  {
    "ApplicationNo": 4441,
    "EUNumber": "EU/1/18/1317",
    "EUNoShort": 1317,
    "BrandName": "Pazenir",
    "MAH": "ratiopharm GmbH",
    "ActiveSubstance": "paclitaxel",
    "DecisionDate": "05/06/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 358,
    "TotalTimeElapsed": 561
  },
  {
    "ApplicationNo": 4646,
    "EUNumber": "EU/1/19/1355",
    "EUNoShort": 1355,
    "BrandName": "Lorviqua",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "lorlatinib",
    "DecisionDate": "05/06/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 185,
    "TotalTimeElapsed": 393
  },
  {
    "ApplicationNo": 3691,
    "EUNumber": "EU/1/19/1367",
    "EUNoShort": 1367,
    "BrandName": "Zynteglo",
    "MAH": "bluebird bio (Netherlands) B.V.",
    "ActiveSubstance": "betibeglogene autotemcel",
    "DecisionDate": "05/29/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "France",
    "ATCCodeL2": "B06",
    "ATCCodeL1": "B",
    "ATCNameL2": "Other hematological agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "yes",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "yes",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 26,
    "TotalTimeElapsed": 176
  },
  {
    "ApplicationNo": 5254,
    "EUNumber": "EU/1/19/1378",
    "EUNoShort": 1378,
    "BrandName": "Temybric Ellipta",
    "MAH": "GlaxoSmithKline Trading Services Limited",
    "ActiveSubstance": "fluticasone furoate / umeclidinium / vilanterol",
    "DecisionDate": "06/12/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 4751,
    "EUNumber": "EU/1/18/1351",
    "EUNoShort": 1351,
    "BrandName": "Trecondi",
    "MAH": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "ActiveSubstance": "treosulfan",
    "DecisionDate": "06/20/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 316
  },
  {
    "ApplicationNo": 4985,
    "EUNumber": "EU/1/19/1368",
    "EUNoShort": 1368,
    "BrandName": "Ambrisentan Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "ambrisentan",
    "DecisionDate": "06/20/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Greece",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "C02",
    "ATCCodeL1": "C",
    "ATCNameL2": "Antihypertensives",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 128,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 4743,
    "EUNumber": "EU/1/19/1369",
    "EUNoShort": 1369,
    "BrandName": "Sixmo",
    "MAH": "L. Molteni & C. dei F.lli Alitti Soc.Es.S.p.A",
    "ActiveSubstance": "buprenorphine",
    "DecisionDate": "06/20/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "United Kingdom",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 310,
    "TotalTimeElapsed": 520
  },
  {
    "ApplicationNo": 4722,
    "EUNumber": "EU/1/19/1373",
    "EUNoShort": 1373,
    "BrandName": "Doptelet",
    "MAH": "Swedish Orphan Biovitrum AB (publ)",
    "ActiveSubstance": "avatrombopag",
    "DecisionDate": "06/20/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 128,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 4883,
    "EUNumber": "EU/1/19/1374",
    "EUNoShort": 1374,
    "BrandName": "Esperoct",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "turoctocog alfa pegol",
    "DecisionDate": "06/20/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 191,
    "TotalTimeElapsed": 394
  },
  {
    "ApplicationNo": 4556,
    "EUNumber": "EU/1/19/1375",
    "EUNoShort": 1375,
    "BrandName": "Grasustek",
    "MAH": "Juta Pharma GmbH",
    "ActiveSubstance": "pegfilgrastim",
    "DecisionDate": "06/20/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 310,
    "TotalTimeElapsed": 520
  },
  {
    "ApplicationNo": 4674,
    "EUNumber": "EU/1/19/1377",
    "EUNoShort": 1377,
    "BrandName": "Talzenna",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "talazoparib",
    "DecisionDate": "06/20/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Iceland",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 128,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 4745,
    "EUNumber": "EU/1/19/1372",
    "EUNoShort": 1372,
    "BrandName": "Striascan",
    "MAH": "CIS bio international",
    "ActiveSubstance": "ioflupane (<sup>123</sup>I)",
    "DecisionDate": "06/25/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Poland",
    "CoRapporteur": "Romania",
    "ATCCodeL2": "V09",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic radiopharmaceuticals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 128,
    "TotalTimeElapsed": 338
  },
  {
    "ApplicationNo": 4844,
    "EUNumber": "EU/1/19/1376",
    "EUNoShort": 1376,
    "BrandName": "LIBTAYO",
    "MAH": "Regeneron Ireland Designated Activity Company (DAC)",
    "ActiveSubstance": "cemiplimab",
    "DecisionDate": "06/28/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 191,
    "TotalTimeElapsed": 394
  },
  {
    "ApplicationNo": 4837,
    "EUNumber": "EU/1/19/1366",
    "EUNoShort": 1366,
    "BrandName": "Xromi",
    "MAH": "Nova Laboratories Ireland Limited",
    "ActiveSubstance": "hydroxycarbamide",
    "DecisionDate": "07/01/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Greece",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 219,
    "TotalTimeElapsed": 422
  },
  {
    "ApplicationNo": 4909,
    "EUNumber": "EU/1/19/1370",
    "EUNoShort": 1370,
    "BrandName": "Dovato",
    "MAH": "ViiV Healthcare B.V.",
    "ActiveSubstance": "dolutegravir/lamivudine",
    "DecisionDate": "07/01/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 25,
    "TotalTimeElapsed": 205
  },
  {
    "ApplicationNo": 4954,
    "EUNumber": "EU/1/19/1371",
    "EUNoShort": 1371,
    "BrandName": "Ultomiris",
    "MAH": "Alexion Europe SAS",
    "ActiveSubstance": "Ravulizumab",
    "DecisionDate": "07/02/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 72,
    "TotalTimeElapsed": 282
  },
  {
    "ApplicationNo": 4111,
    "EUNumber": "EU/1/19/1365",
    "EUNoShort": 1365,
    "BrandName": "Cufence",
    "MAH": "Univar Solutions B.V.",
    "ActiveSubstance": "trientine dihydrochloride",
    "DecisionDate": "07/25/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Greece",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 245,
    "TotalTimeElapsed": 455
  },
  {
    "ApplicationNo": 5005,
    "EUNumber": "EU/1/19/1379",
    "EUNoShort": 1379,
    "BrandName": "Posaconazole Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "posaconazole",
    "DecisionDate": "07/25/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Iceland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J02",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycotics for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 161,
    "TotalTimeElapsed": 371
  },
  {
    "ApplicationNo": 5028,
    "EUNumber": "EU/1/19/1380",
    "EUNoShort": 1380,
    "BrandName": "Posaconazole AHCL",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "posaconazole",
    "DecisionDate": "07/25/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Iceland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J02",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycotics for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 133,
    "TotalTimeElapsed": 343
  },
  {
    "ApplicationNo": 4541,
    "EUNumber": "EU/1/19/1381",
    "EUNoShort": 1381,
    "BrandName": "LysaKare",
    "MAH": "Advanced Accelerator Applications",
    "ActiveSubstance": "arginine/lysine",
    "DecisionDate": "07/25/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10a",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 133,
    "TotalTimeElapsed": 343
  },
  {
    "ApplicationNo": 5300,
    "EUNumber": "EU/1/19/1382",
    "EUNoShort": 1382,
    "BrandName": "Azacitidine Celgene",
    "MAH": "Celgene Europe B.V",
    "ActiveSubstance": "azacitidine",
    "DecisionDate": "08/02/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 4930,
    "EUNumber": "EU/1/19/1384",
    "EUNoShort": 1384,
    "BrandName": "Giapreza",
    "MAH": "PAION Deutschland GmbH",
    "ActiveSubstance": "angiotensin II acetate",
    "DecisionDate": "08/23/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "France",
    "ATCCodeL2": "C01",
    "ATCCodeL1": "C",
    "ATCNameL2": "Cardiac therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 164,
    "TotalTimeElapsed": 372
  },
  {
    "ApplicationNo": 5243,
    "EUNumber": "EU/1/19/1383",
    "EUNoShort": 1383,
    "BrandName": "Lacosamide UCB",
    "MAH": "UCB Pharma S.A.",
    "ActiveSubstance": "lacosamide",
    "DecisionDate": "08/26/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 4919,
    "EUNumber": "EU/1/19/1385",
    "EUNoShort": 1385,
    "BrandName": "VITRAKVI",
    "MAH": "Bayer AG",
    "ActiveSubstance": "larotrectinib",
    "DecisionDate": "09/19/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 178,
    "ClockStopElapsed": 138,
    "TotalTimeElapsed": 316
  },
  {
    "ApplicationNo": 4675,
    "EUNumber": "EU/1/19/1389",
    "EUNoShort": 1389,
    "BrandName": "Epidyolex",
    "MAH": "GW Pharma (International) B.V.",
    "ActiveSubstance": "cannabidiol",
    "DecisionDate": "09/19/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Czech Republic",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 332,
    "TotalTimeElapsed": 540
  },
  {
    "ApplicationNo": 4786,
    "EUNumber": "EU/1/19/1390",
    "EUNoShort": 1390,
    "BrandName": "Inbrija",
    "MAH": "Acorda Therapeutics Ireland Limited",
    "ActiveSubstance": "levodopa",
    "DecisionDate": "09/19/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "N04",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anti-parkinson drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 218,
    "TotalTimeElapsed": 428
  },
  {
    "ApplicationNo": 4961,
    "EUNumber": "EU/1/19/1359",
    "EUNoShort": 1359,
    "BrandName": "Trogarzo",
    "MAH": "Theratechnologies Europe Limited",
    "ActiveSubstance": "ibalizumab",
    "DecisionDate": "09/26/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 182,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 316
  },
  {
    "ApplicationNo": 5014,
    "EUNumber": "EU/1/19/1386",
    "EUNoShort": 1386,
    "BrandName": "Deferasirox Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "deferasirox",
    "DecisionDate": "09/26/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Hungary",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 162,
    "TotalTimeElapsed": 372
  },
  {
    "ApplicationNo": 4587,
    "EUNumber": "EU/1/19/1364",
    "EUNoShort": 1364,
    "BrandName": "NUCEIVA",
    "MAH": "Evolus Pharma Limited",
    "ActiveSubstance": "botulinum toxin type A",
    "DecisionDate": "09/27/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "United Kingdom",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "M03",
    "ATCCodeL1": "M",
    "ATCNameL2": "Muscle relaxants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 445,
    "TotalTimeElapsed": 653
  },
  {
    "ApplicationNo": 4752,
    "EUNumber": "EU/1/19/1399",
    "EUNoShort": 1399,
    "BrandName": "Xospata",
    "MAH": "Astellas Pharma Europe B.V.",
    "ActiveSubstance": "gilteritinib",
    "DecisionDate": "10/24/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Norway",
    "CoRapporteur": "Latvia",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 55,
    "TotalTimeElapsed": 205
  },
  {
    "ApplicationNo": 4910,
    "EUNumber": "EU/1/19/1401",
    "EUNoShort": 1401,
    "BrandName": "Qtrilmet",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "metformin hydrochloride / saxagliptin / dapagliflozin",
    "DecisionDate": "11/11/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 218,
    "TotalTimeElapsed": 428
  },
  {
    "ApplicationNo": 4554,
    "EUNumber": "EU/1/19/1392",
    "EUNoShort": 1392,
    "BrandName": "Ervebo",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "Ebola Zaire Vaccine (rVSV<U+2206>G-ZEBOV-GP, live)",
    "DecisionDate": "11/11/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "yes",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 143,
    "ClockStopElapsed": 61,
    "TotalTimeElapsed": 204
  },
  {
    "ApplicationNo": 5298,
    "EUNumber": "EU/1/19/1387",
    "EUNoShort": 1387,
    "BrandName": "Senstend",
    "MAH": "Plethora Pharma Solutions Ltd.",
    "ActiveSubstance": "lidocaine / prilocaine",
    "DecisionDate": "11/14/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "N01",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anesthetics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 90,
    "ClockStopElapsed": 26,
    "TotalTimeElapsed": 116
  },
  {
    "ApplicationNo": 5039,
    "EUNumber": "EU/1/19/1396",
    "EUNoShort": 1396,
    "BrandName": "Ivozall",
    "MAH": "ORPHELIA Pharma SAS",
    "ActiveSubstance": "clofarabine",
    "DecisionDate": "11/14/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Romania",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 5074,
    "EUNumber": "EU/1/19/1397",
    "EUNoShort": 1397,
    "BrandName": "Bortezomib Fresenius Kabi",
    "MAH": "Fresenius Kabi Deutschland GmbH",
    "ActiveSubstance": "bortezomib",
    "DecisionDate": "11/14/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Iceland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 5175,
    "EUNumber": "EU/1/19/1398",
    "EUNoShort": 1398,
    "BrandName": "Arsenic Trioxide Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "arsenic trioxide",
    "DecisionDate": "11/14/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 56,
    "TotalTimeElapsed": 266
  },
  {
    "ApplicationNo": 4583,
    "EUNumber": "EU/1/19/1400",
    "EUNoShort": 1400,
    "BrandName": "Rhokiinsa",
    "MAH": "Aerie Pharmaceuticals Ireland Ltd",
    "ActiveSubstance": "netarsudil",
    "DecisionDate": "11/19/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 4465,
    "EUNumber": "EU/1/19/1411",
    "EUNoShort": 1411,
    "BrandName": "Evenity",
    "MAH": "UCB Pharma S.A.",
    "ActiveSubstance": "romosozumab",
    "DecisionDate": "12/09/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "M05",
    "ATCCodeL1": "M",
    "ATCNameL2": "Drugs for treatment of bone diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 344,
    "TotalTimeElapsed": 547
  },
  {
    "ApplicationNo": 4860,
    "EUNumber": "EU/1/19/1393",
    "EUNoShort": 1393,
    "BrandName": "Quofenix",
    "MAH": "A. Menarini - Industrie Farmaceutiche Riunite - s.r.l.",
    "ActiveSubstance": "delafloxacin",
    "DecisionDate": "12/16/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 309,
    "TotalTimeElapsed": 512
  },
  {
    "ApplicationNo": 4760,
    "EUNumber": "EU/1/19/1404",
    "EUNoShort": 1404,
    "BrandName": "Rinvoq",
    "MAH": "AbbVie Deutschland GmbH & Co. KG",
    "ActiveSubstance": "upadacitinib",
    "DecisionDate": "12/16/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 58,
    "TotalTimeElapsed": 261
  },
  {
    "ApplicationNo": 3848,
    "EUNumber": "EU/1/19/1406",
    "EUNoShort": 1406,
    "BrandName": "Baqsimi",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "Glucagon",
    "DecisionDate": "12/16/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "H04",
    "ATCCodeL1": "H",
    "ATCNameL2": "Pancreatic hormones",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 218,
    "TotalTimeElapsed": 428
  },
  {
    "ApplicationNo": 4535,
    "EUNumber": "EU/1/19/1410",
    "EUNoShort": 1410,
    "BrandName": "Spravato",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "esketamine",
    "DecisionDate": "12/18/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 5312,
    "EUNumber": "EU/1/19/1409",
    "EUNoShort": 1409,
    "BrandName": "Cegfila",
    "MAH": "Mundipharma Corporation (Ireland) Limited",
    "ActiveSubstance": "pegfilgrastim",
    "DecisionDate": "12/19/2019",
    "DecisionYear": "2019",
    "Period": "2016-2020",
    "Rapporteur": "Belgium",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 4996,
    "EUNumber": "EU/1/19/1395",
    "EUNoShort": 1395,
    "BrandName": "Clopidogrel/Acetylsalicylic acid Mylan",
    "MAH": "Mylan S.A.S.",
    "ActiveSubstance": "clopidogrel / acetylsalicylic acid",
    "DecisionDate": "01/09/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Slovenia",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 197,
    "TotalTimeElapsed": 407
  },
  {
    "ApplicationNo": 5012,
    "EUNumber": "EU/1/19/1405",
    "EUNoShort": 1405,
    "BrandName": "TAVLESSE",
    "MAH": "Instituto Grifols, S.A.",
    "ActiveSubstance": "fostamatinib",
    "DecisionDate": "01/09/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "B02",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antihemorrhagics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 199,
    "TotalTimeElapsed": 407
  },
  {
    "ApplicationNo": 4821,
    "EUNumber": "EU/1/19/1407",
    "EUNoShort": 1407,
    "BrandName": "Isturisa",
    "MAH": "Recordati Rare Diseases",
    "ActiveSubstance": "osilodrostat",
    "DecisionDate": "01/09/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "H02",
    "ATCCodeL1": "H",
    "ATCNameL2": "Corticosteroids for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 148,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 5156,
    "EUNumber": "EU/1/19/1412",
    "EUNoShort": 1412,
    "BrandName": "Deferasirox Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "deferasirox",
    "DecisionDate": "01/09/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "V03",
    "ATCCodeL1": "V",
    "ATCNameL2": "All other therapeutic products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 4712,
    "EUNumber": "EU/1/19/1414",
    "EUNoShort": 1414,
    "BrandName": "Mayzent",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "siponimod",
    "DecisionDate": "01/13/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 197,
    "TotalTimeElapsed": 407
  },
  {
    "ApplicationNo": 4893,
    "EUNumber": "EU/1/19/1408",
    "EUNoShort": 1408,
    "BrandName": "Sunosi",
    "MAH": "Jazz Pharmaceuticals Ireland Ltd",
    "ActiveSubstance": "solriamfetol",
    "DecisionDate": "01/16/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 143,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 4870,
    "EUNumber": "EU/1/19/1388",
    "EUNoShort": 1388,
    "BrandName": "Polivy",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "polatuzumab vedotin",
    "DecisionDate": "01/16/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "yes",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 173,
    "ClockStopElapsed": 121,
    "TotalTimeElapsed": 294
  },
  {
    "ApplicationNo": 5147,
    "EUNumber": "EU/1/19/1413",
    "EUNoShort": 1413,
    "BrandName": "Azacitidine Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "Azacitidine",
    "DecisionDate": "02/13/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Iceland",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 114,
    "TotalTimeElapsed": 317
  },
  {
    "ApplicationNo": 4879,
    "EUNumber": "EU/1/19/1415",
    "EUNoShort": 1415,
    "BrandName": "Amsparity",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "adalimumab",
    "DecisionDate": "02/13/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Finland",
    "CoRapporteur": "Romania",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 169,
    "TotalTimeElapsed": 379
  },
  {
    "ApplicationNo": 4913,
    "EUNumber": "EU/1/19/1417",
    "EUNoShort": 1417,
    "BrandName": "Beovu",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "brolucizumab",
    "DecisionDate": "02/13/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "S01",
    "ATCCodeL1": "S",
    "ATCNameL2": "Ophthalmologicals",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 78,
    "TotalTimeElapsed": 288
  },
  {
    "ApplicationNo": 5152,
    "EUNumber": "EU/1/19/1418",
    "EUNoShort": 1418,
    "BrandName": "Dexmedetomidine Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "dexmedetomidine",
    "DecisionDate": "02/13/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 140,
    "TotalTimeElapsed": 350
  },
  {
    "ApplicationNo": 4808,
    "EUNumber": "EU/1/19/1420",
    "EUNoShort": 1420,
    "BrandName": "Recarbrio",
    "MAH": "Merck Sharp & Dohme B.V.",
    "ActiveSubstance": "imipenem / cilastatin / relebactam",
    "DecisionDate": "02/13/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 169,
    "TotalTimeElapsed": 379
  },
  {
    "ApplicationNo": 4775,
    "EUNumber": "EU/1/20/1428",
    "EUNoShort": 1428,
    "BrandName": "Givlaari",
    "MAH": "Alnylam Netherlands B.V.",
    "ActiveSubstance": "givosiran",
    "DecisionDate": "03/02/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "yes",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 143,
    "ClockStopElapsed": 54,
    "TotalTimeElapsed": 197
  },
  {
    "ApplicationNo": 5075,
    "EUNumber": "EU/1/19/1416",
    "EUNoShort": 1416,
    "BrandName": "Azacitidine Betapharm",
    "MAH": "betapharm Arzneimittel GmbH",
    "ActiveSubstance": "Azacitidine",
    "DecisionDate": "03/24/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 163,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 5037,
    "EUNumber": "EU/1/20/1422",
    "EUNoShort": 1422,
    "BrandName": "Lyumjev",
    "MAH": "Eli Lilly Nederland B.V.",
    "ActiveSubstance": "Insulin lispro",
    "DecisionDate": "03/24/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Finland",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 4863,
    "EUNumber": "EU/1/19/1421",
    "EUNoShort": 1421,
    "BrandName": "Staquis",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "crisaborole",
    "DecisionDate": "03/27/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "D11",
    "ATCCodeL1": "D",
    "ATCNameL2": "Other dermatological preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 409,
    "TotalTimeElapsed": 617
  },
  {
    "ApplicationNo": 4959,
    "EUNumber": "EU/1/20/1424",
    "EUNoShort": 1424,
    "BrandName": "Nustendi",
    "MAH": "Daiichi Sankyo Europe GmbH",
    "ActiveSubstance": "bempedoic acid / ezetimibe",
    "DecisionDate": "03/27/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C10",
    "ATCCodeL1": "C",
    "ATCNameL2": "Lipid modifying agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 4984,
    "EUNumber": "EU/1/20/1426",
    "EUNoShort": 1426,
    "BrandName": "Azacitidine Mylan",
    "MAH": "Mylan Ireland Limited",
    "ActiveSubstance": "Azacitidine",
    "DecisionDate": "03/27/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Iceland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 4790,
    "EUNumber": "EU/1/20/1432",
    "EUNoShort": 1432,
    "BrandName": "NUBEQA",
    "MAH": "Bayer AG",
    "ActiveSubstance": "darolutamide",
    "DecisionDate": "03/27/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L02",
    "ATCCodeL1": "L",
    "ATCNameL2": "Endocrine therapy",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 3876,
    "EUNumber": "EU/1/20/1423",
    "EUNoShort": 1423,
    "BrandName": "Vaxchora",
    "MAH": "Emergent Netherlands B.V.",
    "ActiveSubstance": "Cholera vaccine (recombinant, live, oral)",
    "DecisionDate": "04/01/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Norway",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 156,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 4958,
    "EUNumber": "EU/1/20/1425",
    "EUNoShort": 1425,
    "BrandName": "Nilemdo",
    "MAH": "Daiichi Sankyo Europe GmbH",
    "ActiveSubstance": "bempedoic acid",
    "DecisionDate": "04/01/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Estonia",
    "ATCCodeL2": "C10",
    "ATCCodeL1": "C",
    "ATCNameL2": "Lipid modifying agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 127,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 5235,
    "EUNumber": "EU/1/20/1427",
    "EUNoShort": 1427,
    "BrandName": "Arsenic trioxide Mylan",
    "MAH": "Mylan Ireland Limited",
    "ActiveSubstance": "arsenic trioxide",
    "DecisionDate": "04/01/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 4696,
    "EUNumber": "EU/1/20/1431",
    "EUNoShort": 1431,
    "BrandName": "Ruxience",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "rituximab",
    "DecisionDate": "04/01/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 330,
    "TotalTimeElapsed": 533
  },
  {
    "ApplicationNo": 4882,
    "EUNumber": "EU/1/19/1403",
    "EUNoShort": 1403,
    "BrandName": "Budesonide/Formoterol Teva Pharma B.V.",
    "MAH": "Teva Pharma B.V.",
    "ActiveSubstance": "budesonide / formoterol fumarate dihydrate",
    "DecisionDate": "04/03/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Malta",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 120,
    "ClockStopElapsed": 45,
    "TotalTimeElapsed": 165
  },
  {
    "ApplicationNo": 5207,
    "EUNumber": "EU/1/19/1419",
    "EUNoShort": 1419,
    "BrandName": "Trepulmix",
    "MAH": "SciPharm S√†rl",
    "ActiveSubstance": "treprostinil sodium",
    "DecisionDate": "04/03/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 5236,
    "EUNumber": "EU/1/20/1429",
    "EUNoShort": 1429,
    "BrandName": "Cinacalcet Accordpharma",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "cinacalcet",
    "DecisionDate": "04/03/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "H05",
    "ATCCodeL1": "H",
    "ATCNameL2": "Calcium homeostasis",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 163,
    "TotalTimeElapsed": 366
  },
  {
    "ApplicationNo": 4953,
    "EUNumber": "EU/1/20/1430",
    "EUNoShort": 1430,
    "BrandName": "Rybelsus",
    "MAH": "Novo Nordisk A/S",
    "ActiveSubstance": "semaglutide",
    "DecisionDate": "04/03/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 50,
    "TotalTimeElapsed": 253
  },
  {
    "ApplicationNo": 5114,
    "EUNumber": "EU/1/19/1394",
    "EUNoShort": 1394,
    "BrandName": "Tigecycline Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "tigecycline",
    "DecisionDate": "04/17/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 351,
    "TotalTimeElapsed": 561
  },
  {
    "ApplicationNo": 4829,
    "EUNumber": "EU/1/20/1434",
    "EUNoShort": 1434,
    "BrandName": "Fetcroja",
    "MAH": "Shionogi B.V.",
    "ActiveSubstance": "cefiderocol",
    "DecisionDate": "04/23/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 180,
    "ClockStopElapsed": 157,
    "TotalTimeElapsed": 337
  },
  {
    "ApplicationNo": 4750,
    "EUNumber": "EU/1/20/1443",
    "EUNoShort": 1443,
    "BrandName": "Zolgensma",
    "MAH": "Novartis Gene Therapies EU Limited",
    "ActiveSubstance": "onasemnogene abeparvovec",
    "DecisionDate": "05/18/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Luxembourg",
    "ATCCodeL2": "M09",
    "ATCCodeL1": "M",
    "ATCNameL2": "Other drugs for disorders of the musculo-skeletal system",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "yes",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 302,
    "TotalTimeElapsed": 512
  },
  {
    "ApplicationNo": 4993,
    "EUNumber": "EU/1/20/1433",
    "EUNoShort": 1433,
    "BrandName": "Fluad Tetra",
    "MAH": "Seqirus Netherlands B.V.",
    "ActiveSubstance": "influenza vaccine (surface antigen, inactivated, adjuvanted)",
    "DecisionDate": "05/20/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 162,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 4711,
    "EUNumber": "EU/1/20/1436",
    "EUNoShort": 1436,
    "BrandName": "Nepexto",
    "MAH": "Mylan IRE Healthcare Limited",
    "ActiveSubstance": "etanercept",
    "DecisionDate": "05/20/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 463,
    "TotalTimeElapsed": 673
  },
  {
    "ApplicationNo": 4835,
    "EUNumber": "EU/1/20/1442",
    "EUNoShort": 1442,
    "BrandName": "Zeposia",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "ozanimod",
    "DecisionDate": "05/20/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Portugal",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 155,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 4977,
    "EUNumber": "EU/1/20/1435",
    "EUNoShort": 1435,
    "BrandName": "Sarclisa",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "isatuximab",
    "DecisionDate": "05/30/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "France",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 309
  },
  {
    "ApplicationNo": 5067,
    "EUNumber": "EU/1/20/1439",
    "EUNoShort": 1439,
    "BrandName": "Atectura Breezhaler",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "indacaterol / mometasone furoate",
    "DecisionDate": "05/30/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 217,
    "ClockStopElapsed": 99,
    "TotalTimeElapsed": 316
  },
  {
    "ApplicationNo": 5516,
    "EUNumber": "EU/1/20/1441",
    "EUNoShort": 1441,
    "BrandName": "Bemrist Breezhaler",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "indacaterol / mometasone furoate",
    "DecisionDate": "05/30/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 36,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 36
  },
  {
    "ApplicationNo": 5486,
    "EUNumber": "EU/1/20/1453",
    "EUNoShort": 1453,
    "BrandName": "Paliperidone Janssen-Cilag International",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "paliperidone",
    "DecisionDate": "06/18/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Germany",
    "ATCCodeL2": "N05",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psycholeptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10c",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 60,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 60
  },
  {
    "ApplicationNo": 5033,
    "EUNumber": "EU/1/20/1447",
    "EUNoShort": 1447,
    "BrandName": "Insulin aspart Sanofi",
    "MAH": "Sanofi-Aventis groupe",
    "ActiveSubstance": "insulin aspart",
    "DecisionDate": "06/25/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "A10",
    "ATCCodeL1": "A",
    "ATCNameL2": "Drugs used in diabetes",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 106,
    "TotalTimeElapsed": 316
  },
  {
    "ApplicationNo": 5191,
    "EUNumber": "EU/1/20/1450",
    "EUNoShort": 1450,
    "BrandName": "Fingolimod Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "fingolimod",
    "DecisionDate": "06/25/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Croatia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 4444,
    "EUNumber": "EU/1/20/1452",
    "EUNoShort": 1452,
    "BrandName": "Reblozyl",
    "MAH": "Bristol-Myers Squibb Pharma EEIG",
    "ActiveSubstance": "luspatercept",
    "DecisionDate": "06/25/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "B03",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antianemic preparations",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 4878,
    "EUNumber": "EU/1/20/1451",
    "EUNoShort": 1451,
    "BrandName": "Daurismo",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "glasdegib",
    "DecisionDate": "06/26/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 5337,
    "EUNumber": "EU/1/20/1444",
    "EUNoShort": 1444,
    "BrandName": "Zabdeno",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "Ebola vaccine (Ad26.ZEBOV-GP [recombinant])",
    "DecisionDate": "07/01/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "France",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 143,
    "ClockStopElapsed": 40,
    "TotalTimeElapsed": 183
  },
  {
    "ApplicationNo": 5343,
    "EUNumber": "EU/1/20/1445",
    "EUNoShort": 1445,
    "BrandName": "Mvabea",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "Ebola vaccine (MVA-BN-Filo [recombinant])",
    "DecisionDate": "07/01/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "France",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 143,
    "ClockStopElapsed": 40,
    "TotalTimeElapsed": 183
  },
  {
    "ApplicationNo": 5622,
    "EUNumber": "EU/1/20/1459",
    "EUNoShort": 1459,
    "BrandName": "Veklury",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "remdesivir",
    "DecisionDate": "07/03/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 0,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 0
  },
  {
    "ApplicationNo": 5061,
    "EUNumber": "EU/1/20/1438",
    "EUNoShort": 1438,
    "BrandName": "Enerzair Breezhaler",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "indacaterol / glycopyrronium / mometasone furoate",
    "DecisionDate": "07/03/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 5518,
    "EUNumber": "EU/1/20/1440",
    "EUNoShort": 1440,
    "BrandName": "Zimbus Breezhaler",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "indacaterol / glycopyrronium / mometasone furoate",
    "DecisionDate": "07/03/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 82,
    "ClockStopElapsed": 68,
    "TotalTimeElapsed": 150
  },
  {
    "ApplicationNo": 5358,
    "EUNumber": "EU/1/20/1458",
    "EUNoShort": 1458,
    "BrandName": "Apixaban Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "apixaban",
    "DecisionDate": "07/23/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 4804,
    "EUNumber": "EU/1/20/1455",
    "EUNoShort": 1455,
    "BrandName": "Piqray",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "alpelisib",
    "DecisionDate": "07/27/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 277,
    "TotalTimeElapsed": 485
  },
  {
    "ApplicationNo": 5209,
    "EUNumber": "EU/1/20/1456",
    "EUNoShort": 1456,
    "BrandName": "Zercepac",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "trastuzumab",
    "DecisionDate": "07/27/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 5048,
    "EUNumber": "EU/1/20/1457",
    "EUNoShort": 1457,
    "BrandName": "Xenleta",
    "MAH": "Nabriva Therapeutics Ireland DAC",
    "ActiveSubstance": "lefamulin",
    "DecisionDate": "07/27/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 5167,
    "EUNumber": "EU/1/20/1437",
    "EUNoShort": 1437,
    "BrandName": "Dovprela",
    "MAH": "Mylan IRE Healthcare Limited",
    "ActiveSubstance": "pretomanid",
    "DecisionDate": "07/31/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J04",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antimycobacterials",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 155,
    "TotalTimeElapsed": 365
  },
  {
    "ApplicationNo": 4854,
    "EUNumber": "EU/1/20/1446",
    "EUNoShort": 1446,
    "BrandName": "Hepcludex",
    "MAH": "MYR GmbH",
    "ActiveSubstance": "bulevirtide",
    "DecisionDate": "07/31/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "yes",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 150,
    "ClockStopElapsed": 61,
    "TotalTimeElapsed": 211
  },
  {
    "ApplicationNo": 4936,
    "EUNumber": "EU/1/20/1460",
    "EUNoShort": 1460,
    "BrandName": "Rozlytrek",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "entrectinib",
    "DecisionDate": "07/31/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Italy",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "yes",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 275,
    "TotalTimeElapsed": 485
  },
  {
    "ApplicationNo": 5106,
    "EUNumber": "EU/1/20/1454",
    "EUNoShort": 1454,
    "BrandName": "Aybintio",
    "MAH": "Samsung Bioepis NL B.V.",
    "ActiveSubstance": "bevacizumab",
    "DecisionDate": "08/19/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Hungary",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 5435,
    "EUNumber": "EU/1/20/1465",
    "EUNoShort": 1465,
    "BrandName": "Gencebok",
    "MAH": "Gennisium Pharma",
    "ActiveSubstance": "caffeine citrate",
    "DecisionDate": "08/19/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Estonia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N06",
    "ATCCodeL1": "N",
    "ATCNameL2": "Psychoanaleptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 36,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 2776,
    "EUNumber": "EU/1/20/1470",
    "EUNoShort": 1470,
    "BrandName": "Lumeblue",
    "MAH": "Alfasigma S.p.A.",
    "ActiveSubstance": "methylthioninium chloride",
    "DecisionDate": "08/19/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Latvia",
    "ATCCodeL2": "V04",
    "ATCCodeL1": "V",
    "ATCNameL2": "Diagnostic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 274,
    "TotalTimeElapsed": 484
  },
  {
    "ApplicationNo": 5269,
    "EUNumber": "EU/1/20/1468",
    "EUNoShort": 1468,
    "BrandName": "Kaftrio",
    "MAH": "Vertex Pharmaceuticals (Ireland) Limited",
    "ActiveSubstance": "ivacaftor / tezacaftor / elexacaftor",
    "DecisionDate": "08/21/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Ireland",
    "ATCCodeL2": "R07",
    "ATCCodeL1": "R",
    "ATCNameL2": "Other respiratory system products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 173,
    "ClockStopElapsed": 66,
    "TotalTimeElapsed": 239
  },
  {
    "ApplicationNo": 4935,
    "EUNumber": "EU/1/20/1474",
    "EUNoShort": 1474,
    "BrandName": "BLENREP",
    "MAH": "GlaxoSmithKline (Ireland) Limited",
    "ActiveSubstance": "belantamab mafodotin",
    "DecisionDate": "08/25/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Finland",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "yes",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 143,
    "ClockStopElapsed": 33,
    "TotalTimeElapsed": 176
  },
  {
    "ApplicationNo": 4849,
    "EUNumber": "EU/1/20/1471",
    "EUNoShort": 1471,
    "BrandName": "Idefirix",
    "MAH": "Hansa Biopharma AB",
    "ActiveSubstance": "imlifidase",
    "DecisionDate": "08/25/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "yes",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 274,
    "TotalTimeElapsed": 484
  },
  {
    "ApplicationNo": 5087,
    "EUNumber": "EU/1/20/1462",
    "EUNoShort": 1462,
    "BrandName": "Livogiva",
    "MAH": "Theramex Ireland Limited",
    "ActiveSubstance": "teriparatide",
    "DecisionDate": "08/27/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "H05",
    "ATCCodeL1": "H",
    "ATCNameL2": "Calcium homeostasis",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 192,
    "TotalTimeElapsed": 400
  },
  {
    "ApplicationNo": 5388,
    "EUNumber": "EU/1/20/1463",
    "EUNoShort": 1463,
    "BrandName": "Qutavina",
    "MAH": "EuroGenerics Holdings BV",
    "ActiveSubstance": "teriparatide",
    "DecisionDate": "08/27/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "H05",
    "ATCCodeL1": "H",
    "ATCNameL2": "Calcium homeostasis",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 207,
    "ClockStopElapsed": 192,
    "TotalTimeElapsed": 399
  },
  {
    "ApplicationNo": 5178,
    "EUNumber": "EU/1/20/1448",
    "EUNoShort": 1448,
    "BrandName": "Cabazitaxel Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "cabazitaxel",
    "DecisionDate": "08/28/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Iceland",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 5218,
    "EUNumber": "EU/1/20/1475",
    "EUNoShort": 1475,
    "BrandName": "Arsenic trioxide medac",
    "MAH": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "ActiveSubstance": "arsenic trioxide",
    "DecisionDate": "09/17/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 5208,
    "EUNumber": "EU/1/20/1473",
    "EUNoShort": 1473,
    "BrandName": "AYVAKYT",
    "MAH": "Blueprint Medicines (Netherlands) B.V.",
    "ActiveSubstance": "avapritinib",
    "DecisionDate": "09/24/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Spain",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 162,
    "TotalTimeElapsed": 372
  },
  {
    "ApplicationNo": 5181,
    "EUNumber": "EU/1/20/1472",
    "EUNoShort": 1472,
    "BrandName": "Equidacent",
    "MAH": "Centus Biotherapeutics Europe Limited",
    "ActiveSubstance": "bevacizumab",
    "DecisionDate": "09/24/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Norway",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 85,
    "TotalTimeElapsed": 295
  },
  {
    "ApplicationNo": 5359,
    "EUNumber": "EU/1/20/1477",
    "EUNoShort": 1477,
    "BrandName": "Fampridine Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "fampridine",
    "DecisionDate": "09/24/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Slovenia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 5205,
    "EUNumber": "EU/1/20/1478",
    "EUNoShort": 1478,
    "BrandName": "Zynrelef",
    "MAH": "Heron Therapeutics, B.V.",
    "ActiveSubstance": "bupivacaine/meloxicam",
    "DecisionDate": "09/24/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "Latvia",
    "ATCCodeL2": "N01",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anesthetics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 274,
    "TotalTimeElapsed": 484
  },
  {
    "ApplicationNo": 5113,
    "EUNumber": "EU/1/20/1480",
    "EUNoShort": 1480,
    "BrandName": "Jyseleca",
    "MAH": "Gilead Sciences Ireland UC",
    "ActiveSubstance": "filgotinib",
    "DecisionDate": "09/24/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 134,
    "TotalTimeElapsed": 344
  },
  {
    "ApplicationNo": 5264,
    "EUNumber": "EU/1/20/1469",
    "EUNoShort": 1469,
    "BrandName": "ARIKAYCE liposomal",
    "MAH": "Insmed Netherlands B.V.",
    "ActiveSubstance": "amikacin",
    "DecisionDate": "10/27/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "J01",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antibacterials for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 169,
    "TotalTimeElapsed": 372
  },
  {
    "ApplicationNo": 4874,
    "EUNumber": "EU/1/20/1476",
    "EUNoShort": 1476,
    "BrandName": "Adakveo",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "crizanlizumab",
    "DecisionDate": "10/28/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "B06",
    "ATCCodeL1": "B",
    "ATCNameL2": "Other hematological agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 400
  },
  {
    "ApplicationNo": 5299,
    "EUNumber": "EU/1/20/1479",
    "EUNoShort": 1479,
    "BrandName": "Calquence",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "acalabrutinib",
    "DecisionDate": "11/05/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "Spain",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 57,
    "TotalTimeElapsed": 267
  },
  {
    "ApplicationNo": 5159,
    "EUNumber": "EU/1/20/1484",
    "EUNoShort": 1484,
    "BrandName": "Supemtek",
    "MAH": "Sanofi Pasteur",
    "ActiveSubstance": "quadrivalent influenza vaccine (recombinant, prepared in cell culture)",
    "DecisionDate": "11/16/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Austria",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 113,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 5173,
    "EUNumber": "EU/1/20/1487",
    "EUNoShort": 1487,
    "BrandName": "PHELINUN",
    "MAH": "ADIENNE S.r.l.S.U.",
    "ActiveSubstance": "melphalan",
    "DecisionDate": "11/16/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Latvia",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 330,
    "TotalTimeElapsed": 540
  },
  {
    "ApplicationNo": 5279,
    "EUNumber": "EU/1/20/1488",
    "EUNoShort": 1488,
    "BrandName": "Rivaroxaban Accord",
    "MAH": "Accord Healthcare S.L.U.",
    "ActiveSubstance": "rivaroxaban",
    "DecisionDate": "11/16/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Slovakia",
    "CoRapporteur": "No Co-rap",
    "ATCCodeL2": "B01",
    "ATCCodeL1": "B",
    "ATCNameL2": "Antithrombotic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 190,
    "TotalTimeElapsed": 400
  },
  {
    "ApplicationNo": 4586,
    "EUNumber": "EU/1/20/1489",
    "EUNoShort": 1489,
    "BrandName": "EXPAREL liposomal",
    "MAH": "Pacira Ireland Ltd",
    "ActiveSubstance": "bupivacaine",
    "DecisionDate": "11/16/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Latvia",
    "CoRapporteur": "Croatia",
    "ATCCodeL2": "N01",
    "ATCCodeL1": "N",
    "ATCNameL2": "Anesthetics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 246,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 5169,
    "EUNumber": "EU/1/20/1485",
    "EUNoShort": 1485,
    "BrandName": "Obiltoxaximab SFL",
    "MAH": "SFL Pharmaceuticals Deutschland GmbH",
    "ActiveSubstance": "obiltoxaximab",
    "DecisionDate": "11/18/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Sweden",
    "ATCCodeL2": "J06",
    "ATCCodeL1": "J",
    "ATCNameL2": "Immune sera and immunoglobulins",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "yes",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 246,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 5084,
    "EUNumber": "EU/1/20/1483",
    "EUNoShort": 1483,
    "BrandName": "MenQuadfi",
    "MAH": "Sanofi Pasteur",
    "ActiveSubstance": "Meningococcal group A, C, W and Y conjugate vaccine",
    "DecisionDate": "11/18/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Austria",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 113,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 5085,
    "EUNumber": "EU/1/20/1486",
    "EUNoShort": 1486,
    "BrandName": "Nyvepria",
    "MAH": "Pfizer Europe MA EEIG",
    "ActiveSubstance": "pegfilgrastim",
    "DecisionDate": "11/18/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Czech Republic",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L03",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunomodulating agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.4",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 141,
    "TotalTimeElapsed": 351
  },
  {
    "ApplicationNo": 5040,
    "EUNumber": "EU/1/20/1496",
    "EUNoShort": 1496,
    "BrandName": "Oxlumo",
    "MAH": "Alnylam Netherlands B.V.",
    "ActiveSubstance": "lumasiran",
    "DecisionDate": "11/19/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "A16",
    "ATCCodeL1": "A",
    "ATCNameL2": "Other alimentary tract and metabolism products",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "yes",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 143,
    "ClockStopElapsed": 33,
    "TotalTimeElapsed": 176
  },
  {
    "ApplicationNo": 5333,
    "EUNumber": "EU/1/20/1494",
    "EUNoShort": 1494,
    "BrandName": "Leqvio",
    "MAH": "Novartis Europharm Limited",
    "ActiveSubstance": "inclisiran",
    "DecisionDate": "12/09/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "C10",
    "ATCCodeL1": "C",
    "ATCNameL2": "Lipid modifying agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 57,
    "TotalTimeElapsed": 260
  },
  {
    "ApplicationNo": 4983,
    "EUNumber": "EU/1/20/1498",
    "EUNoShort": 1498,
    "BrandName": "TRIXEO AEROSPHERE",
    "MAH": "AstraZeneca AB",
    "ActiveSubstance": "Formoterol / glycopyrronium bromide / budesonide",
    "DecisionDate": "12/09/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Ireland",
    "CoRapporteur": "Poland",
    "ATCCodeL2": "R03",
    "ATCCodeL1": "R",
    "ATCNameL2": "Drugs for obstructive airway diseases",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 210,
    "ClockStopElapsed": 448,
    "TotalTimeElapsed": 658
  },
  {
    "ApplicationNo": 5102,
    "EUNumber": "EU/1/20/1492",
    "EUNoShort": 1492,
    "BrandName": "Tecartus",
    "MAH": "Kite Pharma EU B.V.",
    "ActiveSubstance": "autologous anti-CD19-transduced CD3+ cells",
    "DecisionDate": "12/14/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Norway",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "yes",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 172,
    "ClockStopElapsed": 90,
    "TotalTimeElapsed": 262
  },
  {
    "ApplicationNo": 5321,
    "EUNumber": "EU/1/20/1493",
    "EUNoShort": 1493,
    "BrandName": "Libmeldy",
    "MAH": "Orchard Therapeutics (Netherlands) B.V.",
    "ActiveSubstance": "atidarsagene autotemcel",
    "DecisionDate": "12/17/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Italy",
    "ATCCodeL2": "N07",
    "ATCCodeL1": "N",
    "ATCNameL2": "Other nervous system drugs",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "yes",
    "OrphanDesignation": "yes",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "yes",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 172,
    "ClockStopElapsed": 151,
    "TotalTimeElapsed": 323
  },
  {
    "ApplicationNo": 4976,
    "EUNumber": "EU/1/20/1481",
    "EUNoShort": 1481,
    "BrandName": "Vocabria",
    "MAH": "ViiV Healthcare BV",
    "ActiveSubstance": "cabotegravir",
    "DecisionDate": "12/17/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "France",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 220,
    "TotalTimeElapsed": 428
  },
  {
    "ApplicationNo": 5060,
    "EUNumber": "EU/1/20/1482",
    "EUNoShort": 1482,
    "BrandName": "REKAMBYS",
    "MAH": "Janssen-Cilag International NV",
    "ActiveSubstance": "rilpivirine",
    "DecisionDate": "12/17/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Netherlands",
    "CoRapporteur": "Portugal",
    "ATCCodeL2": "J05",
    "ATCCodeL1": "J",
    "ATCNameL2": "Antivirals for systemic use",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 208,
    "ClockStopElapsed": 220,
    "TotalTimeElapsed": 428
  },
  {
    "ApplicationNo": 4917,
    "EUNumber": "EU/1/20/1495",
    "EUNoShort": 1495,
    "BrandName": "Palforzia",
    "MAH": "Aimmune Therapeutics Ireland Limited",
    "ActiveSubstance": "defatted powder of Arachis hypogaea L., semen (peanuts)",
    "DecisionDate": "12/17/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Germany",
    "CoRapporteur": "Denmark",
    "ATCCodeL2": "V01",
    "ATCCodeL1": "V",
    "ATCNameL2": "Allergens",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 253,
    "TotalTimeElapsed": 456
  },
  {
    "ApplicationNo": 5306,
    "EUNumber": "EU/1/20/1490",
    "EUNoShort": 1490,
    "BrandName": "Lenalidomide Mylan",
    "MAH": "Mylan Ireland Limited",
    "ActiveSubstance": "lenalidomide",
    "DecisionDate": "12/18/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Greece",
    "CoRapporteur": "Belgium",
    "ATCCodeL2": "L04",
    "ATCCodeL1": "L",
    "ATCNameL2": "Immunosuppressants",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10.1",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 176,
    "TotalTimeElapsed": 379
  },
  {
    "ApplicationNo": 3933,
    "EUNumber": "EU/1/20/1491",
    "EUNoShort": 1491,
    "BrandName": "Fintepla",
    "MAH": "Zogenix ROI Limited",
    "ActiveSubstance": "fenfluramine",
    "DecisionDate": "12/18/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Netherlands",
    "ATCCodeL2": "N03",
    "ATCCodeL1": "N",
    "ATCNameL2": "Antiepileptics",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "yes",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 393,
    "TotalTimeElapsed": 596
  },
  {
    "ApplicationNo": 5735,
    "EUNumber": "EU/1/20/1528",
    "EUNoShort": 1528,
    "BrandName": "Comirnaty",
    "MAH": "BioNTech Manufacturing GmbH",
    "ActiveSubstance": "COVID-19 mRNA Vaccine (nucleoside modified)",
    "DecisionDate": "12/21/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Sweden",
    "CoRapporteur": "France",
    "ATCCodeL2": "J07",
    "ATCCodeL1": "J",
    "ATCNameL2": "Vaccines",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "yes",
    "CMA": "yes",
    "AEC": "no",
    "LegalType": "article 8.3",
    "PRIME": "no",
    "NAS": 1,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 21,
    "ClockStopElapsed": 0,
    "TotalTimeElapsed": 21
  },
  {
    "ApplicationNo": 5386,
    "EUNumber": "EU/1/20/1497",
    "EUNoShort": 1497,
    "BrandName": "Phesgo",
    "MAH": "Roche Registration GmbH",
    "ActiveSubstance": "pertuzumab / trastuzumab",
    "DecisionDate": "12/21/2020",
    "DecisionYear": "2020",
    "Period": "2016-2020",
    "Rapporteur": "Denmark",
    "CoRapporteur": "Finland",
    "ATCCodeL2": "L01",
    "ATCCodeL1": "L",
    "ATCNameL2": "Antineoplastic agents",
    "LegalSCope": "regulation 726/2004",
    "ATMP": "no",
    "OrphanDesignation": "no",
    "NASQualified": "no",
    "CMA": "no",
    "AEC": "no",
    "LegalType": "article 10b",
    "PRIME": "no",
    "NAS": 0,
    "AcceleratedGranted": "no",
    "AcceleratedExecuted": "no",
    "ActiveTimeElapsed": 203,
    "ClockStopElapsed": 85,
    "TotalTimeElapsed": 288
  }
]
